Trait_category,Trait,Protein,Protein_definition,sample_size,Estimated_effect,se,lowerCI,upperCI,Pvalue
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,AGRP,Agouti-related protein,42296,0.198485789998254,0.004997498050973,0.188690693818347,0.208280886178161,0
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FGFBP1,Fibroblast growth factor-binding protein 1,42181,-0.150169693405458,0.00314244958851411,-0.156328894598946,-0.14401049221197,0
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GCG,Pro-glucagon,41843,0.549884878142118,0.0117819917751517,0.526792174262821,0.572977582021415,0
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MFGE8,Lactadherin,42137,0.230172593455451,0.00418886734607123,0.221962413457152,0.238382773453751,0
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NPY,Pro-neuropeptide Y,42262,0.25530905466038,0.00611597787622843,0.243321738022973,0.267296371297788,0
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PLA2G7,Platelet-activating factor acetylhydrolase,42137,-0.133080356812587,0.00308184671641462,-0.13912077637676,-0.127039937248414,0
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PRAP1,Proline-rich acidic protein 1,39966,0.141005187540016,0.00379583354352405,0.133565353794709,0.148445021285323,3.54152389820219e-285
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PRSS8,Prostasin,42080,0.143976284494705,0.00408596700663195,0.135967789161706,0.151984779827703,2.88954574796631e-260
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PYY,Peptide YY,39575,0.333035506151195,0.00980127956106621,0.313824998211505,0.352246014090885,1.02976545673036e-240
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,C9,Complement component C9,39990,-0.187473725450812,0.00567119393768102,-0.198589265568667,-0.176358185332958,6.4905337234798e-229
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TMPRSS15,Enteropeptidase,42070,0.284758823417132,0.00865471741496263,0.267795577283805,0.301722069550459,1.98013678686666e-228
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IGSF9,Protein turtle homolog A,39958,0.278242038799317,0.00846327873693952,0.261654012474915,0.294830065123718,1.60461775840404e-226
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,LDLR,Low-density lipoprotein receptor,42170,0.162128311735152,0.00502801606989363,0.152273400238161,0.171983223232144,7.3154733665728e-220
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PON3,Serum paraoxonase/lactonase 3,42185,-0.0919698732156034,0.00289553138946418,-0.0976451147389532,-0.0862946316922537,1.2448010189349e-213
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IGFBP1,Insulin-like growth factor-binding protein 1,42287,-0.379336438746759,0.0125525989368138,-0.403939532662914,-0.354733344830604,2.91423701811321e-194
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,LPL,Lipoprotein lipase,42145,-0.133798676067239,0.00478553943099038,-0.14317833335198,-0.124419018782498,2.75315253243348e-167
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,APOF,Apolipoprotein F,39990,-0.072320962800157,0.00258177321331683,-0.077381238298258,-0.067260687302056,4.90305648525065e-167
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PPY,Pancreatic prohormone,42089,0.283170203322938,0.0102301876293791,0.263119035569355,0.303221371076521,4.48533927837832e-164
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MVK,Mevalonate kinase,41913,0.227230104236774,0.00821987652767564,0.21111914624253,0.243341062231018,1.31259236248008e-163
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,LGALS4,Galectin-4,42123,0.152453166060358,0.00561727917719886,0.141443298873048,0.163463033247668,5.4531703258642e-158
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CES1,Liver carboxylesterase 1,42163,0.229079377534705,0.00845236155790334,0.212512748881214,0.245646006188195,1.39830371995317e-157
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NFASC,Neurofascin,42296,0.0780713785373523,0.00290529734868156,0.0723769957339365,0.0837657613407682,4.71176122421352e-155
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CCN1,CCN family member 1,42047,0.191769455888922,0.00715086630335961,0.177753757934337,0.205785153843506,2.22781858336401e-154
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GPR37,Prosaposin receptor GPR37,41900,0.173543213576995,0.00648763757653213,0.160827443926992,0.186258983226998,1.38233172404395e-153
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SMOC1,SPARC-related modular calcium-binding protein 1,42262,0.0850943890771484,0.00322403746088908,0.0787752756538058,0.091413502500491,8.91022951906779e-150
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MAMDC4,Apical endosomal glycoprotein,39919,0.149691577556892,0.00566150695866822,0.138595023917902,0.160788131195881,1.55181887868476e-149
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CD4,T-cell surface glycoprotein CD4,42100,0.0758529304363618,0.00289603076814433,0.0701767101307989,0.0815291507419246,1.53984066023653e-147
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ASGR1,Asialoglycoprotein receptor 1,42016,0.0789963903897533,0.00302146460175279,0.0730743197703178,0.0849184610091888,5.22756875882932e-147
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CCL27,C-C motif chemokine 27,42145,0.162857906601036,0.00623823762141726,0.150630960863058,0.175084852339014,1.2670607510608e-146
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ACY1,Aminoacylase-1,42145,0.16193548621469,0.0062811767916875,0.149624379702982,0.174246592726397,3.98034316573635e-143
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,UPB1,Beta-ureidopropionase,39958,0.233231840524963,0.00906474741328592,0.215464935594923,0.250998745455004,6.0673548449562e-142
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ADH4,All-trans-retinol dehydrogenase [NAD(+)] ADH4,41900,0.208887824622061,0.0081483067825606,0.192917143328242,0.22485850591588,1.61994120889186e-141
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DCBLD2,"Discoidin, CUB and LCCL domain-containing protein 2",42181,0.0893599616702985,0.00350757806387434,0.0824851086651048,0.0962348146754922,6.79532528252128e-140
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PTH,Parathyroid hormone,39649,0.210681083949556,0.00833973803758338,0.194335197395892,0.227026970503219,6.10087038117291e-137
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GIP,Gastric inhibitory polypeptide,39638,0.126484998741804,0.00507117391476531,0.116545497868864,0.136424499614744,1.2536340601649e-133
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ACE2,Angiotensin-converting enzyme 2,41900,0.135269020001234,0.00545018969834438,0.124586648192479,0.145951391809989,5.76674670068489e-133
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,RARRES2,Retinoic acid receptor responder protein 2,42230,0.118905227310195,0.00483540860239729,0.109427826449497,0.128382628170894,1.10058518591002e-130
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ADIPOQ,Adiponectin,39979,-0.167553108374417,0.00690577009084348,-0.18108841775247,-0.154017798996364,7.82251708568051e-127
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MUC13,Mucin-13,41839,0.126748551195092,0.00527305027936169,0.116413372647543,0.137083729742641,5.33275502167278e-125
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CTSD,Cathepsin D,41225,0.0994441621056663,0.00414902895543898,0.0913120653530059,0.107576258858327,3.48289834397513e-124
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DEFB4A_DEFB4B,Beta-defensin 4A,41921,0.350370348357774,0.0146413813224839,0.321673240965705,0.379067455749842,6.02873655077727e-124
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SLC39A5,Zinc transporter ZIP5,42119,0.126963939512438,0.00531279562719807,0.116550860083129,0.137377018941746,1.16482393260782e-123
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2,41843,0.15200519076613,0.0065435769750918,0.13917977989495,0.16483060163731,4.91580814793434e-117
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MME,Neprilysin,42070,0.180533147351299,0.00781445724587194,0.16521681114939,0.195849483553208,7.70049355232467e-116
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SCG2,Secretogranin-2,42193,0.0763626963992889,0.00331205534419447,0.0698710679246677,0.0828543248739101,2.06905036234921e-115
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CCL16,C-C motif chemokine 16,42310,0.118433160624649,0.00514219743059941,0.108354453660674,0.128511867588624,3.40828742448229e-115
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,VMO1,Vitelline membrane outer layer protein 1 homolog,42070,0.158428535323669,0.00689326711394625,0.144917731780335,0.171939338867004,1.09134324401448e-114
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FTCD,Formimidoyltransferase-cyclodeaminase,39910,0.200292845282437,0.00871081763897876,0.183219642710039,0.217366047854835,2.21468560400515e-114
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,APOM,Apolipoprotein M,42199,-0.0650316454376674,0.0028475201681139,-0.0706127849671707,-0.0594505059081642,2.57182682737093e-113
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,INHBC,Inhibin beta C chain,42137,0.0910205164696323,0.00398556228424534,0.0832088143925114,0.0988322185467531,2.65389023794186e-113
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NHLRC3,NHL repeat-containing protein 3,39481,0.0736272948028068,0.00325051957032728,0.0672562764449653,0.0799983131606482,4.9238889375957e-111
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TNFRSF10A,Tumor necrosis factor receptor superfamily member 10A,42016,0.0759493417673107,0.00339799898397624,0.0692892637587172,0.0826094197759041,1.11985669444931e-108
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NOS3,"Nitric oxide synthase, endothelial",41839,0.113284060593837,0.00507901941277632,0.103329182544795,0.123238938642879,3.26534931413171e-108
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FURIN,Furin,42181,0.0735426418057223,0.00331830603138195,0.0670387619842136,0.0800465216272309,6.12439174018456e-107
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,COL18A1,Collagen alpha-1(XVIII) chain,42194,0.0523518994563935,0.00237512934417184,0.0476966459418167,0.0570071529709703,8.10531113903315e-106
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,RTN4R,Reticulon-4 receptor,42262,0.0742609425923358,0.00338993692531095,0.0676166662187263,0.0809052189659453,1.41423317546598e-104
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SHBG,Sex hormone-binding globulin,39990,-0.103641718609164,0.00472940147871681,-0.112911345507449,-0.0943720917108787,2.66298790089246e-104
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,OXT,Oxytocin-neurophysin 1,42249,0.315740190845601,0.0145542837403995,0.287213794714417,0.344266586976784,1.25547005275063e-102
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GSTA1,Glutathione S-transferase A1,42119,0.184088774574163,0.00852711104347442,0.167375636928953,0.200801912219373,1.18540590898354e-101
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ELN,Elastin,39958,0.0755224886612548,0.00350312194073696,0.0686563696574104,0.0823886076650993,4.59110432273468e-101
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FGF21,Fibroblast growth factor 21,42247,0.258861493051529,0.0120752687874227,0.23519396622818,0.282529019874878,2.68214292721779e-100
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CHI3L1,Chitinase-3-like protein 1,41907,0.180115582637286,0.00842036799419264,0.163611661368669,0.196619503905904,7.79711327840496e-100
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NCS1,Neuronal calcium sensor 1,42262,0.060269284583552,0.00284579960451731,0.0546915173586981,0.0658470518084059,5.64197658507157e-98
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PSRC1,Proline/serine-rich coiled-coil protein 1,41843,0.126790272611017,0.00603370967962852,0.114964201638945,0.138616343583089,1.83249123169356e-96
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IGSF8,Immunoglobulin superfamily member 8,42145,0.0653816415291793,0.00312542889526042,0.0592558008944689,0.0715074821638897,1.15655283035489e-95
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PRCP,Lysosomal Pro-X carboxypeptidase,42238,0.0665504956173704,0.0031948431915547,0.0602886029619232,0.0728123882728177,6.81897017791709e-95
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MXRA8,Matrix remodeling-associated protein 8,39736,-0.0648629418835167,0.00311293621103881,-0.0709642968571528,-0.0587615869098806,1.27206023087474e-94
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PGF,Placenta growth factor,42296,0.0541433679168852,0.00263783140033494,0.0489732183722288,0.0593135174615417,3.08240691740946e-92
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CPM,Carboxypeptidase M,42195,0.0701854286721749,0.00342101942583649,0.0634802305975354,0.0768906267468144,3.83398332990157e-92
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CPA2,Carboxypeptidase A2,42205,0.136832954907299,0.00669256011617512,0.123715537079596,0.149950372735002,1.55456217505567e-91
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MAD1L1,Mitotic spindle assembly checkpoint protein MAD1,41966,0.100764813056594,0.00493017822501986,0.0911016637355555,0.110427962377633,1.89434056178348e-91
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TNFRSF6B,Tumor necrosis factor receptor superfamily member 6B,42016,0.117862492018516,0.00580601379239904,0.106482704985414,0.129242279051618,2.89698080681793e-90
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SCLY,Selenocysteine lyase,42224,0.0988179360762081,0.00490635780708252,0.0892014747743264,0.10843439737809,6.35272951981477e-89
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IL1RN,Interleukin-1 receptor antagonist protein,42092,0.106653536797973,0.0053103095041428,0.0962453301698529,0.117061743426093,1.9775250797371e-88
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,KRT18,"Keratin, type I cytoskeletal 18",42070,0.169650637627363,0.00856637572726029,0.152860541201933,0.186440734052793,4.56789406782892e-86
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,RBP5,Retinol-binding protein 5,42070,0.111956112659541,0.0056786498212762,0.10082595900984,0.123086266309242,2.53324459764356e-85
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GDF15,Growth/differentiation factor 15,42310,0.0908948055341877,0.00461292144408594,0.0818534795037792,0.0999361315645961,2.97735546960316e-85
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ADAMTSL2,ADAMTS-like protein 2,39966,0.0691134411041058,0.00350738673860345,0.0622389630964431,0.0759879191117686,5.07441484853333e-85
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ADGRG1,Adhesion G-protein coupled receptor G1,42070,0.159317891010827,0.00810893700468407,0.143424374481646,0.175211407540008,9.34770083451692e-85
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MEP1A,Meprin A subunit alpha,39930,0.150468196931505,0.00770751676109483,0.135361464079759,0.165574929783251,1.65963470878176e-83
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,VPS37A,Vacuolar protein sorting-associated protein 37A,42070,0.15686603942328,0.00807288252723118,0.141043189669907,0.172688889176653,5.72121602503602e-83
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CXCL13,C-X-C motif chemokine 13,42249,0.111989870897487,0.00579178012578613,0.100637981850946,0.123341759944028,3.350613782556e-82
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FAM3B,Protein FAM3B,42070,0.0686886419434654,0.00355218689283191,0.0617263556335148,0.0756509282534159,3.39831577448303e-82
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,APOD,Apolipoprotein D,39468,-0.0825448252011188,0.00427378695327638,-0.0909214476295405,-0.0741682027726971,9.48610888813937e-82
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CCL15,C-C motif chemokine 15,42310,0.0846194222593711,0.00438991586159486,0.0760151871706452,0.093223657348097,1.02922837661904e-81
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TNFRSF12A,Tumor necrosis factor receptor superfamily member 12A,42181,0.0724341646708321,0.0037575535017489,0.0650693598074043,0.07979896953426,1.03211431403794e-81
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FAM20A,Pseudokinase FAM20A,39958,0.0550036674905583,0.00285155205182563,0.04941462546898,0.0605927095121365,1.33147516051947e-81
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,HEG1,Protein HEG homolog 1,39736,0.0538139060611094,0.00279487640146834,0.0483359483142315,0.0592918638079873,2.69313591708187e-81
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PCBD1,Pterin-4-alpha-carbinolamine dehydratase,39728,0.0945597829577438,0.00491946118793928,0.0849176390293828,0.104201926886105,4.98916843160106e-81
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SIT1,Signaling threshold-regulating transmembrane adapter 1,41913,0.105282743312526,0.0055153947962445,0.0944725695118869,0.116092917113165,3.66440282061771e-80
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SELE,E-selectin,42310,0.0969967436331847,0.00509135338455144,0.0870176909994638,0.106975796266905,6.8849168225956e-80
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,HAO1,Hydroxyacid oxidase 1,42262,0.237534996445998,0.0124786208033368,0.213076899671458,0.261993093220538,9.33275403579101e-80
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CXADR,Coxsackievirus and adenovirus receptor,42119,0.0938713669201117,0.00494110498248861,0.084186801154434,0.103555932685789,1.91258238774084e-79
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CD38,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1,42070,0.0625585968927957,0.00331242782703026,0.0560662383518164,0.0690509554337751,1.53272145208781e-78
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CA14,Carbonic anhydrase 14,42262,-0.0699531815239001,0.00370738653842627,-0.0772196591392156,-0.0626867039085846,2.04695305783632e-78
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CA5A,"Carbonic anhydrase 5A, mitochondrial",41900,0.174347432639986,0.00924469835524278,0.15622782386371,0.192467041416262,2.58869831406682e-78
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GRP,Gastrin-releasing peptide,39638,0.101604670444556,0.00541557428075553,0.0909901448542756,0.112219196034837,2.46958030671837e-77
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SMAD1,Mothers against decapentaplegic homolog 1,41843,0.158315545793282,0.00848611221688913,0.141682765848179,0.174948325738384,1.08531854214321e-76
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,KHK,Ketohexokinase,39638,0.118832453180252,0.00639090534813834,0.106306278697901,0.131358627662603,5.17661829471425e-76
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DNAJB1,DnaJ homolog subfamily B member 1,42070,0.160009755488287,0.00862738861416182,0.143100073804529,0.176919437172044,7.60681695421484e-76
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CD74,HLA class II histocompatibility antigen gamma chain,42249,0.064858706000676,0.00349793310808757,0.0580027571088244,0.0717146548925277,8.0565480608788e-76
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IGFBPL1,Insulin-like growth factor-binding protein-like 1,42145,0.0633603943044878,0.00342897960613362,0.0566395942764659,0.0700811943325097,2.61307942090535e-75
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GPRC5C,G-protein coupled receptor family C group 5 member C,39919,0.105710387928021,0.00571645342700407,0.094506139211093,0.116914636644949,3.04049974450741e-75
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,LECT2,Leukocyte cell-derived chemotaxin-2,39958,0.123369375470027,0.00669303059133303,0.110251035511014,0.13648771542904,8.83101100410699e-75
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GSTA3,Glutathione S-transferase A3,41843,0.143182992057028,0.00779578743505415,0.127903248684322,0.158462735429734,2.03181535991208e-74
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,RIDA,2-iminobutanoate/2-iminopropanoate deaminase,39736,0.0927609095536868,0.00507023980325117,0.0828232395393146,0.102698579568059,1.08032633833914e-73
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,AGR2,Anterior gradient protein 2 homolog,41740,0.184966877276632,0.0101360144496535,0.165100288955311,0.204833465597953,1.71544539697672e-73
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CTSO,Cathepsin O,42296,0.0562083766456098,0.00309215357765642,0.0501477556334032,0.0622689976578163,5.57302427404945e-73
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,AMBP,Protein AMBP,42239,0.0369154452047927,0.00203783209171082,0.0329212943050395,0.0409095961045459,1.71179994782789e-72
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IL17RB,Interleukin-17 receptor B,41934,-0.0987873219558603,0.00545306199698036,-0.109475323469942,-0.0880993204417788,1.76113098969425e-72
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CCL23,C-C motif chemokine 23,42185,0.0773107011595833,0.00426958954937445,0.0689423056428094,0.0856790966763573,1.97970354995824e-72
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,EPHA1,Ephrin type-A receptor 1,42162,0.0587185396099547,0.00325855741881091,0.0523317670690853,0.0651053121508241,9.33957219789749e-72
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IL18R1,Interleukin-18 receptor 1,42296,0.0600812857853498,0.00333838703470388,0.0535380471973301,0.0666245243733694,1.36836674777233e-71
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,HGF,Hepatocyte growth factor,42296,0.0625053352736306,0.00348925068158855,0.055666403937717,0.0693442666095441,5.93843792779806e-71
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,HHEX,Hematopoietically-expressed homeobox protein HHEX,39929,0.140122415249118,0.00781383576426675,0.124807297151156,0.155437533347081,6.2503522470856e-71
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FGFR2,Fibroblast growth factor receptor 2,42181,0.0406902144367371,0.00227319454821382,0.036234753122238,0.0451456757512362,7.66649027740764e-71
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CLUL1,Clusterin-like protein 1,42123,-0.0803652814925364,0.00452034359606239,-0.0892251549408187,-0.0715054080442541,6.45795204937704e-70
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GGT1,Glutathione hydrolase 1 proenzyme,42113,0.0929364901589663,0.00523570806331858,0.0826745023548619,0.103198477963071,1.05424662258675e-69
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,F9,Coagulation factor IX,42199,0.0327861429778795,0.0018542826698,0.0291517489450715,0.0364205370106875,3.4681109828342e-69
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,AREG,Amphiregulin,42070,0.0698863492777699,0.00396305280568299,0.0621187657786312,0.0776539327769085,7.93492335211968e-69
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IGSF3,Immunoglobulin superfamily member 3,42070,0.0660012023537942,0.00374582582490322,0.0586593837369839,0.0733430209706045,1.02020810305215e-68
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CRIP2,Cysteine-rich protein 2,42016,0.064684127639939,0.00367343141534756,0.0574842020658578,0.0718840532140202,1.24870713225934e-68
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,KIT,Mast/stem cell growth factor receptor Kit,42199,-0.0516938889678803,0.0029440077416528,-0.0574641441415198,-0.0459236337942409,2.8702972632256e-68
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ACAA1,"3-ketoacyl-CoA thiolase, peroxisomal",41843,0.146492290341652,0.00834210516658688,0.130141764215141,0.162842816468162,2.92485697106875e-68
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FUOM,Fucose mutarotase,39736,0.114887606163809,0.00655144643497424,0.102046771151259,0.127728441176358,6.18003029311641e-68
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GLA,Alpha-galactosidase A,39713,0.0696019486505592,0.00398257390605604,0.0617961037946893,0.077407793506429,1.71875146478578e-67
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PTS,6-pyruvoyl tetrahydrobiopterin synthase,41783,0.0959851484442144,0.00553944988579629,0.0851278266680537,0.106842470220375,1.5877312607825e-66
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IGFBP4,Insulin-like growth factor-binding protein 4,41930,0.0798844069696247,0.00461294631949658,0.0708430321834114,0.088925781755838,1.8514050561377e-66
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,REN,Renin,42145,0.141905863445251,0.00822135896556166,0.12579199987275,0.158019727017752,4.72959862410676e-66
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,KLRB1,Killer cell lectin-like receptor subfamily B member 1,42296,0.0676177143780504,0.00392772562673374,0.0599193721496523,0.0753160566064486,9.97826710955739e-66
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CST3,Cystatin-C,42184,0.0498157604554584,0.00289975716254612,0.044132236416868,0.0554992844940488,1.86284518593792e-65
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CDKN1A,Cyclin-dependent kinase inhibitor 1,42070,0.185303387346458,0.0108090191105423,0.164117709889795,0.20648906480312,3.45569440461503e-65
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ADAMTS15,A disintegrin and metalloproteinase with thrombospondin motifs 15,42070,0.0717602016532111,0.00419116066004038,0.063545526759532,0.0799748765468903,4.97064337070113e-65
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,KYNU,Kynureninase,42296,0.0787325636825565,0.00459883392293406,0.0697188491936057,0.0877462781715072,4.98328135514434e-65
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CLEC4M,C-type lectin domain family 4 member M,39945,-0.086183015274061,0.0050310202633181,-0.0960438149901645,-0.0763222155579575,5.76728008283551e-65
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FCAMR,High affinity immunoglobulin alpha and immunoglobulin mu Fc receptor,39958,0.125430990553188,0.007377573754577,0.110970945994217,0.139891035112159,4.93193724379217e-64
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FGF23,Fibroblast growth factor 23,42250,0.0868533004575919,0.00511736363391724,0.0768232677351141,0.0968833331800696,5.95773346326431e-64
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,INPP5D,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 1",39638,0.0993002146376595,0.00584512102907759,0.0878437774206674,0.110756651854652,6.45744678848456e-64
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,HS6ST1,Heparan-sulfate 6-O-sulfotransferase 1,42262,0.0573120807212148,0.00338307052921993,0.0506812624839438,0.0639428989584859,1.00452679472565e-63
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TNFRSF11A,Tumor necrosis factor receptor superfamily member 11A,42296,0.0680118205286717,0.0040211169202629,0.0601304313649564,0.075893209692387,1.57321373015348e-63
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NTRK3,NT-3 growth factor receptor,42249,-0.0360585733893719,0.00214597010988626,-0.040264674804749,-0.0318524719739948,9.90808118954304e-63
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NPPC,C-type natriuretic peptide,42119,0.0893111886820985,0.00532518107311309,0.0788738337787968,0.0997485435854002,1.68769543669512e-62
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PLXNB2,Plexin-B2,42255,0.0412385398570847,0.00247532433068762,0.036386904168937,0.0460901755452325,1.04243694205728e-61
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,F7,Coagulation factor VII,42194,0.0520347970350229,0.00314167938396068,0.04587710544246,0.0581924886275858,5.12766042423918e-61
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CDH2,Cadherin-2,42145,0.0586455092643044,0.00357637140664409,0.051635821307282,0.0656551972213268,7.44410635643625e-60
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CNTN3,Contactin-3,42137,0.0469183865119686,0.00286737832208029,0.0412983250006912,0.052538448023246,1.31466966830031e-59
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CRELD1,Protein disulfide isomerase CRELD1,39736,0.0621398074655843,0.00381254096841104,0.0546672271674986,0.0696123877636699,4.84483266164934e-59
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PIGR,Polymeric immunoglobulin receptor,41987,0.0610460608664965,0.00375277473474674,0.0536906223863928,0.0684014993466001,6.22152915220653e-59
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SEMA3F,Semaphorin-3F,42145,0.0439028188784714,0.00270289700075904,0.0386051407569837,0.0492004969999591,9.00462228681823e-59
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ACY3,N-acyl-aromatic-L-amino acid amidohydrolase,39575,0.0924808136729524,0.00569222373358703,0.0813240551551218,0.103637572190783,1.13441024228184e-58
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SPINK1,Serine protease inhibitor Kazal-type 1,42137,0.0693325133271702,0.00427388876980728,0.0609556913383479,0.0777093353159924,1.25103328059548e-58
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DPY30,Protein dpy-30 homolog,42216,0.0986653739825362,0.00608428589764598,0.0867401736231501,0.110590574341922,1.36515968279327e-58
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GPD1,Glycerol-3-phosphate dehydrogenase,39919,0.0879062841720846,0.00542445679359959,0.0772743488566294,0.0985382194875398,2.08913250955126e-58
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,LILRB4,Leukocyte immunoglobulin-like receptor subfamily B member 4,41913,0.0717063677753828,0.00445202302200639,0.0629804026522502,0.0804323328985153,8.0780964418926e-58
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,EPO,Erythropoietin,42119,0.11887632575335,0.00738595043225805,0.104399862906124,0.133352788600576,9.51891167349625e-58
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CD300LG,CMRF35-like molecule 9,42137,-0.0605452236794162,0.0037774701847966,-0.0679490652416175,-0.0531413821172148,2.74078824273075e-57
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PLTP,Phospholipid transfer protein,42267,-0.0611508406095453,0.00382576837457976,-0.0686493466237216,-0.053652334595369,5.42782708186039e-57
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CDH1,Cadherin-1,41697,0.0650278264857057,0.00408110888494105,0.0570288530712213,0.0730267999001902,1.25479188304858e-56
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CPB1,Carboxypeptidase B,42310,0.0997825403586368,0.00628270527857455,0.0874684380126307,0.112096642704643,2.67674741171369e-56
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,AMOT,Angiomotin,39736,0.0618991699125874,0.0039041932327587,0.0542469511763804,0.0695513886487944,5.34983436794428e-56
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MTSS1,Protein MTSS 1,39930,0.179806463308356,0.0113659282786472,0.157529243882207,0.202083682734504,8.97067551412699e-56
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,RNASET2,Ribonuclease T2,42258,0.0428623844447645,0.00271407307779238,0.0375428012122915,0.0481819676772376,1.08660979832595e-55
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GH1,Somatotropin,42129,-0.283439980280725,0.0180194041693533,-0.318758012452657,-0.248121948108792,2.92019439955483e-55
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MENT,Protein MENT,39736,-0.0380306980878026,0.00242227414791005,-0.0427783554177063,-0.0332830407578989,5.82694699287225e-55
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,LRCH4,Leucine-rich repeat and calponin homology domain-containing protein 4,39575,0.109483041233445,0.00697715662720041,0.0958078142441322,0.123158268222758,6.80213925699736e-55
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PRSS2,Trypsin-2,42217,0.0903853204734737,0.00579463312872073,0.079027839541181,0.101742801405766,2.21429498462596e-54
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ANG,Angiogenin,42152,0.0517587433620167,0.00332377534395028,0.0452441436878741,0.0582733430361592,3.31091699822423e-54
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,AGXT,Serine--pyruvate aminotransferase,42145,0.12116313240353,0.007789487700453,0.105895736510642,0.136430528296418,4.33890600139553e-54
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SORD,Sorbitol dehydrogenase,42204,0.107806986755526,0.00697409525802286,0.0941377600498016,0.121476213461251,1.89039650207543e-53
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,OCLN,Occludin,39934,0.0697267731873872,0.00451430675517978,0.0608787319472348,0.0785748144275395,2.80917615547254e-53
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CD2AP,CD2-associated protein,42145,0.0985866078529933,0.00640228162354586,0.0860381358708435,0.111135079835143,4.70081516808989e-53
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,C1QTNF1,Complement C1q tumor necrosis factor-related protein 1,42217,0.0668464537400588,0.004343459103993,0.0583332738962325,0.0753596335838851,5.32210069275643e-53
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ANGPTL7,Angiopoietin-related protein 7,42262,0.0572330495165618,0.003728102881443,0.0499259678689335,0.06454013116419,9.49209463527581e-53
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,AFM,Afamin,39979,0.0316167545373142,0.00205784615636903,0.0275833760708309,0.0356501330037975,9.64540200532785e-53
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,HAVCR1,Hepatitis A virus cellular receptor 1,42239,0.100844130302727,0.00657154567752829,0.0879639007747712,0.113724359830682,1.04472863150891e-52
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,REG4,Regenerating islet-derived protein 4,42144,0.0792409509354005,0.00517054466770012,0.0691066833867083,0.0893752184840927,1.42661597679765e-52
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,RNASE4,Ribonuclease 4,39645,0.0433933296380639,0.00283054138317273,0.0378454685270454,0.0489411907490824,1.66078022487337e-52
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ADH1B,All-trans-retinol dehydrogenase,39736,0.119213543287402,0.00777858243567369,0.103967521713481,0.134459564861322,1.7604086678841e-52
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ADM,Pro-adrenomedullin,42262,0.0405919189874212,0.00265429245104324,0.0353895057833764,0.0457943321914659,2.31216726303504e-52
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,POSTN,Periostin,39966,-0.0586857937211118,0.00385175868477287,-0.0662352407432666,-0.0511363466989569,6.62447227001755e-52
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,AGRN,Agrin,42185,0.0551385275730728,0.00363501751868023,0.0480138932364596,0.0622631619096861,1.50592196340915e-51
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DSG2,Desmoglein-2,42137,-0.0414270783380281,0.00274135691348966,-0.0468001378884678,-0.0360540187875884,3.53408197618693e-51
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,EFCAB14,EF-hand calcium-binding domain-containing protein 14,39930,0.0435841645276662,0.00288191404750642,0.0379356129945536,0.0492327160607788,3.58481542172412e-51
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NPC2,NPC intracellular cholesterol transporter 2,39820,0.0509180563718579,0.00336720107737166,0.0443183422602095,0.0575177704835064,3.71029299501232e-51
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ECHDC3,"Enoyl-CoA hydratase domain-containing protein 3, mitochondrial",39958,0.116931781404311,0.00776289872106492,0.101716499911024,0.132147062897598,8.77634632273419e-51
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PON1,Serum paraoxonase/arylesterase 1,39990,-0.0414858418002706,0.00276622810694777,-0.0469076488898883,-0.036064034710653,2.31175791095435e-50
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ENO3,Beta-enolase,39638,0.0961490942720266,0.00641179717004156,0.0835819718187452,0.108716216725308,2.45100786952324e-50
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SERPINF1,Pigment epithelium-derived factor,39815,0.0396029814159749,0.002671021191993,0.0343677798796687,0.0448381829522812,2.87049417985174e-49
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SKAP1,Src kinase-associated phosphoprotein 1,41997,0.108245552776284,0.00731608535927493,0.0939060254721049,0.122585080080463,3.82095733913187e-49
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TTR,Transthyretin,39862,0.0373629808493954,0.00252965556263171,0.0324048559466373,0.0423211057521536,6.55382167933548e-49
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TGFB1,Transforming growth factor beta-1 proprotein,42284,0.0581263844489618,0.00394020937837162,0.0504035740673535,0.0658491948305702,7.07593235787124e-49
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PLA2G10,Group 10 secretory phospholipase A2,42016,0.0869215464814852,0.00589434807865397,0.0753686242473235,0.098474468715647,7.80030502285184e-49
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TNFRSF10B,Tumor necrosis factor receptor superfamily member 10B,42016,0.0606279095190899,0.00411821177505756,0.052556214439977,0.0686996045982027,1.11762964671033e-48
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,BTN3A2,Butyrophilin subfamily 3 member A2,42119,0.0567597431983939,0.00385646365695396,0.0492010744307642,0.0643184119660237,1.1737862271525e-48
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,XCL1,Lymphotactin,42262,0.0810941388986134,0.00553693216047902,0.0702417518640745,0.0919465259331522,3.31115580189196e-48
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DMP1,Dentin matrix acidic phosphoprotein 1,39638,-0.0842983174568426,0.0057655261613392,-0.0955987487330674,-0.0729978861806178,5.78014932762664e-48
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,VAT1,Synaptic vesicle membrane protein VAT-1 homolog,42070,-0.0289993785902107,0.00198590456100247,-0.0328917515297756,-0.0251070056506459,6.27999448982195e-48
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IL10RB,Interleukin-10 receptor subunit beta,42185,0.0440183475477954,0.00302377915404867,0.03809174040586,0.0499449546897307,1.19691003953635e-47
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NECTIN2,Nectin-2,42129,0.045660081190369,0.00314201257774944,0.0395017365379801,0.0518184258427579,1.72785920861776e-47
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MET,Hepatocyte growth factor receptor,42158,-0.0283275061040074,0.00194993389526524,-0.0321493765387273,-0.0245056356692875,1.845248202192e-47
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,F11R,Junctional adhesion molecule A,42137,0.0819614666417298,0.00565032729063873,0.0708868251520779,0.0930361081313817,2.52695515721159e-47
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GFRA1,GDNF family receptor alpha-1,42247,0.0418868323237955,0.002897690434659,0.0362073590718639,0.0475663055757271,5.16643329836189e-47
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PDZK1,Na(+)/H(+) exchange regulatory cofactor NHE-RF3,39657,0.0683087848171912,0.00472178091894355,0.0590540942160619,0.0775634754183206,5.27617064795862e-47
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ITGAV,Integrin alpha-V,42262,-0.0243851032312913,0.0016876997736098,-0.0276929947875665,-0.0210772116750161,5.66696630819963e-47
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PVR,Poliovirus receptor,42249,0.0547646200566513,0.00379228350534482,0.0473317443861755,0.0621974957271272,6.32696066263964e-47
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SERPIND1,Heparin cofactor 2,39959,0.0429381353382618,0.00297179925404183,0.0371134088003399,0.0487628618761838,6.66592847449645e-47
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PXN,Paxillin,41839,0.075047603763554,0.00520268749029575,0.0648503362825743,0.0852448712445337,8.1808771927008e-47
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ITGA11,Integrin alpha-11,42119,-0.0495034068456244,0.00343604142807088,-0.0562380480446434,-0.0427687656466055,1.03517133515797e-46
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CXCL6,C-X-C motif chemokine 6,42296,0.110331160941578,0.00766184985801408,0.09531393521987,0.125348386663285,1.13279273533128e-46
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,UMOD,Uromodulin,42274,-0.0786069938070466,0.00545974291774104,-0.0893080899258191,-0.0679058976882742,1.17543272161974e-46
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,HEPH,Hephaestin,39958,0.0408965268177991,0.00284596462610587,0.0353184361506316,0.0464746174849666,2.03602782368748e-46
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GAST,Gastrin,39929,0.191741200807423,0.0133431117664061,0.165588701745267,0.217893699869579,2.03952454708678e-46
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,RRM2,Ribonucleoside-diphosphate reductase subunit M2,41843,0.0710375488757868,0.00495311858255422,0.0613294364539805,0.0807456612975931,2.65673200252234e-46
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SCARB2,Lysosome membrane protein 2,41777,0.0479483864567539,0.00334354037044417,0.0413950473306833,0.0545017255828245,2.72004090694811e-46
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,AGR3,Anterior gradient protein 3,41827,0.0860407718226064,0.00601112358747335,0.0742589695911587,0.0978225740540542,3.97714176743442e-46
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PSIP1,PC4 and SFRS1-interacting protein,42119,0.0953339754929394,0.00667361928891448,0.082253681686667,0.108414269299212,5.84454937829618e-46
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FGFBP3,Fibroblast growth factor-binding protein 3,39929,-0.0537050885013028,0.00375934254564597,-0.0610733998907689,-0.0463367771118368,6.71655263768025e-46
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,LSP1,Lymphocyte-specific protein 1,42119,0.0585585167512706,0.00410877123007702,0.0505053251403196,0.0666117083622216,9.33139180988773e-46
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SBSN,Suprabasin,39954,-0.0515535207019342,0.00362023518659201,-0.0586491816676545,-0.0444578597362138,1.27005084776831e-45
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,HSD11B1,Corticosteroid 11-beta-dehydrogenase isozyme 1,42119,-0.0570815603377052,0.00401185193761493,-0.0649447901354305,-0.04921833053998,1.30596954264396e-45
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PRKRA,Interferon-inducible double-stranded RNA-dependent protein kinase activator A,41843,0.0986256107985213,0.00693407426820631,0.0850348252328369,0.112216396364206,1.42138939312368e-45
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,41900,0.080328249795658,0.00565039329989746,0.069253478927859,0.091403020663457,1.56185259718874e-45
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SULT2A1,Bile salt sulfotransferase,42119,0.0845732383916002,0.00596815759531986,0.0728756495047733,0.0962708272784271,2.93054753418463e-45
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PTGR1,Prostaglandin reductase 1,39958,0.120812933156872,0.00853234328150341,0.104089540325125,0.137536325988619,3.95114852402931e-45
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CD209,CD209 antigen,42171,-0.0560299726240266,0.00396017575505844,-0.0637919171039412,-0.0482680281441121,4.00008727248821e-45
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GRPEL1,"GrpE protein homolog 1, mitochondrial",42070,0.087833764291133,0.0062124595331345,0.0756573436061894,0.100010184976077,4.62876237401061e-45
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PLAT,Tissue-type plasminogen activator,42272,0.0733981922618121,0.00519192938249472,0.0632220106721224,0.0835743738515018,4.66589310797894e-45
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PSME1,Proteasome activator complex subunit 1,42002,0.0517419740083851,0.0036801573005583,0.0445288656992908,0.0589550823174794,1.39227016336631e-44
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ITGBL1,Integrin beta-like protein 1,39966,0.0564649490304774,0.00401397501180223,0.048597558007345,0.0643323400536098,1.42995012942962e-44
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CHMP6,Charged multivesicular body protein 6,39958,0.0821147087721373,0.00584593006317387,0.0706566858483165,0.0935727316959581,1.90503316632018e-44
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,EFNA4,Ephrin-A4,41992,0.0459082253166884,0.00327617994103835,0.0394869126322532,0.0523295380011235,2.67704036768231e-44
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ALDH1A1,Retinal dehydrogenase 1,42137,0.0756490441381069,0.00540181277292531,0.0650614911031732,0.0862365971730405,2.98303700282262e-44
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,AKR7L,Aflatoxin B1 aldehyde reductase member 4,39657,0.0990916494787712,0.00707191699110247,0.0852306921762103,0.112952606781332,3.14308805288231e-44
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MCAM,Cell surface glycoprotein MUC18,42217,-0.0454401681324267,0.00325250133274996,-0.0518150707446167,-0.0390652655202368,4.72889239396162e-44
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FAM3C,Protein FAM3C,42129,0.0431254254085323,0.00308976110544566,0.0370694936418589,0.0491813571752058,5.71078322777955e-44
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,THBS2,Thrombospondin-2,42137,0.0544668159861895,0.00392026170624054,0.046783103041958,0.062150528930421,1.37788789614333e-43
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GHR,Growth hormone receptor,39736,0.0400215213940833,0.0028889275164745,0.0343592234617933,0.0456838193263734,2.77071975729046e-43
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,KRT19,"Keratin, type I cytoskeletal 19",42094,0.0951853401766697,0.00688557096682997,0.0816896210816829,0.108681059271656,3.60089046403267e-43
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CRHBP,Corticotropin-releasing factor-binding protein,42123,0.0383733681351982,0.00277958965863608,0.0329253724042715,0.043821363866125,4.63090481290762e-43
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FLI1,Friend leukemia integration 1 transcription factor,41843,0.155837085046763,0.0113434385925176,0.133603945405428,0.178070224688097,1.17717871663176e-42
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,LAT2,Linker for activation of T-cells family member 2,42070,0.17573787878068,0.0128240664156006,0.150602708606103,0.200873048955257,1.85671148697999e-42
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CD5,T-cell surface glycoprotein CD5,42239,0.0494971892224872,0.0036165427432527,0.0424087654457119,0.0565856129992625,2.33367988967659e-42
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SSC5D,Soluble scavenger receptor cysteine-rich domain-containing protein SSC5D,42217,0.0593946091127272,0.00434936512735323,0.0508698534631148,0.0679193647623395,3.52769294463596e-42
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,LEP,Leptin,42145,0.0963311734389619,0.00707290705174729,0.0824682756175372,0.110194071260387,5.77410725462669e-42
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,42231,0.0421896606299537,0.00309818635524602,0.0361172153736715,0.0482621058862359,5.92527645335161e-42
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CDHR2,Cadherin-related family member 2,42070,0.0910823567763942,0.00669204085113679,0.0779659567081661,0.104198756844622,6.56013779410889e-42
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,YES1,Tyrosine-protein kinase Yes,42070,0.157509660560272,0.0116016471733005,0.134770432100603,0.180248889019941,1.03830128470244e-41
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SUOX,"Sulfite oxidase, mitochondrial",39934,0.0881485796695581,0.00649318137527199,0.075421944174025,0.100875215165091,1.18275586225322e-41
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TNFRSF14,Tumor necrosis factor receptor superfamily member 14,42144,0.043351324526213,0.00320552132947882,0.0370685027204345,0.0496341463319915,2.09659071380375e-41
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CC2D1A,Coiled-coil and C2 domain-containing protein 1A,42016,0.100169515800997,0.00741328690494432,0.0856394734673066,0.114699558134688,2.47023871178776e-41
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TNFRSF1A,Tumor necrosis factor receptor superfamily member 1A,42137,0.0424607048832913,0.00314815497035349,0.0362903211413985,0.0486310886251842,3.41853580019045e-41
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MLN,Promotilin,42119,0.122240478117364,0.00907302119146303,0.104457356582096,0.140023599652632,4.15489477853525e-41
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NOTCH3,Neurogenic locus notch homolog protein 3,42310,-0.0457308697902537,0.00339919066417864,-0.0523932834920439,-0.0390684560884636,5.3464774791045e-41
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IL4R,Interleukin-4 receptor subunit alpha,42119,0.0511588753975167,0.00380416543769296,0.0437027111396385,0.0586150396553949,5.78956918154958e-41
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CGREF1,Cell growth regulator with EF hand domain protein 1,42145,0.0592231605312662,0.00440689143380061,0.050585653321017,0.0678606677415154,6.55188373414148e-41
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FSTL3,Follistatin-related protein 3,42084,0.044660365212358,0.0033237655800396,0.0381457846754804,0.0511749457492357,6.754709696885e-41
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,EGLN1,Egl nine homolog 1,42119,0.0757183754610805,0.00567763325745437,0.0645902142764699,0.086846536645691,2.56026473752375e-40
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TIMP1,Metalloproteinase inhibitor 1,42032,0.0389908182243783,0.00292401694882009,0.0332597450046909,0.0447218914440657,2.62426095131152e-40
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PAXX,Protein PAXX,39736,0.0630295680033884,0.00473035049465931,0.0537580810338561,0.0723010549729206,3.38503685580732e-40
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,AP3S2,AP-3 complex subunit sigma-2,39929,0.0654351245351383,0.00492460706062741,0.0557828946963086,0.075087354373968,5.45480190707403e-40
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IL1R2,Interleukin-1 receptor type 2,42100,0.0269949195135509,0.00203373019024525,0.0230088083406702,0.0309810306864316,5.86141184690764e-40
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,AIFM1,"Apoptosis-inducing factor 1, mitochondrial",42056,0.142184813756512,0.0107269449701818,0.121160001614956,0.163209625898068,7.50959812412946e-40
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CPA1,Carboxypeptidase A1,42310,0.0870401595286681,0.00656966098298096,0.0741636240020254,0.0999166950553108,8.05340369574826e-40
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SIGLEC7,Sialic acid-binding Ig-like lectin 7,42145,0.0372192732773648,0.00282637775578076,0.0316795728760345,0.0427589736786951,2.32318840874603e-39
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IL16,Pro-interleukin-16,42296,0.0565723837686614,0.00429859225144426,0.0481471429558307,0.0649976245814922,2.55916345155085e-39
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DDAH1,"N(G),N(G)-dimethylarginine dimethylaminohydrolase 1",42070,0.0591781745133807,0.0045038191587074,0.0503506889623142,0.0680056600644472,3.40292629148369e-39
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ERMAP,Erythroid membrane-associated protein,39657,0.0599198728158645,0.00456039135412385,0.0509815057617818,0.0688582398699473,3.85416255696153e-39
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GZMA,Granzyme A,42296,0.0451747082855058,0.00344831348085084,0.0384160138630382,0.0519334027079734,5.60801616508914e-39
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CLEC4A,C-type lectin domain family 4 member A,42119,-0.047421419436837,0.00362563678758075,-0.0545276675404952,-0.0403151713331787,7.42502226639892e-39
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CDH17,Cadherin-17,42145,0.0904591895306152,0.00694276002165687,0.0768513798881678,0.104066999173063,1.42197050924966e-38
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,S100P,Protein S100-P,41900,0.0705107696682265,0.00543311730964479,0.0598618597413227,0.0811596795951303,2.78620842274776e-38
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SELPLG,P-selectin glycoprotein ligand 1,42119,0.0366542405626275,0.00282765275605988,0.0311120411607502,0.0421964399645049,3.35910886314408e-38
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,OMD,Osteomodulin,42185,-0.0540268767960573,0.00417191045861218,-0.0622038212949372,-0.0458499322971774,3.94209471963074e-38
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CPE,Carboxypeptidase E,42134,-0.0514511053576923,0.00397614054813297,-0.0592443408320329,-0.0436578698833517,4.50295204100624e-38
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,EEF1D,Elongation factor 1-delta,39958,0.120612466899772,0.00931599112135139,0.102353124301923,0.138871809497621,4.55099276341014e-38
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NUMB,Protein numb homolog,39657,0.110976042361436,0.00858375806530879,0.094151876553431,0.127800208169441,5.84470752320337e-38
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,HJV,Hemojuvelin,39934,0.0557023379169494,0.00430929617709964,0.0472561174098341,0.0641485584240647,5.94483003206293e-38
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ABL1,Tyrosine-protein kinase ABL1,42070,0.0884854024142574,0.00686229379320575,0.0750353065795741,0.101935498248941,8.09704748706313e-38
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IFI30,Gamma-interferon-inducible lysosomal thiol reductase,39662,0.0517917868301317,0.00402566451000852,0.043901484390515,0.0596820892697484,1.31068191203857e-37
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PTPRB,Receptor-type tyrosine-protein phosphatase beta,39958,0.0390959259738857,0.00304016657739533,0.0331371994821909,0.0450546524655806,1.38540956386011e-37
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TFPI,Tissue factor pathway inhibitor,42152,-0.0407175071848895,0.00316889443410103,-0.0469285402757275,-0.0345064740940515,1.44122355651225e-37
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,LAIR1,Leukocyte-associated immunoglobulin-like receptor 1,42123,0.0517584293151071,0.00403155549524808,0.0438565805444209,0.0596602780857933,1.6558970149253e-37
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,BMPER,BMP-binding endothelial regulator protein,39736,0.0303434627698638,0.00236318201241225,0.0257116260255358,0.0349752995141918,1.80214182264009e-37
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SORCS2,VPS10 domain-containing receptor SorCS2,41843,0.046576093391864,0.00363210128783549,0.0394571748677065,0.0536950119160216,2.0228543269356e-37
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TNFSF10,Tumor necrosis factor ligand superfamily member 10,42296,-0.0331908979071976,0.00259485075897207,-0.0382768053947829,-0.0281049904196124,3.00457388440996e-37
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NAGPA,N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase,39736,0.0288446204941605,0.00225611063521593,0.0244226436491372,0.0332665973391837,3.62310539373674e-37
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CTSE,Cathepsin E,39736,0.0691341700623712,0.00542652732870821,0.0584981764981031,0.0797701636266393,6.40889565466567e-37
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CD248,Endosialin,39966,-0.0525184808941149,0.00413358171119137,-0.06062030104805,-0.0444166607401798,9.81555133295253e-37
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SMAD2,Mothers against decapentaplegic homolog 2,39919,0.0922428568920482,0.00727218834000988,0.0779893677456288,0.106496346038468,1.28152936841636e-36
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,HLA_E,,42119,0.0378131680588334,0.00298290685134836,0.0319666706301906,0.0436596654874762,1.28756404091827e-36
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,LGALS9,Galectin-9,42129,0.0403285769579304,0.0031933394847011,0.0340696315679162,0.0465875223479445,2.34419158681074e-36
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,COL6A3,Collagen alpha-3(VI) chain,42310,0.045847423180744,0.00364150843558057,0.0387100666470061,0.0529847797144819,3.78718322963381e-36
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ADGRG2,Adhesion G-protein coupled receptor G2,42145,-0.0345441153127696,0.00275006233466227,-0.0399342374887076,-0.0291539931368316,5.47468669293156e-36
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NOMO1,Nodal modulator 1,42137,0.0296337014138124,0.00236413204913135,0.0250000025975149,0.0342674002301098,7.62346106385633e-36
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,EZR,Ezrin,42249,0.0309493302950767,0.00246919727756034,0.0261097036310584,0.0357889569590949,7.64636838498025e-36
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PALM2,Paralemmin-2,39929,0.0496436581531152,0.00396156382856979,0.0418789930491184,0.057408323257112,8.68615277782741e-36
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CXCL9,C-X-C motif chemokine 9,42185,0.0824567715166994,0.00660774697146338,0.0695055874526312,0.0954079555807676,1.52595076063407e-35
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SERPINA4,Kallistatin,39802,0.0298188253071789,0.00239364381512618,0.0251272834295315,0.0345103671848262,2.18313351893614e-35
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,RNASE6,Ribonuclease K6,39937,0.0410647403792125,0.00330244521528498,0.0345919477572539,0.047537533001171,2.87720444869949e-35
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,STC1,Stanniocalcin-1,42249,0.0578186675242374,0.00465475965892097,0.0486953385927524,0.0669419964557225,3.10055752997664e-35
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,LATS1,Serine/threonine-protein kinase LATS1,39657,0.110340572693843,0.00888139107025449,0.092933046196144,0.127748099191542,3.33336818992119e-35
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,LRP11,Low-density lipoprotein receptor-related protein 11,42145,0.0467609252575098,0.00376910467499197,0.0393734800945255,0.054148370420494,3.74575199810047e-35
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DCXR,L-xylulose reductase,42181,0.0682824945456622,0.00551545814125533,0.0574721965888018,0.0790927925025226,5.16677015732291e-35
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GUSB,Beta-glucuronidase,42211,0.0767071819513374,0.00620513569499642,0.0645451159891444,0.0888692479135304,6.46773550599659e-35
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CCL11,Eotaxin,42296,0.0469806346664908,0.00380098178495126,0.0395307103679863,0.0544305589649953,6.59135788722174e-35
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IL12A_IL12B,Interleukin-12,42070,0.0968343267128342,0.00783548126395747,0.0814767834354775,0.112191869990191,6.7780939250665e-35
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,BECN1,Beclin-1,39638,0.0751829940130746,0.00608256765550946,0.0632611614082761,0.0871048266178732,7.2764341748576e-35
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CBS,Cystathionine beta-synthase,39638,0.0653155632310655,0.00528780524521464,0.0549514649504448,0.0756796615116862,8.05549150441758e-35
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,B3GNT7,"UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7",39638,0.0476413067266877,0.00386333326407217,0.0400691735291062,0.0552134399242692,1.03497969692936e-34
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ALPI,Intestinal-type alkaline phosphatase,39657,0.158131725202437,0.0128255393985632,0.132993667981253,0.183269782423621,1.06251658083034e-34
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PTP4A3,Protein tyrosine phosphatase type IVA 3,39657,0.0650684539496382,0.00527865531450535,0.0547222895332077,0.0754146183660687,1.09862561289083e-34
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,B4GALT1,"Beta-1,4-galactosyltransferase 1",42185,0.0349243887954529,0.00283607121416438,0.0293656892156907,0.0404830883752151,1.16039983947966e-34
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SARG,Specifically androgen-regulated gene protein,39915,0.13814925086166,0.0112437615307612,0.116111478261368,0.160187023461952,1.76950509560808e-34
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,C19orf12,Protein C19orf12,41839,0.083051018610265,0.00678894714978969,0.0697446821966772,0.0963573550238528,3.15910508990556e-34
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GPKOW,G-patch domain and KOW motifs-containing protein,41839,0.0364576492550866,0.00298521843356317,0.0306066211253027,0.0423086773848704,4.05621340034753e-34
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,RBKS,Ribokinase,41830,0.0613737440173866,0.00502789666536772,0.0515190665532658,0.0712284214815073,4.36855473546372e-34
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SPINK4,Serine protease inhibitor Kazal-type 4,42119,0.0818844966056477,0.00670870984843736,0.0687354253027105,0.0950335679085849,4.37958251853675e-34
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IMMT,MICOS complex subunit MIC60,39919,0.0557427320781512,0.00456558694712746,0.0467941816617813,0.064691282494521,4.5382817578058e-34
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,INPPL1,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 2",42070,0.121178484772999,0.00994533708656337,0.101685624083334,0.140671345462663,5.67702724245823e-34
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GSN,Gelsolin,39943,-0.0235433504396722,0.00193858038053655,-0.0273429679855238,-0.0197437328938205,9.91699640182915e-34
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IL12B,Interleukin-12 subunit beta,42296,0.0676743965647946,0.0055755672800218,0.0567462846959519,0.0786025084336374,9.93717476950643e-34
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MTSS2,Protein MTSS 2,39919,0.124984084521809,0.0102928154087388,0.104810166320681,0.145158002722937,1.01435045817392e-33
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CFC1,Cryptic protein,41843,0.0590582536210513,0.00486989962519015,0.0495132503556786,0.068603256886424,1.14304160742261e-33
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TXLNA,Alpha-taxilin,42016,0.108378680186345,0.00893776858865531,0.0908606537525807,0.125896706620109,1.15475625399382e-33
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FABP1,"Fatty acid-binding protein, liver",42123,0.117251321653275,0.00967074451012184,0.0982966624134359,0.136205980893114,1.17338458359577e-33
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TSPAN8,Tetraspanin-8,39930,0.118338107768504,0.0097658801819636,0.0991969826118551,0.137479232925152,1.37613075246905e-33
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,YOD1,Ubiquitin thioesterase OTU1,39575,0.0753314425532557,0.00621765477805333,0.0631448391882712,0.0875180459182403,1.42753010713332e-33
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ARF6,ADP-ribosylation factor 6,39930,0.134784067341388,0.0111287059172263,0.112971803743624,0.156596330939151,1.48132927298876e-33
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,COL3A1,Collagen alpha-1(III) chain,39966,0.0291503244005345,0.00240899387405077,0.024428696407395,0.033871952393674,1.68366427758351e-33
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IDUA,Alpha-L-iduronidase,42262,0.0577776808250411,0.00479629725196814,0.0483769382111836,0.0671784234388987,2.98946069721928e-33
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CXCL10,C-X-C motif chemokine 10,42185,0.0806857099020596,0.00670355770175407,0.0675467368066217,0.0938246829974976,3.38013854346368e-33
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,VSIG2,V-set and immunoglobulin domain-containing protein 2,39919,0.0762948077549217,0.00635173131831949,0.0638454143710155,0.0887442011388279,4.89937086667636e-33
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SNAP29,Synaptosomal-associated protein 29,42181,0.111639954764441,0.0093086277208519,0.0933950444315713,0.129884865097311,5.66158791503122e-33
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MYH9,Myosin-9,39966,0.139018695559721,0.0116098428614293,0.11626340355132,0.161773987568123,7.64247821170027e-33
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DTYMK,Thymidylate kinase,39958,0.0823095695625349,0.00687876619539269,0.0688271878195652,0.0957919513055045,8.45517124941466e-33
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ANGPT2,Angiopoietin-2,42262,0.0454431472765164,0.00380027235651369,0.0379946134577496,0.0528916810952832,8.60821823153341e-33
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TANK,TRAF family member-associated NF-kappa-B activator,41913,0.0861190696814842,0.0072064719800877,0.0719943846005123,0.100243754762456,9.5194672715161e-33
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GALNT10,Polypeptide N-acetylgalactosaminyltransferase 10,42070,0.0342554969834013,0.00286679068338363,0.0286365872439694,0.0398744067228332,9.60944228746151e-33
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,THOP1,Thimet oligopeptidase,42081,0.0380893034969502,0.00319050182051246,0.0318359199287458,0.0443426870651547,1.09152236670594e-32
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CDH15,Cadherin-15,42230,0.0838882164551819,0.00702886480571185,0.0701116414359867,0.0976647914743771,1.13358900015761e-32
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ZBTB16,Zinc finger and BTB domain-containing protein 16,41843,0.088692858446919,0.00745414090065995,0.0740827422816255,0.103302974612213,1.76438315865415e-32
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DCTN1,Dynactin subunit 1,42262,0.0773056164651658,0.00650153658100625,0.0645626047663935,0.090048628163938,1.91996021492685e-32
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PLAUR,Urokinase plasminogen activator surface receptor,42040,0.0344341109974856,0.00289671590429343,0.0287565478250705,0.0401116741699007,2.00309267986257e-32
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ADGRD1,Adhesion G-protein coupled receptor D1,39736,0.0498857702840331,0.0042017056377802,0.0416504272339839,0.0581211133340823,2.56850688500061e-32
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,RELT,Tumor necrosis factor receptor superfamily member 19L,42137,0.0361316497563183,0.00306841978467681,0.0301175469783517,0.0421457525342848,7.48125792158463e-32
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SUMF2,Inactive C-alpha-formylglycine-generating enzyme 2,42249,0.0623034448032761,0.00529425562583379,0.0519267037766419,0.0726801858299103,8.11781687788987e-32
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TOP2B,DNA topoisomerase 2-beta,39657,0.0969374574379801,0.00824004754505335,0.0807869642496755,0.113087950626285,9.22953382404768e-32
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SRP14,Signal recognition particle 14 kDa protein,42070,0.071565847052341,0.00608742924156149,0.0596344857388805,0.0834972083658015,9.36481993708924e-32
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NUCB2,Nucleobindin-2,42231,0.0447619243478997,0.0038130913653774,0.03728826527176,0.0522355834240394,1.14233141292682e-31
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CHCHD10,"Coiled-coil-helix-coiled-coil-helix domain-containing protein 10, mitochondrial",39929,0.0499806423332788,0.00426304245666959,0.0416250791182064,0.0583362055483512,1.45798359783494e-31
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PBLD,Phenazine biosynthesis-like domain-containing protein,41839,0.0628348507184696,0.00536650402525403,0.0523165028289717,0.0733531986079675,1.64459184263953e-31
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,EGFR,Epidermal growth factor receptor,42310,-0.0189844680838252,0.00162363576899469,-0.0221667941910548,-0.0158021419765956,1.96145900220216e-31
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ABCA2,ATP-binding cassette sub-family A member 2,39575,0.0430228728240768,0.00368319866004007,0.0358038034503982,0.0502419421977553,2.44700624854324e-31
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CFI,Complement factor I,39979,0.0231734656280651,0.00198474459644282,0.0192833662190372,0.027063565037093,2.55630869496658e-31
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PBXIP1,Pre-B-cell leukemia transcription factor-interacting protein 1,39930,0.0359173649657204,0.00307706157530546,0.0298863242781217,0.041948405653319,2.65702441986554e-31
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NFX1,Transcriptional repressor NF-X1,39575,0.0807015481110495,0.00691683056395386,0.0671445602056999,0.094258536016399,2.85999683494474e-31
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SORT1,Sortilin,42129,0.0452681172953976,0.00388309595357357,0.0376572492263934,0.0528789853644018,2.95566282686853e-31
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,VWA1,von Willebrand factor A domain-containing protein 1,42247,0.0500786478359206,0.00429765413577029,0.0416552457298108,0.0585020499420304,3.12999173115552e-31
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CD80,T-lymphocyte activation antigen CD80,39958,0.0408207492359836,0.00350307380838436,0.0339547245715503,0.047686773900417,3.33949392926472e-31
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GFER,FAD-linked sulfhydryl oxidase ALR,41843,0.0755646509602364,0.00648796722630876,0.0628482351966713,0.0882810667238016,3.37744450093734e-31
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CFHR4,Complement factor H-related protein 4,39945,-0.086801056293878,0.00747038370488075,-0.101443008355444,-0.0721591042323117,4.92374815803975e-31
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TNFSF13,Tumor necrosis factor ligand superfamily member 13,42185,0.0326325483436914,0.00281072223572024,0.0271235327616797,0.0381415639257031,5.13440195186774e-31
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IL18BP,Interleukin-18-binding protein,42217,0.0369131404525249,0.00319526730158824,0.030650416541412,0.0431758643636379,9.97793195484982e-31
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PRKAR2A,cAMP-dependent protein kinase type II-alpha regulatory subunit,39909,0.0926944571835255,0.00802193895349886,0.0769714568346677,0.108417457532383,1.03435034584751e-30
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TCOF1,Treacle protein,39958,0.0383626590259635,0.00332004902624887,0.0318553629345157,0.0448699551174112,1.03582615018578e-30
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PCDH17,Protocadherin-17,42145,0.0440493506359708,0.00381764035283722,0.0365667755444099,0.0515319257275318,1.17538408358312e-30
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TFF2,Trefoil factor 2,42166,0.068604289440157,0.00594673217788157,0.0569486943715091,0.0802598845088049,1.20079394021846e-30
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ULBP2,UL16-binding protein 2,42016,0.0461151291203063,0.00399944545963648,0.0382762160194188,0.0539540422211938,1.29262998548563e-30
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SEL1L,Protein sel-1 homolog 1,39638,0.0370655238034614,0.00321604763824128,0.0307620704325085,0.0433689771744143,1.47308574876747e-30
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CEP85,Centrosomal protein of 85 kDa,41843,0.076352799608678,0.00662906643869754,0.0633598293888308,0.0893457698285252,1.49879885578693e-30
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,LBR,Delta(14)-sterol reductase LBR,42249,0.0796234488684195,0.00691940485958477,0.0660614153436334,0.0931854823932056,1.67643266442306e-30
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CCL25,C-C motif chemokine 25,42296,0.0575168262327037,0.00499953238755444,0.047717742753097,0.0673159097123104,1.72982746881708e-30
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IPCEF1,Interactor protein for cytohesin exchange factors 1,41992,0.104962124916852,0.0091416178276663,0.0870445539746265,0.122879695859078,2.25922403709737e-30
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ANGPTL2,Angiopoietin-related protein 2,42140,0.0460667557689756,0.00402379875822871,0.0381801102028474,0.0539534013351039,3.29185827794514e-30
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NFATC3,"Nuclear factor of activated T-cells, cytoplasmic 3",41913,0.0716644632479149,0.00627509544471871,0.0593652761762662,0.0839636503195635,4.56141466663999e-30
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CTSF,Cathepsin F,42181,0.0468415899242029,0.0041031219912185,0.0387994708214146,0.0548837090269911,4.76426159954904e-30
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,APOE,Apolipoprotein E,39979,0.0815088301634588,0.007137113642216,0.0675200874247154,0.0954975729022021,4.8183250500048e-30
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SCAMP3,Secretory carrier-associated membrane protein 3,42070,0.0971174244661906,0.008525204976005,0.0804080227132209,0.11382682621916,6.29722005429453e-30
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MMP7,Matrilysin,41881,0.0600282062094712,0.00527342273017909,0.0496922976583202,0.0703641147606222,6.97794511576808e-30
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TNFRSF13B,Tumor necrosis factor receptor superfamily member 13B,42144,0.04018229908532,0.00354191322467804,0.033240149164951,0.0471244490056889,1.07153360663569e-29
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PIK3IP1,Phosphoinositide-3-kinase-interacting protein 1,42137,0.0336158198991228,0.00296435868543893,0.0278056768756625,0.0394259629225831,1.13159538645978e-29
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,LDLRAP1,Low density lipoprotein receptor adapter protein 1,39934,0.11601535540174,0.01022819668748,0.0959680898942797,0.136062620909201,1.16480991878008e-29
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SIGLEC10,Sialic acid-binding Ig-like lectin 10,42119,0.0398547526605255,0.00351728907668127,0.0329608660702302,0.0467486392508207,1.2519657214515e-29
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PTH1R,Parathyroid hormone/parathyroid hormone-related peptide receptor,42119,0.0435297520241648,0.00385153050861665,0.0359807522272761,0.0510787518210534,1.74047791429298e-29
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CD40,Tumor necrosis factor receptor superfamily member 5,42129,0.0581304276286746,0.00514390727034396,0.0480483693788004,0.0682124858785488,1.76191770875469e-29
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PTGDS,Prostaglandin-H2 D-isomerase,42083,0.0363433835127991,0.00322453418669471,0.0300232965068775,0.0426634705187207,2.47125227752519e-29
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,AP1G2,AP-1 complex subunit gamma-like 2,39919,0.0917822813410677,0.00814801051005126,0.0758121807413672,0.107752381940768,2.81565621481399e-29
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CCN4,CCN family member 4,42262,0.044759903156215,0.00398331270350892,0.0369526102573375,0.0525671960550925,3.60855876010478e-29
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,HYAL1,Hyaluronidase-1,42077,0.0263540895723321,0.00234754138313627,0.021752908461385,0.0309552706832792,4.08053186393734e-29
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SPINT2,Kunitz-type protease inhibitor 2,42185,0.0449329641659411,0.00401929898346554,0.0370551381583486,0.0528107901735336,6.88327255519799e-29
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PTPRS,Receptor-type tyrosine-protein phosphatase S,42310,-0.0285793490761056,0.002558331358863,-0.0335936785394771,-0.0235650196127341,7.52436086238979e-29
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CPXM2,Inactive carboxypeptidase-like protein X2,39958,0.0290929495461417,0.00260533856678965,0.023986485955234,0.0341994131370494,8.38414280056237e-29
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,VEGFA,Vascular endothelial growth factor A,42253,0.0643423074355311,0.00576632330527606,0.05304031375719,0.0756443011138721,8.68907498974916e-29
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CD72,B-cell differentiation antigen CD72,39736,0.0496444232270072,0.00444858023615063,0.040925205964152,0.0583636404898625,9.1311701539264e-29
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PLA2G15,Phospholipase A2 group XV,42181,0.0311627405337606,0.00279835927985894,0.025677956345237,0.0366475247222841,1.11440220315658e-28
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,BCAN,Brevican core protein,42016,-0.0390351978140689,0.00350838159004249,-0.0459116257305522,-0.0321587698975856,1.24711264642161e-28
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DNAJC6,Putative tyrosine-protein phosphatase auxilin,39638,0.0964815900192056,0.00868580176416387,0.0794574185614444,0.113505761476967,1.62471687882605e-28
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,BACH1,Transcription regulator protein BACH1,42119,0.084733901614519,0.00763335200684087,0.0697725316811109,0.0996952715479271,1.65678006519027e-28
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,KITLG,Kit ligand,42145,-0.0431679046567561,0.00389066839456785,-0.050793614710109,-0.0355421946034031,1.75497364458161e-28
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,VSNL1,Visinin-like protein 1,39929,0.0440390295254613,0.00396795219391713,0.0362618432253837,0.0518162158255389,1.78475060448789e-28
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TNF,Tumor necrosis factor,41880,0.0410241087272374,0.00369966983529552,0.0337727558500582,0.0482754616044166,1.89985976051487e-28
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,39736,0.0328720253610522,0.00296432465506299,0.0270619490371287,0.0386821016849757,1.99332057402108e-28
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,BANK1,B-cell scaffold protein with ankyrin repeats,42119,0.119469438453128,0.0108264960148792,0.0982495062639651,0.140689370642292,3.42075292223752e-28
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SHMT1,"Serine hydroxymethyltransferase, cytosolic",42166,0.095107384218012,0.00862778355640756,0.0781969284474532,0.112017839988571,3.88037297089049e-28
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TRIM5,Tripartite motif-containing protein 5,42119,0.0971184524675406,0.0088342498314753,0.079803322797849,0.114433582137232,5.40154282523493e-28
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,COLEC12,Collectin-12,42123,0.0306154380899748,0.0027869691404996,0.0251529785745956,0.0360778976053541,5.90950680958292e-28
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CXCL17,C-X-C motif chemokine 17,42296,0.0476042251144481,0.00433637754687577,0.0391049251225716,0.0561035251063246,6.38272353250069e-28
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PNLIPRP1,Inactive pancreatic lipase-related protein 1,39929,0.0936700447926332,0.00855000527943233,0.0769120344449458,0.110428055140321,8.61422939197794e-28
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GOLM2,Protein GOLM2,42249,0.0253337513913362,0.0023137633249264,0.0207987752744805,0.029868727508192,8.75159454750483e-28
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TNFRSF1B,Tumor necrosis factor receptor superfamily member 1B,42137,0.0411296532141499,0.00375754569126696,0.0337648636592667,0.0484944427690331,9.09040601638389e-28
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SH2D1A,SH2 domain-containing protein 1A,42119,0.0666602836218745,0.00609206390083163,0.0547198383762445,0.0786007288675045,9.47241217964526e-28
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NPL,N-acetylneuraminate lyase,39958,0.0519269187909904,0.00475325222050901,0.0426105444387928,0.0612432931431881,1.20796267832299e-27
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IFNGR2,Interferon gamma receptor 2,42016,0.0584983047243203,0.0053664581104688,0.0479800468278014,0.0690165626208391,1.49174346220791e-27
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CCL21,C-C motif chemokine 21,42185,0.0424840567890032,0.00389765689729578,0.0348446492703035,0.0501234643077029,1.50038931690975e-27
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,YTHDF3,YTH domain-containing family protein 3,41913,0.094862093897451,0.00871291363803913,0.0777847831668943,0.111939404628008,1.72583356128709e-27
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TFF3,Trefoil factor 3,42143,0.0399617659901958,0.00367214069722151,0.0327643702236417,0.04715916175675,1.81633266308205e-27
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,REG1B,Lithostathine-1-beta,42310,0.0630191130898615,0.00580583408386587,0.0516396782854844,0.0743985478942386,2.45361198297306e-27
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FEN1,Flap endonuclease 1,41843,0.0710875047220367,0.0065517163079875,0.0582461407583812,0.0839288686856922,2.59210224505771e-27
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SMOC2,SPARC-related modular calcium-binding protein 2,42185,0.0431222986058214,0.00397645115256904,0.0353284543467861,0.0509161428648567,2.74194673353921e-27
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,RNASE1,Ribonuclease pancreatic,39990,0.0274299239746305,0.00253421043136343,0.0224628715291581,0.0323969764201028,3.59769026043263e-27
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PLEKHO1,Pleckstrin homology domain-containing family O member 1,39929,0.0772763097832116,0.00715043857543875,0.0632614501753517,0.0912911693910716,4.31270160917394e-27
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FABP4,"Fatty acid-binding protein, adipocyte",42310,0.0552704912714597,0.00512022600470415,0.0452348483022395,0.0653061342406798,4.69220055914408e-27
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MAPK9,Mitogen-activated protein kinase 9,42119,0.0469502495382134,0.00436105602796529,0.0384025797234014,0.0554979193530253,6.41881112474691e-27
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,LAT,Linker for activation of T-cells family member 1,42296,0.0830488393181511,0.00771868573445654,0.0679202152786162,0.0981774633576859,6.85031031456427e-27
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DKK4,Dickkopf-related protein 4,41992,0.0504560426583791,0.00468926972458174,0.0412650739981989,0.0596470113185593,6.85614036627397e-27
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PARP1,Poly [ADP-ribose] polymerase 1,42119,0.0644321645399044,0.00599397709784985,0.0526839694281187,0.0761803596516901,7.65009920548285e-27
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ERP44,Endoplasmic reticulum resident protein 44,42047,0.0284860037379808,0.00265094711597947,0.0232901473906611,0.0336818600853006,7.98727899063194e-27
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IGFBP2,Insulin-like growth factor-binding protein 2,42286,-0.0660138913688946,0.00615076120861098,-0.0780693833377721,-0.0539583994000171,9.139984861579e-27
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CCL3,C-C motif chemokine 3,42119,0.0647620611975051,0.0060417515799256,0.052920228100851,0.0766038942941593,1.0601735289559e-26
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CTSS,Cathepsin S,39358,0.0265587943723771,0.00247970847868608,0.0216985657541524,0.0314190229906018,1.23827562207683e-26
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TGFA,Protransforming growth factor alpha,42119,0.0492724829674074,0.00460753027306722,0.0402417236321957,0.0583032423026192,1.38831256138962e-26
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FYB1,FYN-binding protein 1,42115,0.100622283377702,0.00941336788794131,0.0821720823173369,0.119072484438067,1.45851407398576e-26
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,APOA1,Apolipoprotein A-I,39979,-0.0300000172247393,0.00280604023943256,-0.0354998560940272,-0.0245001783554515,1.49535120736964e-26
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PSME2,Proteasome activator complex subunit 2,41955,0.0382788685625749,0.00358525473860938,0.0312517692749005,0.0453059678502493,1.67259423282993e-26
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CEP20,Centrosomal protein 20,41843,0.0816400495568075,0.00766084966188219,0.0666247842195184,0.0966553148940966,2.07380966048721e-26
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NFKB1,Nuclear factor NF-kappa-B p105 subunit,39575,0.0816437517013133,0.00766186863201423,0.0666264891825654,0.0966610142200612,2.2031444135105e-26
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CBLIF,Cobalamin binding intrinsic factor,42129,0.0828845261679291,0.00778251514037786,0.0676307964927885,0.0981382558430697,2.21561205438829e-26
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ACAN,Aggrecan core protein,41994,-0.0297022920319005,0.00278973894976243,-0.0351701803734349,-0.0242344036903662,2.29590735393859e-26
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CTRB1,Chymotrypsinogen B,42137,0.0632877788539073,0.00594466852018728,0.0516362285543403,0.0749393291534744,2.31059196906243e-26
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SSNA1,Sjoegren syndrome nuclear autoantigen 1,39930,0.0561514372252784,0.00527551465781111,0.0458114284959686,0.0664914459545881,2.48188808514889e-26
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CKB,Creatine kinase B-type,39966,-0.062348222888467,0.00587610133190766,-0.073865381499006,-0.0508310642779279,3.53131052815937e-26
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IKBKG,NF-kappa-B essential modulator,42119,0.0986876102161933,0.00930508517346795,0.0804496432761962,0.116925577156191,3.54994484863506e-26
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,LCAT,Phosphatidylcholine-sterol acyltransferase,39990,0.0235258044038641,0.00222344834918173,0.0191678456394679,0.0278837631682603,4.83282033078231e-26
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,KLK14,Kallikrein-14,42262,-0.0498991603580956,0.00472002636415112,-0.0591504120318318,-0.0406479086843594,5.07546762185589e-26
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PLSCR3,Phospholipid scramblase 3,39911,0.0623971480366729,0.00590504449086942,0.0508232608345688,0.0739710352387769,5.61505534824828e-26
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NFKBIE,NF-kappa-B inhibitor epsilon,41843,0.0529717713670373,0.00502833380839329,0.0431162371025864,0.0628273056314881,7.5670801469651e-26
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TDRKH,Tudor and KH domain-containing protein,41839,0.0910970658681876,0.00865988028529167,0.0741237005090159,0.108070431227359,8.88332808092677e-26
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ECHS1,"Enoyl-CoA hydratase, mitochondrial",39638,0.104384416175987,0.00992905100214537,0.0849234762117818,0.123845356140192,9.95271542678132e-26
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ACP5,Tartrate-resistant acid phosphatase type 5,42211,0.0354615676255928,0.00337524957964966,0.0288460784494795,0.0420770568017062,1.01295455744593e-25
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SMNDC1,Survival of motor neuron-related-splicing factor 30,39930,0.0666430573332717,0.00634143899763957,0.0542138368978982,0.0790722777686453,1.02939963651938e-25
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SERPINA9,Serpin A9,42025,0.0773156827428897,0.00736908774241212,0.0628722707677619,0.0917590947180174,1.18284913463379e-25
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SCPEP1,Retinoid-inducible serine carboxypeptidase,39601,0.0550705006345048,0.00524676297427862,0.0447868452049187,0.0653541560640909,1.18998509709018e-25
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TGFBR2,TGF-beta receptor type-2,42181,0.0366094380274394,0.00348960261840339,0.0297698168953688,0.0434490591595101,1.19082303588296e-25
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PAK4,Serine/threonine-protein kinase PAK 4,41839,0.0654867155483388,0.0062424457411031,0.0532515218957767,0.0777219092009008,1.20343060379489e-25
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,STAB2,Stabilin-2,39966,0.0301287343212538,0.00287589511142267,0.0244919799028654,0.0357654887396422,1.45126945385857e-25
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SRPK2,SRSF protein kinase 2,42119,0.0907599733506607,0.00866878175532626,0.0737691611102212,0.1077507855911,1.48976758177038e-25
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CEP43,Centrosomal protein 43,41797,0.0749669216052141,0.00716571705674836,0.0609221161739873,0.0890117270364409,1.62648830297833e-25
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,RET,Proto-oncogene tyrosine-protein kinase receptor Ret,42070,0.0392375586268798,0.00375105921042909,0.0318854825744388,0.0465896346793208,1.64446957211607e-25
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,INSL5,Insulin-like peptide INSL5,39930,0.109800639437139,0.0105022633789017,0.0892162032144921,0.130385075659787,1.81584337082063e-25
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NFATC1,"Nuclear factor of activated T-cells, cytoplasmic 1",42119,0.105971867208653,0.0101870782524103,0.086005193833929,0.125938540583377,3.00510128936182e-25
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PILRA,Paired immunoglobulin-like type 2 receptor alpha,42137,0.0451171903437485,0.00434126455481538,0.0366083118163104,0.0536260688711867,3.33168573158806e-25
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PPP1R9B,Neurabin-2,42296,0.100298610441936,0.00965378550208049,0.0813771908578578,0.119220030026013,3.43133619305187e-25
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FMNL1,Formin-like protein 1,41839,0.0668256043693472,0.00643732256445883,0.0542084521430079,0.0794427565956865,3.78009338039327e-25
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CDC27,Cell division cycle protein 27 homolog,41843,0.0644436429326809,0.00620958495132283,0.0522728564280882,0.0766144294372737,3.89427445709144e-25
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,RNF41,E3 ubiquitin-protein ligase NRDP1,41843,0.0702016824150227,0.00676980046119773,0.0569328735110752,0.0834704913189703,4.24311016852172e-25
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TFF1,Trefoil factor 1,42084,0.0848837115113382,0.00819015862858311,0.0688310005993153,0.100936422423361,4.48495306210933e-25
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,KCTD5,BTB/POZ domain-containing protein KCTD5,39739,0.0488493187328312,0.00471518054207509,0.0396075648703641,0.0580910725952984,4.89657571445569e-25
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DNAJA2,DnaJ homolog subfamily A member 2,42259,0.0859543217593637,0.00830277399612289,0.0696808847269628,0.102227758791765,5.04587426354981e-25
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ELOA,Elongin-A,42070,0.0566389114256161,0.00548310842479456,0.0458920189130187,0.0673858039382134,6.40668902105013e-25
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,LAMP2,Lysosome-associated membrane glycoprotein 2,41734,0.0216613252969677,0.00210407862520177,0.0175373311915722,0.0257853194023631,9.22506797731119e-25
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CALCA,Calcitonin,41997,0.0726610225322877,0.00706037701517786,0.058822683582539,0.0864993614820363,9.52767711098057e-25
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SNCG,Gamma-synuclein,42016,0.0697985260070353,0.0067933671335167,0.0564835264253426,0.0831135255887281,1.13317122271207e-24
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ASS1,Argininosuccinate synthase,39575,0.0814491966112089,0.00792577454941932,0.065914678494347,0.0969837147280708,1.16316032889021e-24
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TJAP1,Tight junction-associated protein 1,42181,0.0869370460768445,0.0084645715049367,0.0703464859271685,0.10352760622652,1.17553110943167e-24
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NPDC1,Neural proliferation differentiation and control protein 1,42145,0.0348302443811182,0.00339305209739462,0.0281798622702247,0.0414806264920117,1.245004632399e-24
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,APEX1,DNA-(apurinic or apyrimidinic site) endonuclease,42216,0.0602491728182836,0.00587060198425764,0.0487427929291386,0.0717555527074285,1.27348870005651e-24
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SHISA5,Protein shisa-5,39966,0.02721623740377,0.0026562604341405,0.0220099669528546,0.0324225078546854,1.57547366411949e-24
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CEMIP2,Cell surface hyaluronidase,39657,0.0340388349415135,0.00332312573721499,0.0275255084965721,0.0405521613864549,1.63667863098872e-24
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TXNRD1,"Thioredoxin reductase 1, cytoplasmic",42137,0.0482289124908465,0.00471163165261068,0.0389941144517295,0.0574637105299634,1.67746974614178e-24
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,RPL14,60S ribosomal protein L14,39638,0.0408159368301259,0.00400260647567553,0.0329708281378018,0.0486610455224499,2.61145410283447e-24
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,HNMT,Histamine N-methyltransferase,41961,0.0495739473388679,0.00486659986897047,0.0400354115956858,0.05911248308205,2.79260045337983e-24
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ITPR1,"Inositol 1,4,5-trisphosphate receptor type 1",39638,0.0715994434854114,0.00703537269677627,0.0578101129997299,0.0853887739710929,3.21060905205376e-24
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CCL14,C-C motif chemokine 14,42152,0.0419056184480393,0.00412079454497072,0.0338288611398967,0.0499823757561819,3.32050933175192e-24
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,VSIG4,V-set and immunoglobulin domain-containing protein 4,42113,0.0447427946365241,0.00440684598421502,0.0361053765074626,0.0533802127655855,3.9215218270772e-24
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,BCR,Breakpoint cluster region protein,42119,0.0954433757817779,0.00940558065744003,0.0770084376931954,0.11387831387036,4.1464779592575e-24
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,APOC1,Apolipoprotein C-I,39959,-0.0398916631991446,0.00394708421780521,-0.0476279482660429,-0.0321553781322464,6.51674125092425e-24
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CHCHD6,MICOS complex subunit MIC25,39919,0.0300847855565037,0.00297816021284905,0.0242475915393196,0.0359219795736878,6.84731167319229e-24
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ARHGEF12,Rho guanine nucleotide exchange factor 12,42119,0.10687005800334,0.0105990694105877,0.0860958819585885,0.127644234048092,7.97737816617745e-24
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TOMM20,Mitochondrial import receptor subunit TOM20 homolog,39958,0.0796408160668851,0.00789685242027546,0.0641629853231451,0.095118646810625,8.09631922971451e-24
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ATP6AP2,Renin receptor,41843,0.0404170485249151,0.00401093743846482,0.032555611145524,0.0482784859043061,8.53203644041392e-24
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,KRT8,"Keratin, type II cytoskeletal 8",39586,0.086751811624285,0.00860585735607946,0.0698843312063692,0.103619292042201,8.54523356853712e-24
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MTHFSD,Methenyltetrahydrofolate synthase domain-containing protein,39757,0.11799191046845,0.0117235131516231,0.0950138246912686,0.140969996245631,1.00043361715338e-23
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FUS,RNA-binding protein FUS,41831,0.0407141685429298,0.00404794717225085,0.0327801920853182,0.0486481450005415,1.03082144474301e-23
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IGF2R,Cation-independent mannose-6-phosphate receptor,42137,0.0245814743980718,0.00244417356685348,0.019790894207039,0.0293720545891046,1.03466534520734e-23
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GRHPR,Glyoxylate reductase/hydroxypyruvate reductase,39958,0.0644998570087731,0.00641337134801517,0.0519296491666634,0.0770700648508829,1.0740768104617e-23
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,EIF2AK2,"Interferon-induced, double-stranded RNA-activated protein kinase",39906,0.113417298721333,0.0112973199373933,0.0912745516440426,0.135560045798624,1.28570374696787e-23
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,AXIN1,Axin-1,42119,0.0985396662080904,0.00983234301357916,0.0792682739014753,0.117811058514706,1.47450326903873e-23
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SERPINA5,Plasma serine protease inhibitor,39835,0.0309168890207765,0.00308411419330837,0.0248720252018921,0.0369617528396609,1.49304989827886e-23
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SERPINH1,Serpin H1,39757,0.132599116758194,0.0132400709593533,0.106648577677861,0.158549655838526,1.64611391166955e-23
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DDC,Aromatic-L-amino-acid decarboxylase,42129,0.048519263238755,0.00485022871779522,0.0390128149518764,0.0580257115256336,1.77495750426211e-23
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SNAPIN,SNARE-associated protein Snapin,39934,0.0598818767975857,0.00598902373085278,0.0481433902851143,0.0716203633100572,1.93276123687611e-23
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CD27,CD27 antigen,42181,0.0434202852395059,0.00435209233475432,0.0348901842633875,0.0519503862156244,2.31566114761486e-23
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DDR1,Epithelial discoidin domain-containing receptor 1,42249,0.0240297974237468,0.00241267913374993,0.0193009463215969,0.0287586485258966,2.74409374856873e-23
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SNAP23,Synaptosomal-associated protein 23,42145,0.0881435285224398,0.00886030929382551,0.0707773223065418,0.105509734738338,3.08721613149424e-23
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,HDGFL2,Hepatoma-derived growth factor-related protein 2,39929,0.0652099414599234,0.00655843935983133,0.052355400314654,0.0780644826051928,3.37031275903648e-23
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,RBFOX3,RNA binding protein fox-1 homolog 3,39934,0.04050872230617,0.00408123866808481,0.0325094945167238,0.0485079500956162,4.00315716704545e-23
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,RAB6A,Ras-related protein Rab-6A,42119,-0.0448563119402504,0.00452153589512352,-0.0537185222946925,-0.0359941015858083,4.06304799068795e-23
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ASAH2,Neutral ceramidase,42016,0.0536521542130113,0.00541104988170017,0.043046496444879,0.0642578119811436,4.28875625714115e-23
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CLEC4D,C-type lectin domain family 4 member D,42119,0.0623123273387972,0.00630562857841009,0.0499532953251134,0.074671359352481,5.95909728250542e-23
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SEPTIN8,Septin-8,39906,0.0329890439737363,0.00333851194580033,0.0264455605599676,0.0395325273875049,6.21059145218217e-23
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,WARS,"Tryptophan--tRNA ligase, cytoplasmic",42137,0.0387992288917856,0.00393475686850746,0.031087105429511,0.0465113523540602,7.36161119522489e-23
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SH3GLB2,Endophilin-B2,39929,0.0664117719014709,0.00673924086473658,0.0532028598065872,0.0796206839963546,8.09618754676422e-23
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,WWP2,NEDD4-like E3 ubiquitin-protein ligase WWP2,42016,0.0526452973184528,0.00534585222016475,0.0421674269669299,0.0631231676699757,8.36463710892733e-23
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CANT1,Soluble calcium-activated nucleotidase 1,42084,0.0200554612371999,0.00204283335735219,0.0160515078567896,0.0240594146176102,1.12791699331033e-22
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,S100A4,Protein S100-A4,42181,0.0560400631335479,0.00570858933206491,0.0448512280427007,0.0672288982243951,1.1340372961276e-22
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ZBTB17,Zinc finger and BTB domain-containing protein 17,41900,0.0419962269557097,0.00428077833972901,0.0336059014098408,0.0503865525015786,1.2119315497838e-22
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IL15,Interleukin-15,42119,0.0328753478647069,0.0033560540653669,0.0262974818965878,0.039453213832826,1.3948372896205e-22
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,BCHE,Cholinesterase,39806,0.0270281012939808,0.00275938315427615,0.0216197103115995,0.0324364922763621,1.45741835810228e-22
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IL12RB1,Interleukin-12 receptor subunit beta-1,41913,0.0374917526261929,0.00383534007106794,0.0299744860868997,0.045009019165486,1.71017016890375e-22
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SIAE,Sialate O-acetylesterase,42147,0.0462651402890017,0.00473550578192545,0.0369835489564278,0.0555467316215756,1.79949012962097e-22
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ENPP7,Ectonucleotide pyrophosphatase/phosphodiesterase family member 7,41768,0.0835150717617868,0.00854884393288984,0.0667593376533228,0.100270805870251,1.82033215008771e-22
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,EIF4G1,Eukaryotic translation initiation factor 4 gamma 1,42296,0.0972461759633352,0.00996298835772998,0.0777187187821844,0.116773633144486,1.96361453406257e-22
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ERBIN,Erbin,42070,0.101982216831895,0.0104491641414592,0.0815018551146348,0.122462578549155,1.98655807694023e-22
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ICAM1,Intercellular adhesion molecule 1,42126,0.0289345092016615,0.00296896703832945,0.0231153338065358,0.0347536845967872,2.28096233709317e-22
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,BPIFB1,BPI fold-containing family B member 1,42098,-0.0642795985042173,0.00659741478483129,-0.0772105314824866,-0.0513486655259479,2.33819241708775e-22
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FCN1,Ficolin-1,39978,0.0557558364899899,0.00572219513487987,0.0445403340256254,0.0669713389543545,2.39793468807497e-22
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IDO1,"Indoleamine 2,3-dioxygenase 1",39638,0.0626109832025463,0.00642534266420034,0.0500173115807136,0.0752046548243789,2.39875739405383e-22
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PENK,Proenkephalin-A,39736,0.0309648517459485,0.00318071981479538,0.0247306409089495,0.0371990625829474,2.61952754109989e-22
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SEMA7A,Semaphorin-7A,42272,0.0282971178167142,0.00290928203190338,0.0225949250341836,0.0339993105992449,2.74533830263857e-22
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SNCA,Alpha-synuclein,39736,0.117333476278539,0.0120976244616042,0.0936221323337947,0.141044820223283,3.72938871293484e-22
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,AKT1S1,Proline-rich AKT1 substrate 1,41839,0.0655851335869235,0.00677225185353642,0.0523115199539922,0.0788587472198549,4.15908097387048e-22
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NT5C1A,Cytosolic 5'-nucleotidase 1A,39929,0.0306403788362202,0.00316434487091963,0.0244382628892177,0.0368424947832226,4.33627693087067e-22
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,EIF4EBP1,Eukaryotic translation initiation factor 4E-binding protein 1,42145,0.0618922927136313,0.00640231132960958,0.0493437625075966,0.0744408229196661,4.8969755834787e-22
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,UFD1,Ubiquitin recognition factor in ER-associated degradation protein 1,39930,0.139052617684105,0.0143970870576243,0.110834327051161,0.167270908317048,5.50493886105658e-22
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,BST2,Bone marrow stromal antigen 2,42249,0.0501320760440014,0.0051932528101699,0.0399533005360684,0.0603108515519344,5.59487073839915e-22
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MFAP5,Microfibrillar-associated protein 5,42310,0.0397243205018252,0.00411641153138959,0.0316561539003016,0.0477924871033488,5.76012623510233e-22
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NIT2,Omega-amidase NIT2,39903,0.0721958970834401,0.00748264900597623,0.0575299050317267,0.0868618891351535,6.06372420198073e-22
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NCAN,Neurocan core protein,42249,-0.0367814247085129,0.00381640995586494,-0.0442615882220082,-0.0293012611950176,6.50739337881171e-22
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TRIM24,Transcription intermediary factor 1-alpha,39735,0.0653984164470881,0.00678491061051476,0.0520999916504791,0.078696841243697,6.67515078572822e-22
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,BTN2A1,Butyrophilin subfamily 2 member A1,42185,0.0266151511237324,0.00277499146810589,0.0211761678462449,0.03205413440122,1.02131699221342e-21
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,BSG,Basigin,42284,0.0204137559708623,0.00212914230120341,0.0162406370605036,0.024586874881221,1.05299230134263e-21
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ATG16L1,Autophagy-related protein 16-1,39930,0.0848105326270761,0.0088489776058798,0.0674665365195517,0.1021545287346,1.12563986744263e-21
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CES3,Carboxylesterase 3,42070,0.0693925342708821,0.00724647981618326,0.055189433831163,0.0835956347106013,1.18191809947326e-21
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,AMN,Protein amnionless,41913,0.0460406439009379,0.00481111117323406,0.0366108660013992,0.0554704218004767,1.25904610490339e-21
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,VPS53,Vacuolar protein sorting-associated protein 53 homolog,42070,0.0756848187753544,0.00791021266388393,0.060180801954142,0.0911888355965669,1.27691846122282e-21
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,S100A14,Protein S100-A14,39934,0.0508776076232165,0.00531595037184735,0.0404583448943957,0.0612968703520373,1.28101335442605e-21
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FGR,Tyrosine-protein kinase Fgr,41839,0.057230648801915,0.00598270726334829,0.0455045425657523,0.0689567550380776,1.30496069506089e-21
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NAA80,N-alpha-acetyltransferase 80,39649,0.120749050784267,0.0126352257689966,0.0959840082770341,0.145514093291501,1.47498977961799e-21
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DAG1,Dystroglycan,42185,0.0461179921859503,0.00483726641101397,0.0366369500203629,0.0555990343515377,1.76832134439915e-21
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CTSZ,Cathepsin Z,42168,0.0313421333872346,0.00328926854119526,0.0248951670464919,0.0377890997279773,1.86055301097617e-21
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TIMD4,T-cell immunoglobulin and mucin domain-containing protein 4,42217,-0.0417761629380569,0.00438476783181313,-0.0503703078884107,-0.0331820179877032,1.87806764946937e-21
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,RNF149,E3 ubiquitin-protein ligase RNF149,39638,0.0308926896997348,0.00324313330543749,0.0245361484210773,0.0372492309783923,1.98393224465876e-21
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TARBP2,RISC-loading complex subunit TARBP2,41839,0.0766711167888233,0.0080598580169678,0.0608737950755664,0.0924684385020802,2.17400523089459e-21
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,LIFR,Leukemia inhibitory factor receptor,42119,0.0232581362187676,0.00244694760696388,0.0184621189091184,0.0280541535284168,2.33348852052384e-21
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CTSB,Cathepsin B,42153,-0.0491438640654595,0.00517201568313749,-0.059281014804409,-0.0390067133265101,2.40218005938806e-21
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,STAT5B,Signal transducer and activator of transcription 5B,42070,0.132836339935456,0.0139819092210701,0.105431797862159,0.160240882008754,2.43425079443848e-21
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,COL5A1,Collagen alpha-1(V) chain,39736,0.0399990481665418,0.00420948512090428,0.0317484573295694,0.0482496390035142,2.47705555983315e-21
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ISM1,Isthmin-1,42119,0.0382267316211261,0.00402466372301863,0.0303383907240096,0.0461150725182426,2.49086465965136e-21
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TREH,Trehalase,39966,0.0732566789126652,0.00771105552168287,0.0581430100901667,0.0883703477351636,2.51310743550754e-21
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,KRT5,"Keratin, type II cytoskeletal 5",41839,0.0516194107712221,0.00543627579185729,0.0409643102191818,0.0622745113232624,2.56543129084243e-21
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,LYN,Tyrosine-protein kinase Lyn,42070,0.0821616988141561,0.00865567600146103,0.0651965738512925,0.0991268237770198,2.63607310504204e-21
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DNER,Delta and Notch-like epidermal growth factor-related receptor,42089,-0.0251397713231247,0.00264957722155348,-0.0303329426773695,-0.0199465999688799,2.73826659129435e-21
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GUCA2A,Guanylin,42083,0.0340109573608516,0.00358473377560137,0.0269848791606729,0.0410370355610303,2.7514745324136e-21
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MDK,Midkine,42129,0.0494655061842415,0.00521679100256456,0.039240595819215,0.059690416549268,2.90465062144472e-21
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,42295,0.0269875991476251,0.00284907475775933,0.0214034126224169,0.0325717856728334,3.17586485709701e-21
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PDCD5,Programmed cell death protein 5,42249,0.0551880849234263,0.00583168243155769,0.0437579873575732,0.0666181824892794,3.45857651841454e-21
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CSF1,Macrophage colony-stimulating factor 1,42185,0.0260434777027782,0.0027521884081236,0.020649188422856,0.0314377669827005,3.48303499649967e-21
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FGF19,Fibroblast growth factor 19,42185,0.074903794599747,0.00791813823288443,0.0593842436632935,0.0904233455362005,3.58551031619753e-21
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GGT5,Glutathione hydrolase 5 proenzyme,42016,0.023044327103662,0.00243659651683327,0.0182685979306688,0.0278200562766552,3.66760040914759e-21
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ITIH3,Inter-alpha-trypsin inhibitor heavy chain H3,42217,-0.0372240372964299,0.00393844918483451,-0.0449433976987055,-0.0295046768941542,3.87924501932921e-21
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MTDH,Protein LYRIC,39657,0.0924373997108654,0.00978436392600985,0.0732600464158861,0.111614753005845,4.16925297744824e-21
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CEACAM8,Carcinoembryonic antigen-related cell adhesion molecule 8,41900,0.0467501653713672,0.00495113664105804,0.0370459375548935,0.056454393187841,4.24544932709129e-21
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DDT,D-dopachrome decarboxylase,39966,0.0392901856452364,0.00416701321334585,0.0311228397470786,0.0474575315433943,4.94754059554147e-21
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SCGN,Secretagogin,41913,0.042616037654257,0.00452510535823676,0.0337468311521129,0.051485244156401,5.35946650451351e-21
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PSMG3,Proteasome assembly chaperone 3,42119,0.0474175892239794,0.00503648718236062,0.0375460743465526,0.0572891041014062,5.49469085506205e-21
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,VSIR,V-type immunoglobulin domain-containing suppressor of T-cell activation,42119,0.0588880170253197,0.00625557204272192,0.0466270958215848,0.0711489382290547,5.55338687905602e-21
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SLITRK2,SLIT and NTRK-like protein 2,42262,0.0389058159778848,0.00413592245789594,0.0307994079604088,0.0470122239953609,5.91772747883654e-21
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,HIP1R,Huntingtin-interacting protein 1-related protein,39904,0.0440127447143535,0.00467797378330471,0.0348439160990763,0.0531815733296308,6.00247078095327e-21
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IQGAP2,Ras GTPase-activating-like protein IQGAP2,42070,0.0514641339490001,0.00547362944779049,0.0407358202313307,0.0621924476666694,6.19391104737456e-21
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NBL1,Neuroblastoma suppressor of tumorigenicity 1,42181,0.0262499258193713,0.00279428283345333,0.0207731314658028,0.0317267201729398,6.67437018342538e-21
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NCAM2,Neural cell adhesion molecule 2,42137,-0.0257691842609782,0.00274487447666423,-0.0311491382352401,-0.0203892302867163,7.06937140120123e-21
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,LAYN,Layilin,41997,0.0341752392616613,0.00364078572764554,0.027039299235476,0.0413111792878465,7.16978151279991e-21
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PGLYRP2,N-acetylmuramoyl-L-alanine amidase,39862,0.0279676365252138,0.00299264704261933,0.0221020483216799,0.0338332247287476,1.08703333316059e-20
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DTNB,Dystrobrevin beta,39900,0.0436246998581084,0.00466810690932393,0.0344752103158335,0.0527741894003834,1.08829606832772e-20
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PQBP1,Polyglutamine-binding protein 1,41843,0.0535883448776665,0.00576733957621052,0.0422843593082938,0.0648923304470391,1.75257725512527e-20
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GDNF,Glial cell line-derived neurotrophic factor,41839,0.0362574057686834,0.00390293549209438,0.0286076522041784,0.0439071593331884,1.78424870235454e-20
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FKBP4,Peptidyl-prolyl cis-trans isomerase FKBP4,42016,0.0406615208448247,0.00437736157924558,0.0320818921495034,0.0492411495401461,1.79308091241235e-20
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CNST,Consortin,42145,0.10316288846596,0.0111134822547657,0.0813804632466188,0.1249453136853,1.90032849462134e-20
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,COCH,Cochlin,39958,0.043627455475661,0.00470754111397937,0.0344006748922615,0.0528542360590606,2.24670286879466e-20
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ARHGEF1,Rho guanine nucleotide exchange factor 1,39929,0.0851962534966485,0.00920159039402173,0.0671611363243659,0.103231370668931,2.43716271324014e-20
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MTUS1,Microtubule-associated tumor suppressor 1,39757,0.0542465437460119,0.00586348028170477,0.0427541223938706,0.0657389650981533,2.61397950643604e-20
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CCL22,C-C motif chemokine 22,41991,0.0487098398495282,0.00528659475128288,0.0383481141370138,0.0590715655620427,3.60908664575894e-20
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ATP6V1G1,V-type proton ATPase subunit G 1,39638,0.068804624445493,0.00748038206595263,0.0541430755962259,0.0834661732947602,4.30094511044427e-20
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,USP8,Ubiquitin carboxyl-terminal hydrolase 8,41900,0.0890351439370791,0.00969291689969334,0.0700370268136801,0.108033261060478,4.69096854882082e-20
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TAX1BP1,Tax1-binding protein 1,39929,0.0584554436541254,0.00636477848789463,0.0459804778178519,0.0709304094903989,4.8646347703367e-20
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SLA2,Src-like-adapter 2,39934,0.100594608739249,0.01096232563475,0.0791084504951396,0.122080766983359,5.22760338207704e-20
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GCC1,GRIP and coiled-coil domain-containing protein 1,39929,0.102459503502487,0.0111667647718158,0.0805726445497285,0.124346362455246,5.27615446574396e-20
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FOXO1,Forkhead box protein O1,42119,0.0810070981718924,0.00883254168313705,0.0636953164729438,0.098318879870841,5.33357134212902e-20
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DAAM1,Disheveled-associated activator of morphogenesis 1,39736,0.0779047913163033,0.00851284944838557,0.0612196063974676,0.094589976235139,6.5956588328611e-20
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,EPHA2,Ephrin type-A receptor 2,41614,0.0302782177813156,0.00330969725228159,0.0237912111668437,0.0367652243957876,6.63184255237817e-20
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PNLIP,Pancreatic triacylglycerol lipase,39990,0.0624095126611181,0.0068213061308654,0.0490397526446219,0.0757792726776143,6.70845600821284e-20
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MEGF9,Multiple epidermal growth factor-like domains protein 9,42272,0.0182872194143281,0.00200021574843525,0.014366796547395,0.0222076422812612,6.9436504093346e-20
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,EPPK1,Epiplakin,39638,0.0693794507354864,0.00759646796204812,0.054490373529872,0.0842685279411007,7.8143404178377e-20
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,USP25,Ubiquitin carboxyl-terminal hydrolase 25,39919,0.0676711912839615,0.00741438633360587,0.053138994070094,0.082203388497829,8.23176875178024e-20
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SPRR3,Small proline-rich protein 3,39929,0.0589123986678246,0.00645778194478167,0.0462551460560525,0.0715696512795967,8.56249458298478e-20
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FAS,Tumor necrosis factor receptor superfamily member 6,42272,0.0308478428237983,0.00338850096855465,0.0242063809254312,0.0374893047221654,9.9251512101595e-20
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CD302,CD302 antigen,42070,0.0289198052077708,0.00317779109279179,0.0226913346658989,0.0351482757496427,1.02288988755642e-19
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,BLOC1S3,Biogenesis of lysosome-related organelles complex 1 subunit 3,39929,0.0385163213919272,0.00423182174323293,0.0302219507751906,0.0468106920086638,1.03869681848509e-19
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CD79B,B-cell antigen receptor complex-associated protein beta chain,42296,0.0423108688157869,0.00465573757589401,0.0331856231670346,0.0514361144645391,1.14645408779488e-19
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PPP1R12A,Protein phosphatase 1 regulatory subunit 12A,42181,0.0878860586731061,0.0096772755373486,0.0689185986199028,0.106853518726309,1.21461547235217e-19
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ILKAP,Integrin-linked kinase-associated serine/threonine phosphatase 2C,41825,0.0546543423886766,0.0060192192343952,0.0428566726892621,0.0664520120880912,1.23810119998994e-19
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PILRB,Paired immunoglobulin-like type 2 receptor beta,42145,0.0534923838974776,0.00589361595075099,0.0419408966340057,0.0650438711609496,1.27606087751236e-19
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,THY1,Thy-1 membrane glycoprotein,42249,0.0270207120175297,0.00297829162578497,0.0211832604309911,0.0328581636040682,1.31948387989864e-19
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,EHBP1,EH domain-binding protein 1,39958,0.0696919439360773,0.00768351988269412,0.0546322449659968,0.0847516429061577,1.38134854918601e-19
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,POF1B,Protein POF1B,39657,0.0422973584601173,0.00466390337932151,0.0331561078366472,0.0514386090835875,1.40260764396409e-19
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ADA2,Adenosine deaminase 2,42096,0.0405824681655357,0.00447722877376308,0.0318070997689601,0.0493578365621113,1.42607080272713e-19
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CD83,CD83 antigen,42119,0.0318812947719459,0.00351837225674093,0.0249852851487337,0.0387773043951581,1.46285081899895e-19
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ENTPD5,Ectonucleoside triphosphate diphosphohydrolase 5,41900,-0.0204011448514578,0.00225150259407216,-0.0248140899358392,-0.0159881997670763,1.46927451504723e-19
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TNFRSF9,Tumor necrosis factor receptor superfamily member 9,42016,0.0395500433175912,0.0043676838835948,0.0309893829057454,0.048110703729437,1.54969939618304e-19
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CMIP,C-Maf-inducing protein,39919,0.0779526551493185,0.00861782942157294,0.0610617094830356,0.0948436008156015,1.73205189320785e-19
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ERBB3,Receptor tyrosine-protein kinase erbB-3,42084,0.0178446650371846,0.00197490268708177,0.0139738557705043,0.0217154743038648,1.84823611989581e-19
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IL1R1,Interleukin-1 receptor type 1,42113,0.0219457887114996,0.00243023138106248,0.0171825352046171,0.026709042218382,1.94047903241139e-19
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SDCCAG8,Serologically defined colon cancer antigen 8,39919,0.105720387720925,0.0117244492813275,0.082740467129523,0.128700308312327,2.24163308391363e-19
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,APLP1,Amyloid-like protein 1,42145,-0.0467675955006566,0.0051890588525719,-0.0569381508516975,-0.0365970401496157,2.27581515337244e-19
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,AP3B1,AP-3 complex subunit beta-1,39930,0.0712694436671872,0.00791513119089471,0.0557557865330335,0.0867831008013408,2.51865733396365e-19
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SLC16A1,Monocarboxylate transporter 1,41839,0.0505833867524361,0.0056226353575399,0.0395630214516579,0.0616037520532143,2.6465833249921e-19
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PLIN1,Perilipin-1,41839,0.031097062548142,0.00345873557559084,0.0243179408199839,0.0378761842763,2.7818059525026e-19
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PDLIM7,PDZ and LIM domain protein 7,42185,0.114785183232404,0.0127804573369236,0.0897354868520333,0.139834879612774,3.0235710624019e-19
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NRCAM,Neuronal cell adhesion molecule,42145,0.026315346354332,0.00293304691342357,0.0205665744040218,0.0320641183046423,3.28933148954042e-19
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CD48,CD48 antigen,42166,0.0280537671555971,0.00313504575733843,0.0219090774712138,0.0341984568399804,4.06765299167911e-19
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CD207,C-type lectin domain family 4 member K,41832,0.0355506597701499,0.00398334613977014,0.0277433013362004,0.0433580182040994,5.04525121492654e-19
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,KLF4,Krueppel-like factor 4,39586,0.0371906972390719,0.00416687525216264,0.0290236217448331,0.0453577727333107,5.14942601204146e-19
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ANXA2,Annexin A2,39492,0.0645536263607917,0.00723354952962621,0.0503758692827244,0.0787313834388591,5.20812669663118e-19
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ASPN,Asporin,39958,-0.0254298608403878,0.00285327037651051,-0.0310222707783484,-0.0198374509024272,5.74740235065943e-19
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,LGALS8,Galectin-8,42249,0.0552226255466371,0.00620002070980382,0.0430705849554216,0.0673746661378526,5.90641414263043e-19
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SCARA5,Scavenger receptor class A member 5,42249,0.0276921922410574,0.00310919505616622,0.0215981699309716,0.0337862145511432,5.92222525622269e-19
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PRSS22,Brain-specific serine protease 4,39657,0.0316263948030873,0.00355545219575727,0.0246577084994031,0.0385950811067715,6.73857345220432e-19
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,QDPR,Dihydropteridine reductase,42081,0.0382227220769268,0.00430206523821494,0.0297906742100255,0.0466547699438281,7.20969791907265e-19
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,REG1A,Lithostathine-1-alpha,42105,0.0452000867444353,0.00508925197309945,0.0352251528771604,0.0551750206117102,7.42127762651877e-19
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,HAVCR2,Hepatitis A virus cellular receptor 2,42137,0.0326339295778705,0.00367591685294426,0.0254291325460997,0.0398387266096412,7.66959008345335e-19
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GCHFR,GTP cyclohydrolase 1 feedback regulatory protein,39410,0.0451992946089791,0.00509257544738064,0.035217846732113,0.0551807424858451,8.05784058105303e-19
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PTPRH,Receptor-type tyrosine-protein phosphatase H,39930,0.0457241549040855,0.00515405638160487,0.0356222043961399,0.055826105412031,8.29776908374963e-19
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ACHE,Acetylcholinesterase,39736,0.0311740358799101,0.00351555659626641,0.0242835449512279,0.0380645268085922,8.62259052486613e-19
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NUDT5,ADP-sugar pyrophosphatase,42137,0.0450801871085252,0.00508623487684858,0.0351111667499019,0.0550492074671484,8.73680699679505e-19
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PCSK9,Proprotein convertase subtilisin/kexin type 9,42310,0.0358931651586658,0.00405223062668832,0.0279507931303567,0.0438355371869748,9.16620094901709e-19
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ITGA5,Integrin alpha-5,42137,0.0224420183318131,0.00253379777450677,0.0174757746937798,0.0274082619698463,9.22584350489371e-19
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TIMM8A,Mitochondrial import inner membrane translocase subunit Tim8 A,39929,0.078861630697044,0.0089085862172753,0.0614008017111844,0.0963224596829036,9.84364018667757e-19
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,LAMB1,Laminin subunit beta-1,39638,0.0284981426090527,0.00322025345883845,0.0221864458297294,0.0348098393883761,1.01159585317864e-18
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CCL4,C-C motif chemokine 4,42148,0.0560549818167277,0.00634561656692184,0.0436175733455609,0.0684923902878945,1.13633703738113e-18
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PCBP2,Poly(rC)-binding protein 2,39934,0.0662499178796806,0.00750178364746867,0.0515464219306421,0.0809534138287192,1.18735886110766e-18
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,KAZN,Kazrin,39930,0.0950420439169649,0.0107714608112032,0.0739299807270066,0.116154107106923,1.27160363001643e-18
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MMP1,Interstitial collagenase,41693,0.0810901600540249,0.00919411829295596,0.0630696881998312,0.0991106319082186,1.29044731695604e-18
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,WFDC2,WAP four-disulfide core domain protein 2,41430,0.0377798396381609,0.00428458444461725,0.0293820541267111,0.0461776251496107,1.31866884296241e-18
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CA6,Carbonic anhydrase 6,42103,-0.0562367400408206,0.00638047496430605,-0.0687424709708605,-0.0437310091107808,1.35506264594112e-18
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SH2B3,SH2B adapter protein 3,41843,0.0886201090254599,0.0100548903357086,0.068912523967471,0.108327694083449,1.36107470299993e-18
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PLXNA4,Plexin-A4,42119,0.0719921174857173,0.00820302680529306,0.0559141849473429,0.0880700500240917,1.89006415227168e-18
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CLEC1B,C-type lectin domain family 1 member B,42249,0.0853536866948692,0.00972937224301672,0.0662841170985564,0.104423256291182,1.94739743597628e-18
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CCDC80,Coiled-coil domain-containing protein 80,42145,0.0314903980787046,0.00359156254457265,0.0244509354913422,0.038529860666067,2.03528298381151e-18
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SPOCK1,Testican-1,42016,-0.0233145331340302,0.00265909479734673,-0.0285263589368298,-0.0181027073312306,2.03811643238122e-18
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CD163,Scavenger receptor cysteine-rich type 1 protein M130,42217,0.0386317636849505,0.00440781635892321,0.0299924436214611,0.04727108374844,2.09801824964097e-18
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DKK1,Dickkopf-related protein 1,42249,0.0525683512440418,0.00600532347385462,0.0407979172352868,0.0643387852527969,2.3061328117091e-18
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,HEXIM1,Protein HEXIM1,42119,0.0720202000418295,0.00822938201928216,0.0558906112840365,0.0881497887996225,2.35029257729976e-18
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PTPRM,Receptor-type tyrosine-protein phosphatase mu,42100,0.0217477477659694,0.00249029501586684,0.0168667695348704,0.0266287259970684,2.76870905112665e-18
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ENTR1,Endosome-associated-trafficking regulator 1,39638,0.0554292017553632,0.00634897513937968,0.042985210482179,0.0678731930285473,2.90234035467361e-18
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PDGFC,Platelet-derived growth factor C,41843,0.024867230105944,0.0028502088084108,0.0192808208414588,0.0304536393704292,2.98449540425463e-18
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SERPINE1,Plasminogen activator inhibitor 1,42310,0.058999895583499,0.00676877079618948,0.0457331048229676,0.0722666863440304,3.19576519439928e-18
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FAM3D,Protein FAM3D,39930,0.0782953947302264,0.00898581006013547,0.0606832070123608,0.0959075824480919,3.36327764117628e-18
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ERBB2,Receptor tyrosine-protein kinase erbB-2,42181,0.0216813889570305,0.00248953987130422,0.0168018908092743,0.0265608871047868,3.41640013093343e-18
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ADD1,Alpha-adducin,39736,0.0622912791116842,0.00715957588306524,0.0482585103808764,0.0763240478424921,3.7711761594109e-18
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,B2M,Beta-2-microglobulin,39979,0.0271160534624519,0.0031185879893727,0.0210036210032814,0.0332284859216224,3.94391438176105e-18
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,RARRES1,Retinoic acid receptor responder protein 1,41843,0.0280385778947521,0.00322582893184524,0.0217159531883354,0.0343612026011687,3.97944298640992e-18
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,JAM2,Junctional adhesion molecule B,42249,0.0241719247287299,0.00278439042434256,0.0187145194970185,0.0296293299604414,4.35471643494748e-18
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FLT4,Vascular endothelial growth factor receptor 3,42181,0.0300782689291626,0.0034702059169153,0.0232766653320086,0.0368798725263166,4.9090843446e-18
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,RFC4,Replication factor C subunit 4,39919,0.01971180956656,0.00227755272704092,0.0152478062215598,0.0241758129115602,5.60352474245508e-18
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FETUB,Fetuin-B,42199,0.0283552476186924,0.00328126712946691,0.0219239640449373,0.0347865311924476,6.1584473131253e-18
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SLMAP,Sarcolemmal membrane-associated protein,39930,0.0740700398905349,0.00857330460425934,0.0572663628661866,0.0908737169148832,6.39559113459545e-18
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CRELD2,Protein disulfide isomerase CRELD2,42166,0.0459557981590783,0.00532335654732223,0.0355220193263267,0.0563895769918299,6.64408382423131e-18
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,KLRD1,Natural killer cells antigen CD94,42296,0.041521751227791,0.00481201368383034,0.0320902044074835,0.0509532980480984,6.87801433845642e-18
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SLIT2,Slit homolog 2 protein,41839,0.0453139646099431,0.00526847038493767,0.0349877626554653,0.0556401665644209,8.78588657561127e-18
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,WDR46,WD repeat-containing protein 46,39919,0.032369088331436,0.00376266052772824,0.0249942736970886,0.0397439029657833,8.81034870233047e-18
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NCR1,Natural cytotoxicity triggering receptor 1,42095,0.0336348985530983,0.00391183148279101,0.025967708846828,0.0413020882593687,8.97773150701106e-18
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CEACAM20,Carcinoembryonic antigen-related cell adhesion molecule 20,39757,0.0395412879254938,0.00459758125494958,0.0305300286657927,0.048552547185195,9.00039175854335e-18
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NFE2,Transcription factor NF-E2 45 kDa subunit,39638,0.0654535253271838,0.00761797862882543,0.050522287214686,0.0803847634396817,9.6980513538181e-18
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,HSD17B14,17-beta-hydroxysteroid dehydrogenase 14,39929,0.0561654255299989,0.00654483880119617,0.0433375414796544,0.0689933095803434,1.05710121377608e-17
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IDS,Iduronate 2-sulfatase,42296,-0.00803151161824935,0.000938395507949039,-0.00987076681382947,-0.00619225642266923,1.26106907445161e-17
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,EVI5,Ecotropic viral integration site 5 protein homolog,39657,0.0794071254918011,0.00932924217786879,0.0611218108231783,0.097692440160424,1.93630815322491e-17
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CNP,"2',3'-cyclic-nucleotide 3'-phosphodiesterase",39627,0.0690981198074963,0.00811872341661758,0.0531854219109258,0.0850108177040668,1.94824099388488e-17
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ATXN3,Ataxin-3,39929,0.0532998770078134,0.00626324303553632,0.0410239206581622,0.0655758333574645,1.95883982369616e-17
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DLK1,Protein delta homolog 1,42310,0.0500551324759438,0.00589574298645904,0.038499476222484,0.0616107887294035,2.27597842683773e-17
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SPON1,Spondin-1,42144,0.0282436120554417,0.00332707362295131,0.0217225477544571,0.0347646763564262,2.29868194622503e-17
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TNIP1,TNFAIP3-interacting protein 1,39929,0.0769338225917748,0.00906491758192582,0.0591665841312002,0.0947010610523494,2.38424964282387e-17
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CD300C,CMRF35-like molecule 6,42249,0.0304179643299745,0.0035913940491935,0.0233788319935552,0.0374570966663938,2.71001738454287e-17
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TRAF2,TNF receptor-associated factor 2,42119,0.0598302304663308,0.00707471945670126,0.0459637803311963,0.0736966806014653,3.02498128179025e-17
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CTBS,Di-N-acetylchitobiase,39860,0.023900901636963,0.00283053669523176,0.0183530497143087,0.0294487535596172,3.44372700126259e-17
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CDCP1,CUB domain-containing protein 1,42016,0.0481232443791793,0.0057025162601441,0.0369463125092968,0.0593001762490617,3.52751011265418e-17
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ZHX2,Zinc fingers and homeoboxes protein 2,39929,0.0292361903277745,0.00346520286086027,0.0224443927204884,0.0360279879350607,3.6482488371795e-17
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,RAPGEF2,Rap guanine nucleotide exchange factor 2,39757,0.0468369433513197,0.00555215190152905,0.0359547256243227,0.0577191610783166,3.69403552460598e-17
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GLO1,Lactoylglutathione lyase,41900,0.0485238841711529,0.00575538679532265,0.0372433260523205,0.0598044422899853,3.77619769949779e-17
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CLEC6A,C-type lectin domain family 6 member A,41843,0.0407062180979571,0.0048370732476194,0.0312255545326231,0.0501868816632911,4.31201288940093e-17
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GORASP2,Golgi reassembly-stacking protein 2,39930,0.0412950174740679,0.00490913730170502,0.031673108362726,0.0509169265854097,4.51856878838522e-17
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FOLR1,Folate receptor alpha,42110,0.0252998294299906,0.00300968249774263,0.019400851734415,0.0311988071255661,4.65777559232823e-17
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IL18,Interleukin-18,42069,0.0379636557451414,0.00451660157225828,0.0291111166635152,0.0468161948267676,4.69030342937098e-17
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TP53I3,Quinone oxidoreductase PIG3,39513,0.0457354505758076,0.00545831138737422,0.0350371602565541,0.056433740895061,5.989802597838e-17
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,RABEP1,Rab GTPase-binding effector protein 1,39736,0.0662828754022911,0.0079113802750501,0.050776570063193,0.0817891807413894,6.02052700995744e-17
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CEBPB,CCAAT/enhancer-binding protein beta,41900,0.0321053087698282,0.00383457990695557,0.0245895321521953,0.0396210853874611,6.19692649434624e-17
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ADGRE5,Adhesion G protein-coupled receptor E5,42248,0.0265914580105221,0.00317726372176351,0.0203640211158656,0.0328188949051786,6.35564973292265e-17
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,LMNB2,Lamin-B2,39929,0.0246222520581439,0.00294128361931941,0.0188573361642779,0.0303871679520099,6.36964467947163e-17
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NMNAT1,Nicotinamide/nicotinic acid mononucleotide adenylyltransferase 1,42016,0.0619582211301097,0.00740621646805269,0.0474420368527264,0.076474405407493,6.56159049998793e-17
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PRDX1,Peroxiredoxin-1,41742,-0.0780789624963142,0.00933936735789221,-0.0963841225177829,-0.0597738024748454,6.88690401614819e-17
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FIS1,Mitochondrial fission 1 protein,42125,0.0653727880678503,0.0078242776061399,0.0500372039598161,0.0807083721758845,7.16878214776574e-17
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MOCS2,Molybdopterin synthase catalytic subunit,39736,0.0576553767848341,0.0069034235641577,0.044124666599085,0.0711860869705832,7.52470533633455e-17
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,EGFL7,Epidermal growth factor-like protein 7,41843,0.0330143836019388,0.00395776661348646,0.0252571610395053,0.0407716061643722,8.04428373491294e-17
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SIRPB1,Signal-regulatory protein beta-1,42100,0.0406296518103102,0.00487091525173866,0.0310826579169024,0.050176645703718,8.05662831540315e-17
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TNFRSF4,Tumor necrosis factor receptor superfamily member 4,42284,0.0326168381778263,0.00391204179072797,0.0249492362679995,0.0402844400876531,8.30310908729708e-17
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,VAMP5,Vesicle-associated membrane protein 5,41900,0.0440310258253123,0.005282103770041,0.0336781024360319,0.0543839492145926,8.44181552814669e-17
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,LETM1,Mitochondrial proton/calcium exchanger protein,39934,0.0459675157508997,0.00551325172888956,0.0351615423622762,0.0567734891395232,8.45314666410682e-17
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,RTBDN,Retbindin,42070,0.0254530820249199,0.00305943777977712,0.0194565839765567,0.031449580073283,9.67419994910006e-17
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CTSL,Cathepsin L1,42145,0.0207791646737454,0.00249944594954312,0.0158802506126408,0.0256780787348499,1.01703731854787e-16
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MZB1,Marginal zone B- and B1-cell-specific protein,42163,0.0435200024426468,0.00523733094784741,0.0332548337848658,0.0537851711004277,1.05100355341912e-16
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CD300E,CMRF35-like molecule 2,42232,0.0354279484519648,0.00426469693449931,0.0270691424603462,0.0437867544435835,1.07112165542562e-16
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,LRRFIP1,Leucine-rich repeat flightless-interacting protein 1,39919,0.0417546613007573,0.00502719060907225,0.0319013677069757,0.0516079548945389,1.10457265493253e-16
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,BRAP,BRCA1-associated protein,39813,0.0939286070370019,0.011316784135624,0.0717477101311789,0.116109503942825,1.16094196317775e-16
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GMPR,GMP reductase 1,42296,0.040294661195062,0.0048570999740785,0.0307747452458682,0.0498145771442559,1.17625929247336e-16
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SYTL4,Synaptotagmin-like protein 4,39958,0.0619220923621418,0.00746318662373372,0.0472942465796237,0.0765499381446599,1.18814437847698e-16
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FARSA,Phenylalanine--tRNA ligase alpha subunit,39649,0.0596634368253871,0.00719583127912676,0.0455596075182987,0.0737672661324755,1.24895956280985e-16
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NADK,NAD kinase,42145,0.0462377878186608,0.00558311551338072,0.0352948814124346,0.0571806942248871,1.32717419159508e-16
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FGD3,"FYVE, RhoGEF and PH domain-containing protein 3",39934,0.0690213319716135,0.00833331165622595,0.0526880411254106,0.0853546228178163,1.34063534211233e-16
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IL1RL2,Interleukin-1 receptor-like 2,41913,0.0318175990379916,0.00384642916137664,0.0242785978816934,0.0393566001942898,1.44180139684227e-16
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,OSM,Oncostatin-M,42051,0.0582470060328768,0.0070490022978871,0.0444309615290181,0.0720630505367355,1.55056289479282e-16
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MMP12,Macrophage metalloelastase,42146,0.0460827567002542,0.00557831563697876,0.0351492580517758,0.0570162553487326,1.5770220484182e-16
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,EIF4B,Eukaryotic translation initiation factor 4B,42016,0.0472236060716752,0.00571856796356353,0.0360152128630907,0.0584319992802597,1.61980818457492e-16
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,METAP2,Methionine aminopeptidase 2,42247,0.0469141495209031,0.00568720836135126,0.0357672211326546,0.0580610779091515,1.74152172232027e-16
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SNRPB2,U2 small nuclear ribonucleoprotein B'',39929,0.0375060744739939,0.00454739031265825,0.0285931894611837,0.046418959486804,1.79106661387095e-16
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,AP2B1,AP-2 complex subunit beta,39649,0.0411499904257843,0.00499366477067863,0.0313624074752541,0.0509375733763144,1.90947465079164e-16
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IRAK1,Interleukin-1 receptor-associated kinase 1,41913,0.0587174310791621,0.00712949933226729,0.0447436123879182,0.072691249770406,1.94822668666441e-16
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,EBAG9,Receptor-binding cancer antigen expressed on SiSo cells,42016,0.0795343005024265,0.00966215912393633,0.0605964686195113,0.0984721323853417,2.01802495297815e-16
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CCL20,C-C motif chemokine 20,42296,0.0726572995835898,0.00882824432402379,0.0553539407085032,0.0899606584586765,2.03846723075582e-16
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CSTB,Cystatin-B,41959,0.0364581782993212,0.00443086481011703,0.0277736832714919,0.0451426733271506,2.07477045068802e-16
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NGRN,Neugrin,39929,0.0189288032919458,0.00230019437410154,0.0144204223187068,0.0234371842651849,2.09040508661819e-16
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,HSDL2,Hydroxysteroid dehydrogenase-like protein 2,39638,0.0413255308842159,0.00502582984086094,0.0314749043961285,0.0511761573723033,2.21386663969242e-16
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DNMBP,Dynamin-binding protein,42016,0.0507529627832965,0.00617521910704436,0.0386495333334895,0.0628563922331034,2.24264491868253e-16
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TXNDC5,Thioredoxin domain-containing protein 5,42249,0.0576049361592179,0.00701150921729688,0.043862378093316,0.0713474942251198,2.29656323185874e-16
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TALDO1,Transaldolase,39948,0.037216169030063,0.00453198254600421,0.0283334832398947,0.0460988548202312,2.41279032508385e-16
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CD63,CD63 antigen,41992,0.0421618764226925,0.00513611865399066,0.0320950838608708,0.0522286689845142,2.43512177035672e-16
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ESM1,Endothelial cell-specific molecule 1,42123,-0.0290182830014611,0.00354001490428717,-0.035956712213864,-0.0220798537890583,2.68009970397232e-16
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GOLGA3,Golgin subfamily A member 3,39934,0.0653698985551039,0.0079840642440859,0.0497211326366956,0.0810186644735123,2.9513411968238e-16
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,AHSP,Alpha-hemoglobin-stabilizing protein,42115,0.0669990618005987,0.00820792051898009,0.0509115375833978,0.0830865860177997,3.56335306183689e-16
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FABP5,Fatty acid-binding protein 5,42218,0.055314345378104,0.0067814035826172,0.0420227943561743,0.0686058964000337,3.74041269369662e-16
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GOT1,"Aspartate aminotransferase, cytoplasmic",39966,0.0362047502356668,0.00444460204860099,0.0274933302204089,0.0449161702509248,4.16210507144426e-16
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NCF2,Neutrophil cytosol factor 2,42097,0.0687511089717875,0.00847788976261213,0.0521344450370677,0.0853677729065073,5.52046132598179e-16
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ADGRE2,Adhesion G protein-coupled receptor E2,42185,0.0237379036489323,0.00292879780587835,0.0179974599494108,0.0294783473484539,5.7227788158887e-16
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FABP2,"Fatty acid-binding protein, intestinal",42145,-0.0661678194876725,0.00816957594854598,-0.0821801883468226,-0.0501554506285224,5.99756822252762e-16
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IGFBP6,Insulin-like growth factor-binding protein 6,42129,0.0258332209452819,0.00319199439636531,0.0195769119284058,0.0320895299621579,6.30841659193531e-16
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CHL1,Neural cell adhesion molecule L1-like protein,42189,-0.0247491786505754,0.00305922539890791,-0.0307452604324349,-0.0187530968687159,6.46868529224508e-16
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ANKRD54,Ankyrin repeat domain-containing protein 54,41843,0.0466825354937689,0.00577965744756401,0.0353544068965435,0.0580106640909944,7.20649990012196e-16
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,BIRC2,Baculoviral IAP repeat-containing protein 2,41843,0.0520936785477996,0.00645017460408428,0.0394513363237944,0.0647360207718048,7.24902062022163e-16
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,LGALS3,Galectin-3,42196,0.0243383512729009,0.00301849468800952,0.0184221016844023,0.0302546008613996,8.05820731293723e-16
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TNFRSF19,Tumor necrosis factor receptor superfamily member 19,42262,0.0275884506604167,0.00342189208716763,0.0208815421695681,0.0342953591512652,8.10365260545918e-16
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",42070,0.0284833427174487,0.00353374962435288,0.0215571934537171,0.0354094919811804,8.2436036656484e-16
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FBP1,"Fructose-1,6-bisphosphatase 1",42145,0.0605609189744624,0.00751766195088488,0.0458263015507281,0.0752955363981968,8.55120876701912e-16
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SELP,P-selectin,42217,0.0458521820151683,0.00569240446837892,0.0346950692571456,0.057009294773191,8.60639076494351e-16
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CASP10,Caspase-10,41839,0.0585755276566367,0.007272798027799,0.0443208435221506,0.0728302117911227,8.69062213965489e-16
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CD244,Natural killer cell receptor 2B4,42296,0.0226003709289753,0.00280841666571328,0.0170958742641773,0.0281048675937734,9.15136323444745e-16
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PACS2,Phosphofurin acidic cluster sorting protein 2,39575,0.0518200658528802,0.0064376082676129,0.0392023536483589,0.0644377780574015,9.16470028348137e-16
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PECAM1,Platelet endothelial cell adhesion molecule,42137,0.0247990046622302,0.00308192723466109,0.0187584272822945,0.0308395820421659,9.21813914719759e-16
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,WIF1,Wnt inhibitory factor 1,42262,-0.0275811806435024,0.00343511453364475,-0.0343140051294461,-0.0208483561575587,1.06095652719056e-15
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IL32,Interleukin-32,42119,-0.0363643658139417,0.0045342570347301,-0.0452515096020127,-0.0274772220258707,1.14471265472586e-15
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CLIP2,CAP-Gly domain-containing linker protein 2,42119,0.0922331707399801,0.0115300650594215,0.069634243223514,0.114832098256446,1.3518726320492e-15
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SOST,Sclerostin,42129,0.0316208756067662,0.00395498133117693,0.0238691121976594,0.039372639015873,1.3980113309528e-15
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NCK2,Cytoplasmic protein NCK2,42185,0.0871468262491763,0.0109004961299449,0.0657818538344843,0.108511798663868,1.40259255097731e-15
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,LARP1,La-related protein 1,39919,0.0511114738607425,0.00640150011929105,0.038564533626932,0.0636584140945529,1.54977883736412e-15
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,WFIKKN2,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 2",42144,-0.0267916100986075,0.00335974422740399,-0.0333767087843193,-0.0202065114128956,1.65467958327712e-15
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SERPINA3,Alpha-1-antichymotrypsin,39951,-0.0121500136620349,0.00152433870130996,-0.0151377175166024,-0.00916230980746735,1.72897975605664e-15
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TRIM25,E3 ubiquitin/ISG15 ligase TRIM25,39930,0.0885547357932982,0.0111260394765005,0.0667476984193573,0.110361773167239,1.89599833038402e-15
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ADAM8,Disintegrin and metalloproteinase domain-containing protein 8,42224,0.0246123966680235,0.00309703813896173,0.0185422019156585,0.0306825914203885,2.05892997247187e-15
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,RASSF2,Ras association domain-containing protein 2,41843,0.0462927646702157,0.00582667098605771,0.0348724895375426,0.0577130398028888,2.09845366295603e-15
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,EPHB4,Ephrin type-B receptor 4,42310,0.0205173534437258,0.00258638189737376,0.0154480449248732,0.0255866619625784,2.30703343466059e-15
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,S100G,Protein S100-G,39934,-0.039882884838286,0.00502739767553654,-0.0497365842823376,-0.0300291853942344,2.33808610197884e-15
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CKMT1A_CKMT1B,"Creatine kinase U-type, mitochondrial",42085,0.0516276870661732,0.00650967520109179,0.0388687236720333,0.0643866504603131,2.34578785581177e-15
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CCN2,CCN family member 2,42146,0.0456878177788226,0.00576163965185322,0.0343950040611903,0.0569806314964549,2.3688050926278e-15
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,LYPD8,Ly6/PLAUR domain-containing protein 8,41843,0.0422068402554715,0.00532508430986759,0.031769675008131,0.052644005502812,2.44257354074186e-15
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,VSTM2L,V-set and transmembrane domain-containing protein 2-like protein,41900,0.0462285269384553,0.00583514920924714,0.0347916344883309,0.0576654193885797,2.51355324466141e-15
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MNDA,Myeloid cell nuclear differentiation antigen,42119,0.0792498611557577,0.010020692752003,0.0596093033618319,0.0988904189496836,2.80360637503184e-15
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,HNRNPUL1,Heterogeneous nuclear ribonucleoprotein U-like protein 1,39934,0.0397818550099425,0.00503125853925217,0.0299205882730082,0.0496431217468768,2.88242514471491e-15
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SIGLEC6,Sialic acid-binding Ig-like lectin 6,42262,0.027032581758613,0.00342059466685146,0.0203282162115841,0.0337369473056418,2.93273523078511e-15
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CD6,T-cell differentiation antigen CD6,42284,0.0419402182953483,0.00531533357123074,0.0315221644957361,0.0523582720949606,3.23930120043123e-15
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DSC2,Desmocollin-2,41984,0.0282508583316611,0.00358159668040475,0.0212309288380678,0.0352707878252544,3.31354819530622e-15
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ZNRD2,Protein ZNRD2,39930,0.0564892878173708,0.00717146525066345,0.0424332159260704,0.0705453597086711,3.66083610706106e-15
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GIPC2,PDZ domain-containing protein GIPC2,39929,0.0246517065488041,0.00313146239036902,0.0185140402636808,0.0307893728339274,3.7998779604266e-15
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,OPHN1,Oligophrenin-1,39929,0.0875978903320202,0.0111336769335918,0.0657758835421802,0.10941989712186,3.93625315677742e-15
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CXCL11,C-X-C motif chemokine 11,42249,0.0626053126015506,0.00795941392433546,0.0470048613098531,0.0782057638932481,3.94911869602921e-15
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DOK2,Docking protein 2,42145,0.0985962252038078,0.0125486723741274,0.0740008273505181,0.123191623057097,4.22627329875108e-15
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ING1,Inhibitor of growth protein 1,41820,0.0381527899359733,0.00485977371405711,0.0286276334564214,0.0476779464155253,4.45343976447778e-15
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,OGA,Protein O-GlcNAcase,39930,0.0575773896788356,0.00733880253923699,0.0431933367019311,0.0719614426557401,4.69539120862663e-15
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,F10,Coagulation factor X,39990,0.0233582219202755,0.00297947876170019,0.0175184435473431,0.0291980002932079,4.91828372286565e-15
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GET3,ATPase GET3,39958,0.0434834292056911,0.00554740576541933,0.0326105139054692,0.054356344505913,4.96583677919676e-15
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,AZI2,5-azacytidine-induced protein 2,39934,0.0447678982551592,0.00571882064816862,0.0335590097847487,0.0559767867255697,5.39054517054893e-15
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,BAP18,Chromatin complexes subunit BAP18,39929,0.0546240808455104,0.00699477625057322,0.0409143193943869,0.068333842296634,6.25893745139511e-15
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SAA4,Serum amyloid A-4 protein,39979,0.0263489370727045,0.00337826737593968,0.0197275330158627,0.0329703411295463,6.75541915225612e-15
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CCL5,C-C motif chemokine 5,42217,0.0802010074527426,0.0102927256346526,0.0600272652088235,0.100374749696662,7.07121471717488e-15
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ADAM9,Disintegrin and metalloproteinase domain-containing protein 9,39930,0.0243191884558459,0.00312061832915349,0.018202776530705,0.0304356003809867,7.11150113908006e-15
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SERPINI2,Serpin I2,39930,0.0462716401071257,0.00593869591771391,0.0346317961084064,0.057911484105845,7.19703313980681e-15
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IL7R,Interleukin-7 receptor subunit alpha,42137,-0.0413926588832869,0.00531539686017862,-0.051810836729237,-0.0309744810373368,7.34073804150704e-15
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PLIN3,Perilipin-3,42145,0.0339135081955478,0.00437693428557025,0.0253347169958301,0.0424922993952655,9.97884976205018e-15
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CIT,Citron Rho-interacting kinase,39649,0.0363984849051879,0.00470322005413246,0.0271801735990883,0.0456167962112875,1.08885733008828e-14
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ICAM4,Intercellular adhesion molecule 4,42119,-0.0414452199239917,0.00535906733537327,-0.0519489919013233,-0.0309414479466601,1.11864905503093e-14
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CRTAC1,Cartilage acidic protein 1,42310,-0.0243880729533055,0.00315770536218444,-0.030577175463187,-0.018198970443424,1.21142411498057e-14
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IGDCC4,Immunoglobulin superfamily DCC subclass member 4,39966,-0.0215283313304444,0.0027903558085799,-0.026997428715261,-0.0160592339456278,1.30821222898585e-14
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CD274,Programmed cell death 1 ligand 1,42016,0.0264962901813537,0.00343822473397649,0.0197573697027598,0.0332352106599477,1.3849868144782e-14
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,WASF1,Wiskott-Aldrich syndrome protein family member 1,41900,0.07470088820255,0.00969333955020318,0.0557019426841518,0.0936998337209483,1.38550966710945e-14
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IMPACT,Protein IMPACT,39929,0.042892447933892,0.00556513002211459,0.0319847930905474,0.0538001027772366,1.39174585435032e-14
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GAPDH,Glyceraldehyde-3-phosphate dehydrogenase,39485,0.0243504256931918,0.00316159952452511,0.0181536906251226,0.030547160761261,1.45655000350149e-14
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CKAP4,Cytoskeleton-associated protein 4,42247,0.0222911220189271,0.00289583949214807,0.0166152766143169,0.0279669674235374,1.48103567352488e-14
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ALDH3A1,"Aldehyde dehydrogenase, dimeric NADP-preferring",42094,0.0532853072402069,0.00692835296292275,0.0397057354328783,0.0668648790475354,1.56190362721167e-14
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SIGLEC8,Sialic acid-binding Ig-like lectin 8,39638,0.0368426569840843,0.00479100307214656,0.027452290962677,0.0462330230054915,1.59681343012531e-14
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CACNB3,Voltage-dependent L-type calcium channel subunit beta-3,39934,0.0666850068334707,0.00867250641105028,0.0496868942678121,0.0836831193991292,1.60242894614149e-14
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PAM,Peptidyl-glycine alpha-amidating monooxygenase,42246,0.0221099758806829,0.00288400457281552,0.0164573269179645,0.0277626248434013,1.88793495834993e-14
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ANGPTL1,Angiopoietin-related protein 1,41920,0.0224592961812054,0.00293288658052435,0.0167108384833776,0.0282077538790331,2.02244833296958e-14
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GALNT3,Polypeptide N-acetylgalactosaminyltransferase 3,41913,0.0338583045598309,0.00442196142947493,0.02519126015806,0.0425253489616018,2.03655551527235e-14
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TPP1,Tripeptidyl-peptidase 1,42057,0.0369832923694212,0.00483035328328485,0.0275157999341829,0.0464507848046595,2.04167740441587e-14
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ADAM12,Disintegrin and metalloproteinase domain-containing protein 12,39657,0.0265583787184771,0.0034763694126917,0.0197446946696014,0.0333720627673529,2.35733597214429e-14
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DUT,"Deoxyuridine 5'-triphosphate nucleotidohydrolase, mitochondrial",39930,0.0814010699760087,0.0106910646267814,0.0604465833075171,0.1023555566445,2.8699417871743e-14
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SFRP4,Secreted frizzled-related protein 4,39736,0.0312117441751931,0.00411145212549799,0.023153298009217,0.0392701903411691,3.41708993287933e-14
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,STAT2,Signal transducer and activator of transcription 2,39657,0.0611475032255225,0.00808166403489954,0.0453074417171194,0.0769875647339256,4.14807650653313e-14
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,HSPA1A,Heat shock 70 kDa protein 1A,42162,0.0542229496732382,0.00716841374116977,0.0401728587405455,0.068273040605931,4.15494495315979e-14
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CHAD,Chondroadherin,39736,-0.0364489120469592,0.00481882894291971,-0.0458938167750819,-0.0270040073188366,4.22105948019394e-14
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TIMP4,Metalloproteinase inhibitor 4,42137,-0.0306935225509463,0.0040613451964758,-0.0386537591360389,-0.0227332859658537,4.37321506605879e-14
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,OTUD7B,OTU domain-containing protein 7B,39934,0.0490918484908393,0.00650061478405121,0.036350643514099,0.0618330534675797,4.61975904311161e-14
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,VTI1A,Vesicle transport through interaction with t-SNAREs homolog 1A,39736,0.044627516941684,0.00591424844421251,0.0330355899910274,0.0562194438923405,4.84699123041209e-14
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PFKFB2,"6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 2",42047,0.058305508997412,0.00773019343461133,0.0431543298655738,0.0734566881292502,4.90327782843991e-14
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,41843,0.0595529639525267,0.00789593756417053,0.0440769263267524,0.0750290015783009,4.92070366050914e-14
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DEFA1_DEFA1B,Neutrophil defensin 1,41879,0.0410643215087611,0.00546028226783066,0.030362168263813,0.0517664747537092,5.80449839018854e-14
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MAP4K5,Mitogen-activated protein kinase kinase kinase kinase 5,41997,0.0855124125747151,0.0113819964671218,0.0632036994991564,0.107821125650274,6.14669297094944e-14
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,KLRF1,Killer cell lectin-like receptor subfamily F member 1,39657,0.0342697609302141,0.00456204420210067,0.0253281542940968,0.0432113675663315,6.27538263213008e-14
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,WFDC1,WAP four-disulfide core domain protein 1,39699,0.0418858392531429,0.00558497366578351,0.0309392908682073,0.0528323876380786,6.88244059935052e-14
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SH3BP1,SH3 domain-binding protein 1,39930,0.0380872127677664,0.00507996534754868,0.028130480686571,0.0480439448489618,6.98809227206063e-14
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NBN,Nibrin,41913,0.0415372647207527,0.00554276566138986,0.0306734440244286,0.0524010854170769,7.10398380336763e-14
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DHPS,Deoxyhypusine synthase,39919,0.0310474486563711,0.00414286019427491,0.0229274426755923,0.0391674546371499,7.16727576097922e-14
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CCL19,C-C motif chemokine 19,42249,0.0862158749357465,0.0115154042855939,0.0636456825359826,0.108786067335511,7.47782609185672e-14
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,AMPD3,AMP deaminase 3,39929,0.0529162864933793,0.00706979349172921,0.03905949124959,0.0667730817371685,7.6941041951602e-14
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,LACRT,Extracellular glycoprotein lacritin,39895,0.0349195079592005,0.00467476138757765,0.0257569756395484,0.0440820402788527,8.62412281644436e-14
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ESYT2,Extended synaptotagmin-2,39929,0.0638975708309056,0.00856008423351327,0.0471198057332196,0.0806753359285916,8.96788446033863e-14
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FAM13A,Protein FAM13A,39930,0.0521378105278738,0.00698485737862278,0.0384474900657732,0.0658281309899745,8.98072409489254e-14
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,OPLAH,5-oxoprolinase,39638,0.0531814778488548,0.00713070596426379,0.0392052941588977,0.0671576615388118,9.43677417107088e-14
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,EIF4G3,Eukaryotic translation initiation factor 4 gamma 3,39934,0.0507451798460219,0.00680532389112873,0.0374067450194096,0.0640836146726343,9.51953468965749e-14
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CD28,T-cell-specific surface glycoprotein CD28,41843,0.0282951960229192,0.00380045682192785,0.0208463006519406,0.0357440913938978,1.02767417651902e-13
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CD46,Membrane cofactor protein,42107,0.0217802409819318,0.00292556772481195,0.0160461282413004,0.0275143537225633,1.02971610290128e-13
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CDH3,Cadherin-3,42249,0.027963503474498,0.00375667827938907,0.0206004140468954,0.0353265929021005,1.0377671205886e-13
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NELL1,Protein kinase C-binding protein NELL1,42181,-0.0319956555009749,0.00430057103112265,-0.0404247747219753,-0.0235665362799745,1.06837280426948e-13
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ROBO1,Roundabout homolog 1,42144,0.0181393024653195,0.00244487678970632,0.0133473439574951,0.0229312609731439,1.24734969132648e-13
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,BAMBI,BMP and activin membrane-bound inhibitor homolog,41843,0.0225566855053604,0.00304082682708357,0.0165966649242766,0.0285167060864442,1.26188348499783e-13
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NSFL1C,NSFL1 cofactor p47,42249,0.0475383692472596,0.00641020567110439,0.034974366131895,0.0601023723626242,1.27779928150108e-13
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,EDN1,Endothelin-1,39638,0.0223483450329834,0.00301681600478925,0.0164353856635964,0.0282613044023703,1.37654459472391e-13
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GBP1,Guanylate-binding protein 1,39911,0.0490710568129077,0.00663521097415791,0.0360660433035581,0.0620760703222572,1.50774490788768e-13
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,USO1,General vesicular transport factor p115,42070,0.0671535255505177,0.00909236575268643,0.0493324886752523,0.0849745624257831,1.60556534492677e-13
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,JAM3,Junctional adhesion molecule C,39736,0.0385917619450686,0.00522665984362699,0.0283475086515597,0.0488360152385775,1.65013739584232e-13
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CARHSP1,Calcium-regulated heat-stable protein 1,41839,0.037474068723157,0.00507746067440881,0.0275222458013157,0.0474258916449982,1.67130636288478e-13
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,OSCAR,Osteoclast-associated immunoglobulin-like receptor,42144,0.0261620331959533,0.00354570162596915,0.0192124580090537,0.0331116083828528,1.6937055366797e-13
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TSC22D1,TSC22 domain family protein 1,39934,0.0501016879207173,0.00678998245157808,0.0367933223156243,0.0634100535258104,1.70929811011007e-13
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CA9,Carbonic anhydrase 9,42262,0.0351177637836843,0.0047678273651002,0.0257728221480879,0.0444627054192807,1.86492597144798e-13
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IGFBP7,Insulin-like growth factor-binding protein 7,42310,0.0232847113644852,0.0031708660416204,0.0170698139229092,0.0294996088060611,2.20089272136397e-13
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,RETN,Resistin,42105,0.0321315324127689,0.00437554284290787,0.0235554684406695,0.0407075963848683,2.20090944473687e-13
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,RAB27B,Ras-related protein Rab-27B,39958,0.0621404679068671,0.00847195692720457,0.0455354323295461,0.078745503484188,2.37092853292655e-13
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,RABGAP1L,Rab GTPase-activating protein 1-like,41913,0.0444834875165049,0.00606812331740707,0.032589965814387,0.0563770092186227,2.42191887012098e-13
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SLAMF1,Signaling lymphocytic activation molecule,41913,0.0445504434272609,0.00608594529493583,0.0326219906491867,0.0564788962053352,2.61768298171124e-13
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,INPP5J,"Phosphatidylinositol 4,5-bisphosphate 5-phosphatase A",39934,0.0305288118008725,0.00417191561594384,0.0223518571936226,0.0387057664081225,2.6931012084688e-13
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,VASN,Vasorin,41975,-0.0204919444642829,0.00280118659122407,-0.0259822701830821,-0.0150016187454837,2.71121405689701e-13
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GIT1,ARF GTPase-activating protein GIT1,39657,0.0729521817524606,0.00997098081597598,0.0534090593531477,0.0924953041517736,2.7225433217953e-13
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CALCOCO2,Calcium-binding and coiled-coil domain-containing protein 2,39638,0.0568665148389203,0.00777355380217812,0.0416303493866511,0.0721026802911894,2.74449597118123e-13
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TCTN3,Tectonic-3,39958,0.0228196919816217,0.00312151348461585,0.0167015255517746,0.0289378584114688,2.8411348287144e-13
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TAFA5,Chemokine-like protein TAFA-5,42070,0.0274278127105064,0.00375367518913559,0.0200706093398007,0.0347850160812122,2.88706683245629e-13
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PCYT2,Ethanolamine-phosphate cytidylyltransferase,39930,0.0569203816112078,0.00779115075285473,0.0416497261356125,0.072191037086803,2.94188930717137e-13
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,OGFR,Opioid growth factor receptor,42070,0.0239458665972732,0.00327901247982384,0.0175190021368185,0.030372731057728,2.97729777779694e-13
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DGKA,Diacylglycerol kinase alpha,39657,0.0415763496423875,0.00569356878478911,0.0304169548242009,0.0527357444605742,3.02252735211105e-13
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,APOA4,Apolipoprotein A-IV,39979,0.0257574975367793,0.00352852422719013,0.0188415900514867,0.032673405022072,3.07414612588208e-13
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CNTN5,Contactin-5,42170,-0.0275195868394801,0.0037760166257507,-0.0349205794259515,-0.0201185942530087,3.31985317652234e-13
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,42072,0.0200099999200211,0.00274642157312217,0.0146270136367017,0.0253929862033406,3.37433525650379e-13
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CFH,Complement factor H,39418,0.01757315880689,0.00241450096269689,0.0128407369200041,0.0223055806937759,3.61836146727744e-13
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PIBF1,"Progesterone-induced-blocking factor 1, Isoform 4",39934,0.0585436569516882,0.00804622429507463,0.042773057333342,0.0743142565700345,3.6679343281231e-13
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TPR,Nucleoprotein TPR,39575,0.0365061047856345,0.00501791487009009,0.0266709916402579,0.0463412179310111,3.69630558568534e-13
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DNM3,Dynamin-3,39934,0.0412195921727133,0.00566896922328544,0.0301084124950738,0.0523307718503527,3.80075835111492e-13
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NAAA,N-acylethanolamine-hydrolyzing acid amidase,41954,-0.044421087756968,0.0061138687700703,-0.0564042705463058,-0.0324379049676303,3.9191085898533e-13
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PTPRF,Receptor-type tyrosine-protein phosphatase F,42310,-0.020987793808557,0.00289510772127211,-0.0266622049422504,-0.0153133826748637,4.41024358939022e-13
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,LGALS3BP,Galectin-3-binding protein,39979,0.0232199562119727,0.00320291069280011,0.0169422512540845,0.0294976611698609,4.4495246993806e-13
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SCRG1,Scrapie-responsive protein 1,39958,0.0203212838236964,0.00280596256083986,0.0148215972044503,0.0258209704429425,4.70078096302772e-13
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,LRRN1,Leucine-rich repeat neuronal protein 1,41913,-0.029792020426731,0.00412716296045699,-0.0378812598292267,-0.0217027810242353,5.54042657715406e-13
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,STK11,Serine/threonine-protein kinase STK11,41900,0.0536809630547523,0.0074392279300326,0.0391000763118884,0.0682618497976162,5.64682857873299e-13
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PRKAB1,5'-AMP-activated protein kinase subunit beta-1,41913,0.0403311828165805,0.00558925651742296,0.0293762400424315,0.0512861255907295,5.65032843650162e-13
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DECR1,"2,4-dienoyl-CoA reductase, mitochondrial",42119,0.0704403562471544,0.00977345666488761,0.0512843811839747,0.0895963313103341,6.00932629136263e-13
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,BNIP3L,BCL2/adenovirus E1B 19 kDa protein-interacting protein 3-like,39657,0.0329945326389645,0.00457903384385963,0.0240196263049996,0.0419694389729293,6.15668960255058e-13
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,LAMP1,Lysosome-associated membrane glycoprotein 1,39661,0.0202247553510054,0.00280990812149058,0.0147173354328838,0.0257321752691269,6.52254458026361e-13
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SIGLEC1,Sialoadhesin,42185,0.0305338084414706,0.0042445350045177,0.0222145198326159,0.0388530970503253,6.63726584116413e-13
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CD164,Sialomucin core protein 24,42137,0.0198077529369251,0.00275522168301326,0.0144075184382191,0.0252079874356311,6.8604486669592e-13
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CD160,CD160 antigen,42296,0.0355323868618552,0.00494607536656876,0.0258380791433804,0.04522669458033,7.12207164176789e-13
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ADAMTSL4,ADAMTS-like protein 4,39638,0.0182340144712264,0.00253838218024328,0.0132587853979495,0.0232092435445032,7.24209933826366e-13
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,HCLS1,Hematopoietic lineage cell-specific protein,42296,0.0404831485778766,0.00564229533385393,0.0294242497235229,0.0515420474322303,7.60546930541088e-13
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MBL2,Mannose-binding protein C,39826,-0.0811480940840241,0.011308057768662,-0.103311887310602,-0.0589843008574466,7.62341159913821e-13
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,YJU2,Splicing factor YJU2,39919,0.0243984265287214,0.00340202011026174,0.0177304671126084,0.0310663859448344,7.86650366492489e-13
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CD300A,CMRF35-like molecule 8,39736,0.0225265973914286,0.00314240042522223,0.016367492557993,0.0286857022248642,8.05681219829719e-13
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,OGN,Mimecan,42137,0.0316176607151986,0.00441188451285119,0.0229703670700103,0.0402649543603869,8.09366328845288e-13
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,HNRNPK,Heterogeneous nuclear ribonucleoprotein K,41837,0.0579167858423176,0.00809931165460159,0.0420421349992985,0.0737914366853367,9.07842749111795e-13
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SLC39A14,Zinc transporter ZIP14,41839,0.0246207845195457,0.00344473949136527,0.0178690951164698,0.0313724739226217,9.30988195093556e-13
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,STIP1,Stress-induced-phosphoprotein 1,42105,0.0465596172262607,0.00651521983970793,0.0337897863404331,0.0593294481120882,9.37319280738881e-13
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CALCOCO1,Calcium-binding and coiled-coil domain-containing protein 1,42212,0.074665188497328,0.010449070394813,0.0541850105234945,0.0951453664711616,9.41414775971596e-13
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ANXA10,Annexin A10,41839,0.0596185121408265,0.00834853306897657,0.0432553873256324,0.0759816369560206,9.73525445163782e-13
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FOXO3,Forkhead box protein O3,41843,0.0700482910418792,0.00981289566967423,0.0508150155293177,0.0892815665544407,9.93499574312523e-13
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SPAG1,Sperm-associated antigen 1,39934,0.0428949289880696,0.00600958706736118,0.0311161383360417,0.0546737196400975,1.00667709942115e-12
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ALDH5A1,"Succinate-semialdehyde dehydrogenase, mitochondrial",39934,0.0349871078016498,0.00490257542149251,0.0253780599755245,0.0445961556277751,1.01600963501462e-12
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DAB2,Disabled homolog 2,42262,0.0806889037796632,0.0113180432827106,0.0585055389455503,0.102872268613776,1.06002305503002e-12
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,POLR2F,"DNA-directed RNA polymerases I, II, and III subunit RPABC2",42070,0.0250570534455285,0.00351762320033153,0.0181625119728787,0.0319515949181783,1.1073090838622e-12
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TADA3,Transcriptional adapter 3,39919,0.0296470023880966,0.00416149974513499,0.0214904628876321,0.0378035418885612,1.11111367521025e-12
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GRN,Progranulin,42077,0.0182292498892464,0.00256084234812418,0.013209998886923,0.0232485008915698,1.14664605903413e-12
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CETN2,Centrin-2,41839,0.0494411975682582,0.00694701819589053,0.0358250419043128,0.0630573532322037,1.1607017989541e-12
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SKAP2,Src kinase-associated phosphoprotein 2,42185,0.0754239017981301,0.0106129880385737,0.0546224452425257,0.0962253583537344,1.24728056892738e-12
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CCL2,C-C motif chemokine 2,41992,0.0375484477602048,0.00528430599540524,0.0271912080092105,0.0479056875111991,1.25810788748484e-12
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,HTRA2,"Serine protease HTRA2, mitochondrial",42181,0.0440284926321874,0.00620939155349377,0.0318580851873396,0.0561989000770351,1.40102984861517e-12
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MSR1,Macrophage scavenger receptor types I and II,42249,0.0342036098664671,0.00482381633169766,0.0247489298563397,0.0436582898765945,1.40128515783914e-12
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,STAMBP,STAM-binding protein,41997,0.0454971359073236,0.0064165561065405,0.0329206859385042,0.058073585876143,1.40240267681803e-12
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FLT3LG,Fms-related tyrosine kinase 3 ligand,42296,0.0254557224074075,0.00359075974626596,0.0184178333047263,0.0324936115100888,1.41463981984401e-12
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PTN,Pleiotrophin,41900,0.0359812423832515,0.0050775149539378,0.0260293130735334,0.0459331716929696,1.44592171369326e-12
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IGBP1,Immunoglobulin-binding protein 1,39934,0.043690782558947,0.00617065004232727,0.0315963084759856,0.0557852566419085,1.52220285626488e-12
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SPARCL1,SPARC-like protein 1,42169,-0.0197464892272448,0.00279015110164036,-0.0252151853864599,-0.0142777930680297,1.5430610977514e-12
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TRIM21,E3 ubiquitin-protein ligase TRIM21,42119,0.0524521202865244,0.00741790659858082,0.037913023353306,0.0669912172197429,1.61359809424902e-12
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,C8B,Complement component C8 beta chain,39979,-0.0219263787806417,0.00310118043045285,-0.0280046924243293,-0.0158480651369541,1.63614323341735e-12
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FST,Follistatin,42166,-0.0351497858727383,0.00497395099124515,-0.0448987298155788,-0.0254008419298978,1.66319418875096e-12
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CSNK2A1,Casein kinase II subunit alpha,39934,-0.0323801224458944,0.00458446951280093,-0.0413656826909843,-0.0233945622008046,1.72483877336081e-12
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,APBB1IP,Amyloid beta A4 precursor protein-binding family B member 1-interacting protein,42070,0.0326825199278033,0.0046323303649367,0.0236031524125274,0.0417618874430793,1.80632506829145e-12
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DSCAM,Down syndrome cell adhesion molecule,39934,0.0263498514425462,0.00373594074883835,0.019027407574823,0.0336722953102693,1.85203504591571e-12
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MAP2,Microtubule-associated protein 2,39929,0.033878456876973,0.00480941301795997,0.0244520073617714,0.0433049063921745,1.97344365232577e-12
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TSNAX,Translin-associated protein X,39575,0.0284505335815812,0.00403882771615962,0.0205344312579084,0.0363666359052541,1.9762108339856e-12
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,LRIG3,Leucine-rich repeats and immunoglobulin-like domains protein 3,39640,0.0194162892066597,0.00275889913837523,0.0140088468954442,0.0248237315178751,2.07035785170376e-12
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SCRIB,Protein scribble homolog,39638,0.0632286500229072,0.00899828867448081,0.0455920042209249,0.0808652958248896,2.23871924409388e-12
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ADAMTS4,A disintegrin and metalloproteinase with thrombospondin motifs 4,39657,0.026331399758472,0.00374800142105055,0.018985316973213,0.0336774825437311,2.25920075957863e-12
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CDC42BPB,Serine/threonine-protein kinase MRCK beta,39930,0.0741038281040495,0.0105563031092975,0.0534134740098263,0.0947941821982726,2.34774436240281e-12
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,BAG6,Large proline-rich protein BAG6,41900,0.0264144228123434,0.00376483519117967,0.0190353458376313,0.0337934997870556,2.39206493064322e-12
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SAMD9L,Sterile alpha motif domain-containing protein 9-like,42119,0.0520831754140231,0.00742656221087476,0.0375271134807085,0.0666392373473376,2.44182623540822e-12
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,RLN2,Prorelaxin H2,39709,0.0371238403153538,0.00529459972659662,0.0267464248512244,0.0475012557794831,2.49207902217883e-12
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DNAJB2,DnaJ homolog subfamily B member 2,39736,0.0377064293065144,0.00538634352369348,0.0271491960000751,0.0482636626129536,2.69961649662101e-12
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NT5E,5'-nucleotidase,42181,0.0383644007607934,0.00548980165367369,0.027604389519593,0.0491244120019938,2.91204093302279e-12
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CST5,Cystatin-D,41846,0.0400322795707847,0.0057316614559073,0.0287982231172064,0.051266336024363,2.99706500068805e-12
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ATG4A,Cysteine protease ATG4A,41843,0.0414528601643705,0.00594297276801516,0.0298046335390608,0.0531010867896802,3.2015566453594e-12
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,RBPMS2,RNA-binding protein with multiple splicing 2,39638,0.0736888284282948,0.0105638665209167,0.052983650047298,0.0943940068092916,3.22100874780465e-12
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MSTN,Growth/differentiation factor 8,41900,0.0383848575772949,0.00550603643382058,0.0275930261670066,0.0491766889875832,3.28574907395286e-12
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ST3GAL1,"CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 1",42070,-0.0304163541921379,0.0043649947844882,-0.0389717439697348,-0.0218609644145411,3.35836422346051e-12
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SEC31A,Protein transport protein Sec31A,39638,0.0554642133119852,0.00795849684683215,0.0398655594921942,0.0710628671317762,3.36964635693826e-12
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TRIM58,E3 ubiquitin-protein ligase TRIM58,39919,0.0616991391133292,0.00886870637643971,0.0443164746155074,0.079081803611151,3.66905379061513e-12
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,HS6ST2,Heparan-sulfate 6-O-sulfotransferase 2,39657,0.0267238815101279,0.00384144200264591,0.019194655184942,0.0342531078353139,3.67935843275115e-12
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DDHD2,Phospholipase DDHD2,39934,0.0474405453117662,0.00682518919621689,0.0340631744871811,0.0608179161363513,3.8315439947316e-12
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MAN1A2,"Mannosyl-oligosaccharide 1,2-alpha-mannosidase IB",39638,0.0182682812090901,0.00262833802807371,0.0131167386740656,0.0234198237441146,3.84505451432182e-12
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DYNLT1,Dynein light chain Tctex-type 1,39649,0.0566011525758003,0.00815659383106087,0.040614228666921,0.0725880764846796,4.16070017957643e-12
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PIK3AP1,Phosphoinositide 3-kinase adapter protein 1,42119,0.0431922463714592,0.00622556442008161,0.0309901401080992,0.0553943526348191,4.16128954549445e-12
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SUGP1,SURP and G-patch domain-containing protein 1,39930,0.0290176828594831,0.00418205984060665,0.0208208455718941,0.0372145201470722,4.17571383478288e-12
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SLITRK1,SLIT and NTRK-like protein 1,39657,-0.0231266979779584,0.00334052095194134,-0.0296741190437634,-0.0165792769121533,4.66413092572232e-12
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TTF2,Transcription termination factor 2,39649,0.035403320575245,0.00511506301844707,0.0253777970590887,0.0454288440914012,4.72027062054123e-12
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ARSA,Arylsulfatase A,42137,0.0318464906448489,0.00460266590879512,0.0228252654636104,0.0408677158260873,4.74822108932434e-12
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ARHGEF10,Rho guanine nucleotide exchange factor 10,39934,0.0671930945373649,0.00971020299420088,0.0481610966687312,0.0862250924059986,4.76522111807502e-12
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MPO,Myeloperoxidase,42137,0.0317392331850976,0.00458924670400641,0.022744309645245,0.0407341567249502,4.85421064399286e-12
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CILP,Cartilage intermediate layer protein 1,39966,0.0391539804506479,0.00566857380816583,0.0280435757866429,0.0502643851146529,5.20693183298051e-12
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,RAB33A,Ras-related protein Rab-33A,39575,0.047171131697518,0.00683148365923457,0.0337814237254183,0.0605608396696178,5.29916912235704e-12
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,LEFTY2,Left-right determination factor 2,42247,0.0362785881517771,0.00526137649876188,0.0259662902142038,0.0465908860893504,5.61286650401904e-12
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,COMT,Catechol O-methyltransferase,41740,0.0586956292310774,0.00851457911382813,0.0420070541679742,0.0753842042941805,5.69040206340568e-12
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MASP1,Mannan-binding lectin serine protease 1,41997,0.0161742794655375,0.00234843811869141,0.0115713407529024,0.0207772181781727,5.94186095623296e-12
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,LPO,Lactoperoxidase,41647,0.0432210483117416,0.00627806453993155,0.0309160418134758,0.0555260548100075,6.06635262007318e-12
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GOPC,Golgi-associated PDZ and coiled-coil motif-containing protein,42119,0.0714616427508091,0.0103880769550015,0.0511010119190061,0.091822273582612,6.28379789580641e-12
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,KYAT1,Kynurenine--oxoglutarate transaminase 1,42130,0.0398278130285888,0.00579419674495532,0.0284711874084764,0.0511844386487012,6.52793618325588e-12
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CAMKK1,Calcium/calmodulin-dependent protein kinase kinase 1,41843,0.0313985608740424,0.00456989408495036,0.0224415684675397,0.0403555532805451,6.67242008765751e-12
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CD34,Hematopoietic progenitor cell antigen CD34,42211,-0.0168041890248893,0.00244641166882624,-0.0215991558957887,-0.0120092221539899,6.75022329740055e-12
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,WASHC3,WASH complex subunit 3,39929,0.0535805811853982,0.00780093532988286,0.0382907479388277,0.0688704144319685,6.82864065624326e-12
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MAP2K1,Dual specificity mitogen-activated protein kinase kinase 1,39930,0.0453337529326695,0.00660094948297587,0.0323958919460368,0.0582716139193022,6.86297171343376e-12
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,QPCT,Glutaminyl-peptide cyclotransferase,42170,0.0188889233235926,0.00275500134583644,0.0134891206857532,0.024288725961432,7.37584441191434e-12
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PAMR1,Inactive serine protease PAMR1,42137,0.018447154701242,0.00269661007873498,0.0131617989469215,0.0237325104555626,8.20960117103987e-12
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CFHR5,Complement factor H-related protein 5,39864,-0.0293103662953016,0.00428769670700092,-0.0377142518410234,-0.0209064807495798,8.56887992501451e-12
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,RILP,Rab-interacting lysosomal protein,42224,0.0408318715264431,0.0059869792119267,0.0290973922710668,0.0525663507818195,9.48049026788919e-12
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CHRDL1,Chordin-like protein 1,42166,0.0227723199538791,0.0033398657183795,0.0162261831458553,0.029318456761903,9.59985790665768e-12
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ENTPD2,Ectonucleoside triphosphate diphosphohydrolase 2,41843,0.0302790308026259,0.00444156472981694,0.0215735639321846,0.0389844976730671,9.68546885312548e-12
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GIGYF2,GRB10-interacting GYF protein 2,39934,0.0535744544842618,0.00785933122425077,0.0381701652847303,0.0689787436837933,9.79065704423298e-12
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ATXN2L,Ataxin-2-like protein,39934,0.0337255627010314,0.00494948456282111,0.024024572957902,0.0434265524441607,9.97647459772277e-12
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ITIH4,Inter-alpha-trypsin inhibitor heavy chain H4,39979,-0.0171186467532253,0.00251327874775987,-0.0220446730988346,-0.012192620407616,1.01609585627275e-11
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ESAM,Endothelial cell-selective adhesion molecule,42310,0.0226055748532402,0.00332020262561789,0.0160979777070291,0.0291131719994513,1.02730577874764e-11
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NIT1,Deaminated glutathione amidase,39638,0.0310208587177856,0.00456345999310157,0.0220764771313066,0.0399652403042647,1.11815210161943e-11
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CXCL8,Interleukin-8,42035,0.0470586618561485,0.00692978092831728,0.0334762912366467,0.0606410324756504,1.16212237589481e-11
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FCAR,Immunoglobulin alpha Fc receptor,42119,0.0337569916350241,0.00497263617165928,0.0240106247385719,0.0435033585314763,1.17990899871297e-11
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MPHOSPH8,M-phase phosphoprotein 8,41900,0.0531616745208169,0.00784106501200549,0.0377931870972861,0.0685301619443476,1.25330033335585e-11
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MYCBP2,E3 ubiquitin-protein ligase MYCBP2,39934,0.0458694329993909,0.00676448452311535,0.0326110433340848,0.059127822664697,1.25348524508798e-11
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CCL7,C-C motif chemokine 7,42119,0.0388663788265137,0.00573529818931576,0.0276251943754548,0.0501075632775726,1.28047900469408e-11
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CWC15,Spliceosome-associated protein CWC15 homolog,39872,0.043702821255604,0.00645613876789543,0.031048789270529,0.056356853240679,1.35935878450401e-11
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FCRLB,Fc receptor-like B,41843,0.0425619669150527,0.00629771540661436,0.0302184447180885,0.0549054891120168,1.45444702825746e-11
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,AKR1B10,Aldo-keto reductase family 1 member B10,39649,0.0448932637851778,0.00665219518141907,0.0318549612295965,0.0579315663407592,1.56708491657284e-11
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FSTL1,Follistatin-related protein 1,39638,0.0161140281040645,0.0023879184474813,0.0114337079470011,0.0207943482611278,1.57244566736418e-11
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,LEPR,Leptin receptor,42145,-0.0216759161727067,0.00321326733204626,-0.0279739201435174,-0.015377912201896,1.58412955271854e-11
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CTSC,Dipeptidyl peptidase 1,42123,0.0304618698418252,0.00452791197975451,0.0215871623615063,0.039336577322144,1.7945338523308e-11
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MMP3,Stromelysin-1,42137,-0.0340809685499988,0.00507029649073212,-0.0440187496718337,-0.0241431874281638,1.86820535356301e-11
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GIMAP8,GTPase IMAP family member 8,39560,0.0346372314239405,0.00515214810492195,0.0245390211382935,0.0447354417095876,1.87033115455696e-11
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DFFA,DNA fragmentation factor subunit alpha,42296,0.0457912227523662,0.0068201020844891,0.0324238226667676,0.0591586228379649,1.96611468451448e-11
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,HBEGF,Proheparin-binding EGF-like growth factor,42224,0.0499840824946581,0.00744933619506394,0.0353833835523328,0.0645847814369834,2.02493095470894e-11
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IL19,Interleukin-19,41756,0.0502957575836164,0.00750625749636712,0.0355834928907368,0.0650080222764959,2.16148092370187e-11
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ATP5IF1,"ATPase inhibitor, mitochondrial",42185,0.0747428272484911,0.0111564172567738,0.0528762494252145,0.0966094050717677,2.17315131166307e-11
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MATN2,Matrilin-2,42144,0.020245044813748,0.00302577023029953,0.0143145351623609,0.026175554465135,2.30561085050012e-11
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,AAMDC,Mth938 domain-containing protein,39638,0.0362564650455428,0.00544490833978269,0.0255844446995687,0.0469284853915169,2.89214896182924e-11
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PAFAH2,"Platelet-activating factor acetylhydrolase 2, cytoplasmic",39757,0.0341594259640275,0.00513325050122205,0.0240982549816322,0.0442205969464227,2.97499773568158e-11
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MYL4,Myosin light chain 4,39638,0.0352065473203104,0.00529565081308097,0.0248270717266717,0.0455860229139491,3.10698321958052e-11
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,RBP2,Retinol-binding protein 2,42070,-0.0529020895944452,0.00796337849882168,-0.0685103114521357,-0.0372938677367547,3.18795358056003e-11
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PCDH7,Protocadherin-7,39930,0.0238049247149719,0.00358846122686709,0.0167715407103124,0.0308383087196314,3.42189266560614e-11
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ENOX2,Ecto-NOX disulfide-thiol exchanger 2,39575,0.0191560997639567,0.00289430244085786,0.0134832669798753,0.0248289325480381,3.79637900928437e-11
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TEK,Angiopoietin-1 receptor,42181,0.0149547393004341,0.00226036252895797,0.0105244287436765,0.0193850498571917,3.82670825246951e-11
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PROC,Vitamin K-dependent protein C,42199,0.017318139715374,0.00262120173597983,0.0121805843128536,0.0224556951178945,4.06929161590381e-11
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GALNT7,N-acetylgalactosaminyltransferase 7,42070,0.0140268300825394,0.00212405327641146,0.00986368566077295,0.0181899745043059,4.15772412724074e-11
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,RRAS,Ras-related protein R-Ras,39649,0.0892460192256243,0.013518088003477,0.0627505667388095,0.115741471712439,4.24326957223132e-11
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,LZTFL1,Leucine zipper transcription factor-like protein 1,39736,0.0489466934503873,0.00742045164094243,0.0344026082341402,0.0634907786666345,4.40981619013557e-11
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CSF1R,Macrophage colony-stimulating factor 1 receptor,39990,0.0276422424991964,0.00419735531610218,0.0194154260796361,0.0358690589187567,4.72882598405934e-11
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PHYKPL,5-phosphohydroxy-L-lysine phospho-lyase,39736,0.0290263575511074,0.00441027604036593,0.0203822165119902,0.0376704985902247,4.86550490104846e-11
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CCN5,CCN family member 5,42137,0.0254657131026418,0.00387367217713067,0.0178733156354657,0.0330581105698179,5.07597221726819e-11
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,HPSE,Heparanase,39866,0.0642882244689082,0.00980108644820228,0.0450780950304318,0.0834983539073847,5.64299804691054e-11
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CPPED1,Serine/threonine-protein phosphatase CPPED1,42249,0.0432750795411521,0.0066081467522388,0.030323111906764,0.0562270471755401,6.00988987886859e-11
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ASAH1,Acid ceramidase,39876,0.0317828926131466,0.0048568401105955,0.0222634859963795,0.0413022992299138,6.25140918988066e-11
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ALDH2,"Aldehyde dehydrogenase, mitochondrial",39919,0.0351671220498857,0.00538556541601451,0.0246114138344973,0.0457228302652741,6.86379145509233e-11
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IFNG,Interferon gamma,41913,0.0759695739441876,0.0116529538755916,0.053129784348028,0.0988093635403472,7.31638417024321e-11
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GLYR1,Putative oxidoreductase GLYR1,39919,0.0388343622273562,0.00596216734023728,0.0271485142404912,0.0505202102142213,7.65495139038227e-11
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IRAK4,Interleukin-1 receptor-associated kinase 4,42119,0.0693248589196076,0.0106453014582507,0.0484600680614362,0.0901896497777789,7.66508156211144e-11
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CDA,Cytidine deaminase,39946,0.0318593467708445,0.00489368566695073,0.0222677228636211,0.041450970678068,7.81671779847649e-11
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TREM2,Triggering receptor expressed on myeloid cells 2,42123,0.0358867280853453,0.00551448986723047,0.0250783279455735,0.046695128225117,7.89916700824566e-11
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CMC1,COX assembly mitochondrial protein homolog,39958,0.0610145530322382,0.0093861737261337,0.0426176525290162,0.0794114535354603,8.34234167903488e-11
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,AKR1C4,Aldo-keto reductase family 1 member C4,41900,0.0337203001544273,0.0051936702803723,0.0235407064048976,0.043899893903957,8.73774053413437e-11
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,BCL2L15,Bcl-2-like protein 15,39657,0.037780551401857,0.0058212376713552,0.0263709255660008,0.0491901772377132,8.94356529040145e-11
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MITD1,MIT domain-containing protein 1,42016,0.0638599788352289,0.00984845754543935,0.0445570020461677,0.08316295562429,9.22900039796061e-11
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,UROD,Uroporphyrinogen decarboxylase,39736,0.0451314318694541,0.00697150685618944,0.0314672784313228,0.0587955853075854,9.96541585324126e-11
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ST6GAL1,"Beta-galactoside alpha-2,6-sialyltransferase 1",42310,0.0195564815495767,0.00302710681924756,0.0136233521838515,0.0254896109153019,1.07914491831469e-10
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ST13,Hsc70-interacting protein,39736,0.0360678887261354,0.00559009245338357,0.0251113075175036,0.0470244699347672,1.1488076775662e-10
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,OLFM4,Olfactomedin-4,39347,0.0819936883254449,0.0127202310185136,0.0570620355291582,0.106925341121732,1.19819893274204e-10
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,LPP,Lipoma-preferred partner,39575,0.0435938502723419,0.00678934010002837,0.0302867436762863,0.0569009568683975,1.41043038548908e-10
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,HSPB6,Heat shock protein beta-6,42262,0.0266471997191258,0.00415547840899052,0.0185024620375044,0.0347919374007472,1.47816311727145e-10
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,YARS1,"Tyrosine--tRNA ligase, cytoplasmic",39930,0.0962896323264466,0.015021473066505,0.0668475451160968,0.125731719536796,1.51168983237498e-10
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IL1RAP,Interleukin-1 receptor accessory protein,42137,-0.0290560053494679,0.00456638507558885,-0.038006120097622,-0.0201058906013137,2.04193040930132e-10
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,LRRC59,Leucine-rich repeat-containing protein 59,39958,0.0316099394821264,0.00496766815168288,0.0218733099048279,0.0413465690594248,2.05284763445384e-10
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CCN3,CCN family member 3,42299,0.0219965298904323,0.00346681494254716,0.0152015726030399,0.0287914871778248,2.29598575728138e-10
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PIKFYVE,1-phosphatidylinositol 3-phosphate 5-kinase,39657,0.0361756770527764,0.00570075253405895,0.0250022020860208,0.0473491520195319,2.29970207084247e-10
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FOXJ3,Forkhead box protein J3,39657,0.0295344998062466,0.00465729218166906,0.0204062071301753,0.038662792482318,2.36323843504722e-10
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SNX15,Sorting nexin-15,39736,0.0351611906093174,0.00554866627446477,0.0242858047113664,0.0460365765072683,2.43531726209011e-10
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,STX8,Syntaxin-8,42119,0.0309186345584014,0.0048844138450085,0.0213451834221848,0.0404920856946181,2.52805803414118e-10
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GMPR2,GMP reductase 2,39736,0.0431630909653984,0.00683329410871175,0.0297698345123233,0.0565563474184734,2.77601157656056e-10
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DLG4,Disks large homolog 4,39929,0.0467656608184655,0.0074104973747823,0.0322410859638922,0.0612902356730389,2.88087748562353e-10
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CR2,Complement receptor type 2,42217,0.0300637108358173,0.00476637560042137,0.0207216146589914,0.0394058070126432,2.92425615985818e-10
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,LCN2,Neutrophil gelatinase-associated lipocalin,41747,0.0252607842149583,0.00400620126145183,0.0174086297425127,0.0331129386874039,2.96607462734159e-10
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CRKL,Crk-like protein,42143,0.0678478139204348,0.0107664271641916,0.0467456166786193,0.0889500111622503,3.03331973279959e-10
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FUT3_FUT5,3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase FUT3_4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase FUT5,42249,-0.029955635431791,0.00475443749465803,-0.0392743329213207,-0.0206369379422612,3.0567210276359e-10
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SART1,U4/U6.U5 tri-snRNP-associated protein 1,39575,0.0242726698454373,0.00386491228166559,0.0166974417733728,0.0318478979175019,3.50782849778814e-10
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MGLL,Monoglyceride lipase,42166,0.0559380115870675,0.00890928090121573,0.0384758210206846,0.0734002021534503,3.51995126038601e-10
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MFAP4,Microfibril-associated glycoprotein 4,39736,0.0212881476075595,0.00339367702480913,0.0146365406389336,0.0279397545761854,3.67564464115665e-10
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NUB1,NEDD8 ultimate buster 1,42119,0.0538644143892054,0.00859006316725392,0.0370278905813877,0.0707009381970231,3.70723004954534e-10
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PPP1R2,Protein phosphatase inhibitor 2,42145,0.0515217152751689,0.0082351876793698,0.0353807474236041,0.0676626831267337,4.06109826442086e-10
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MYDGF,Myeloid-derived growth factor,39958,0.0639405609787862,0.0102228564713594,0.0439037622949218,0.0839773596626506,4.12683163346147e-10
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SERPINB8,Serpin B8,42296,0.0373338898833499,0.00596999982092144,0.0256326902343439,0.049035089532356,4.13057601587602e-10
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,COMMD1,COMM domain-containing protein 1,39638,0.0392117442714183,0.00627249065021111,0.0269176625970046,0.0515058259458321,4.21853914708084e-10
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SELL,L-selectin,39979,-0.0149156138114585,0.00239022429724236,-0.0196004534340535,-0.0102307741888635,4.52381373600595e-10
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FNTA,Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha,39919,0.0227166304396366,0.00364082193825027,0.015580619440666,0.0298526414386071,4.5487347797214e-10
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ACE,Angiotensin-converting enzyme,39990,0.0173274554960188,0.0027794515277682,0.0118797305015932,0.0227751804904445,4.70373050829134e-10
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MARS1,"Methionine--tRNA ligase, cytoplasmic",39713,0.0551592435407615,0.00885798428688823,0.0377975943384605,0.0725208927430624,4.92413833968538e-10
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CSF2,Granulocyte-macrophage colony-stimulating factor,39575,0.0231489759824291,0.00371750856860532,0.0158626591879626,0.0304352927768955,4.92794231465897e-10
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,KDR,Vascular endothelial growth factor receptor 2,42181,0.0159323007747364,0.00256112045201442,0.0109125046887882,0.0209520968606847,5.09036584014803e-10
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,BAG4,BAG family molecular chaperone regulator 4,39657,0.0323578404380762,0.00520676621306748,0.022152578660464,0.0425631022156885,5.33165704913224e-10
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SCARF1,Scavenger receptor class F member 1,42310,0.0268945393688758,0.00433535891050073,0.0183972359042944,0.0353918428334573,5.67968088632435e-10
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,RALY,RNA-binding protein Raly,39919,0.0307043858680187,0.0049492046068776,0.0210039448385386,0.0404048268974988,5.70030465759545e-10
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TRIM40,E3 ubiquitin ligase TRIM40,39649,0.0464353901199716,0.00749276254294707,0.0317495755357953,0.0611212047041478,5.94620608088414e-10
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SLC9A3R2,Na(+)/H(+) exchange regulatory cofactor NHE-RF2,39930,0.0321536076618033,0.00519038828014096,0.021980446632727,0.0423267686908796,6.03691053031456e-10
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PTPN1,Tyrosine-protein phosphatase non-receptor type 1,42016,0.0498429802093334,0.00804964491135831,0.0340656761830711,0.0656202842355957,6.11586427492562e-10
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IL6,Interleukin-6,42070,0.0472379173886692,0.00763409574673371,0.0322750897250711,0.0622007450522672,6.27950296380953e-10
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PDCD1LG2,Programmed cell death 1 ligand 2,42070,0.0200457786482804,0.00324094367842844,0.0136935290385606,0.0263980282580001,6.38310687648161e-10
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PDGFB,Platelet-derived growth factor subunit B,42185,0.0540467405984113,0.00874980615740195,0.0368971205299035,0.0711963606669191,6.72341918397986e-10
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,VCAM1,Vascular cell adhesion protein 1,42199,0.0174990944922263,0.00283339677894037,0.0119456368055032,0.0230525521789494,6.76129839992154e-10
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TP53,Cellular tumor antigen p53,41843,0.0280514892413018,0.00454470051553767,0.019143876230848,0.0369591022517556,6.9245411661217e-10
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,LAMP3,Lysosome-associated membrane glycoprotein 3,42284,0.0327286083562867,0.00530378886917802,0.0223331821726978,0.0431240345398756,6.98628171410407e-10
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,RAB11FIP3,Rab11 family-interacting protein 3,39958,0.0682696204714228,0.0110636779509091,0.0465848116876409,0.0899544292552046,7.03450972857601e-10
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FABP3,"Fatty acid-binding protein, heart",39958,0.0344051768472969,0.00558520745311231,0.0234581702391968,0.045352183455397,7.51806937869732e-10
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DBI,Acyl-CoA-binding protein,42085,0.0488875904386875,0.00794018938103227,0.0333248192518643,0.0644503616255108,7.62488981383528e-10
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CRLF1,Cytokine receptor-like factor 1,42185,0.0156309525391491,0.0025403065693413,0.0106519516632401,0.020609953415058,7.8080334008571e-10
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PTPRC,Receptor-type tyrosine-protein phosphatase C,39966,0.0146488660464753,0.0023817399336185,0.00998065577658302,0.0193170763163675,7.98397490773936e-10
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PDLIM5,PDZ and LIM domain protein 5,39934,0.0749792351456887,0.0122153647763395,0.0510371201840632,0.0989213501073142,8.63014720933046e-10
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FCRL6,Fc receptor-like protein 6,42119,0.0430008661774221,0.00700812737814465,0.0292649365162585,0.0567367958385856,8.70663810017749e-10
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ITPA,Inosine triphosphate pyrophosphatase,39575,0.0423715373551024,0.00691142363743516,0.0288251470257295,0.0559179276844753,9.052763363574e-10
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TBCC,Tubulin-specific chaperone C,42016,0.050141413985615,0.0081971010254941,0.0340750959756466,0.0662077319955835,9.80229209971652e-10
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CHRDL2,Chordin-like protein 2,42145,0.0285118586741432,0.0046740112913083,0.0193507965431789,0.0376729208051074,1.08899947245272e-09
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NRP2,Neuropilin-2,42137,-0.0174893577273075,0.00287048958773074,-0.0231155173192597,-0.0118631981353552,1.13951949684301e-09
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,RGCC,Regulator of cell cycle RGCC,39934,0.047960481164169,0.007882175142801,0.0325114178842791,0.063409544444059,1.2049654238996e-09
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,LXN,Latexin,41960,-0.042517838574734,0.00698888628980119,-0.0562160557027443,-0.0288196214467237,1.20697021876141e-09
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,KEL,Kell blood group glycoprotein,41839,0.0224805981757375,0.00369768210744737,0.0152331412451407,0.0297280551063343,1.23760581675633e-09
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SOD2,"Superoxide dismutase [Mn], mitochondrial",42137,0.0236274366917983,0.00388710349223435,0.016008713847019,0.0312461595365776,1.24635588155981e-09
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DLL1,Delta-like protein 1,42181,0.0190427731312316,0.00313502126146396,0.0128981314587622,0.0251874148037009,1.27928213564528e-09
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,C2,Complement C2,42199,0.0140115970980464,0.00230836581335222,0.00948720010387607,0.0185359940922168,1.31377088330244e-09
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SSC4D,Scavenger receptor cysteine-rich domain-containing group B protein,42129,0.0768821004233057,0.0126689339037193,0.0520509899720159,0.101713210874596,1.32515138261192e-09
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,XIAP,E3 ubiquitin-protein ligase XIAP,39657,0.0364201604474359,0.0060033553909323,0.0246535838812086,0.0481867370136632,1.34893246102748e-09
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SMAD3,Mothers against decapentaplegic homolog 3,39919,0.0325292786650622,0.00536345085660714,0.0220169149861122,0.0430416423440122,1.36174090045442e-09
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CLEC14A,C-type lectin domain family 14 member A,42137,0.0198778813206468,0.00327866808920724,0.0134516918658006,0.0263040707754929,1.37336855780568e-09
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,APOL1,Apolipoprotein L1,39990,-0.0332718102189068,0.00549496326376756,-0.0440419382158912,-0.0225016822219224,1.4487440695283e-09
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GPI,Glucose-6-phosphate isomerase,39990,0.0297853234220327,0.00492153674559062,0.020139111400675,0.0394315354433903,1.47524250410816e-09
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DNPEP,Aspartyl aminopeptidase,39929,0.0353618580566313,0.00584662769549263,0.0239024677734658,0.0468212483397969,1.51048391675556e-09
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,KAZALD1,Kazal-type serine protease inhibitor domain-containing protein 1,42070,0.027756932158465,0.0045969372430633,0.0187469351620609,0.036766929154869,1.600053783429e-09
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IL17C,Interleukin-17C,41913,0.0436703688882668,0.00723533674204551,0.0294891088738576,0.057851628902676,1.62474567044727e-09
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MMP8,Neutrophil collagenase,42224,0.044110280676259,0.00730967215486912,0.0297833232527155,0.0584372380998024,1.6358311644816e-09
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PDCD1,Programmed cell death protein 1,42232,0.0258680471713405,0.00428773299454081,0.0174640905020405,0.0342720038406405,1.65075167587195e-09
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GAS2,Growth arrest-specific protein 2,39757,0.0323819957724013,0.005372540386963,0.0218518166139538,0.0429121749308488,1.71974092328856e-09
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DNAJB6,DnaJ homolog subfamily B member 6,39639,0.0526730093183754,0.00875005319996687,0.0355229050464404,0.0698231135903105,1.80255406095532e-09
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TNXB,Tenascin-X,42137,-0.0160418048857917,0.0026683935129223,-0.0212718561711194,-0.010811753600464,1.88213009409334e-09
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PKD1,Polycystin-1,39958,0.0167692967607622,0.00279424526909792,0.0112925760333303,0.0222460174881942,2.01631093349327e-09
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TXNDC9,Thioredoxin domain-containing protein 9,39929,0.0330199442994421,0.00550436828799927,0.0222313824549636,0.0438085061439207,2.04774301332269e-09
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IFT20,Intraflagellar transport protein 20 homolog,39649,0.0269015509956938,0.00448516400537669,0.0181106295451555,0.0356924724462321,2.06147236683238e-09
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,BCL2L11,"Bcl-2-like protein 11, Isoform BimL ",42119,0.0251795126702658,0.00420790303257837,0.0169320227264122,0.0334270026141194,2.23418245034215e-09
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ATOX1,Copper transport protein ATOX1,42181,0.0433764290066614,0.00725703912240378,0.02915263232675,0.0576002256865728,2.32762562366398e-09
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ADA,Adenosine deaminase,42296,0.0216771690709229,0.00362700083342043,0.0145682474374189,0.028786090704427,2.33488229409622e-09
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,UROS,Uroporphyrinogen-III synthase,39649,0.0404783487497379,0.00679379839333998,0.0271625038987916,0.0537941936006843,2.62917342302499e-09
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ICAM2,Intercellular adhesion molecule 2,42310,0.0198937245681485,0.00334170607625225,0.0133439806586941,0.0264434684776029,2.69433542371122e-09
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ABRAXAS2,BRISC complex subunit Abraxas 2,39575,0.0406478794760502,0.00682728682395615,0.0272663973010961,0.0540293616510042,2.70108939071446e-09
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,HMOX2,Heme oxygenase 2,41839,0.0290279911437258,0.00488061140248422,0.0194619927948567,0.0385939894925948,2.7894142165414e-09
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,EBI3_IL27,Interleukin-27,42247,0.018541067476114,0.00312905513046652,0.0124081194203996,0.0246740155318283,3.18944438377798e-09
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DEFB103A_DEFB103B,Beta-defensin 103,39596,0.0253239495825995,0.00427826533307737,0.0169385495297678,0.0337093496354311,3.33151859582998e-09
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MCFD2,Multiple coagulation factor deficiency protein 2,42062,0.0274806534974894,0.00464372772963707,0.0183789471474007,0.0365823598475781,3.34207809309107e-09
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ADAMTS13,A disintegrin and metalloproteinase with thrombospondin motifs 13,42310,0.0140908476541383,0.00238286991332908,0.0094204226240133,0.0187612726842633,3.43105137302882e-09
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CCL13,C-C motif chemokine 13,42275,0.0411260527605517,0.00695634721614176,0.0274916122169139,0.0547604933041896,3.4599612667592e-09
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NRP1,Neuropilin-1,42230,-0.0164896816416162,0.00278940724916405,-0.0219569198499777,-0.0110224434332546,3.47035292727625e-09
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SLAMF6,SLAM family member 6,41843,0.0233367484559374,0.00395063560301729,0.0155935026740236,0.0310799942378513,3.56755351779457e-09
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CSDE1,Cold shock domain-containing protein E1,39575,0.0730723225819552,0.0123951787789998,0.0487777721751156,0.0973668729887948,3.85196169378205e-09
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PLXNB3,Plexin-B3,42099,0.0289418827128172,0.00491418041911201,0.0193100890913576,0.0385736763342767,3.9667050010503e-09
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,STX4,Syntaxin-4,42070,0.0354560916871476,0.00603023138259937,0.0236368381772529,0.0472753451970424,4.20687156217952e-09
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MINK1,Misshapen-like kinase 1,39929,0.0562086873948062,0.00957510786465694,0.0374414759800786,0.0749758988095338,4.47223576913823e-09
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ALPP,"Alkaline phosphatase, placental type",42070,0.0625042348655065,0.0106545104375399,0.0416213944079283,0.0833870753230847,4.55655921561087e-09
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,AZU1,Azurocidin,41751,0.04505212601149,0.00768274541466688,0.0299939449987429,0.0601103070242371,4.6251420797212e-09
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,AARSD1,Alanyl-tRNA editing protein Aarsd1,42070,0.0321147307243093,0.00548256903578995,0.021368895414161,0.0428605660344576,4.80545651730292e-09
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ERI1,3'-5' exoribonuclease 1,39757,0.0207109943183944,0.00354029035489129,0.0137720252228075,0.0276499634139814,5.05128370230693e-09
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MAVS,Mitochondrial antiviral-signaling protein,41843,0.05414540148117,0.00926506360044085,0.035985876824306,0.0723049261380341,5.21484920254056e-09
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SFTPD,Pulmonary surfactant-associated protein D,42145,0.0403766655597153,0.00691210783555512,0.0268289342020273,0.0539243969174034,5.29394595371439e-09
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CLMP,CXADR-like membrane protein,42262,0.0131803938625554,0.00226170912645568,0.00874744397470223,0.0176133437504085,5.74892077777745e-09
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,STK24,Serine/threonine-protein kinase 24,41839,0.0369680280492219,0.00634929780595575,0.0245234043495486,0.0494126517488951,5.93607925043217e-09
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PGA4,Pepsin A-4,39990,0.0448892355003516,0.00771310264903402,0.0297715543082449,0.0600069166924583,6.04817745249902e-09
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,LAIR2,Leukocyte-associated immunoglobulin-like receptor 2,42016,0.0623614322811603,0.0107189528769457,0.0413522846423467,0.0833705799199738,6.09634261941853e-09
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CD69,Early activation antigen CD69,42082,0.0521170064915794,0.00895932117668307,0.0345567369852806,0.0696772759978782,6.12465449750635e-09
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DBNL,Drebrin-like protein,42185,0.0550309168554467,0.00946648831227338,0.0364765997633909,0.0735852339475025,6.26532187548894e-09
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CENPF,Centromere protein F,39757,0.0322652135348212,0.0055558522605998,0.0213757431040456,0.0431546839655968,6.51711846564994e-09
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CTHRC1,Collagen triple helix repeat-containing protein 1,39966,0.0169271696591649,0.00291937841902023,0.0112051879578852,0.0226491513604445,6.88105672245796e-09
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CD7,T-cell antigen CD7,39636,0.0266840718136969,0.00460320330348961,0.0176617933388573,0.0357063502885365,6.94240986043311e-09
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MERTK,Tyrosine-protein kinase Mer,42296,0.0146111438686548,0.00252092376301222,0.00967013329315087,0.0195521544441588,6.94317458178844e-09
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TNFSF14,Tumor necrosis factor ligand superfamily member 14,42016,0.0340951930422603,0.00588537440515572,0.022559859208155,0.0456305268763655,7.06041866064458e-09
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PGLYRP1,Peptidoglycan recognition protein 1,42248,0.0247907822599237,0.00428174688360587,0.0163985583680562,0.0331830061517912,7.19882905456551e-09
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,REEP4,Receptor expression-enhancing protein 4,39934,0.0371769156622586,0.00642232120725465,0.0245891660960395,0.0497646652284777,7.28129182654141e-09
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CD8A,T-cell surface glycoprotein CD8 alpha chain,42249,0.0299508755999528,0.00518492643488263,0.0197884197875829,0.0401133314123228,7.79200891578331e-09
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CSPG4,Chondroitin sulfate proteoglycan 4,39966,-0.0195507397453774,0.00338668303081418,-0.0261886384857732,-0.0129128410049816,7.99912942202407e-09
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,USP28,Ubiquitin carboxyl-terminal hydrolase 28,39929,0.0215670986570338,0.00374683877793555,0.0142232946522801,0.0289109026617875,8.83244061521292e-09
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ASPSCR1,Tether containing UBX domain for GLUT4,39934,0.0394121288493684,0.00685574851877497,0.0259748617525694,0.0528493959461673,9.22145957001612e-09
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,BTD,Biotinidase,39979,0.0121035995720843,0.00210629338038874,0.00797526454652233,0.0162319345976462,9.35044535042693e-09
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TDP1,Tyrosyl-DNA phosphodiesterase 1,39919,0.0423415353002863,0.00737043768426949,0.0278954774391181,0.0567875931614545,9.44134076708947e-09
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ATRN,"Attractin, Isoform 2",39979,0.00981828504737385,0.00171050823461815,0.00646568890752227,0.0131708811872254,9.71065721310493e-09
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GRAP2,GRB2-related adapter protein 2,42145,0.0756306001935786,0.0132004648745367,0.0497576890394867,0.10150351134767,1.02937267087766e-08
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PPL,Periplakin,39657,0.0190189454286002,0.00332140537509252,0.0125089908934189,0.0255288999637816,1.05397382004144e-08
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GLRX,Glutaredoxin-1,42057,0.0325335525854471,0.00568586705513898,0.0213892531573748,0.0436778520135195,1.07629184726214e-08
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ACVRL1,Serine/threonine-protein kinase receptor R3,41992,0.0150185318822044,0.00262550951222926,0.00987253323823507,0.0201645305261738,1.08651601725646e-08
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,LTA4H,Leukotriene A-4 hydrolase,42262,-0.0348083286162528,0.00608698547297348,-0.0467388201432808,-0.0228778370892248,1.09728610218472e-08
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NEDD4L,E3 ubiquitin-protein ligase NEDD4-like,39657,0.0288788803095243,0.00505052572882715,0.0189798498810231,0.0387779107380255,1.10581255988963e-08
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ITGAM,Integrin alpha-M,42137,-0.0183697831043193,0.00322395942475251,-0.0246887435768342,-0.0120508226318044,1.2382233976423e-08
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SERPINA6,Corticosteroid-binding globulin,39979,-0.00901002925322047,0.00158242239865922,-0.0121115771545925,-0.0059084813518484,1.2730274679769e-08
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CD300LF,CMRF35-like molecule 1,42262,0.0348812459383501,0.00613661838580683,0.0228534739021687,0.0469090179745315,1.34179888073363e-08
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,EDIL3,EGF-like repeat and discoidin I-like domain-containing protein 3,41900,0.0206845779895884,0.00363959147042348,0.0135509787075584,0.0278181772716185,1.34961486768683e-08
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,A1BG,Alpha-1B-glycoprotein,39979,0.00962632980404721,0.00169708056811769,0.00630005189053653,0.0129526077175579,1.44339171643537e-08
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GNE,Bifunctional UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase,41843,0.0377829809143228,0.00666605112826836,0.0247175207029168,0.0508484411257288,1.47513537871637e-08
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,UBAC1,Ubiquitin-associated domain-containing protein 1,42070,0.0191291667881192,0.00337797468353914,0.0125083364083825,0.025749997167856,1.51868709402614e-08
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NAMPT,Nicotinamide phosphoribosyltransferase,41843,0.0300362828517494,0.00530399666986683,0.0196404493788104,0.0404321163246884,1.51883523560226e-08
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ARHGAP25,Rho GTPase-activating protein 25,41843,0.0351214858516334,0.0062106915819158,0.0229485303510784,0.0472944413521884,1.59064890034822e-08
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,OMG,Oligodendrocyte-myelin glycoprotein,42070,-0.0397872700739822,0.00703817499131698,-0.0535820930569635,-0.0259924470910009,1.60809574839353e-08
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ATRAID,All-trans retinoic acid-induced differentiation factor,39930,0.0172457657656074,0.00305141719256869,0.0112649880681728,0.0232265434630421,1.62682920712839e-08
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CLPP,"ATP-dependent Clp protease proteolytic subunit, mitochondrial",41997,0.0560108192636445,0.00991196002272742,0.0365833776190988,0.0754382609081903,1.62927002127883e-08
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FCRL2,Fc receptor-like protein 2,42229,0.0288348806339944,0.00511492002718732,0.0188096373807073,0.0388601238872816,1.76056157036781e-08
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,COX5B,"Cytochrome c oxidase subunit 5B, mitochondrial",42070,0.0398928197838249,0.00707726757587169,0.0260213753351164,0.0537642642325335,1.76762544341846e-08
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,KLRK1,NKG2-D type II integral membrane protein,39929,0.0272603727738642,0.0048399931159033,0.0177739862666938,0.0367467592810347,1.82041425183816e-08
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SPRY2,Protein sprouty homolog 2,41913,0.0533460333759408,0.00947889788682068,0.0347673935177723,0.0719246732341094,1.86127567205456e-08
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CASC3,Protein CASC3,39649,0.0249812754950321,0.00443874604022288,0.0162813332561952,0.0336812177338689,1.8674952085885e-08
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,BMP6,Bone morphogenetic protein 6,41886,0.0229088461857718,0.00408681882386439,0.0148986812909976,0.030919011080546,2.11734472865505e-08
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,BCAT1,"Branched-chain-amino-acid aminotransferase, cytosolic",39958,0.0171129348089866,0.00305311939976285,0.0111288207854514,0.0230970488325218,2.13029897218133e-08
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PRDX3,"Thioredoxin-dependent peroxide reductase, mitochondrial",41913,0.04122658499659,0.00736541380876708,0.0267903739314065,0.0556627960617734,2.21990304723199e-08
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SERPINE2,Glia-derived nexin,39958,0.0372629617233562,0.00666600037392017,0.0241976009904726,0.0503283224562397,2.32304503842519e-08
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PPCDC,Phosphopantothenoylcysteine decarboxylase,42249,0.0264218428395487,0.00472795851715345,0.017155044145928,0.0356886415331695,2.33525192934075e-08
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PAGR1,PAXIP1-associated glutamate-rich protein 1,39638,0.0243200045301886,0.00435822086095756,0.0157778916427117,0.0328621174176654,2.45823796456101e-08
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,EREG,Proepiregulin,41997,0.0456113670047244,0.00817643435336866,0.0295855556721218,0.061637178337327,2.47453043837539e-08
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PRDX6,Peroxiredoxin-6,42262,-0.0341972185905467,0.00613638623621343,-0.046224535613525,-0.0221699015675684,2.55332949589719e-08
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,F12,Coagulation factor XII,39979,0.0236057674096451,0.0042356967301478,0.0153038018185554,0.0319077330007348,2.56007716174024e-08
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ACADSB,"Short/branched chain specific acyl-CoA dehydrogenase, mitochondrial",39958,0.050736762437813,0.0091124147230834,0.0328764295805696,0.0685970952950565,2.63726098451313e-08
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FKBPL,FK506-binding protein-like,39930,0.0339992353321607,0.00610808118739099,0.0220273962048744,0.0459710744594471,2.66168047619454e-08
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,RWDD1,RWD domain-containing protein 1,42249,0.0353365334500124,0.00635584107672166,0.022879084939638,0.0477939819603869,2.753185599818e-08
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SESTD1,SEC14 domain and spectrin repeat-containing protein 1,41839,0.0365332898205732,0.00657631546617519,0.0236437115068698,0.0494228681342766,2.82509704840204e-08
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CAMSAP1,Calmodulin-regulated spectrin-associated protein 1,39934,0.0607669873187049,0.0109639621138728,0.0392776215755142,0.0822563530618957,3.04973161218309e-08
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,LRPAP1,Alpha-2-macroglobulin receptor-associated protein,42249,0.0317385842358575,0.00572791763002631,0.020511865681006,0.0429653027907091,3.06259938694649e-08
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,BOLA1,BolA-like protein 1,39586,0.0310642049321957,0.00561057860358243,0.0200674708691741,0.0420609389952172,3.15270351289453e-08
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PRL,Prolactin,42249,0.0415645625301141,0.00751234925384429,0.0268403579925793,0.0562887670676489,3.20903792538063e-08
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SLC27A4,Long-chain fatty acid transport protein 4,41839,0.0385837739487909,0.00697445499233758,0.0249138421638092,0.0522537057337726,3.22321085457151e-08
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,VAMP8,Vesicle-associated membrane protein 8,39657,0.0500820850419151,0.00905693384682344,0.0323304947021412,0.0678336753816891,3.28075153783396e-08
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CD59,CD59 glycoprotein,41638,0.0133166864146446,0.00241418803593196,0.00858487786421794,0.0180484949650712,3.53388987772391e-08
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CD226,CD226 antigen,39657,0.0241733304554481,0.00438239411717536,0.0155838379857844,0.0327628229251118,3.54584415083255e-08
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PCDH12,Protocadherin-12,39934,0.0144667986948702,0.00262426732664064,0.0093232347346545,0.0196103626550858,3.61106234152569e-08
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,BOLA2_BOLA2B,BolA-like protein 2,39638,0.0298940074322375,0.00542537526998769,0.0192602719030616,0.0405277429614134,3.66813908017785e-08
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ARL13B,ADP-ribosylation factor-like protein 13B,39575,0.0391245698824949,0.00710881798747312,0.0251912866270476,0.0530578531379422,3.80329298065022e-08
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CD276,CD276 antigen,42123,0.0201888862126951,0.00366885880637763,0.0129979229521949,0.0273798494731952,3.80671782009798e-08
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SERPINA12,Serpin A12,41751,0.0610034852432121,0.011096986614867,0.0392533914780727,0.0827535790083514,3.92834239471688e-08
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PCDH9,Protocadherin-9,39930,0.0191522854489491,0.0034840629850438,0.0123235219982632,0.0259810488996349,3.94422428573102e-08
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GALNT2,Polypeptide N-acetylgalactosaminyltransferase 2,42262,-0.0148885153363921,0.00271184968197337,-0.0202037407130599,-0.00957328995972429,4.0871333216904e-08
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SYAP1,Synapse-associated protein 1,39736,0.0330870025603291,0.00602632728276778,0.0212754010861042,0.0448986040345539,4.09799402861048e-08
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FKBP5,Peptidyl-prolyl cis-trans isomerase FKBP5,42016,0.0523091186497615,0.00954370383508112,0.0336034591330025,0.0710147781665205,4.3054547406526e-08
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PTK7,Inactive tyrosine-protein kinase 7,41839,0.0214044156122758,0.00391149559047963,0.0137378842549358,0.0290709469696159,4.52611973009609e-08
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TIMP3,Metalloproteinase inhibitor 3,42185,0.0713440621036816,0.0130471292517006,0.0457716887703485,0.0969164354370147,4.62711248773147e-08
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TNC,Tenascin,42217,-0.0269807514635243,0.0049352444740836,-0.0366538306327281,-0.0173076722943204,4.65899342339961e-08
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,HS1BP3,HCLS1-binding protein 3,39638,0.051294885754919,0.00938935710007759,0.0328917458387669,0.0696980256710711,4.78077167029906e-08
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CHAC2,Glutathione-specific gamma-glutamylcyclotransferase 2,41843,0.0321674133412366,0.00588963502860408,0.0206237286851726,0.0437110979973006,4.80108972232324e-08
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IL34,Interleukin-34,41814,0.0203811982104106,0.00373352697642755,0.0130634853366126,0.0276989110842086,4.87558212498449e-08
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CA2,Carbonic anhydrase 2,42103,0.0369319793166505,0.00677011210954318,0.0236625595819459,0.0502013990513551,4.97931790885495e-08
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MDH1,"Malate dehydrogenase, cytoplasmic",39950,0.0219960594454379,0.00403772454894741,0.014082119329501,0.0299099995613749,5.21084520944641e-08
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,UBXN1,UBX domain-containing protein 1,39736,0.038582704176718,0.00708373337528544,0.0246985867611585,0.0524668215922774,5.24147801691334e-08
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IL10,Interleukin-10,41913,0.0427428057724986,0.00785167766580208,0.0273535175475265,0.0581320939974707,5.30859163484851e-08
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ADGRF5,Adhesion G protein-coupled receptor F5,39958,0.015002748806264,0.00275618277604873,0.00960063056520853,0.0204048670473195,5.33876687726341e-08
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ANGPT1,Angiopoietin-1,42085,0.0464221763032027,0.00853487184942763,0.0296938274783245,0.0631505251280809,5.44784108557546e-08
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PTPRK,Receptor-type tyrosine-protein phosphatase kappa,39930,0.0120246903769407,0.00221266751295344,0.00768786205155192,0.0163615187023294,5.6095515587165e-08
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,RHOC,Rho-related GTP-binding protein RhoC,41963,0.065119429078246,0.0119855863899306,0.0416276797539819,0.08861117840251,5.63393492497848e-08
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CRISP3,Cysteine-rich secretory protein 3,39889,-0.0152075896805166,0.00280481630564968,-0.02070502963959,-0.00971014972144324,6.0164742056536e-08
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IL3RA,Interleukin-3 receptor subunit alpha,41913,0.0173683818892114,0.00320856619130475,0.0110795921542541,0.0236571716241688,6.30064025977927e-08
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TIA1,Nucleolysin TIA-1 isoform p40,41728,0.0682594228982916,0.0126391946962509,0.0434866012936398,0.0930322445029435,6.75698275690744e-08
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,BLVRB,Flavin reductase,42137,0.0351120042305721,0.00650492361563615,0.0223623539439253,0.047861654517219,6.86161695014027e-08
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,P4HB,Protein disulfide-isomerase,42073,0.0212682334816229,0.003943747195478,0.013538488978486,0.0289979779847597,7.04996961597114e-08
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GTPBP2,GTP-binding protein 2,39649,0.0455520887006683,0.0084461854767857,0.0289975651661683,0.0621066122351683,7.06350978752373e-08
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CDK5RAP3,CDK5 regulatory subunit-associated protein 3,39934,0.0329730196670948,0.00611653085532308,0.0209846191906616,0.044961420143528,7.15500389176311e-08
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NID1,Nidogen-1,42189,0.0198417205748264,0.003681677475679,0.0126256327224955,0.0270578084271572,7.19069753722875e-08
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CD36,Platelet glycoprotein 4,39657,0.0257876860980669,0.00479092825580066,0.0163974667166976,0.0351779054794362,7.49153284675213e-08
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,UBE2L6,Ubiquitin/ISG15-conjugating enzyme E2 L6,39958,0.0340463208414412,0.00632555443282086,0.0216482341531123,0.0464444075297701,7.49839332829194e-08
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GAL,Galanin peptides,42185,-0.0365999484728262,0.00680334127606752,-0.0499344973739186,-0.0232653995717339,7.58460951398897e-08
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SEZ6L2,Seizure 6-like protein 2,42070,-0.0133010442410852,0.00247396353759556,-0.0181500127747725,-0.00845207570739793,7.72527796604322e-08
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PEBP1,Phosphatidylethanolamine-binding protein 1,42137,0.0305906804803989,0.00569357029002457,0.0194312827119507,0.041750078248847,7.87862151795283e-08
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,LTA,Lymphotoxin-alpha,42119,0.0219371544867484,0.00408941369057327,0.0139219036532248,0.029952405320272,8.25675672659583e-08
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SLAMF8,SLAM family member 8,41843,0.0295120182151909,0.00550650311416058,0.0187192721114362,0.0403047643189456,8.48585837029996e-08
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,HMBS,Porphobilinogen deaminase,42262,0.0220191713116219,0.00410914153876586,0.0139652538956408,0.030073088727603,8.52392771724092e-08
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SCGB3A2,Secretoglobin family 3A member 2,42166,-0.0429711164377445,0.00802528004742177,-0.0587006653306912,-0.0272415675447978,8.72064451562429e-08
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,BOC,Brother of CDO,41900,-0.0126734448146319,0.00237294100366322,-0.0173244091818118,-0.00802248044745196,9.40516421905076e-08
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MPIG6B,Megakaryocyte and platelet inhibitory receptor G6b,42166,0.0414141722098908,0.00777665493816056,0.0261719285310961,0.0566564158886855,1.02311454908583e-07
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,HYOU1,Hypoxia up-regulated protein 1,42310,0.0124508166353355,0.00233827951761354,0.00786778878081293,0.017033844489858,1.02672142716855e-07
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ECI2,Enoyl-CoA delta isomerase 2,39575,0.0332344008292896,0.00625517546080296,0.0209742569261158,0.0454945447324634,1.09883073714902e-07
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SIGLEC9,Sialic acid-binding Ig-like lectin 9,42239,0.0165780242822891,0.00312581762710031,0.0104514217331725,0.0227046268314057,1.15326896287155e-07
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NEXN,Nexilin,39990,0.0380862000325024,0.00718061454649672,0.0240121955213689,0.052160204543636,1.15395170569183e-07
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MAN2B2,Epididymis-specific alpha-mannosidase,39958,0.0324358268758967,0.00611591494458343,0.0204486335845132,0.0444230201672802,1.15729071617173e-07
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,LGALS7_LGALS7B,Galectin-7,42076,0.0238348615751777,0.00449519799986616,0.01502427349544,0.0326454496549154,1.16162606036098e-07
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IL6ST,Interleukin-6 receptor subunit beta,42145,0.00951594084186089,0.00179540239323969,0.00599695215111109,0.0130349295326107,1.17508942587722e-07
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TMSB10,Thymosin beta-10,42137,0.0410770317646426,0.00775839862638058,0.0258705704569366,0.0562834930723485,1.21191892241758e-07
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SIRT2,NAD-dependent protein deacetylase sirtuin-2,42070,0.0470793764180698,0.00890139881850788,0.0296326347337944,0.0645261181023453,1.24920641656157e-07
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ANGPTL4,Angiopoietin-related protein 4,42166,-0.024095658783981,0.00455651800182237,-0.0330264340675528,-0.0151648835004092,1.25461807431844e-07
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NTF3,Neurotrophin-3,42119,0.0185643336128421,0.0035162137748764,0.0116725546140843,0.0254561126115998,1.3144392672946e-07
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NDUFB7,NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 7,39930,0.0482191476891423,0.00913497871351772,0.0303145894106475,0.066123705967637,1.32639949808109e-07
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,KIF1C,Kinesin-like protein KIF1C,39575,0.0189158262397345,0.00358523768178439,0.011888760383437,0.0259428920960319,1.34526252607425e-07
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ITGAL,Integrin alpha-L,39657,0.0237141330313081,0.00449847308379749,0.0148971257870651,0.0325311402755512,1.37791085175723e-07
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NME3,Nucleoside diphosphate kinase 3,42144,-0.0128686272180116,0.0024415599766433,-0.0176540847722325,-0.00808316966379078,1.38022568803748e-07
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SPART,Spartin,39736,0.0421442200505371,0.00800406344853783,0.0264562556914029,0.0578321844096712,1.42526035696219e-07
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TLR3,Toll-like receptor 3,42296,0.0328687496803391,0.00624641998961319,0.0206257665006972,0.0451117328599809,1.44635125679302e-07
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,THTPA,Thiamine-triphosphatase,39897,0.0475036924086367,0.00903513867015959,0.0297948206151239,0.0652125642021495,1.48562444265064e-07
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,HARS1,"Histidine--tRNA ligase, cytoplasmic",42137,0.0411320204474393,0.00784165730313058,0.0257623721333034,0.0565016687615752,1.58361065303958e-07
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,COMP,Cartilage oligomeric matrix protein,42042,-0.0178578940483875,0.00340614886091066,-0.0245339458157724,-0.0111818422810026,1.60519670744396e-07
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PTGES2,Prostaglandin E synthase 2,39579,0.0300144257784253,0.0057370621162349,0.0187697840306048,0.0412590675262457,1.71078993870623e-07
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ICA1,Islet cell autoantigen 1,41913,0.0426986187173042,0.00816356770717282,0.0266980260112455,0.0586992114233629,1.71719987339631e-07
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TRAF3,"TNF receptor-associated factor 3, Isoform 2",39657,0.0201300580534461,0.00384828921321187,0.0125874111955509,0.0276727049113414,1.71760851548265e-07
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,LGMN,Legumain,42185,0.0193652613416649,0.00371007915557029,0.0120935061967471,0.0266370164865826,1.81917391140809e-07
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PLPBP,Pyridoxal phosphate homeostasis protein,42145,0.0358310122174674,0.00686884815508776,0.0223680698334953,0.0492939546014394,1.85072744463415e-07
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PI3,Elafin,41966,0.0299165713519372,0.00573916330574332,0.0186678112726803,0.0411653314311941,1.88879048020087e-07
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,EIF2S2,Eukaryotic translation initiation factor 2 subunit 2,39638,0.023136523662098,0.00444094519352316,0.0144322710827926,0.0318407762414034,1.92432245062535e-07
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,EFEMP1,EGF-containing fibulin-like extracellular matrix protein 1,42203,-0.017053753851487,0.00327821467199088,-0.0234790546085891,-0.0106284530943848,1.99861160693438e-07
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NAGK,N-acetyl-D-glucosamine kinase,39627,0.0304320940059009,0.00585243579661736,0.0189613198445309,0.0419028681672709,2.02965303304802e-07
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,APOA2,Apolipoprotein A-II,39990,-0.0263929080883675,0.00508451181051364,-0.0363585512369742,-0.0164272649397608,2.12948102102096e-07
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,LY75,Lymphocyte antigen 75,42119,0.020508339776597,0.00395211022956173,0.012762203726656,0.028254475826538,2.14242387669206e-07
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,39958,0.0153315456139311,0.00295440871182602,0.00954090453875215,0.0211221866891101,2.14636933200907e-07
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ACYP1,Acylphosphatase-1,39701,0.0347265754576493,0.00669637839637347,0.0216016738007573,0.0478514771145413,2.18789662669144e-07
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GFAP,Glial fibrillary acidic protein,41820,-0.0241274277614696,0.00465532176607332,-0.0332518584229733,-0.0150029970999659,2.21844329093872e-07
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SWAP70,Switch-associated protein 70,39930,0.0195546871911434,0.00377294231989868,0.012159720244142,0.0269496541381448,2.22252155482482e-07
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PDGFA,Platelet-derived growth factor subunit A,42310,0.0379911135874977,0.00733469028931957,0.0236151206204313,0.052367106554564,2.25455309716461e-07
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,VNN2,Vascular non-inflammatory molecule 2,42070,0.0250316360768449,0.00483632818612322,0.0155524328320434,0.0345108393216464,2.30259432739873e-07
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NPPB,Natriuretic peptides B,41900,0.074049592629863,0.0143155978777189,0.0459910207895339,0.102108164470192,2.34150109345949e-07
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GLB1,Beta-galactosidase,42016,0.0227244248447218,0.0043964703536261,0.0141073429516147,0.031341506737829,2.39001289438379e-07
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,STC2,Stanniocalcin-2,42113,0.012673785326859,0.00245215427944404,0.00786756293914866,0.0174800077145693,2.3943581040136e-07
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,EHD3,EH domain-containing protein 3,39638,0.0627186859124815,0.0121463213377891,0.0389118960904149,0.0865254757345482,2.46469958761028e-07
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,AGER,Advanced glycosylation end product-specific receptor,42093,0.0216239420685347,0.00419223810254,0.0134071553875563,0.0298407287495131,2.53016288044705e-07
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CCL17,C-C motif chemokine 17,42107,0.0481847887984043,0.00934388438089124,0.0298707754118575,0.0664988021849511,2.54722215039552e-07
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SPINK2,Serine protease inhibitor Kazal-type 2,39736,0.0189652125907334,0.00367783442720688,0.0117566571134079,0.0261737680680589,2.55757846094781e-07
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,C7,Complement component C7,39722,0.0176383448841245,0.0034211287119951,0.0109329326086141,0.0243437571596349,2.5701343522206e-07
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PRKAR1A,cAMP-dependent protein kinase type I-alpha regulatory subunit,42145,0.0434772477700496,0.0084372789077644,0.0269401811108314,0.0600143144292679,2.59964486860443e-07
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ERN1,Serine/threonine-protein kinase/endoribonuclease IRE1,39919,0.0196903469814336,0.00382561001068287,0.0121921513604952,0.027188542602372,2.69148758474778e-07
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SPTLC1,Serine palmitoyltransferase 1,39929,0.0204467044496608,0.00397360029808159,0.0126584478654208,0.0282349610339007,2.71076505375377e-07
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,L3HYPDH,Trans-3-hydroxy-L-proline dehydratase,39958,0.0473643026067756,0.00920756447095531,0.0293174762437032,0.065411128969848,2.73340116721932e-07
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,EPHA4,Ephrin type-A receptor 4,39736,0.0154591413721864,0.00300551180384696,0.00956833823664635,0.0213499445077264,2.7410970033153e-07
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,RSPO3,R-spondin-3,42262,0.0147654022790734,0.00287222490589578,0.00913584146351766,0.0203949630946291,2.77416857695923e-07
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CLEC10A,C-type lectin domain family 10 member A,42016,-0.019128250413205,0.00372763313198968,-0.0264344113519047,-0.0118220894745052,2.91497950174454e-07
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,BID,BH3-interacting domain death agonist,42119,0.0347119882717019,0.00676519495838798,0.0214522061532615,0.0479717703901423,2.92251917731804e-07
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TBC1D23,TBC1 domain family member 23,42070,0.0472507733244229,0.00920922810928978,0.029200686230215,0.0653008604186309,2.92513517800359e-07
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GLOD4,Glyoxalase domain-containing protein 4,42106,0.0179827929438699,0.00350494997637288,0.011113090990179,0.0248524948975607,2.92692858463636e-07
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SORBS1,Sorbin and SH3 domain-containing protein 1,39934,0.0206760277230407,0.00403265113274319,0.012772031502864,0.0285800239432173,2.99005351293627e-07
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ZBP1,Z-DNA-binding protein 1,39657,0.0218128291516314,0.00425470441734284,0.0134736084936395,0.0301520498096234,2.99761546152723e-07
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TWF2,Twinfilin-2,39966,0.0448512695483745,0.00874909727634186,0.0277030388867445,0.0619995002100046,3.00208508695131e-07
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,EDA2R,Tumor necrosis factor receptor superfamily member 27,42262,0.0217238218923338,0.00424235277826446,0.0134088104469354,0.0300388333377321,3.08541813866686e-07
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SLC51B,Organic solute transporter subunit beta,39575,0.0381911149701213,0.00746027329884071,0.0235689793043935,0.052813250635849,3.119239212854e-07
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MRC1,Macrophage mannose receptor 1,39990,0.014970082920489,0.00292480398420007,0.00923746711145686,0.0207026987295211,3.1329511878684e-07
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TSPAN1,Tetraspanin-1,41900,0.0380309954227401,0.00743444040225768,0.0234594922343151,0.0526024986111652,3.17240416661124e-07
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MMP9,Matrix metalloproteinase-9,42125,0.0312360016280531,0.00610937006989874,0.0192616362910515,0.0432103669650546,3.21749797299422e-07
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ADAM22,Disintegrin and metalloproteinase domain-containing protein 22,42016,0.0190829774470307,0.00373403260237628,0.0117642735463732,0.0264016813476882,3.2563010372925e-07
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CETN3,Centrin-3,39930,0.0413732187121792,0.00809740581381967,0.0255023033170926,0.0572441341072658,3.28373489551948e-07
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,39930,0.0188572741818766,0.00369187585401809,0.0116211975080012,0.0260933508557521,3.31273347383067e-07
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CAT,Catalase,39827,0.0274710373926388,0.00538141968791005,0.0169234548043351,0.0380186199809425,3.36577487902094e-07
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",39736,0.0550234212564727,0.010780678652465,0.0338932910976412,0.0761535514153041,3.38226811258648e-07
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SMS,Spermine synthase,39586,0.0336909768795725,0.0066144254070687,0.0207267030817179,0.0466552506774272,3.57230884261321e-07
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,BCL2,Apoptosis regulator Bcl-2,39930,0.0279527488508887,0.00549252481127792,0.017187400220784,0.0387180974809935,3.6527460256451e-07
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,APOBR,Apolipoprotein B receptor,39638,-0.022460697120609,0.00441502802437752,-0.031114152048389,-0.0138072421928291,3.69110911377111e-07
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DMD,Dystrophin,39638,0.0268740556033086,0.00529058749559648,0.0165045041119395,0.0372436070946777,3.84414592262747e-07
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DPEP1,Dipeptidase 1,41997,-0.0237695664790814,0.00468288566063293,-0.0329480223739219,-0.0145911105842409,3.90965143707985e-07
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NACC1,Nucleus accumbens-associated protein 1,39919,0.0289342984758476,0.00570451818795099,0.0177534428274636,0.0401151541242315,3.99529781007121e-07
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,VSTM1,V-set and transmembrane domain-containing protein 1,41839,0.025997314058711,0.00514063006861503,0.0159216791242255,0.0360729489931965,4.31094987680009e-07
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,YWHAQ,14-3-3 protein theta,39736,0.0385824241328295,0.00763045923688378,0.0236267240285373,0.0535381242371217,4.34109457186402e-07
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FGF2,Fibroblast growth factor 2,42119,0.0356250939787157,0.0070584374276148,0.0217905566205907,0.0494596313368407,4.54243141730595e-07
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NUDC,Nuclear migration protein nudC,42296,0.0327385251956432,0.0064874790766866,0.0200230662053374,0.0454539841859489,4.55943273955239e-07
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,APRT,Adenine phosphoribosyltransferase,42002,0.0242111590442672,0.00480044744495095,0.0148022820521634,0.0336200360363711,4.63016900897327e-07
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TGFBI,Transforming growth factor-beta-induced protein ig-h3,42114,0.0138427268407172,0.00274492793211322,0.00846266809377529,0.0192227855876591,4.64179569757356e-07
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,EPCAM,Epithelial cell adhesion molecule,42125,0.048095370701177,0.00955808289171105,0.0293615282334234,0.0668292131689307,4.91863172889567e-07
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PROS1,Vitamin K-dependent protein S,39979,0.0131198075505518,0.00260788360191125,0.00800835569080575,0.0182312594102979,4.9582576248923e-07
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ADAM15,Disintegrin and metalloproteinase domain-containing protein 15,41900,0.0161321857297356,0.00320902519616516,0.00984249634525187,0.0224218751142193,5.04352532320325e-07
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CRISP2,Cysteine-rich secretory protein 2,42262,-0.0272843943621076,0.00542800668381972,-0.0379232874623942,-0.0166455012618209,5.0558298612835e-07
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CXCL5,C-X-C motif chemokine 5,42101,0.0577400730188652,0.0115088429335337,0.0351827408691391,0.0802974051685913,5.31468835813476e-07
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,HPGDS,Hematopoietic prostaglandin D synthase,41843,-0.0194829090487774,0.00388762216368448,-0.027102648489599,-0.0118631696079558,5.46979133351743e-07
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,STAU1,Double-stranded RNA-binding protein Staufen homolog 1,39560,0.0346585381025285,0.00691611248437299,0.0211029576331575,0.0482141185718996,5.49148291543954e-07
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NEFL,Neurofilament light polypeptide,41797,0.0242270409720444,0.00484211596666654,0.014736493677378,0.0337175882667108,5.70530968952916e-07
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,VEGFC,Vascular endothelial growth factor C,42181,0.0282975921348757,0.00565861757720607,0.0172067016835518,0.0393884825861996,5.78067178920376e-07
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PRKD2,Serine/threonine-protein kinase D2,39575,0.0224621201852655,0.00449577522864751,0.0136504007371163,0.0312738396334146,5.93495740139245e-07
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,COL1A1,Collagen alpha-1(I) chain,42310,-0.0119527756240535,0.00239755738282027,-0.0166519880943812,-0.00725356315372574,6.25900863688788e-07
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,RCOR1,REST corepressor 1,41900,0.0226629225825609,0.00455625192058093,0.0137326688182222,0.0315931763468995,6.63946367879427e-07
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TACC3,Transforming acidic coiled-coil-containing protein 3,42070,0.0594132305683611,0.0119470271528108,0.0359970573488518,0.0828294037878703,6.67174611754558e-07
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PCDHB15,Protocadherin beta-15,39919,0.0203792357794429,0.00410073568051321,0.012341793845637,0.0284166777132488,6.80540146087666e-07
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IST1,IST1 homolog,39850,0.0503187812660526,0.0101378515130882,0.0304485923003997,0.0701889702317056,7.02642603054181e-07
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CXCL16,C-X-C motif chemokine 16,42295,0.0118069848716062,0.00238098712691167,0.00714025010285927,0.016473719640353,7.17570223071656e-07
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DNAJC9,DnaJ homolog subfamily C member 9,39930,0.0385508193357886,0.00777400946317583,0.023313760787964,0.0537878778836133,7.19075743158633e-07
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PF4,Platelet factor 4,39914,0.0496573336552013,0.0100183254039957,0.0300214158633697,0.0692932514470329,7.27581898598809e-07
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PSAP,Prosaposin,39886,0.0145290993418821,0.00293184672977387,0.00878267975152531,0.0202755189322389,7.31489440309655e-07
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CHMP1A,Charged multivesicular body protein 1a,42016,0.0400869616518737,0.00809293916972984,0.0242248008792032,0.0559491224245442,7.38441941226438e-07
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TNFAIP2,Tumor necrosis factor alpha-induced protein 2,39930,0.0249948446679404,0.00504584744276396,0.015104983680123,0.0348847056557577,7.39244676349587e-07
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CST1,Cystatin-SN,38503,0.0543993952517076,0.0109904283175676,0.0328581557492751,0.07594063475414,7.55502323022044e-07
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ITGB1,Integrin beta-1,42167,-0.0106666790109163,0.00215601565905086,-0.014892469702656,-0.00644088831917665,7.61114585778264e-07
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DNAJC21,DnaJ homolog subfamily C member 21,39929,0.0200386613682917,0.0040505593003858,0.0120995651395355,0.0279777575970478,7.63957411312424e-07
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,LRG1,Leucine-rich alpha-2-glycoprotein,39979,-0.0134448308119453,0.00273285058077886,-0.0188012179502719,-0.00808844367361872,8.78857819753305e-07
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CCT5,T-complex protein 1 subunit epsilon,41843,0.0227495641467563,0.00462555682654283,0.0136834727667324,0.0318156555267803,8.83772492700549e-07
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DOK1,Docking protein 1,39929,0.0693991343046558,0.0141097823316235,0.0417439609346738,0.0970543076746379,8.8429259744201e-07
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NEK7,Serine/threonine-protein kinase Nek7,39757,0.0376145683119573,0.00765091705306171,0.0226187708879563,0.0526103657359582,8.94291164786984e-07
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SGSH,N-sulphoglucosamine sulphohydrolase,39807,0.0283073402984603,0.00576602279023087,0.0170059356296078,0.0396087449673128,9.2673644713904e-07
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PPP1CC,Serine/threonine-protein phosphatase PP1-gamma catalytic subunit,39919,0.042362521252617,0.00863130401505846,0.0254451653831024,0.0592798771221316,9.32880554607562e-07
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,HRG,Histidine-rich glycoprotein,39925,0.0156667189276972,0.00319529798476774,0.00940393487755238,0.0219295029778419,9.56675469773718e-07
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PKD2,Polycystin-2,39575,0.029498385819709,0.00601937707710463,0.0177004067485839,0.041296364890834,9.69245099770851e-07
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,YAP1,Transcriptional coactivator YAP1,39929,0.0138827241085663,0.00283569838455713,0.00832475527483436,0.0194406929422983,9.93083526863672e-07
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PDCD6,Programmed cell death protein 6,42145,-0.035290834886034,0.0072202139088848,-0.0494424541474482,-0.0211392156246198,1.03146227869667e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CST7,Cystatin-F,42148,0.0471203864872555,0.00964911509494275,0.0282081209011677,0.0660326520733432,1.05467674711665e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,LRP1,Prolow-density lipoprotein receptor-related protein 1,42070,-0.0133590236398643,0.00273643866326185,-0.0187224434198575,-0.00799560385987103,1.06272412840186e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,RRM2B,Ribonucleoside-diphosphate reductase subunit M2 B,41843,0.0334900713625192,0.00686769721366735,0.0200293848237312,0.0469507579013072,1.0925911422526e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,XRCC4,DNA repair protein XRCC4,41839,0.0183911674226667,0.00377143085461316,0.0109991629476249,0.0257831718977085,1.09270573146328e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SNX9,Sorting nexin-9,42145,0.0339001481954709,0.00695217615329671,0.0202738829350093,0.0475264134559324,1.09380659485888e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DGCR6,Protein DGCR6,39586,0.0210107867467138,0.00431014499686913,0.0125629025528503,0.0294586709405773,1.10482716916364e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CLGN,Calmegin,39649,0.022868466722559,0.00469699253659107,0.0136623613508405,0.0320745720942775,1.13863257271438e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SPARC,SPARC,42181,0.03463396729732,0.00714148560254094,0.0206366555163398,0.0486312790783002,1.25027207711555e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NECAP2,Adaptin ear-binding coat-associated protein 2,39575,0.0327249383058582,0.00674767926224837,0.0194994869518514,0.045950389659865,1.25278885493936e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PRTG,Protogenin,42262,0.0121787911205654,0.00251155035018754,0.00725615243419781,0.017101429806933,1.25380543615806e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TBCB,Tubulin-folding cofactor B,42016,0.0494641943260226,0.010202695929357,0.0294669103044829,0.0694614783475623,1.26015073238698e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GRSF1,G-rich sequence factor 1,39486,0.0414895960478316,0.00855918201231271,0.0247135993036987,0.0582655927919645,1.26832047279525e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,LYZL2,Lysozyme-like protein 2,39560,0.0181292751879395,0.00374052625206677,0.0107978437338886,0.0254607066419904,1.27242385342828e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,AIF1,Allograft inflammatory factor 1,41843,0.0258875284904394,0.00534277610500089,0.0154156873246377,0.0363593696562411,1.27831472783099e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CLEC5A,C-type lectin domain family 5 member A,42107,0.0150720936708778,0.00311361478216108,0.00896940869784211,0.0211747786439135,1.308102318097e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DDX58,Antiviral innate immune response receptor RIG-I,41843,0.027981059485602,0.00579269092496645,0.0166273852726678,0.0393347336985362,1.37778893584052e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GSTP1,Glutathione S-transferase P,41759,-0.0344991163736191,0.00714560856311158,-0.0485045091573178,-0.0204937235899204,1.39450192897757e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,LTBP2,Latent-transforming growth factor beta-binding protein 2,42310,-0.0157786589149263,0.00327514068103687,-0.0221979346497585,-0.00935938318009401,1.46773526147756e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DPP4,Dipeptidyl peptidase 4,41948,-0.0137240623477444,0.00285543796186593,-0.0193207207530017,-0.0081274039424872,1.55431802459157e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DNAJB14,DnaJ homolog subfamily B member 14,39930,0.0318376070298919,0.00663011051597915,0.0188425904185728,0.0448326236412111,1.59121135936951e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IFNLR1,Interferon lambda receptor 1,42119,0.0178530768361417,0.0037185721704002,0.0105646753821573,0.0251414782901261,1.5952058389888e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,VWC2,Brorin,41973,0.0200103862328685,0.00417340934159117,0.0118305039233498,0.0281902685423872,1.64645699370277e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GPA33,Cell surface A33 antigen,42070,0.0653461399238138,0.01367887407586,0.0385355467351282,0.0921567331124995,1.79664716334772e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PARK7,Parkinson disease protein 7,42137,0.024655200235321,0.00516914829357103,0.0145236695799217,0.0347867308907202,1.86439821700325e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ELOB,Elongin-B,39575,0.0192437516056169,0.00403428454515085,0.0113365538971213,0.0271509493141126,1.86549139571255e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CDNF,Cerebral dopamine neurotrophic factor,42070,0.0159804284422593,0.00335252528918055,0.00940947887546547,0.0225513780090532,1.89240633407533e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ARAF,Serine/threonine-protein kinase A-Raf,39757,0.0336074427971553,0.00705766857808841,0.019774412384102,0.0474404732102086,1.9425578339535e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TIMM10,Mitochondrial import inner membrane translocase subunit Tim10,39958,0.0195828755669552,0.00413109751167212,0.0114859244440779,0.0276798266898326,2.1593337145654e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,KLK11,Kallikrein-11,42062,0.0156016785521251,0.00329501002487375,0.00914345890337251,0.0220598982008776,2.21352389740849e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CRACR2A,EF-hand calcium-binding domain-containing protein 4B,41843,0.0407373471585914,0.0086153368265818,0.023851286978491,0.0576234073386917,2.28551986144479e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,EFNA1,Ephrin-A1,42113,0.0142072319870223,0.0030056421325352,0.00831617340725332,0.0200982905667913,2.30325408094563e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TNFSF8,Tumor necrosis factor ligand superfamily member 8,39966,0.0179229461681772,0.00379208580595974,0.0104904579884961,0.0253554343478583,2.31267906527281e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,LGALS1,Galectin-1,42145,0.0169184233405583,0.003581164337059,0.00989934123992264,0.0239375054411939,2.33251374204395e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CRYM,Ketimine reductase mu-crystallin,39586,0.0367260383998098,0.00778854238175446,0.021460495331571,0.0519915814680485,2.44213071900143e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MAP3K5,Mitogen-activated protein kinase kinase kinase 5,41843,0.0471193928413233,0.00999440632328129,0.027530356447692,0.0667084292349546,2.44682797095916e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DENR,Density-regulated protein,39657,0.0279008387542772,0.00591863558315509,0.0163003130112932,0.0395013644972611,2.45787316542087e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,LONP1,"Lon protease homolog, mitochondrial",39638,0.0425192458110627,0.00902842924061092,0.0248235244994653,0.0602149671226601,2.51370997969661e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CD86,T-lymphocyte activation antigen CD86,39930,-0.014717195665309,0.00312672400779229,-0.0208455747205819,-0.00858881661003615,2.54484453226827e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GIMAP7,GTPase IMAP family member 7,39736,-0.0155367307611975,0.00331158226072453,-0.0220274319922176,-0.00904602953017742,2.74258466830095e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CA12,Carbonic anhydrase 12,42070,0.0156825151949142,0.00334801376423731,0.00912040821700908,0.0222446221728193,2.83906020261408e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ZFYVE19,Abscission/NoCut checkpoint regulator,39930,0.043611720992498,0.00931294021111732,0.025358358178708,0.0618650838062879,2.86106918210045e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GASK1A,Golgi-associated kinase 1A,39575,0.0205956908439574,0.00439848312809642,0.0119746639128884,0.0292167177750264,2.86860347645999e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,OPTC,Opticin,42070,-0.0217131306604496,0.00464207558079787,-0.0308115987988134,-0.0126146625220858,2.93270794799711e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CTF1,Cardiotrophin-1,41900,0.0402730000699851,0.00862846399375924,0.023361210642217,0.0571847894977532,3.07925164650904e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IGHMBP2,DNA-binding protein SMUBP-2,39575,0.0268797796734696,0.0057709742725762,0.0155686700992203,0.038190889247719,3.23432612015586e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DNPH1,2'-deoxynucleoside 5'-phosphate N-hydrolase 1,42162,0.0236533304188282,0.00508022655580915,0.0136960863694423,0.0336105744682141,3.25533061591139e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,QSOX1,Sulfhydryl oxidase 1,39767,0.0190425081150637,0.00409426361214637,0.0110177514352568,0.0270672647948706,3.34086429051563e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CASP7,Caspase-7,39929,0.0403982615019078,0.00869141780158442,0.0233630826108023,0.0574334403930132,3.38847632305293e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,STX3,Syntaxin-3,39929,0.0182154605203435,0.0039189949180265,0.0105342304810116,0.0258966905596755,3.38963326815191e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TNFRSF11B,Tumor necrosis factor receptor superfamily member 11B,42123,0.0139697172171925,0.00300785220020794,0.00807432690478496,0.0198651075296001,3.44252284486413e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TOR1AIP1,Torsin-1A-interacting protein 1,39638,0.0250728820314948,0.00539824961995943,0.0144923127763743,0.0356534512866153,3.44619248175187e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,LRRC38,Leucine-rich repeat-containing protein 38,39649,0.0224905419802939,0.00484265869834069,0.0129989309315462,0.0319821530290417,3.45243581618532e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MAX,Protein max,41839,0.0503415092555497,0.010846020760262,0.0290833085654361,0.0715997099456633,3.49255596118901e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,VPS28,Vacuolar protein sorting-associated protein 28 homolog,39757,0.031915692665272,0.00688123892831205,0.0184284643657804,0.0454029209647636,3.55668944152618e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CD22,B-cell receptor CD22,42296,0.020208593491132,0.00435844528334054,0.0116660407357845,0.0287511462464794,3.57370320981752e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,BCL2L1,Bcl-2-like protein 1,39929,0.0473924099610714,0.0102475340626446,0.0273072431982879,0.0674775767238548,3.79179746807904e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CLTA,Clathrin light chain A,41900,0.022086796595884,0.00477654449840068,0.0127247693790187,0.0314488238127493,3.79933786286505e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ALCAM,CD166 antigen,42310,0.00928960637021264,0.00201004048358592,0.00534992702238425,0.013229285718041,3.84260316107253e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SUSD2,Sushi domain-containing protein 2,42137,-0.0133761506458014,0.00289590881834189,-0.0190521319297515,-0.00770016936185134,3.89180388145356e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PPP1R14A,Protein phosphatase 1 regulatory subunit 14A,39934,0.0372305344575482,0.00806044296942224,0.0214320662374806,0.0530290026776158,3.89991751053369e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MYO9B,Unconventional myosin-IXb,41913,0.0310901116522195,0.00673300725765653,0.0178934174272127,0.0442868058772263,3.9189894771227e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,LY6D,Lymphocyte antigen 6D,42041,0.0187361875577355,0.00406189645404766,0.0107748705078021,0.0266975046076689,4.01198940557291e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CD200R1,Cell surface glycoprotein CD200 receptor 1,42076,0.0166606198066203,0.00361658511753852,0.00957211297624476,0.0237491266369958,4.12804270118103e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IGF1R,Insulin-like growth factor 1 receptor,42070,0.0100855180330167,0.00219254917586744,0.0057881216483165,0.0143829144177168,4.26535620948947e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IFIT3,Interferon-induced protein with tetratricopeptide repeats 3,39757,0.0187431756711963,0.00407703665533641,0.0107521838267369,0.0267341675156557,4.32797476067741e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,LAP3,Cytosol aminopeptidase,41913,0.0224964429796308,0.00490247451955499,0.012887592921303,0.0321052930379586,4.4988815481538e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,HSPB1,Heat shock protein beta-1,41949,0.0329049771390498,0.00717077547928681,0.0188502571996476,0.0469596970784519,4.49946272560696e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,EGF,Pro-epidermal growth factor,42081,0.0486811692979777,0.0106326349259435,0.0278412048431285,0.0695211337528269,4.72585007027452e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PTPRN2,Receptor-type tyrosine-protein phosphatase N2,41973,0.0161126331889176,0.00352176703214567,0.00920996980591206,0.0230152965719231,4.80144103055808e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TPD52L2,Tumor protein D54,39736,0.0512443264489639,0.0112050313825346,0.0292824649391962,0.0732061879587317,4.85207707107433e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CDHR1,Cadherin-related family member 1,41839,0.0193255165972361,0.00422839573399516,0.0110378609586056,0.0276131722358666,4.91166426510954e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,BGN,Biglycan,41820,-0.0551469028411249,0.0120744346332789,-0.0788127947223515,-0.0314810109598982,4.98640984869758e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SCT,Secretin,39649,0.0226123589236023,0.00495177221582907,0.0129068853805773,0.0323178324666273,5.01252788580514e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SDC1,Syndecan-1,42145,0.0189089080073411,0.00414202577941619,0.0107905374796853,0.0270272785349968,5.03566102924368e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SOD1,Superoxide dismutase [Cu-Zn],41874,0.0220806551732252,0.00484502790369822,0.0125844004819766,0.0315769098644737,5.2256760925899e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,RAB37,Ras-related protein Rab-37,41913,0.037773703323581,0.00829375337147147,0.0215179467154969,0.0540294599316651,5.29823683097516e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,APP,Amyloid-beta precursor protein,42112,0.0307004581246296,0.00675462720224973,0.0174613888082201,0.043939527441039,5.53854778699154e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CALB1,Calbindin,42070,0.0210237059672289,0.00462867921600166,0.0119514947038657,0.0300959172305922,5.61926315945169e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PNLIPRP2,Pancreatic lipase-related protein 2,42123,0.138919295385591,0.0305983304445886,0.0789465677141969,0.198892023056984,5.67145351988556e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,VEGFB,Vascular endothelial growth factor B,39657,0.0138000650791187,0.00303953286406196,0.00784258066555725,0.0197575494926801,5.67966554882639e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CA1,Carbonic anhydrase 1,41890,0.0261237277960653,0.00576893582422054,0.014816613580593,0.0374308420115375,5.99646616021501e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CCL18,C-C motif chemokine 18,42020,0.0324561607510028,0.00717547224095333,0.0183922351587343,0.0465200863432713,6.1431323247617e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PRG3,Proteoglycan 3,39966,-0.0231071541657112,0.00511075106108158,-0.0331242262454311,-0.0130900820859913,6.20874783489562e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TXNL1,Thioredoxin-like protein 1,39570,0.0473131576064297,0.010470995393672,0.0267900066348326,0.0678363085780267,6.29314388569315e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PEPD,Xaa-Pro dipeptidase,39990,-0.0122563178812103,0.00271519207224339,-0.0175780943428074,-0.00693454141961327,6.4260887831664e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CSF2RA,Granulocyte-macrophage colony-stimulating factor receptor subunit alpha,42016,0.0283174265827833,0.0062764017764289,0.0160156791009827,0.040619174064584,6.48473632554347e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CACYBP,Calcyclin-binding protein,39713,0.0481590961638995,0.010681801085028,0.0272227660372445,0.0690954262905544,6.59499711018542e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PHACTR2,Phosphatase and actin regulator 2,39934,0.053019571759953,0.0117683023593008,0.0299536991357234,0.0760854443841825,6.69466941440462e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NCAM1,Neural cell adhesion molecule 1,42217,-0.015071335287903,0.00334571354290215,-0.0216289338319913,-0.00851373674381481,6.7029136729136e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PPBP,Platelet basic protein,39908,0.0396702056900354,0.00880640628810555,0.0224096493653485,0.0569307620147222,6.71334535910677e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PADI4,Protein-arginine deiminase type-4,41814,0.0336363392529989,0.00746915269446236,0.0189967999718527,0.0482758785341451,6.74578340127278e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PSAPL1,Proactivator polypeptide-like 1,39930,-0.0232559101447876,0.0051747966744667,-0.0333985116267423,-0.0131133086628329,7.05665987744046e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,RAB10,Ras-related protein Rab-10,39958,0.0246838872302354,0.00549597885106598,0.0139117686821461,0.0354560057783247,7.15004906781313e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FNDC1,Fibronectin type III domain-containing protein 1,39929,0.0218213418773711,0.00486788344854239,0.012280290318228,0.0313623934365142,7.44223928132864e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FCER2,Low affinity immunoglobulin epsilon Fc receptor,42137,0.0243428448800507,0.00543452477580479,0.0136911763194734,0.0349945134406281,7.55028341998813e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,EDF1,Endothelial differentiation-related factor 1,39934,0.0306214453683083,0.00683780598661415,0.0172193456345446,0.044023545102072,7.59910883899769e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PHLDB1,Pleckstrin homology-like domain family B member 1,39930,0.0244064419764184,0.00545404011131543,0.0137165233582402,0.0350963605945967,7.71821615146298e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MIF,Macrophage migration inhibitory factor,42105,0.0305555347725166,0.00683452072288136,0.0171598741556691,0.0439511953893641,7.85754014956946e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,LRTM2,Leucine-rich repeat and transmembrane domain-containing protein 2,39934,-0.0118166977679883,0.00264400912124777,-0.0169989556456339,-0.00663443989034266,7.92614466998915e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GFRAL,GDNF family receptor alpha-like,39574,-0.029017412949254,0.00650576717503449,-0.0417687166123216,-0.0162661092861864,8.26742882671867e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MCEMP1,Mast cell-expressed membrane protein 1,39657,0.040680529199366,0.0091238986700539,0.0227976878060604,0.0585633705926717,8.327931368759e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GYS1,"Glycogen [starch] synthase, muscle",41900,0.0422170112708562,0.00947548761583234,0.0236450555438249,0.0607889669978876,8.44238011773594e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SPINK6,Serine protease inhibitor Kazal-type 6,42262,0.0244221118670249,0.0054815515993629,0.0136782707322736,0.0351659530017761,8.44306483473042e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CRYZL1,Quinone oxidoreductase-like protein 1,39638,0.0415003918992192,0.0093410937475887,0.0231918481539453,0.059808935644493,8.96701776084563e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CLEC3B,Tetranectin,39726,-0.00957519684831123,0.00215849792464463,-0.0138058527806147,-0.00534454091600777,9.2506159745979e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,AMOTL2,Angiomotin-like protein 2,39882,0.0223042490619276,0.0050296895825601,0.0124460574801098,0.0321624406437454,9.31513496282092e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,RNASEH2A,Ribonuclease H2 subunit A,39934,0.0218743389874489,0.00493321074635244,0.0122052459245981,0.0315434320502997,9.33288510599674e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ITGB1BP2,Integrin beta-1-binding protein 2,41900,0.0506590927045328,0.0114265179276509,0.0282631175663371,0.0730550678427286,9.34725608029213e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DCTN2,Dynactin subunit 2,42070,0.0430165044671249,0.00970474142173729,0.0239952112805198,0.06203779765373,9.38722607885956e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TBCA,Tubulin-specific chaperone A,39736,0.0382937722230356,0.00864919275948595,0.0213413544144431,0.055246190031628,9.62668492033358e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PHOSPHO1,Phosphoethanolamine/phosphocholine phosphatase,42016,0.013630486007846,0.00307909185269931,0.00759546597655535,0.0196655060391366,9.6402074056635e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PMS1,PMS1 protein homolog 1,39649,0.022491388994974,0.0050835433642112,0.0125276440011201,0.032455133988828,9.76580051980057e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SLC9A3R1,Na(+)/H(+) exchange regulatory cofactor NHE-RF1,39736,0.039586932499011,0.00895190471613278,0.0220411992553908,0.0571326657426312,9.86365045284392e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SERPINB1,Leukocyte elastase inhibitor,42093,0.0403362332451496,0.00913931903007567,0.0224231679462013,0.0582492985440979,1.02510002949718e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NUDT16,U8 snoRNA-decapping enzyme,39915,0.0398379198804176,0.00902828130625455,0.0221424885201586,0.0575333512406765,1.03096166402518e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,REXO2,"Oligoribonuclease, mitochondrial",39575,-0.0211336701321978,0.00478955781614154,-0.0305212034518352,-0.0117461368125604,1.03183884057763e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CDH5,Cadherin-5,42310,-0.0136731393047713,0.00310247342465168,-0.0197539872170885,-0.00759229139245397,1.05523768779842e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MRI1,Methylthioribose-1-phosphate isomerase,39649,0.0303922481141549,0.00689598267828272,0.0168761220647207,0.043908374163589,1.05683952302539e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CNTN1,Contactin-1,42310,-0.0120189309995084,0.00272761198094694,-0.0173650504821644,-0.00667281151685236,1.05903975059837e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TST,Thiosulfate sulfurtransferase,41809,0.0339832933989834,0.00771761053268561,0.0188567767549196,0.0491098100430472,1.07432743366387e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TINAGL1,Tubulointerstitial nephritis antigen-like,42126,0.0100023116779737,0.00227170066541439,0.0055497783737615,0.0144548449821859,1.07580314270926e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,AXL,Tyrosine-protein kinase receptor UFO,42217,0.0122508520182416,0.00278541436836206,0.00679143985625193,0.0177102641802312,1.099730112533e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,HSPA2,Heat shock-related 70 kDa protein 2,39919,0.0159184149765841,0.00362055650550589,0.00882212422579252,0.0230147057273756,1.10923894338966e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ERBB4,Receptor tyrosine-protein kinase erbB-4,42181,-0.0105105393817427,0.00239447736908529,-0.0152037150251499,-0.00581736373833553,1.14473723677383e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,LUZP2,Leucine zipper protein 2,39919,0.0202996520791373,0.00462722545157491,0.0112302901940504,0.0293690139642241,1.15962819963003e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NFYA,Nuclear transcription factor Y subunit alpha,39575,0.0173947766859279,0.00396672358030005,0.00961999846853982,0.025169554903316,1.16972273185094e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SDC4,Syndecan-4,42145,-0.0212418441864332,0.00484444301228412,-0.0307369524905101,-0.0117467358823563,1.16975531614505e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ARSB,Arylsulfatase B,42070,0.0248247490650715,0.00567913897061285,0.0136936366826703,0.0359558614474727,1.24481754479568e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,HDGF,Hepatoma-derived growth factor,42243,0.0408016763084637,0.00933880063583997,0.0224976270622173,0.05910572555471,1.25710301513319e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TNFSF12,Tumor necrosis factor ligand superfamily member 12,42296,-0.0124287538090095,0.00284984116928743,-0.0180144425008129,-0.00684306511720613,1.30290442817857e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,STX7,Syntaxin-7,39657,0.0220123754015609,0.00505175129577145,0.0121109428618488,0.0319138079412729,1.32819409715097e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,METAP1D,"Methionine aminopeptidase 1D, mitochondrial",42119,0.036772616760512,0.00844921966660703,0.0202121462139622,0.0533330873070618,1.35773497563231e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PKN3,Serine/threonine-protein kinase N3,39757,0.0330286189920553,0.00759279702185036,0.0181467368292286,0.047910501154882,1.3735108286177e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IFNL1,Interferon lambda-1,41839,0.0201764009932635,0.00464784972954462,0.0110666155233561,0.029286186463171,1.42876905622413e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,LILRA5,Leukocyte immunoglobulin-like receptor subfamily A member 5,42129,0.0145219892861829,0.00334984988834796,0.00795628350502092,0.0210876950673449,1.46735936759706e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CDON,Cell adhesion molecule-related/down-regulated by oncogenes,42144,0.0113772208406514,0.0026246076129743,0.00623298991922179,0.016521451762081,1.46927458903048e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MILR1,Allergin-1,41913,0.0226265867008543,0.00522401343948063,0.0123875203594723,0.0328656530422364,1.49340374641611e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,AHNAK,Neuroblast differentiation-associated protein AHNAK,39638,0.0142081880444723,0.00328222224050812,0.00777503245307637,0.0206413436358682,1.51223748455951e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TLR1,Toll-like receptor 1,39657,0.0119107650924628,0.00275442579367605,0.00651209053685778,0.0173094396480679,1.54408430519858e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TMPRSS5,Transmembrane protease serine 5,41946,-0.0169638307144634,0.00393039783367207,-0.0246674104684607,-0.00926025096046618,1.59983587178126e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NOTCH2,Neurogenic locus notch homolog protein 2,39966,-0.00973511175846424,0.00225962512453854,-0.0141639770025598,-0.0053062465143687,1.65907300818605e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,LCN15,Lipocalin-15,39934,0.0268920995926596,0.00624500871460076,0.0146518825120421,0.0391323166732771,1.67499256710706e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GRK5,G protein-coupled receptor kinase 5,41900,0.0226097861266158,0.00525190259760477,0.0123160570353104,0.0329035152179211,1.68131293722384e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,BAX,Apoptosis regulator BAX,41814,0.0403811650943817,0.00938033689118492,0.0219957047876593,0.0587666254011041,1.68284872418325e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,COL4A1,Collagen alpha-1(IV) chain,42145,0.017292852863465,0.00401880639806054,0.00941599232326629,0.0251697134036636,1.69696699819686e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,LILRA6,Leukocyte immunoglobulin-like receptor subfamily A member 6,39958,0.0330737814195048,0.00769464265020342,0.0179922818251061,0.0481552810139036,1.73558289808939e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,F2R,Proteinase-activated receptor 1,42166,0.0251385176861615,0.00585647154694967,0.0136598334541402,0.0366172019181829,1.77951599492816e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,AMFR,E3 ubiquitin-protein ligase AMFR,41839,0.0277493706579299,0.00647443605884693,0.0150594759825899,0.0404392653332699,1.83213347896793e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,OBP2B,Odorant-binding protein 2b,41979,-0.0250480109011276,0.00584479869473787,-0.0365038163428138,-0.0135922054594414,1.83586098363686e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ANGPTL3,Angiopoietin-related protein 3,42189,-0.0150493301038636,0.00351909765862851,-0.0219467615147755,-0.00815189869295173,1.91173580163749e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SDK2,Protein sidekick-2,39736,0.0173167840825863,0.00404965715385426,0.00937945606103195,0.0252541121041407,1.91771915206806e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SAT2,Thialysine N-epsilon-acetyltransferase,39757,0.0312120915253083,0.00731195814832296,0.0168806535545953,0.0455435294960213,1.98297130462608e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CD101,Immunoglobulin superfamily member 2,39930,0.0189749117483701,0.00445087803248988,0.0102511908046899,0.0276986326920503,2.03166857444164e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PARD3,Partitioning defective 3 homolog,39757,0.0325968663099284,0.00765244349136221,0.0175980770668585,0.0475956555529983,2.06409805231326e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ANXA11,Annexin A11,42087,0.0288095731092144,0.00676595997601806,0.015548291556219,0.0420708546622098,2.07644423835374e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,39757,0.0462958618392624,0.0108792480188354,0.024972535722345,0.0676191879561797,2.10353438707956e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CIAPIN1,Anamorsin,42181,0.0266332875826383,0.00626401665280344,0.0143558149431436,0.0389107602221331,2.13485752094302e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NTproBNP,N-terminal prohormone of brain natriuretic peptide,42145,0.0479909264342194,0.0113186876714055,0.0258062985982645,0.0701755542701742,2.25029602172023e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,LILRB1,Leukocyte immunoglobulin-like receptor subfamily B member 1,42310,0.0119010214670865,0.00280698277528984,0.00639933522751837,0.0174027077066545,2.25193242583718e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CTSV,Cathepsin L2,42200,-0.0173523663127915,0.00409392730411213,-0.0253764638288512,-0.00932826879673169,2.264396790757e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TMED8,Protein TMED8,39930,0.0450902265694338,0.0106407532263752,0.0242343502457383,0.0659461028931293,2.27808054851243e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PMVK,Phosphomevalonate kinase,41832,0.047038929030461,0.0111052538458792,0.0252726314925378,0.0688052265683841,2.29344569582847e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TBC1D17,TBC1 domain family member 17,41839,0.0186460143931737,0.00440284583925175,0.0100164365482402,0.0272755922381071,2.30104458623687e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,LYAR,Cell growth-regulating nucleolar protein,41843,0.0230898268186674,0.00545395220708052,0.0124000804927895,0.0337795731445452,2.31535816640005e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SAFB2,Scaffold attachment factor B2,39934,0.0118659178708008,0.0028059917347445,0.00636617407070155,0.0173656616709,2.36807887373286e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MARCO,Macrophage receptor MARCO,42145,0.0111649257177139,0.00264418491206819,0.00598232329006029,0.0163475281453676,2.43243875675208e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ENPP2,Ectonucleotide pyrophosphatase/phosphodiesterase family member 2,42310,-0.0105698335717964,0.00250333998556879,-0.0154763799435112,-0.00566328720008158,2.43389476308194e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",39929,0.0428852252073903,0.0101753760685783,0.0229414881129768,0.0628289623018037,2.52152024495613e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SCGB2A2,Mammaglobin-A,39575,-0.0134889745533362,0.0032030056990868,-0.0197668657235463,-0.00721108338312602,2.55876250308698e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SNU13,NHP2-like protein 1,39575,0.027310571841863,0.00648937525805565,0.0145913963360739,0.040029747347652,2.59111519197151e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SCN4B,Sodium channel subunit beta-4,39638,0.0188350422364285,0.00447598901386973,0.0100621037692438,0.0276079807036132,2.59658467055505e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MSRA,Mitochondrial peptide methionine sulfoxide reductase,42181,0.030888285114442,0.00734361824960945,0.0164947933452075,0.0452817768836765,2.61436097905741e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SOD3,Extracellular superoxide dismutase,39990,-0.0262929923398824,0.00625349192952071,-0.038549836521743,-0.0140361481580218,2.63624919397119e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ANKMY2,Ankyrin repeat and MYND domain-containing protein 2,39657,0.03498065658109,0.00832161970606965,0.0186702819571935,0.0512910312049865,2.64784036316593e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SLURP1,Secreted Ly-6/uPAR-related protein 1,39908,0.0156996258537256,0.00373548752595586,0.00837807030285214,0.0230211814045991,2.65622311762569e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MICALL2,MICAL-like protein 2,39649,0.0296135216475694,0.00704915853559246,0.0157971709178081,0.0434298723773306,2.67824362191001e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SNX2,Sorting nexin-2,39919,0.0369498063732668,0.00879614961194303,0.0197093531338585,0.0541902596126751,2.68154205236981e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,S100A12,Protein S100-A12,41910,0.0315562076682274,0.00751320737228832,0.0168303212185423,0.0462820941179125,2.68536435078656e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CHM,Rab proteins geranylgeranyltransferase component A 1,39649,0.0263473709137381,0.00629634292801984,0.0140065387748192,0.038688203052657,2.87940280521662e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GGCT,Gamma-glutamylcyclotransferase,39952,0.0204502515670687,0.00488768911952913,0.0108703808927917,0.0300301222413458,2.88538050660373e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NT5C,"5'(3')-deoxyribonucleotidase, cytosolic type",39958,0.0312042370749186,0.00746884212550897,0.016565306508921,0.0458431676409161,2.96385504806375e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,LACTB2,Endoribonuclease LACTB2,42145,0.0281645059295099,0.00674316472445302,0.014947903069582,0.0413811087894378,2.97557090236355e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CD70,CD70 antigen,42119,-0.0188656500309484,0.00451697578890881,-0.0277189225772097,-0.0100123774846871,2.97741024786703e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GNAS,Neuroendocrine secretory protein 55,39934,0.0371445891304731,0.00890815900884847,0.0196845974731301,0.0546045807878162,3.07233989147491e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,LILRA2,Leukocyte immunoglobulin-like receptor subfamily A member 2,42137,0.0152329752235318,0.00365432249732162,0.00807050312878139,0.0223954473182821,3.0854293326001e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,AMIGO2,Amphoterin-induced protein 2,42070,0.00996379801681019,0.00239574963097293,0.00526812874010325,0.0146594672935171,3.21697755397899e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SIL1,Nucleotide exchange factor SIL1,39638,0.0140258793695041,0.00337383269499228,0.00741316728731925,0.020638591451689,3.24528768619858e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,C4BPB,C4b-binding protein beta chain,42181,-0.0162221287920077,0.00390403063576037,-0.023874028838098,-0.00857022874591741,3.26956719069944e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CEACAM16,Carcinoembryonic antigen-related cell adhesion molecule 16,39930,0.03618622111447,0.00870948755736833,0.0191156255020281,0.053256816726912,3.27955495628352e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NGF,Beta-nerve growth factor,42016,-0.00514440230576996,0.00124286558879999,-0.00758041885981794,-0.00270838575172198,3.50730487140139e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NDUFA5,NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 5,39641,0.0154195826599922,0.00372732212698645,0.00811403129109876,0.0227251340288856,3.54628644556107e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NOS1,"Nitric oxide synthase, brain",41839,0.0248095258977592,0.00600843119079709,0.0130330007637969,0.0365860510317215,3.66390057771926e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DPEP2,Dipeptidase 2,42070,-0.0126842993394803,0.00307755422634481,-0.0187163056231161,-0.0066522930558445,3.78581705158711e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FCRL1,Fc receptor-like protein 1,42145,0.0193013461129285,0.00468834988399307,0.010112180340302,0.0284905118855549,3.86322314631794e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CSNK1D,Casein kinase I isoform delta,39657,0.0272444871222723,0.0066241952610712,0.0142610644105727,0.0402279098339718,3.93590455192841e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DHRS4L2,Dehydrogenase/reductase SDR family member 4-like 2,39929,0.0201870796278229,0.00491393281864701,0.0105557713032747,0.029818387952371,4.01679235849819e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ARHGAP5,Rho GTPase-activating protein 5,39560,0.0321269887585654,0.00782723739380781,0.0167856034667021,0.0474683740504287,4.08105422944158e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TSHB,Thyrotropin subunit beta,42145,0.0285874253326126,0.00696792676873674,0.0149302888658886,0.0422445617993366,4.10717154309473e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,VAV3,Guanine nucleotide exchange factor VAV3,39586,0.0418109481833714,0.0101939427021465,0.0218308204871644,0.0617910758795785,4.13353458479154e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DNAJA4,DnaJ homolog subfamily A member 4,39929,0.02908425559088,0.00710204745300289,0.0151642425829944,0.0430042685987657,4.24748002441857e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DTX3,Probable E3 ubiquitin-protein ligase DTX3,42070,0.0101983014203089,0.00249248061935427,0.00531303940637451,0.0150835634342432,4.30851278367056e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CD14,Monocyte differentiation antigen CD14,41932,0.017247988942139,0.00421737070762896,0.00898194235518628,0.0255140355290918,4.34375948132275e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,LIF,Leukemia inhibitory factor,41839,0.0209345941059266,0.00511893259604034,0.0109014862176876,0.0309677019941657,4.34597350159971e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FCN2,Ficolin-2,42116,0.0169520972564757,0.00414590953614085,0.00882611456563966,0.0250780799473118,4.35983319559818e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,UBQLN3,Ubiquilin-3,39575,0.0236477022472875,0.00578463471591685,0.0123098182040905,0.0349855862904846,4.38171139024185e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CTRL,Chymotrypsin-like protease CTRL-1,39929,-0.0298782471029628,0.00731154387119966,-0.0442088730905141,-0.0155476211154115,4.41046057425349e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CPQ,Carboxypeptidase Q,39960,0.0157088722134387,0.00384634125499972,0.0081700433536393,0.0232477010732382,4.45499861641992e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,C7orf50,Uncharacterized protein C7orf50,39929,0.00956357938505295,0.0023441282212555,0.00496908807139217,0.0141580706987137,4.53828213386783e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CDC37,Hsp90 co-chaperone Cdc37,42181,0.0348460389286212,0.00854986112663332,0.0180883111204199,0.0516037667368225,4.61517806551781e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SV2A,Synaptic vesicle glycoprotein 2A,39649,0.0261647550137748,0.00642010110848947,0.0135813568411355,0.0387481531864142,4.62481674226635e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PPP2R5A,Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit alpha isoform,39930,0.0503497005358753,0.0123561276883288,0.0261316902667508,0.0745677108049998,4.63525846559084e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ADGRE1,Adhesion G protein-coupled receptor E1,39930,0.0228267985662096,0.00560580183168278,0.0118394269761114,0.0338141701563078,4.6929092330427e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TK1,"Thymidine kinase, cytosolic",39757,0.0198090109785367,0.00486552711699314,0.0102725778292301,0.0293454441278432,4.70745366715653e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,EPHX2,Bifunctional epoxide hydrolase 2,41900,0.0253297453747253,0.00622345212282674,0.0131317792139848,0.0375277115354657,4.72752579842202e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FKBP1B,Peptidyl-prolyl cis-trans isomerase FKBP1B,42202,0.0472588678296226,0.0116210419408804,0.0244816256254971,0.0700361100337482,4.79596987925848e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,EIF4E,Eukaryotic translation initiation factor 4E,39657,0.0378258138677367,0.00930922804949852,0.0195797268907196,0.0560719008447538,4.87265514411975e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,LY96,Lymphocyte antigen 96,42016,0.0151492757955001,0.00372963472157061,0.00783919174122173,0.0224593598497785,4.89588889925643e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,LPCAT2,Lysophosphatidylcholine acyltransferase 2,42070,0.0170034215275672,0.00419046786268619,0.00879010451670224,0.0252167385384321,4.98501630773809e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,EPHB6,Ephrin type-B receptor 6,41997,0.013560828068403,0.00334285312995363,0.00700883593369393,0.0201128202031122,5.00609541866313e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GBP4,Guanylate-binding protein 4,41839,0.0203193002954757,0.00501420389328749,0.0104914606646322,0.0301471399263191,5.0995727639501e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,UNC79,Protein unc-79 homolog,39560,0.0232610261728606,0.00574028156689732,0.0120100743017418,0.0345119780439793,5.10786456307395e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TF,Serotransferrin,39979,0.0089205509249813,0.00220189249633561,0.00460484163216349,0.0132362602177991,5.12697263006094e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,RGMB,RGM domain family member B,42249,0.0115903442868441,0.00286348909512161,0.00597790566040578,0.0172027829132825,5.20242037403218e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,OTUD6B,Deubiquitinase OTUD6B,39930,0.0241674662015351,0.00597066839272226,0.0124649561517994,0.0358699762512707,5.20675015776007e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TNN,Tenascin-N,39966,0.0179623353576992,0.00444113462819022,0.00925771148644632,0.026666959228952,5.27728773162016e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PLXDC2,Plexin domain-containing protein 2,39929,0.0113905451409666,0.00281710912825463,0.0058690112495875,0.0169120790323457,5.304277968026e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TNR,Tenascin-R,42016,-0.0172752845092854,0.00427287128539914,-0.0256501122286677,-0.00890045678990308,5.30629596964259e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SMPDL3A,Acid sphingomyelinase-like phosphodiesterase 3a,42162,-0.0271904042572477,0.00672610159670601,-0.0403735633867915,-0.0140072451277039,5.31717775202831e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PRELP,Prolargin,42123,0.0096625247118268,0.00239251108611048,0.00497320298305026,0.0143518464406033,5.40555169509561e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ELAC1,Zinc phosphodiesterase ELAC protein 1,39934,0.0354102701168506,0.00877589367772339,0.0182095185085128,0.0526110217251884,5.49730898501857e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IL22RA1,Interleukin-22 receptor subunit alpha-1,41913,0.017554582237167,0.00435289488821511,0.00902290825626535,0.0260862562180686,5.54112088102495e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CERT,Ceramide transfer protein,41839,0.0252583164866292,0.00627276124534924,0.0129637044457447,0.0375529285275137,5.68886394379933e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SERPINB6,Serpin B6,42216,0.0240660325905902,0.00598024272921989,0.0123447568413192,0.0357873083398612,5.74646361781029e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,LY9,T-lymphocyte surface antigen Ly-9,41960,0.0124954476784498,0.00311071705581293,0.00639844224905649,0.0185924531078432,5.92908562662108e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ATXN10,Ataxin-10,41839,0.0301200944964243,0.00750002923155253,0.0154200372025814,0.0448201517902673,5.95217464907865e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IL2RA,Interleukin-2 receptor subunit alpha,42041,0.0167070679699538,0.00416124895169537,0.0085510200246309,0.0248631159152767,5.97897424874672e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CEACAM19,Carcinoembryonic antigen-related cell adhesion molecule 19,39930,0.0165670151943028,0.00413731082325243,0.00845788598072802,0.0246761444078775,6.25994513585032e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TRIAP1,TP53-regulated inhibitor of apoptosis 1,42262,0.0254469893932775,0.0063605523377509,0.0129803068112857,0.0379136719752693,6.34744941090599e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GSR,"Glutathione reductase, mitochondrial",39949,0.00943844712909267,0.00236020814543065,0.0048124391640486,0.0140644550941367,6.40167261550134e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ARID4B,AT-rich interactive domain-containing protein 4B,41839,0.0169778075321625,0.00424739944312851,0.00865290462363064,0.0253027104406944,6.44371215215713e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,VEGFD,Vascular endothelial growth factor D,42275,-0.0157646084056449,0.00394515435881212,-0.0234971109489166,-0.00803210586237309,6.47753037044599e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,HBQ1,Hemoglobin subunit theta-1,42262,-0.0250966956349589,0.00628657957779795,-0.0374183916074429,-0.0127749996624749,6.58313399743709e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,AGT,Angiotensinogen,39990,0.00895028810118265,0.00224223900678574,0.00455549964788261,0.0133450765544827,6.60198515820528e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CX3CL1,Fractalkine,42016,-0.0136098560138694,0.0034099635045932,-0.0202933844828721,-0.00692632754486675,6.60887575609072e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CAPG,Macrophage-capping protein,42015,0.0240100143255267,0.00602464743411431,0.0122017053546626,0.0358183232963907,6.77521051861017e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ARHGAP45,Rho GTPase-activating protein 45,39736,0.03408391522795,0.00855751131314367,0.0173111930541884,0.0508566374017116,6.85056335542668e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,RAB44,Ras-related protein Rab-44,39919,0.0183974549278416,0.00462067749861093,0.00934092703056416,0.027453982825119,6.88954694933427e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,C1QTNF9,Complement C1q and tumor necrosis factor-related protein 9A,39713,-0.0200761535119671,0.00505417347826938,-0.0299823335293751,-0.0101699734945591,7.16632651809852e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,RPE,Ribulose-phosphate 3-epimerase,39757,0.0293188511587259,0.00738540293002954,0.0148434614158681,0.0437942409015838,7.23725946129388e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CABP2,Calcium-binding protein 2,39649,0.0267035218849878,0.00673094328714185,0.0135108730421898,0.0398961707277858,7.31574444260365e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SNX18,Sorting nexin-18,39930,0.01784705086034,0.00450329653292317,0.00902058965581058,0.0266735120648694,7.44341474710216e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PDAP1,28 kDa heat- and acid-stable phosphoprotein,39958,0.0401449052841085,0.0101316088328766,0.0202869519716703,0.0600028585965467,7.46718142836207e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,LRRC37A2,Leucine-rich repeat-containing protein 37A2,39930,0.0178479893074941,0.00450676090051283,0.00901473794248891,0.0266812406724992,7.53231771102569e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NMT1,Glycylpeptide N-tetradecanoyltransferase 1,39934,0.0268100057875368,0.00677803269291779,0.0135250617094179,0.0400949498656556,7.68635532870207e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,COL2A1,Collagen alpha-1(II) chain,39638,0.0320582391403279,0.00810585126433193,0.0161707706622373,0.0479457076184185,7.70289008704206e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MINDY1,Ubiquitin carboxyl-terminal hydrolase MINDY-1,39919,0.043964104542184,0.0111167882002526,0.0221751996696888,0.0657530094146791,7.70818639003472e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,THBD,Thrombomodulin,42145,0.0119590733239781,0.00302491742366199,0.00603023517360062,0.0178879114743556,7.74010863102415e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ADAMTS1,A disintegrin and metalloproteinase with thrombospondin motifs 1,39657,0.0126369625575732,0.00320359780962569,0.00635791085070689,0.0189160142644396,8.04216928963317e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CLEC7A,C-type lectin domain family 7 member A,42296,0.0239835115775511,0.00608170804934584,0.0120633638008332,0.0359036593542689,8.06844461952189e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PKLR,Pyruvate kinase PKLR,42143,0.0251130100751801,0.00636820970181926,0.0126313190596143,0.0375947010907458,8.07066441779151e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FUCA1,Tissue alpha-L-fucosidase,42212,0.0336475874377435,0.00855253733429627,0.0168846142625228,0.0504105606129642,8.3880761332214e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DRAXIN,Draxin,42016,0.0170211594296231,0.00433989257087752,0.00851496999070315,0.025527348868543,8.82457283177937e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PPME1,Protein phosphatase methylesterase 1,42070,0.0233247114561377,0.00594802707102722,0.0116665783969244,0.0349828445153511,8.84650099132321e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CASP3,Caspase-3,42310,0.035075791534581,0.00899044801613373,0.0174545134229589,0.0526970696462031,9.6074533944894e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DCTN6,Dynactin subunit 6,41839,0.0287681269297734,0.0073809906632144,0.0143013852298732,0.0432348686296736,9.76306679052438e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,RBP7,Retinoid-binding protein 7,39930,0.0250515240559911,0.00642975311198049,0.0124492079565094,0.0376538401554729,9.82807958458608e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IGF2BP3,Insulin-like growth factor 2 mRNA-binding protein 3,39575,0.0184729641417664,0.0047495632717207,0.00916382012919377,0.0277821081543389,0.000101084083229713
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SERPINI1,Neuroserpin,39713,-0.0115648173416162,0.00298074314201482,-0.0174070738999652,-0.00572256078326712,0.000105126934599155
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,KIF22,Kinesin-like protein KIF22,39575,0.0495330517982008,0.012783426650779,0.024477535562674,0.0745885680337276,0.00010733878731846
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CGN,Cingulin,39649,0.0149130655619679,0.00385010780288501,0.00736685426831334,0.0224592768556226,0.000107939967838899
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CDK1,Cyclin-dependent kinase 1,39560,0.0145313551173751,0.00375386267480187,0.00717378427476339,0.0218889259599867,0.000109000541615115
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CXCL1,Growth-regulated alpha protein,42117,0.036633468353185,0.00951128062900439,0.0179913583203364,0.0552755783860336,0.000117899207833688
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TDO2,"Tryptophan 2,3-dioxygenase",39649,0.0155390158565895,0.00404106140921221,0.00761853549453354,0.0234594962186454,0.000121090271426979
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,STX16,Syntaxin-16,41843,0.0224021058392991,0.00583626955259528,0.0109630175162124,0.0338411941623859,0.000124399780234278
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SATB1,DNA-binding protein SATB1,39934,0.0115682076143855,0.00301476510629686,0.00565926800604365,0.0174771472227273,0.000125128838380649
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,RBM17,Splicing factor 45,39934,0.0303877020522882,0.00792123186248801,0.0148620876018117,0.0459133165027646,0.000125612638193452
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NECTIN4,Nectin-4,42181,0.0131812349069996,0.00343639678544691,0.00644589720752371,0.0199165726064756,0.00012573644416877
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ERP29,Endoplasmic reticulum resident protein 29,39736,0.0472327218213939,0.0123298509705605,0.0230662139190953,0.0713992297236925,0.000128448397188252
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PALM3,Paralemmin-3,39575,0.0298421850012818,0.00780226116865886,0.0145497531107104,0.0451346168918531,0.000131596420822003
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CALB2,Calretinin,41839,0.0114997816431677,0.00300717624876154,0.00560571619559505,0.0173938470907403,0.000131845607144218
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CASP2,Caspase-2,42119,0.0266529358899515,0.00698303099817906,0.0129661951335206,0.0403396766463825,0.000135788299508638
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MAPKAPK2,MAP kinase-activated protein kinase 2,39757,0.0291768273807545,0.00765750530926437,0.0141681169745963,0.0441855377869126,0.000139585127422263
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MCEE,"Methylmalonyl-CoA epimerase, mitochondrial",39934,-0.0164508218452709,0.00431853212690845,-0.0249151448140115,-0.00798649887653036,0.000140065523119653
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IL17A,Interleukin-17A,41877,0.0167034413924767,0.00438569345038574,0.00810748222972067,0.0252994005552328,0.000140373614972498
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CEACAM21,Carcinoembryonic antigen-related cell adhesion molecule 21,42119,0.0330694498759376,0.00870021840962065,0.0160170217930812,0.0501218779587941,0.000144751229094874
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SPINT1,Kunitz-type protease inhibitor 1,42081,0.0103583446767539,0.00272616086403363,0.00501506938324802,0.0157016199702598,0.000145561722882258
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,BIN2,Bridging integrator 2,42137,0.0345762210426511,0.0091143156982703,0.0167121622740413,0.0524402798112609,0.000149114786217208
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,REG3G,Regenerating islet-derived protein 3-gamma,39919,0.0155003235402862,0.00408661013293511,0.00749056767973335,0.023510079400839,0.000149640254630388
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CRNN,Cornulin,41749,-0.0260620499443388,0.00688393756423254,-0.0395545675702346,-0.012569532318443,0.000153820594489147
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,BMP10,Bone morphogenetic protein 10,39736,-0.0110192338742061,0.00291064305447373,-0.0167240942609746,-0.00531437348743754,0.000153993473653353
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ACTA2,"Actin, aortic smooth muscle",41900,0.0168524492315987,0.00445382250920594,0.00812295711355501,0.0255819413496423,0.000155118790486897
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NID2,Nidogen-2,42137,0.0281442109947958,0.00744726564368438,0.0135475703331744,0.0427408516564172,0.000158050031398479
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GCLM,Glutamate--cysteine ligase regulatory subunit,39575,0.0171686000112231,0.004542769168302,0.00826477244135114,0.026072427581095,0.000158086572130998
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,JPT2,Jupiter microtubule associated homolog 2,39930,0.0341791663371362,0.00905366608535664,0.0164339808098372,0.0519243518644352,0.000160712289788274
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CNPY4,Protein canopy homolog 4,42070,0.0290103844228623,0.00768698974786725,0.0139438845170425,0.0440768843286821,0.000161366169055006
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DUSP13,Dual specificity protein phosphatase 13 isoform A,39919,0.0167739668730248,0.00444730132289526,0.00805725628015005,0.0254906774658995,0.000162953092502827
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SNX5,Sorting nexin-5,39638,0.0115507155867947,0.00306466958032428,0.0055439632093591,0.0175574679642303,0.000164761800145124
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PRUNE2,Protein prune homolog 2,39757,0.0112201536287419,0.00297829907787668,0.00538268743610364,0.0170576198213802,0.000165869917831131
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,C2CD2L,Phospholipid transfer protein C2CD2L,41820,0.0156743045754007,0.00417030135834379,0.00750051391304687,0.0238480952377545,0.000171633178073172
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DXO,Decapping and exoribonuclease protein,39929,0.0175030637736544,0.00466104839124114,0.00836740892682179,0.0266387186204871,0.000174085673665711
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GZMH,Granzyme H,41900,0.0301657363759729,0.00803636026181267,0.0144144702628201,0.0459170024891257,0.000175015261586001
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,C1QA,Complement C1q subcomponent subunit A,42230,0.00858626478526448,0.00228787144632529,0.00410203675046691,0.013070492820062,0.000175491650566379
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,OLR1,Oxidized low-density lipoprotein receptor 1,42017,0.0224539600122448,0.00599973754505995,0.0106944744239273,0.0342134456005623,0.000182965582524036
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CHGB,Secretogranin-1,42210,0.0160380053377754,0.00431858836466099,0.00757357214303981,0.0245024385325109,0.000205054829350762
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PRDX2,Peroxiredoxin-2,39819,0.0229922006027685,0.00620959140633629,0.0108214014463494,0.0351629997591876,0.000214346854871831
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ICAM5,Intercellular adhesion molecule 5,42145,0.0173897603779546,0.0047117041980333,0.00815482014980934,0.0266247006060999,0.000224463436521137
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PRND,Prion-like protein doppel,39929,0.0185243043537143,0.00502524071810756,0.00867483254622353,0.0283737761612052,0.000228643215919171
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TNFRSF8,Tumor necrosis factor receptor superfamily member 8,42249,0.0168998269111315,0.00458597871576056,0.00791130862824078,0.0258883451940222,0.000229490139669819
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ELAVL4,ELAV-like protein 4,39586,0.0310645601995617,0.00844207859302501,0.0145180861572327,0.0476110342418908,0.000234598580897661
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FDX1,"Adrenodoxin, mitochondrial",39575,0.0238058489361806,0.00648041296180796,0.011104239531037,0.0365074583413242,0.00024038111780495
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SMTN,Smoothelin,39897,0.0349458401122231,0.00952325802499013,0.0162802543832425,0.0536114258412038,0.000244119161749546
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DRG2,Developmentally-regulated GTP-binding protein 2,42070,0.0213082797766111,0.0058102982451508,0.00992009521611558,0.0326964643371067,0.000246040197844247
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,L1CAM,Neural cell adhesion molecule L1,42181,-0.011124563494573,0.00303468807866225,-0.017072552128751,-0.00517657486039503,0.000247505327246853
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,AK2,"Adenylate kinase 2, mitochondrial",39929,0.0403619144664851,0.0110154529969227,0.0187716265925167,0.0619522023404536,0.000249325429665109
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NAPRT,Nicotinate phosphoribosyltransferase,39929,0.0125962401808098,0.00344372114079999,0.00584654674484176,0.0193459336167777,0.000255601521938835
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TIGAR,"Fructose-2,6-bisphosphatase TIGAR",41820,0.0175608718936185,0.00480165032371876,0.00814963725912972,0.0269721065281073,0.000255917951199267
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PSPN,Persephin,42119,0.0322936722233357,0.00883465863207552,0.0149777413044677,0.0496096031422038,0.000257815539714534
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DPT,Dermatopontin,42310,0.00947715497567289,0.00259371199103337,0.00439347947324749,0.0145608304780983,0.00025925408135046
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MATN3,Matrilin-3,41992,-0.0122834374108877,0.00336732910441168,-0.0188834024555346,-0.00568347236624083,0.000265470377512842
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,AKAP12,A-kinase anchor protein 12,39736,-0.00795146324568237,0.00218804474763757,-0.012240030951052,-0.00366289554031273,0.000280263023558691
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FUT8,"Alpha-(1,6)-fucosyltransferase",42016,0.0214671822086237,0.00591665964923506,0.00987052929612301,0.0330638351211245,0.000286396813641267
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PROCR,Endothelial protein C receptor,39575,-0.0129261131139252,0.00356350319131575,-0.0199105793689041,-0.00594164685894632,0.000287631426933148
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NFAT5,Nuclear factor of activated T-cells 5,39657,0.0318329575675599,0.00878727204732533,0.0146099043548023,0.0490560107803176,0.000292939376824297
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SDHB,Succinate dehydrogenase,39930,0.0244704992999323,0.00675985184153796,0.0112211896905179,0.0377198089093467,0.000295915334877663
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,AOC3,Membrane primary amine oxidase,42217,0.0109274191754203,0.00303294055449089,0.00498285568861814,0.0168719826622224,0.000315792854324072
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,COX6B1,Cytochrome c oxidase subunit 6B1,39958,0.0119856303715824,0.00333025238919892,0.00545833568875248,0.0185129250544123,0.00032078338035827
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CCER2,Coiled-coil domain-containing glutamate-rich protein 2,39638,0.0236237984698265,0.00657060903062786,0.0107454047697959,0.0365021921698571,0.000325338761651575
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ACOX1,Peroxisomal acyl-coenzyme A oxidase 1,42145,0.0181205886758542,0.00504987131099831,0.00822284090629754,0.0280183364454109,0.000333981165355512
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TBL1X,F-box-like/WD repeat-containing protein TBL1X,41843,0.0312439857406381,0.008714128075238,0.0141642947131717,0.0483236767681046,0.000337720757175657
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FGL1,Fibrinogen-like protein 1,39990,0.0239267995776161,0.0066759367319883,0.010841963582919,0.0370116355723131,0.000339738536058572
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MAGED1,Melanoma-associated antigen D1,41843,0.0176627109063062,0.0049350615380595,0.0079899902917096,0.0273354315209028,0.000346110423916521
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,STXBP3,Syntaxin-binding protein 3,41843,0.015889394028671,0.00444545936106128,0.00717629368099086,0.0246024943763511,0.00035241839113506
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,LPA,Apolipoprotein(a),39775,-0.0669449333114482,0.0187451550177348,-0.103685437146209,-0.0302044294766879,0.000356680143215982
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FOLR2,Folate receptor beta,42249,0.0105904226925151,0.00296769940868288,0.0047737318514967,0.0164071135335336,0.000360175430067243
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,KLK10,Kallikrein-10,42138,0.0149104738204076,0.00418059462740691,0.00671650835069001,0.0231044392901251,0.000362902338942943
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PCDH1,Protocadherin-1,42264,0.00749804168457268,0.00210573227964057,0.00337080641647716,0.0116252769526682,0.000371016387302832
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ORM1,Alpha-1-acid glycoprotein 1,39922,0.00734144934455359,0.00206279445757616,0.00329837220770431,0.0113845264814029,0.000373818566084666
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GGH,Gamma-glutamyl hydrolase,41933,0.0123593881557369,0.00347581128207808,0.00554679804286385,0.0191719782686099,0.000378095438016054
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ENTPD6,Ectonucleoside triphosphate diphosphohydrolase 6,41900,0.0100072959130789,0.0028160627789086,0.00448781286641808,0.0155267789597398,0.000381243790808858
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IL17RA,Interleukin-17 receptor A,42137,0.0161057235250935,0.00453302480363869,0.00722099490996165,0.0249904521402253,0.000382196532911443
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PDZD2,PDZ domain-containing protein 2,39575,0.021532101033882,0.00606309499274335,0.009648434848105,0.0334157672196589,0.000384883409605058
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NAGA,Alpha-N-acetylgalactosaminidase,39636,0.0210025008182568,0.00592112382790778,0.00939709811555752,0.032607903520956,0.000391191917258479
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,LIPF,Gastric triacylglycerol lipase,39638,0.0229330025389165,0.00646632835956003,0.0102589989541789,0.0356070061236542,0.000391963941599639
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CLEC12A,C-type lectin domain family 12 member A,39657,0.00744103268675743,0.0021008011089493,0.00332346251321681,0.0115586028602981,0.000398744230406138
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,VPS4B,Vacuolar protein sorting-associated protein 4B,39919,0.0345425693265797,0.00975612886748515,0.0154205567463088,0.0536645819068506,0.000400818793026561
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,HMCN2,Hemicentin-2,39721,0.0211385653610144,0.00597187934327466,0.00943368184819607,0.0328434488738328,0.000402242679989247
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MED18,Mediator of RNA polymerase II transcription subunit 18,41843,0.0274914635807236,0.00778498098970248,0.0122329008409067,0.0427500263205404,0.000414855427331273
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CEACAM3,Carcinoembryonic antigen-related cell adhesion molecule 3,41843,0.0169816245426675,0.00480982741031836,0.00755436281844353,0.0264088862668915,0.000416010779740375
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TYMP,Thymidine phosphorylase,42070,0.0240207806875893,0.00680512203480381,0.0106827414993739,0.0373588198758048,0.000417247241011441
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,RANBP1,Ran-specific GTPase-activating protein,39638,0.0187232069351885,0.00530517966529597,0.00832505479120837,0.0291213590791686,0.000418464598593913
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MMP10,Stromelysin-2,42124,-0.0207641236574575,0.0058898764503042,-0.0323082815000537,-0.00921996581486126,0.000424255008173277
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FCGR2B,Low affinity immunoglobulin gamma Fc region receptor II-b,41843,0.0209135992835823,0.00593293168381784,0.00928505318329929,0.0325421453838652,0.000424908483271481
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CD1C,T-cell surface glycoprotein CD1c,42181,-0.00890256555417786,0.00252881093832365,-0.0138590349932922,-0.00394609611506349,0.00043221824181434
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,C3,Complement C3,39445,0.0166950879967298,0.00474414378237913,0.00739656618326674,0.0259936098101929,0.000434797741288918
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,BRSK2,Serine/threonine-protein kinase BRSK2,39934,0.0135158215072344,0.00384262324771451,0.005984279941714,0.0210473630727549,0.000437597109549564
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,VIM,Vimentin,41900,0.041233881418983,0.0117281987483273,0.0182466118722616,0.0642211509657045,0.000439907585138771
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PNMA1,Paraneoplastic antigen Ma1,39638,0.0207069152608628,0.00589521144019548,0.00915230083807963,0.0322615296836459,0.000445691051369454
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TPSAB1,Tryptase alpha/beta-1,42281,0.0186537571945086,0.00532530564822249,0.00821615812399249,0.0290913562650246,0.000461774535710054
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CNTNAP2,Contactin-associated protein-like 2,42119,0.0153650096104781,0.00438704873564354,0.00676639408861673,0.0239636251323394,0.000462650630301585
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,THAP12,52 kDa repressor of the inhibitor of the protein kinase,39539,0.0309817521604693,0.00888791337887361,0.013561441937877,0.0484020623830616,0.000492537034341735
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PPP1R12B,Protein phosphatase 1 regulatory subunit 12B,39757,0.0252702128504488,0.00726787437416822,0.011025179077079,0.0395152466238185,0.000509037411057913
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PLB1,"Phospholipase B1, membrane-associated",39929,-0.0211972071277484,0.00609938401645323,-0.0331519997999967,-0.00924241445550008,0.000512186976431147
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SPACA5_SPACA5B,Sperm acrosome-associated protein 5,39934,0.0107315926051044,0.00309133809682959,0.0046725699353184,0.0167906152748904,0.000519480297232694
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PRTFDC1,Phosphoribosyltransferase domain-containing protein 1,41839,0.0394094390825823,0.0113998938683962,0.0170656471005256,0.0617532310646389,0.000547939149456686
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CCL8,C-C motif chemokine 8,42239,0.0214140314277269,0.00619791997805775,0.00926610827073372,0.0335619545847201,0.00055189471037707
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PROK1,Prokineticin-1,42119,0.0175134951411199,0.00508153944770419,0.00755367782361969,0.0274733124586201,0.000569638003424966
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MYBPC1,"Myosin-binding protein C, slow-type",39958,0.0272772913920544,0.00792621416081802,0.0117419116368511,0.0428126711472578,0.000580790766850268
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CPXM1,Probable carboxypeptidase X1,42181,0.024053076258502,0.00703092747760391,0.0102724584023983,0.0378336941146057,0.000625660855335393
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ADAM23,Disintegrin and metalloproteinase domain-containing protein 23,42296,0.0122788654257024,0.00360030365300313,0.00522227026581623,0.0193354605855885,0.000650290641565816
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,INSL3,Insulin-like 3,39929,-0.0315776098949074,0.00926072555310021,-0.0497286319789838,-0.013426587810831,0.00065227233074839
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GFRA2,GDNF family receptor alpha-2,42070,0.00727310288014165,0.00213618134483389,0.00308618744426722,0.0114600183160161,0.000664246715484541
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SERPING1,Plasma protease C1 inhibitor,39959,-0.00647211137886961,0.00190203154008001,-0.0102000931974264,-0.0027441295603128,0.000669449367435663
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SMAD5,Mothers against decapentaplegic homolog 5,42070,0.00690854649461438,0.00203904771274728,0.00291201297762971,0.010905080011599,0.000705739673625211
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,RP2,Protein XRP2,42070,0.0147582419539967,0.00435750572345154,0.00621753073603173,0.0232989531719618,0.000709008086541243
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TREML2,Trem-like transcript 2 protein,42137,0.0119104637423537,0.00352123382227096,0.00500884545070257,0.0188120820340047,0.000720408574627027
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NAP1L4,Nucleosome assembly protein 1-like 4,39911,0.0140012788656663,0.00414713780511759,0.00587288876763585,0.0221296689636968,0.000737604746945769
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PER3,Period circadian protein homolog 3,39657,0.0427119889563389,0.0126556861990351,0.0179068440062301,0.0675171339064477,0.000740897953590677
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,LTBP3,Latent-transforming growth factor beta-binding protein 3,41843,0.0183950174328743,0.00545148583024598,0.00771010520559217,0.0290799296601564,0.000742125795072185
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TCN2,Transcobalamin-2,42286,0.0104098313483936,0.0030898613021504,0.00435370319617881,0.0164659595006084,0.000756417671815289
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DAPK2,Death-associated protein kinase 2,39657,0.0192060445775158,0.00570279836326271,0.00802855978552093,0.0303835293695108,0.000760213412486334
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,STX6,Syntaxin-6,41843,0.0225778123491694,0.00670948032113407,0.00942723091974662,0.0357283937785922,0.000767439873505606
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TBC1D5,TBC1 domain family member 5,42119,0.0267905915431476,0.00797035512049695,0.0111686955069736,0.0424124875793216,0.000777971843241469
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NARS1,"Asparagine--tRNA ligase, cytoplasmic",39934,0.0161929955052137,0.00482916930973605,0.00672782365813106,0.0256581673522964,0.000801550941345513
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IL22,Interleukin-22,39919,0.0242944050455289,0.00725042601461432,0.0100835700568848,0.0385052400341729,0.00080855021027536
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PEAR1,Platelet endothelial aggregation receptor 1,42310,0.00781377953537981,0.00233436369729079,0.00323842668868986,0.0123891323820698,0.000818268875667839
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PRKG1,cGMP-dependent protein kinase 1,39736,0.0435297897662615,0.0130040289479663,0.0180418930282476,0.0690176865042754,0.000818412684811662
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PDIA4,Protein disulfide-isomerase A4,39966,0.0210428718617661,0.00629901838343792,0.00869679583022782,0.0333889478933045,0.000838490507580726
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CELA3A,Chymotrypsin-like elastase family member 3A,42293,0.0205241142770968,0.00614882305181723,0.00847242109553507,0.0325758074586586,0.000846411782895887
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SERPINB9,Serpin B9,42016,0.0111555720111132,0.00335021853637714,0.00458914367981402,0.0177220003424124,0.000871413263759187
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CRTAP,Cartilage-associated protein,39649,0.0168958677510273,0.00507520552882667,0.00694846491452706,0.0268432705875276,0.000874120632320705
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NDUFS6,"NADH dehydrogenase [ubiquinone] iron-sulfur protein 6, mitochondrial",41843,0.0267314515385218,0.00803439871563684,0.0109840300558736,0.04247887302117,0.000879858151856837
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FCRL3,Fc receptor-like protein 3,41913,0.0181999297508719,0.00547085070307339,0.00747706237284802,0.0289227971288957,0.000881159125950388
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,RECK,Reversion-inducing cysteine-rich protein with Kazal motifs,39638,-0.00739519882961469,0.00222392405360828,-0.0117540899746869,-0.00303630768454246,0.000886136921790647
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,EGFLAM,Pikachurin,39930,0.0105845300424607,0.00318313602658162,0.00434558343036075,0.0168234766545607,0.000886391395500694
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PODXL,Podocalyxin,42070,-0.0051472757649391,0.00154865995337888,-0.0081826492735617,-0.0021119022563165,0.000890696832527145
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TGM2,Protein-glutamine gamma-glutamyltransferase 2,42120,0.0248852405406873,0.00748824109735906,0.0102082879898635,0.0395621930915111,0.000892138266984512
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CLIC5,Chloride intracellular channel protein 5,39649,-0.0107644871634919,0.0032412630336784,-0.0171173627095015,-0.00441161161748218,0.0008996120985207
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PDIA3,Protein disulfide-isomerase A3,39736,0.00840304017476175,0.0025306620552003,0.00344294254656915,0.0133631378029543,0.000901481699961501
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,RABEPK,Rab9 effector protein with kelch motifs,41843,0.019585818006009,0.00590520250472072,0.00801162109675642,0.0311600149152616,0.000913306941745196
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,LEO1,RNA polymerase-associated protein LEO1,39934,0.00993820546534428,0.00299952981657327,0.00405912702486068,0.0158172839058279,0.000925059586088911
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ATP6V1G2,V-type proton ATPase subunit G 2,39575,0.0332486632040363,0.0100500198505942,0.0135506242968717,0.0529467021112009,0.000941601207775487
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,HMGCL,"Hydroxymethylglutaryl-CoA lyase, mitochondrial",39638,0.0166346565336866,0.0050331409216763,0.00676970032720109,0.0264996127401722,0.000952706442349199
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,UNC5D,Netrin receptor UNC5D,39657,-0.00888400030780068,0.00268835172933369,-0.0141531696972947,-0.00361483091830665,0.000954052881373791
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ACSL1,Long-chain-fatty-acid--CoA ligase 1,39575,-0.0126229802526088,0.0038243278636774,-0.0201186628654165,-0.00512729763980108,0.000967497185704322
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CUZD1,CUB and zona pellucida-like domain-containing protein 1,39649,0.0135484209535037,0.00411010278022308,0.00549261950426641,0.0216042224027409,0.00098251676911483
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TACSTD2,Tumor-associated calcium signal transducer 2,40518,-0.0105181000644565,0.00319232904793118,-0.0167750649984016,-0.00426113513051138,0.000987776013211819
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PREB,Prolactin regulatory element-binding protein,41913,0.00953747504167606,0.00289707495432081,0.00385920813120726,0.0152157419521449,0.000996994417475785
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,C2orf69,UPF0565 protein C2orf69,39649,0.0199440964457631,0.00606768908271194,0.00805142584364772,0.0318367670478785,0.00101600430650984
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,KIFBP,KIF-binding protein,42070,0.0277072400498699,0.00844595742967383,0.0111531634877092,0.0442613166120306,0.00103874467353093
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CELA2A,Chymotrypsin-like elastase family member 2A,39966,0.0216765661124805,0.00660847210994629,0.00872396077698573,0.0346291714479752,0.00104076122285196
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PINLYP,phospholipase A2 inhibitor and Ly6/PLAUR domain-containing protein,39736,0.0236452766955251,0.00721138896197882,0.00951095433004665,0.0377795990610036,0.00104539796131343
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SERPINA1,Alpha-1-antitrypsin,39795,-0.00274827432053955,0.000838180514833655,-0.00439110812961352,-0.00110544051146559,0.00104546380920344
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PTRHD1,Putative peptidyl-tRNA hydrolase PTRHD1,39736,0.0200557149169747,0.00613114090384658,0.00803867874543542,0.032072751088514,0.00107447142694551
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TMPRSS11D,Transmembrane protease serine 11D,39906,0.0128663623658314,0.00393852946735647,0.00514684460981275,0.0205858801218501,0.001090972179601
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PRSS27,Serine protease 27,42107,0.0134056796434895,0.00411332976034517,0.00534355331321294,0.021467805973766,0.0011204969751759
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SUSD1,Sushi domain-containing protein 1,41900,0.0161957840413448,0.00496971290550305,0.00645514674655879,0.0259364213361307,0.00112126976269721
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,REG3A,Regenerating islet-derived protein 3-alpha,42310,0.0210518518280813,0.00646490982404126,0.00838062857296044,0.0337230750832022,0.00113138321598818
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CD2,T-cell surface antigen CD2,39575,0.0130026066230512,0.00400427427743691,0.0051542290392749,0.0208509842068276,0.00116903921439055
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MESD,LRP chaperone MESD,42137,0.0404148518686399,0.0124473228216126,0.0160180991382793,0.0648116045990006,0.00116965184576931
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FRMD4B,FERM domain-containing protein 4B,39575,0.02350516278346,0.00723945793614974,0.00931582522860652,0.0376945003383135,0.00117055555082048
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SIGLEC5,Sialic acid-binding Ig-like lectin 5,42137,0.0393739570770158,0.0121367633577325,0.01558590089586,0.0631620132581715,0.0011807121160328
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GGACT,Gamma-glutamylaminecyclotransferase,39958,0.0236540095611565,0.00730593096642004,0.00933438486697321,0.0379736342553398,0.00120866684060713
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,VNN1,Pantetheinase,39990,0.0244038168059177,0.00753940621536854,0.0096265806237954,0.0391810529880401,0.00121208730239334
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,KLK3,Prostate-specific antigen,39966,-0.0380832864925633,0.0117664290450874,-0.0611454874209346,-0.0150210855641921,0.00121307132509842
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,BGLAP,Osteocalcin,39966,0.027996994502823,0.00865448174198386,0.0110342102885346,0.0449597787171114,0.00122003110427103
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CCAR2,Cell cycle and apoptosis regulator protein 2,39929,0.01850799135202,0.00572253839268862,0.00729181610235033,0.0297241666016897,0.00122321859434488
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TARS1,"Threonine--tRNA ligase 1, cytoplasmic",39919,0.0124359329661517,0.00385332506399936,0.00488341584071297,0.0199884500915905,0.00125309045999629
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,RGL2,Ral guanine nucleotide dissociation stimulator-like 2,39757,0.0209501365164328,0.00650414326022352,0.0082020157263947,0.0336982573064709,0.00128090401267229
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SEMA3G,Semaphorin-3G,39736,0.015089668204677,0.00468675481822888,0.00590362876094843,0.0242757076484056,0.00128719298897996
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,S100A13,Protein S100-A13,39657,0.0117591313419512,0.00366669553279696,0.00457240809766912,0.0189458545862332,0.00134503885811734
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,RNF5,E3 ubiquitin-protein ligase RNF5,39638,0.0242562567610648,0.00756703444593325,0.00942486924703561,0.0390876442750939,0.00135203939530083
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TCL1A,T-cell leukemia/lymphoma protein 1A,42005,0.0333732732136553,0.0104211565744627,0.0129478063277083,0.0537987400996022,0.00136580367555381
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SPP1,Osteopontin,42286,-0.0143496572638293,0.00449308373234983,-0.0231561013792349,-0.00554321314842359,0.00140769707797716
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SCP2,Non-specific lipid-transfer protein,41843,0.0241041132599907,0.00759307983999605,0.00922167677359846,0.038986549746383,0.00150446547837613
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IL17D,Interleukin-17D,41913,0.0110434631455372,0.00348278306441825,0.0042172083392774,0.0178697179517969,0.00152326112754693
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ANP32C,Acidic leucine-rich nuclear phosphoprotein 32 family member C,39638,-0.0130084548429518,0.00410714659319521,-0.0210584621656144,-0.00495844752028917,0.00154294843592063
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SRC,Proto-oncogene tyrosine-protein kinase Src,42166,0.0386482078514391,0.0122029975308292,0.0147303326910139,0.0625660830118644,0.00154304345805388
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,XG,Glycoprotein Xg,42261,0.0111411791948297,0.00353568880819141,0.00421122913077457,0.0180711292588849,0.00163028482752868
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IL1RL1,Interleukin-1 receptor-like 1,42272,0.0153445620797784,0.00487431601027565,0.00579090269963814,0.0248982214599187,0.00164720216143605
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,LILRB2,Leukocyte immunoglobulin-like receptor subfamily B member 2,42248,0.0111276979966449,0.00353507966241851,0.00419894185830462,0.0180564541349852,0.00164862488271686
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IL15RA,Interleukin-15 receptor subunit alpha,41913,0.0111603309609358,0.00354566536305658,0.00421082684934488,0.0181098350725267,0.00164980893788349
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CPVL,Probable serine carboxypeptidase CPVL,42223,0.0131927505690202,0.00419769684167094,0.00496526475934514,0.0214202363786952,0.00167667755461493
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CCDC134,Coiled-coil domain-containing protein 134,39919,0.0156467664672225,0.00498464163475714,0.00587686886309856,0.0254166640713465,0.00169963825894442
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DBN1,Drebrin,39657,0.0164722095614717,0.00525582101535619,0.00617080037137358,0.0267736187515699,0.00172839592859253
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,UBE2B,Ubiquitin-conjugating enzyme E2 B,39919,0.00933183397463762,0.00298162147891844,0.00348785587595748,0.0151758120733178,0.00175379025045662
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NRGN,Neurogranin,39990,0.029689424555388,0.00951922847654536,0.0110317367413591,0.0483471123694169,0.00181986600512307
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,LTBR,Tumor necrosis factor receptor superfamily member 3,42063,0.00946372221298956,0.00303638568107619,0.00351240627808024,0.0154150381478989,0.00183227651745238
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,BPIFB2,BPI fold-containing family B member 2,39927,-0.0196393062609087,0.00630156730869428,-0.0319903781859495,-0.00728823433586794,0.00183422833734949
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SPON2,Spondin-2,42070,0.0111276541729932,0.00357189046491765,0.00412674886175458,0.0181285594842318,0.00184118652825182
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SUSD5,Sushi domain-containing protein 5,39695,-0.0110365193183404,0.00354397388903795,-0.0179827081408548,-0.00409033049582599,0.00184936008765876
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,THBS4,Thrombospondin-4,42189,0.0144666774746068,0.00464752688293683,0.0053575247840506,0.023575830165163,0.00185725659745553
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NAA10,N-alpha-acetyltransferase 10,39575,0.0162145948178976,0.00521785128089121,0.00598760630735078,0.0264415833284443,0.00189143897540812
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SLC4A1,Band 3 anion transport protein,39966,0.0151875723196831,0.00489397949523357,0.00559537250902526,0.0247797721303409,0.0019183377314623
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,LAMTOR5,Ragulator complex protein LAMTOR5,39919,-0.0130182217990492,0.00420455349774437,-0.0212591466546281,-0.00477729694347019,0.00196483920418231
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SUGT1,Protein SGT1 homolog,41843,0.0252929246294529,0.00816927170746494,0.00928115208282165,0.0413046971760842,0.00196490175665579
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,BLNK,B-cell linker protein,39657,0.0133006453488873,0.00430920575502125,0.00485460206904567,0.021746688628729,0.00202984104812642
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,RNASE3,Eosinophil cationic protein,42081,0.0344207731583083,0.0111565638346846,0.0125539080423264,0.0562876382742901,0.00203793864365745
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PI16,Peptidase inhibitor 16,39990,-0.00765829646980684,0.00248668904224243,-0.012532206992602,-0.00278438594701168,0.00207691275383595
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SPTBN2,"Spectrin beta chain, non-erythrocytic 2",39586,0.0100524457378757,0.00326789077016594,0.00364737982835045,0.0164575116474009,0.00210224256210871
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IFNGR1,Interferon gamma receptor 1,42185,0.00679765124041829,0.00221161720223427,0.00246288152403912,0.0111324209567975,0.00211903981946566
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PLA2G2A,"Phospholipase A2, membrane associated",42135,-0.0166443930563385,0.00541605357493584,-0.0272598580632127,-0.00602892804946421,0.00212226733519818
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ANXA5,Annexin A5,41780,0.00955136037728771,0.00310994515724734,0.00345586786908293,0.0156468528854925,0.00213612246577909
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CDH6,Cadherin-6,42145,0.0122211189110278,0.00398464647428225,0.00441121182143461,0.020031026000621,0.00216607365975328
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FHIT,Bis(5'-adenosyl)-triphosphatase,41839,0.0225483981447694,0.00736869519593502,0.00810575556073676,0.036991040728802,0.00221760634105039
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,RNASE10,Inactive ribonuclease-like protein 10,39638,0.0148870732040595,0.00487166825605721,0.00533860342218741,0.0244355429859317,0.00224961587759905
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DIABLO,"Diablo homolog, mitochondrial",42107,0.034221147329264,0.0112112793182361,0.0122470398655212,0.0561952547930069,0.00227471402143066
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,RNF43,E3 ubiquitin-protein ligase RNF43,39757,0.0180318591215703,0.0059102755041716,0.00644771913339399,0.0296159991097467,0.00228666658044011
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PBK,Lymphokine-activated killer T-cell-originated protein kinase,39560,-0.00978810302668146,0.00320980412784926,-0.016079319117266,-0.00349688693609691,0.00229816058968608
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CD200,OX-2 membrane glycoprotein,42119,-0.00845716331028352,0.00277969370730149,-0.0139053629765944,-0.00300896364397259,0.00235087308786707
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GPIHBP1,Glycosylphosphatidylinositol-anchored high density lipoprotein-binding protein 1,39930,-0.0226082654149764,0.00744468672525266,-0.0371998513964716,-0.00801667943348117,0.00239621995096611
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ANXA3,Annexin A3,42224,0.0215545896088793,0.00710092004533444,0.00763678632002384,0.0354723928977348,0.00240618949637659
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,STXBP1,Syntaxin-binding protein 1,39934,0.0243865243847706,0.00803655343547362,0.00863487965124233,0.0401381691182989,0.00241520365665956
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GMFG,Glia maturation factor gamma,39958,0.0224177002519361,0.00740741569004182,0.00789916549945411,0.0369362350044181,0.00248050326465857
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,HRC,Sarcoplasmic reticulum histidine-rich calcium-binding protein,39638,-0.0105301569062027,0.00348054243946456,-0.0173520200875533,-0.00370829372485218,0.00248846833943639
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ENPP6,Glycerophosphocholine cholinephosphodiesterase ENPP6,39638,0.0112616158108163,0.0037230682807347,0.00396440198057625,0.0185588296410563,0.00249352441596568
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GADD45GIP1,Growth arrest and DNA damage-inducible proteins-interacting protein 1,39638,0.0165874983495388,0.00548820858790799,0.00583060951723912,0.0273443871818384,0.00251363682346278
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,INSL4,Early placenta insulin-like peptide,39919,0.0149535871810708,0.00495746497928531,0.00523695582167159,0.02467021854047,0.00256382333323094
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,THPO,Thrombopoietin,41900,-0.0120020847231084,0.00398111324714507,-0.0198050666875128,-0.00419910275870407,0.00257671132957377
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CDHR5,Cadherin-related family member 5,42145,0.0119381706150815,0.00396186986208682,0.00417290568539137,0.0197034355447717,0.0025892935658393
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,AHNAK2,Protein AHNAK2,39638,0.00961290868700858,0.00320473584817596,0.00333162642458369,0.0158941909494335,0.00270942188827709
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,KIRREL2,Kin of IRRE-like protein 2,41839,0.012221468125331,0.00407741343122764,0.00422973780012482,0.0202131984505371,0.00272835750058622
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ACRBP,Acrosin-binding protein,39919,0.0123177803664361,0.00411311376382641,0.00425607738933636,0.0203794833435359,0.0027525669569609
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,WNT9A,Protein Wnt-9a,41913,0.00891193812374207,0.00297770693998416,0.00307563252137312,0.014748243726111,0.00276859708630139
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,VASH1,Tubulinyl-Tyr carboxypeptidase 1,42119,0.0252475396172022,0.00845915346191436,0.00866759883185006,0.0418274804025543,0.00284418705741502
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GNPDA1,Glucosamine-6-phosphate isomerase 1,39638,0.0103544164290521,0.00346983782367834,0.00355353429464252,0.0171552985634616,0.00285016758765409
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CSF3R,Granulocyte colony-stimulating factor receptor,39657,0.00927682021521661,0.00311594213801189,0.0031695736247133,0.0153840668057199,0.00291513196938858
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CRADD,Death domain-containing protein CRADD,41997,0.0226603238749497,0.00761492116301606,0.00773507839543818,0.0375855693544611,0.00292766942646052
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SMARCA2,Probable global transcription activator SNF2L2,41839,0.0223413989679556,0.0075247294131933,0.00759292931809678,0.0370898686178145,0.0029924413757116
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PLA2G4A,Cytosolic phospholipase A2,42185,0.0267289141370619,0.00901782623369034,0.00905397471902884,0.044403853555095,0.00304186778765204
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DAPP1,Dual adapter for phosphotyrosine and 3-phosphotyrosine and 3-phosphoinositide,42119,0.0368376051046408,0.0124287235358173,0.012477306974439,0.0611979032348426,0.00304287752389399
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CD93,Complement component C1q receptor,41654,-0.00954072196172692,0.00322640120867907,-0.0158644683307379,-0.00321697559271593,0.00311125036947623
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DTD1,D-aminoacyl-tRNA deacylase 1,39736,0.0265332601311673,0.00900589597025801,0.00888170402946157,0.044184816232873,0.00322360270739335
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FKBP14,Peptidyl-prolyl cis-trans isomerase FKBP14,39934,0.0303666028109877,0.0103140798698162,0.0101510062661479,0.0505821993558275,0.00324459242612889
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,M6PR,Cation-dependent mannose-6-phosphate receptor,39638,0.0117418177241059,0.00398851180384097,0.00392433458857762,0.0195593008596342,0.00324770066273277
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,AHSG,Alpha-2-HS-glycoprotein,39990,0.00809345731082336,0.00275379231830098,0.00269602436695344,0.0134908902546933,0.0032991008948585
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FCRL5,Fc receptor-like protein 5,42137,0.0177464708974023,0.00604211861175817,0.00590391841835633,0.0295890233764484,0.00331826259496291
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,RCC1,Regulator of chromosome condensation,39919,0.0157342487577441,0.00536934220810661,0.00521033802985514,0.026258159485633,0.00339216913333706
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DSG4,Desmoglein-4,42018,-0.0143396424083305,0.00490498122749878,-0.0239534056142281,-0.00472587920243287,0.00346714539563074
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SCARF2,Scavenger receptor class F member 2,42249,0.00848222323957071,0.00290584017995791,0.00278677648685322,0.0141776699922882,0.00351700470364923
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TXN,Thioredoxin,39854,0.0129208340098788,0.00443158616659131,0.00423492512335983,0.0216067428963978,0.00355679695948348
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NUDT2,Bis(5'-nucleosyl)-tetraphosphatase [asymmetrical],42070,-0.0168778904379363,0.00578997885087208,-0.0282262489856456,-0.00552953189022703,0.00356254270834925
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GPNMB,Transmembrane glycoprotein NMB,41802,0.0086860262747224,0.0029861335353519,0.00283320454543267,0.0145388480040121,0.0036343906246438
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MIA,Melanoma-derived growth regulatory protein,42181,0.010967195113229,0.0037798554509529,0.00355867842936131,0.0183757117970967,0.00371994735652681
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ANK2,Ankyrin-2,39575,-0.0208563284997849,0.00719295770423777,-0.0349545256000909,-0.00675813139947885,0.00374441787519991
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PON2,Serum paraoxonase/arylesterase 2,41900,0.0103925513155492,0.00359104128541797,0.00335411039613002,0.0174309922349684,0.00380959936245446
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,F3,Tissue factor,42174,-0.00772675010691144,0.0026749255471461,-0.0129696041793178,-0.00248389603450507,0.00387591214641324
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DCTD,Deoxycytidylate deaminase,39736,0.0284247035307443,0.00986511063082734,0.00908908669432275,0.0477603203671659,0.00396749005954864
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ABO,Histo-blood group ABO system transferase,39990,-0.0427797719823278,0.0149326238649374,-0.0720477147576052,-0.0135118292070505,0.00417965990738913
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DYNLT3,Dynein light chain Tctex-type 3,39919,0.01294586791286,0.00452000082295013,0.00408666629987772,0.0218050695258422,0.00418925895801846
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PPIB,Peptidyl-prolyl cis-trans isomerase B,42155,0.0280356227183915,0.00979753177090984,0.00883246044740821,0.0472387849893748,0.00422288715561128
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,KLK8,Kallikrein-8,41668,0.0107132466931733,0.00374600769900119,0.00337107160313097,0.0180554217832156,0.00424431919830646
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CRH,Corticoliberin,41830,0.0250444741425434,0.00876905885633929,0.00785711878411844,0.0422318295009685,0.00429676644239128
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FZD8,Frizzled-8,39586,0.012642129685769,0.00443603766372793,0.0039474958648623,0.0213367635066758,0.00438185131897146
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SELENOP,Selenoprotein P,39979,-0.00660709097634814,0.00232380290395552,-0.011161744668101,-0.00205243728459533,0.0044739295454236
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GNLY,Granulysin,42137,0.0155933797211966,0.00551285757257631,0.00478817887894705,0.0263985805634462,0.00468284666480686
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,VGF,Neurosecretory protein VGF,39934,0.00878951461233841,0.00310968256389657,0.00269453678710114,0.0148844924375757,0.00471422758313971
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PLAU,Urokinase-type plasminogen activator,42137,-0.00824208876206095,0.00291807295910266,-0.0139615117619022,-0.00252266576221974,0.00474240949731775
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,RBPMS,RNA-binding protein with multiple splicing,39657,0.0187460501397495,0.00664055987879891,0.00573055277730361,0.0317615475021954,0.00476671665593054
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,COL9A1,Collagen alpha-1(IX) chain,42119,-0.0128617721995593,0.00455797311767125,-0.0217953995101949,-0.00392814488892363,0.00478218762841201
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CRYBB1,Beta-crystallin B1,39958,0.0191417764947987,0.00680443738194123,0.00580507922619389,0.0324784737634035,0.00491458468400558
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CBX2,Chromobox protein homolog 2,39575,-0.0113989983295606,0.00406213231448658,-0.0193607776659543,-0.00343721899316689,0.00502238995047729
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CASP1,Caspase-1,41839,0.0197470122416902,0.00704695060050292,0.00593498906470443,0.0335590354186759,0.00508280674494436
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PSG1,Pregnancy-specific beta-1-glycoprotein 1,42016,-0.032158943850832,0.0115041376302995,-0.0547070536062191,-0.0096108340954449,0.00519053167386969
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SETMAR,Histone-lysine N-methyltransferase SETMAR,41976,0.00844584853247435,0.00302934710499981,0.00250832820667472,0.014383368858274,0.00531078484547361
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MANF,Mesencephalic astrocyte-derived neurotrophic factor,42185,0.0342973335867616,0.0123093694657514,0.0101709694338889,0.0584236977396343,0.00533909523780803
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GFRA3,GDNF family receptor alpha-3,41989,0.0079113979258867,0.00283995564197104,0.00234508486762346,0.0134777109841499,0.00534796270422768
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DPP7,Dipeptidyl peptidase 2,42054,0.0179301738205057,0.00643782612242645,0.00531203462054988,0.0305483130204615,0.00535813053091897
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MGMT,Methylated-DNA--protein-cysteine methyltransferase,42119,0.0341522901807865,0.0122724877608137,0.0100982141695916,0.0582063661919814,0.0053961208904807
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TDGF1,Teratocarcinoma-derived growth factor 1,41839,0.0423289835294337,0.0152136320019933,0.0125102648055269,0.0721477022533405,0.00540504924088263
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GPR15L,Protein GPR15L,39930,0.0178615303909925,0.00642307181926286,0.00527230962523729,0.0304507511567477,0.00543080983522957
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,C1QTNF6,Complement C1q tumor necrosis factor-related protein 6,39934,0.00899359080011093,0.00323601896810383,0.00265099362262743,0.0153361879775944,0.00545802856717207
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,STK4,Serine/threonine-protein kinase 4,42145,0.0248521113294453,0.0089462292682461,0.0073175019636829,0.0423867206952076,0.00547795506141968
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,AK1,Adenylate kinase isoenzyme 1,42145,0.0173986867533592,0.00629654432470882,0.00505745987692989,0.0297399136297885,0.00573128373089361
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ZCCHC8,Zinc finger CCHC domain-containing protein 8,39575,0.0168094192079609,0.00609083421440525,0.00487138414772656,0.0287474542681952,0.00579345789702507
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CLEC11A,C-type lectin domain family 11 member A,42118,-0.01364014415388,0.00495544249580233,-0.0233528114456526,-0.00392747686210746,0.00592104962652734
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CYB5R2,NADH-cytochrome b5 reductase 2,39803,0.0158790683261575,0.00576895031982836,0.00457192569929387,0.027186210953021,0.00592363110272575
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TNFRSF13C,Tumor necrosis factor receptor superfamily member 13C,41913,0.0120872680116151,0.00439785356625734,0.00346747502175074,0.0207070610014795,0.00599589535450949
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,S100A11,Protein S100-A11,42027,0.0130134872999799,0.00473780606008958,0.00372738742220437,0.0222995871777555,0.0060272367558375
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,LRIG1,Leucine-rich repeats and immunoglobulin-like domains protein 1,42224,0.00987823018933191,0.00360725219585435,0.00280801588545738,0.0169484444932065,0.00618123284184801
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TMEM106A,Transmembrane protein 106A,39919,0.02016460079818,0.0073869451476031,0.00568618830887791,0.0346430132874821,0.00634780924261958
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ACRV1,Acrosomal protein SP-10,39657,0.0298229476337354,0.0109449302430584,0.00837088435734087,0.0512750109101298,0.0064438026551635
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TNNI3,"Troponin I, cardiac muscle",41900,0.0233529936328958,0.0085763823018705,0.00654328432122965,0.040162702944562,0.00647877416122577
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SCGB1A1,Uteroglobin,42165,0.0149181018646038,0.00547991487025631,0.00417746871890142,0.0256587350103062,0.00649074317942537
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CLU,Clusterin,39979,-0.00841226910460912,0.00309326842646839,-0.0144750752204872,-0.00234946298873108,0.00654718619437278
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TIGIT,T-cell immunoreceptor with Ig and ITIM domains,39757,0.0104137227453497,0.00383303084027123,0.00290098229841805,0.0179264631922813,0.00660105518457355
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,HDDC2,5'-deoxynucleotidase HDDC2,39930,-0.0122424924134154,0.0045086640744814,-0.0210794739993989,-0.00340551082743186,0.00663109160725815
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,AIDA,"Axin interactor, dorsalization-associated protein",39649,0.023929775093215,0.00881505265295975,0.00665227189341393,0.0412072782930162,0.00664490312175309
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NMI,N-myc-interactor,39875,-0.0203242608991122,0.00750366245547237,-0.035031439311838,-0.00561708248638632,0.0067674056531242
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CIRBP,Cold-inducible RNA-binding protein,39930,0.0268537126653726,0.00993576556384152,0.00737961216024317,0.0463278131705019,0.00688746466194249
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ADAMTS8,A disintegrin and metalloproteinase with thrombospondin motifs 8,42181,-0.0126301791690176,0.00467542154499915,-0.0217940053972159,-0.00346635294081924,0.00691341413948223
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MAP2K6,Dual specificity mitogen-activated protein kinase kinase 6,42119,0.0274203604206312,0.0101529590189494,0.00752056074349037,0.047320160097772,0.00692744990129613
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DPP10,Inactive dipeptidyl peptidase 10,42119,0.0101265275146723,0.00375012666103542,0.00277627925904286,0.0174767757703017,0.00693598630938134
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CDKN2D,Cyclin-dependent kinase 4 inhibitor D,42070,0.0259102181741361,0.00959593510899022,0.00710218536051525,0.0447182509877569,0.0069400148963536
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GNGT1,Guanine nucleotide-binding protein G(T) subunit gamma-T1,39649,0.0139848343452151,0.00518904272898294,0.00381431059640859,0.0241553580940217,0.00704802705816579
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TRDMT1,tRNA (cytosine(38)-C(5))-methyltransferase,39757,0.0241791130607972,0.00898641403242615,0.00656574155724196,0.0417924845643525,0.00714235108324028
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PCSK7,Proprotein convertase subtilisin/kexin type 7,39919,0.0124055868392445,0.00461248100736055,0.00336512406481777,0.0214460496136711,0.00716491943316285
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NOP56,Nucleolar protein 56,39575,0.0308566811798839,0.011528144229725,0.0082615184896229,0.0534518438701449,0.00744752082393448
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SLAMF7,SLAM family member 7,42119,0.0163164365010048,0.0061018121941376,0.00435688460049514,0.0282759884015145,0.00750355616603021
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,HSBP1,Heat shock factor-binding protein 1,39638,0.0264394530276599,0.00990389618271235,0.00702781650954368,0.0458510895457761,0.00760525434132964
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CD3G,T-cell surface glycoprotein CD3 gamma chain,39657,-0.0240050829665804,0.00899713841951845,-0.0416394742688366,-0.00637069166432426,0.0076397386453722
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,F13B,Coagulation factor XIII B chain,39925,0.00701062155556017,0.00263272858800361,0.00185047352307309,0.0121707695880473,0.0077586212448472
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SNED1,"Sushi, nidogen and EGF-like domain-containing protein 1",39638,0.00861282999900094,0.00323796639292501,0.00226641586886793,0.014959244129134,0.00782650798039855
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IGLC2,Immunoglobulin lambda constant 2,39963,0.00698758215862612,0.00262881321384181,0.00183510825949617,0.0121400560577561,0.00786984721455385
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ANXA1,Annexin A1,39699,0.0121573361117485,0.00457523949159581,0.00318986670822069,0.0211248055152763,0.00789049871876387
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DDX1,ATP-dependent RNA helicase DDX1,39930,0.0131432222732749,0.00496076176027029,0.00342012922314513,0.0228663153234047,0.00807380662140735
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DGKZ,Diacylglycerol kinase zeta,41913,0.00976188665491566,0.00368994386421259,0.00252959668105898,0.0169941766287723,0.0081656952640924
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IRAG2,"Inositol 1,4,5-triphosphate receptor associated 2",41900,0.0239963380266329,0.00908498330602974,0.00618977074681465,0.0418029053064512,0.00826805152835543
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CTRC,Chymotrypsin-C,42122,-0.0176351273733646,0.00668392044392965,-0.0307356114434667,-0.00453464330326248,0.00833836988212795
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,AKT2,RAC-beta serine/threonine-protein kinase,39934,0.0346614278834806,0.0131699295708543,0.00884836592460608,0.0604744898423551,0.00850335683337781
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,AKR1B1,Aldo-keto reductase family 1 member B1,41843,0.0199810302388872,0.00759286499836419,0.00509901484209337,0.034863045635681,0.00850939956325967
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ATXN2,Ataxin-2,39586,0.0287272116552349,0.0109197868075763,0.00732442951238534,0.0501299937980844,0.00853159829862647
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CXCL12,Stromal cell-derived factor 1,41913,-0.010602318693184,0.00403492983502218,-0.0185107811698275,-0.00269385621654054,0.00860795749989464
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CLEC1A,C-type lectin domain family 1 member A,41900,0.00913243783144982,0.0034811053901026,0.00230947126684873,0.0159554043960509,0.00871485697671628
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ASRGL1,Isoaspartyl peptidase/L-asparaginase,39638,0.0275121028871285,0.0104882567075392,0.00695511974035165,0.0480690860339053,0.00872447674397201
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ATP6V1F,V-type proton ATPase subunit F,41820,0.0178862542903961,0.00682042576039275,0.00451821980002628,0.0312542887807658,0.0087399102022049
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,B3GAT3,Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase 3,39575,-0.00561157680148802,0.00214267873944874,-0.00981122713080755,-0.00141192647216849,0.00883211249715392
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ADAMTSL5,ADAMTS-like protein 5,39958,-0.010797847272353,0.00412666521371022,-0.018886111091225,-0.00270958345348098,0.0088926992845009
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TSPYL1,Testis-specific Y-encoded-like protein 1,39657,0.0109185915967568,0.00417353005595387,0.00273847268708719,0.0190987105064263,0.00890476835522691
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MORF4L2,Mortality factor 4-like protein 2,39560,0.0101582511027412,0.00388720021130229,0.00253933868858867,0.0177771635168936,0.00898064821135782
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MKI67,Proliferation marker protein Ki-67,39657,0.0109357857117776,0.00419103708632517,0.00272135302258031,0.019150218400975,0.00908427175293781
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PLG,Plasminogen,39742,0.00586345237862585,0.00224791491581991,0.00145753914361882,0.0102693656136329,0.00910890608017262
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MAPRE3,Microtubule-associated protein RP/EB family member 3,39560,0.0393262871912597,0.0151017880446807,0.00972678262368551,0.0689257917588339,0.00922451126586532
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IL31RA,Interleukin-31 receptor subunit alpha,39616,0.0100391566052912,0.00386386871340328,0.00246597392702079,0.0176123392835617,0.00938349207993067
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PAFAH1B3,Platelet-activating factor acetylhydrolase IB subunit alpha1,39934,0.0315381025224055,0.0121469159102689,0.00773014733827849,0.0553460577065324,0.00943313139658097
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MICB_MICA,MHC class I polypeptide-related sequence A_MHC class I polypeptide-related sequence B,42119,0.0397434758661472,0.0153357528954885,0.00968540019098979,0.0698015515413047,0.00956454534738489
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TP53INP1,Tumor protein p53-inducible nuclear protein 1,41900,-0.0077777101169954,0.00300805866208778,-0.0136735050946874,-0.00188191513930335,0.00973081159796403
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,AHSA1,Activator of 90 kDa heat shock protein ATPase homolog 1,39919,0.0173664926645101,0.00671804504778993,0.00419912437084182,0.0305338609581783,0.00974883434974986
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,EVI2B,Protein EVI2B,39560,-0.0105871775409918,0.0041127452048358,-0.01864815814247,-0.00252619693951362,0.0100591744137762
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,HLA_A,,39934,0.00869104521754393,0.00338130566990922,0.00206368610452185,0.015318404330566,0.0101730479147601
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FAM172A,Cotranscriptional regulator FAM172A,39638,0.0161636317715249,0.0062931465634922,0.00382906450708021,0.0284981990359696,0.0102284760611469
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,C9orf40,Uncharacterized protein C9orf40,39930,0.0205606703308851,0.00800842747013184,0.00486415248942671,0.0362571881723435,0.0102597611807654
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,REPS1,RalBP1-associated Eps domain-containing protein 1,39657,0.010047863044818,0.0039194680425504,0.00236570568141923,0.0177300204082168,0.0103730361484662
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ARNT,Aryl hydrocarbon receptor nuclear translocator,41913,0.00968139469309,0.00378256748951908,0.00226756241363259,0.0170952269725474,0.0104939255454495
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,KIAA0319,Dyslexia-associated protein KIAA0319,39929,-0.00803877913413954,0.00314834653023516,-0.0142095383334005,-0.00186801993487861,0.0106827069416327
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,STOML2,"Stomatin-like protein 2, mitochondrial",39560,0.0250102807119249,0.00979595460237712,0.00581020969126572,0.044210351732584,0.0106895921400416
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,RYR1,Ryanodine receptor 1,39575,-0.00885560862610362,0.00347461401732503,-0.0156658521000607,-0.00204536515214655,0.0108272726186345
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,RPS10,40S ribosomal protein S10,39575,-0.0109322685539531,0.00429717898493183,-0.0193547393644195,-0.00250979774348673,0.0109709055216919
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ENAH,Protein enabled homolog,41913,0.0125106721064912,0.00492347534430789,0.00286066043164774,0.0221606837813347,0.0110640639631082
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,HEBP1,Heme-binding protein 1,41900,-0.013498976522626,0.0053131624586238,-0.0239127749415286,-0.00308517810372331,0.0110753916292583
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GP1BB,Platelet glycoprotein Ib beta chain,39575,0.0181033338770538,0.0071438662987277,0.00410135593154746,0.03210531182256,0.0112871613977127
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TREML1,Trem-like transcript 1 protein,39990,-0.0137919298377078,0.00546023801826911,-0.0244939963535152,-0.00308986332190031,0.0115541895240447
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ART5,Ecto-ADP-ribosyltransferase 5,39586,-0.0161228932672144,0.0063847031519858,-0.0286369114451065,-0.00360887508932218,0.0115759557630036
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ARMCX2,Armadillo repeat-containing X-linked protein 2,39586,-0.0149392077969732,0.00591889837781362,-0.0265402486174879,-0.00333816697645849,0.0116172804958992
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SIRPA,Tyrosine-protein phosphatase non-receptor type substrate 1,42179,0.0149034844609072,0.00591131428163526,0.00331730846890211,0.0264896604529123,0.0117075692785734
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,COQ7,"5-demethoxyubiquinone hydroxylase, mitochondrial",39638,0.0114540322597727,0.00454457673881472,0.00254666185169587,0.0203614026678496,0.0117370087674619
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CD84,SLAM family member 5,42119,0.00815233390765078,0.00325748451799626,0.00176766425237811,0.0145370035629234,0.0123385501814192
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,HCG22,Protein PBMUCL2,39575,-0.0149543733252827,0.00597758815561831,-0.0266704461102945,-0.00323830054027077,0.0123728949265508
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,XPNPEP2,Xaa-Pro aminopeptidase 2,42181,-0.0280050222343077,0.011224549515138,-0.0500051392839782,-0.00600490518463727,0.0126082181284107
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NUP50,Nuclear pore complex protein Nup50,39575,-0.0081403125748506,0.00326445191969011,-0.0145386383374432,-0.00174198681225798,0.0126592819461783
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DAND5,DAN domain family member 5,39657,-0.0140096767158625,0.00563151092133134,-0.0250474381216719,-0.00297191531005304,0.0128707608298747
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CD58,Lymphocyte function-associated antigen 3,42100,-0.00442006858224421,0.00178051373018955,-0.00790987549341574,-0.000930261671072689,0.0130596348570486
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TGFBR1,TGF-beta receptor type-1,39657,0.0055883060674818,0.00226377361833275,0.0011513097755496,0.010025302359414,0.0135800466403128
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ARFIP1,Arfaptin-1,39934,0.0176039567353949,0.00713588900582716,0.00361761428397366,0.0315902991868161,0.0136412124713038
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,POMC,Pro-opiomelanocortin,39638,0.0185398177126534,0.00755761222841973,0.00372689774495071,0.033352737680356,0.0141772046820459
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CA3,Carbonic anhydrase 3,42287,0.0147384618661679,0.00600868765685694,0.00296143405872828,0.0265154896736075,0.0141849862913185
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TIMP2,Metalloproteinase inhibitor 2,39958,0.00717883905629771,0.00293512042350317,0.0014260030262315,0.0129316750863639,0.0144665240235625
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ISLR2,Immunoglobulin superfamily containing leucine-rich repeat protein 2,41619,0.00954686172124362,0.00390699639915443,0.00188914877890094,0.0172045746635863,0.0145575589638245
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NRTN,Neurturin,41913,0.0123416476466869,0.00506358407070133,0.00241702286811231,0.0222662724252615,0.0148089911761302
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,VWC2L,von Willebrand factor C domain-containing protein 2-like,39934,-0.0115353575820317,0.00473588223734603,-0.0208176867672299,-0.00225302839683349,0.0148768422738656
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PRTN3,Myeloblastin,41800,0.0119590228544986,0.00491688091160645,0.00232193626774994,0.0215961094412472,0.0150190597005714
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TPSD1,Tryptase delta,39934,0.00915401755795021,0.00376739725560096,0.00176991893697233,0.0165381161789281,0.0151226289965772
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FBN2,Fibrillin-2,39649,0.0149609170068759,0.00618243530006952,0.00284334381873967,0.0270784901950122,0.0155405156790284
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ERVV_1,,39575,-0.0108500263585011,0.00448517187099267,-0.0196409632256468,-0.00205908949135552,0.0155756208901742
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CASP9,Caspase-9,39657,0.0159022004928832,0.00657684507903368,0.00301158413797715,0.0287928168477892,0.015626119854306
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FLRT2,Leucine-rich repeat transmembrane protein FLRT2,42016,0.00709395088313401,0.00294643931112489,0.00131892983332923,0.0128689719329388,0.0160696289087129
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IFNW1,Interferon omega-1,39575,-0.00873969309710137,0.0036315089760354,-0.0158574506901307,-0.00162193550407199,0.0161169533858798
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DCUN1D1,DCN1-like protein 1,39586,0.0186692711645053,0.00776714419291856,0.00344566854638494,0.0338928737826257,0.0162500547908608
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,HIP1,Huntingtin-interacting protein 1,39575,0.00814547040638673,0.00339078541026545,0.00149953100226646,0.014791409810507,0.0163116525090527
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SCRN1,Secernin-1,42119,0.0135867726157968,0.005658755615287,0.0024956116098343,0.0246779336217593,0.0163629660836381
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CLSTN3,Calsyntenin-3,39929,0.00747040526982321,0.00311169639179556,0.00137148034190392,0.0135693301977425,0.0163775307452458
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PSMD9,26S proteasome non-ATPase regulatory subunit 9,42070,0.0131083353488857,0.00546531411855444,0.00239631967651895,0.0238203510212524,0.0164777056077763
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,AKT3,RAC-gamma serine/threonine-protein kinase,41791,0.0141480784801394,0.00594109626631281,0.00250352979816627,0.0257926271621125,0.0172614530285573
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NDRG1,Protein NDRG1,41839,0.0160494992115203,0.0067532766279616,0.00281307702071554,0.029285921402325,0.0174895296602794
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TTN,Titin,39575,0.0169348908305482,0.00712739681878434,0.00296519306573086,0.0309045885953655,0.0175172201948754
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ODAM,Odontogenic ameloblast-associated protein,41814,0.0130724083537749,0.0055062198044699,0.00228021753701389,0.0238645991705359,0.0176051938696825
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SH3GL3,Endophilin-A3,39690,0.0207990113378578,0.00878935474491447,0.00357187603782541,0.0380261466378901,0.0179797625057177
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CFB,Complement factor B,39794,0.00796884336717403,0.00336791586212957,0.00136772827740008,0.014569958456948,0.0179932672956557
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GPHA2,Glycoprotein hormone alpha-2,39930,-0.0106229554644613,0.00449525854634749,-0.0194336622153024,-0.00181224871362022,0.0181372853511913
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FN1,Fibronectin,39979,0.00659808181255346,0.00280119959211461,0.00110773061200883,0.0120884330130981,0.0185172295250656
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GAD2,Glutamate decarboxylase 2,39657,-0.0109477745307315,0.00466542727929358,-0.020092011998147,-0.00180353706331613,0.0189644121109702
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,RNF31,E3 ubiquitin-protein ligase RNF31,39657,0.00877310620880949,0.00374066792924567,0.00144139706748798,0.016104815350131,0.0190277510521731
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FXYD5,FXYD domain-containing ion transport regulator 5,41913,0.0156004874712175,0.00665206188224884,0.00256244618200981,0.0286385287604252,0.0190309269101777
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IL10RA,Interleukin-10 receptor subunit alpha,41913,0.0134248569352325,0.00572673194795933,0.00220046231723222,0.0246492515532328,0.0190803144724083
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,F11,Coagulation factor XI,39822,-0.0075705770731218,0.00323115973923196,-0.0139036501620165,-0.00123750398422715,0.0191472326274223
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CD55,Complement decay-accelerating factor,41714,0.00632439851490838,0.00270244969428753,0.00102759711410482,0.0116211999157119,0.0192859272093416
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PMM2,Phosphomannomutase 2,39575,0.0144481435382429,0.00617682715667567,0.00234156231115856,0.0265547247653272,0.0193487131752219
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GHRL,Appetite-regulating hormone,42145,0.0198707844861802,0.00850400766456683,0.00320292946362924,0.0365386395087312,0.0194725331492198
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ACOT13,Acyl-coenzyme A thioesterase 13,39930,0.0274957825549003,0.0118108620308718,0.00434649297439157,0.0506450721354091,0.0199291857157446
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,POLR2A,DNA-directed RNA polymerase II subunit RPB1,39657,-0.00716099920401391,0.00307620671797761,-0.01319036437125,-0.00113163403677779,0.0199371304973541
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TFRC,Transferrin receptor protein 1,42200,0.00891323187049775,0.00383548063681727,0.0013956898223359,0.0164307739186596,0.0201460950648122
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NUBP1,Cytosolic Fe-S cluster assembly factor NUBP1,39919,0.0239656785889464,0.0103285108745465,0.00372179727483531,0.0442095599030575,0.0203400656068263
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,LSM1,U6 snRNA-associated Sm-like protein LSm1,41843,-0.0128511338721465,0.00553932743769517,-0.023708215650029,-0.00199405209426392,0.0203570339243371
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MUC2,Mucin-2,39966,0.0220986940638276,0.00953457212975665,0.00341093268950454,0.0407864554381506,0.020480924062486
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FMR1,Synaptic functional regulator FMR1,41843,0.0085433375643126,0.00369672550850179,0.00129775556764909,0.0157889195609761,0.0208450735871678
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CYTL1,Cytokine-like protein 1,39966,-0.00605593238198387,0.00262365026983793,-0.0111982869108662,-0.000913577853101539,0.0210053936809811
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,EIF1AX,"Eukaryotic translation initiation factor 1A, X-chromosomal",39929,0.0132836540520051,0.00575601254816067,0.00200186945761018,0.0245654386464,0.0210288853770549
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DNAJA1,DnaJ homolog subfamily A member 1,39560,-0.0111233113568606,0.00482007678808625,-0.0205706618615096,-0.00167596085221151,0.0210341300881591
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",39586,0.0130498504437448,0.0056568428572484,0.00196243844353794,0.0241372624439517,0.0210781179181336
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TMCO5A,Transmembrane and coiled-coil domain-containing protein 5A,39649,0.0127836693701086,0.00555409519949655,0.00189764277909538,0.0236696959611219,0.0213725549571761
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PTX3,Pentraxin-related protein PTX3,42119,-0.0116697462213162,0.00508344260694236,-0.0216332937309232,-0.00170619871170913,0.0217117966197224
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CBLN4,Cerebellin-4,42262,0.00744386063812744,0.00324650703597016,0.00108070684762593,0.013807014428629,0.0218698651592864
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,VCAN,Versican core protein,42249,-0.0070487297150676,0.00307419230565644,-0.0130741466341542,-0.00102331279598098,0.021870505713503
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,VIT,Vitrin,39958,0.0090644062184845,0.00395428200584424,0.00131401348702979,0.0168147989499392,0.0219064566643121
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NEO1,Neogenin,39934,0.00533403106232841,0.00232760091770833,0.000771933263620082,0.00989612886103674,0.0219444865402315
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,BDNF,Brain-derived neurotrophic factor,39966,0.0197559789303819,0.00863216506307796,0.00283693540674914,0.0366750224540148,0.0221181309680895
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NXPH1,Neurexophilin-1,41839,0.00908326148037697,0.00397098472730737,0.00130013141485452,0.0168663915458994,0.0221877305876051
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DCTPP1,dCTP pyrophosphatase 1,42145,0.00737511857936565,0.00324285925844689,0.00101911443280975,0.0137311227259215,0.0229656786785444
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MYL6B,Myosin light chain 6B,39649,0.0213394394261473,0.00939093743259834,0.00293320205825452,0.03974567679404,0.0230848747819653
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,EFCAB2,Dynein regulatory complex protein 8,39757,0.00824813493162518,0.00364558893740672,0.001102780614308,0.0153934892489423,0.0236858453318343
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PPP3R1,Calcineurin subunit B type 1,42016,0.0093039746094508,0.00412101885120838,0.00122677766108237,0.0173811715578192,0.0239811259318448
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MRPL52,"39S ribosomal protein L52, mitochondrial",39541,-0.0061711193838423,0.0027371725385759,-0.0115359775594511,-0.000806261208233541,0.0241806601547025
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MPI,Mannose-6-phosphate isomerase,42070,0.0195775680860131,0.00871172554320949,0.00250258602132249,0.0366525501507037,0.0246391259817816
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SEMA4D,Semaphorin-4D,42249,0.00689931350244547,0.00307327556208995,0.000875693400749174,0.0129229336041418,0.0247880513233486
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,RBP1,Retinol-binding protein 1,39649,0.0162259592427033,0.00722855768210392,0.00205798618577959,0.0303939322996269,0.0248069622013338
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,COMMD9,COMM domain-containing protein 9,39919,0.00920009443904187,0.00410618082764071,0.00115198001686607,0.0172482088612177,0.0250746998013288
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MST1,Hepatocyte growth factor-like protein,39854,0.0155063347186493,0.00693879838172594,0.00190628989046644,0.0291063795468321,0.025454687464269
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MRPL46,"39S ribosomal protein L46, mitochondrial",41839,0.00633057415520536,0.0028415204559863,0.000761194061472213,0.0118999542489385,0.0259050767095523
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ARHGAP30,Rho GTPase-activating protein 30,39757,0.00923569639697873,0.00415000104836122,0.00110169434219073,0.0173696984517667,0.0260697157633559
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,EIF5,Eukaryotic translation initiation factor 5,39575,0.00968896016882561,0.00438023462741564,0.00110370029909095,0.0182742200385603,0.0269890585650857
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,EFHD1,EF-hand domain-containing protein D1,39934,0.00820223311143644,0.00370909701533504,0.000932402961379765,0.0154720632614931,0.0270292251972208
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SHPK,Sedoheptulokinase,39757,0.00911738451850018,0.00412390953082861,0.00103452183807611,0.0172002471989242,0.0270657758166287
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DKKL1,Dickkopf-like protein 1,42070,0.0188963635537267,0.00857244590568229,0.00209436957858941,0.035698357528864,0.0275191077245257
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DKK3,Dickkopf-related protein 3,42310,-0.00662973705117232,0.00301256337196548,-0.0125343612602247,-0.000725112842119976,0.0277741431773225
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NFIC,Nuclear factor 1 C-type,39934,0.0103194124152062,0.00471315965051454,0.00108161950019775,0.0195572053302147,0.0285816162590638
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CLC,Galectin-10,42119,-0.0150457072377296,0.00687783890028987,-0.0285262714822977,-0.00156514299316144,0.0287185008543114
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DNLZ,DNL-type zinc finger protein,39586,-0.0190289266101676,0.00870203444222115,-0.036084914116921,-0.00197293910341412,0.0287838722717251
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FGA,Fibrinogen alpha chain,39735,-0.00695876663641852,0.00319723257490317,-0.0132253424832287,-0.000692190789608303,0.0295390710922322
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ARG1,Arginase-1,42015,0.0112270778935323,0.00516935026268145,0.00109515137867664,0.0213590044083879,0.0298840808499688
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CPTP,Ceramide-1-phosphate transfer protein,39575,0.00880037735669341,0.00405413191880125,0.000854278795842961,0.0167464759175439,0.029973856583468
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,UPK3A,Uroplakin-3a,39586,-0.0108062033672964,0.00499080364276519,-0.0205881785071161,-0.00102422822747661,0.0303920585550754
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,WFDC12,WAP four-disulfide core domain protein 12,42223,0.0141014392407499,0.00651495280540758,0.00133213174215101,0.0268707467393487,0.0304453828026823
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,HPCAL1,Hippocalcin-like protein 1,42296,0.016181263876677,0.007528165616071,0.00142605926917785,0.0309364684841762,0.0316178056321794
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SLC12A2,Solute carrier family 12 member 2,39575,-0.00583085314793504,0.00271855643157167,-0.0111592237538155,-0.000502482542054573,0.0319879819741513
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,KLK13,Kallikrein-13,41839,0.00984436136892851,0.00459494489681746,0.0008382693711663,0.0188504533666907,0.0321768413938302
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,REST,RE1-silencing transcription factor,39560,-0.00754800279091897,0.00352363938652694,-0.0144543359885118,-0.000641669593326163,0.0322070673230648
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GLRX5,"Glutaredoxin-related protein 5, mitochondrial",39736,0.0196848443529084,0.00919040754720096,0.0016716455603945,0.0376980431454223,0.0322239419876483
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,BATF,Basic leucine zipper transcriptional factor ATF-like,39649,0.0178016958768503,0.00833163724134341,0.00147168688381726,0.0341317048698834,0.0326493173790654
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ZNRF4,E3 ubiquitin-protein ligase ZNRF4,39919,0.0118686323316615,0.00555550908887284,0.000979834517470716,0.0227574301458523,0.0326705142152972
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CD40LG,CD40 ligand,42296,0.0172446344550002,0.00810360595686119,0.00136156677955224,0.0331277021304481,0.0333532418428481
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CEP170,Centrosomal protein of 170 kDa,39638,0.0169147420823473,0.00795365723009948,0.00132557391135237,0.0325039102533423,0.0334702812321851
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DPP6,Dipeptidyl aminopeptidase-like protein 6,42070,0.0074375089952388,0.00350400702617989,0.000569655223926217,0.0143053627665514,0.0338078818386337
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NGFR,Tumor necrosis factor receptor superfamily member 16,39958,0.0065633155952752,0.00309624905849793,0.000494667440619265,0.0126319637499311,0.0340476264405597
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FKBP7,Peptidyl-prolyl cis-trans isomerase FKBP7,41820,0.010433922078304,0.00494574067459561,0.000740270356096626,0.0201275738005114,0.0349048143694944
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SLC34A3,Sodium-dependent phosphate transport protein 2C,39560,-0.010503031625456,0.00498014054335987,-0.0202641070904414,-0.000741956160470703,0.0349686748804512
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,LBP,Lipopolysaccharide-binding protein,42217,-0.012643878901818,0.00599614735584248,-0.0243963277192693,-0.000891430084366767,0.0349915370702674
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FOSB,Protein fosB,41839,0.00828636232443409,0.00393486606747917,0.000574024832174916,0.0159986998166933,0.0352334112387966
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,COL4A4,Collagen alpha-4(IV) chain,39743,-0.0116187154172573,0.00552742619567435,-0.022452470760779,-0.00078496007373554,0.0355746221996598
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ATP1B2,Sodium/potassium-transporting ATPase subunit beta-2,39575,-0.00677274298695303,0.00322379065541864,-0.0130913726715736,-0.000454113302332497,0.0356757312929091
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SPESP1,Sperm equatorial segment protein 1,39958,0.00724110634632527,0.00345021255000058,0.000478689748324136,0.0140035229443264,0.0358616634286049
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,VSIG10,V-set and immunoglobulin domain-containing protein 10,39919,0.00748342017939678,0.00356777681599579,0.000490577620045034,0.0144762627387485,0.0359712527599584
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,INSR,Insulin receptor,39657,0.00370032987628907,0.0017649725622009,0.000240983654375311,0.00715967609820282,0.0360572657243066
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ST8SIA1,"Alpha-N-acetylneuraminide alpha-2,8-sialyltransferase",39657,0.0107038160687771,0.00511508027896585,0.000678258722003994,0.0207293734155501,0.0364076318602366
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,RSPO1,R-spondin-1,42016,-0.00727726637860768,0.00347936186265297,-0.0140968156294075,-0.000457717127807854,0.0364973642140226
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NPTX1,Neuronal pentraxin-1,42137,0.00891128607496652,0.00426749697415804,0.000546992005616765,0.0172755801443163,0.0368005753280714
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CLEC2L,C-type lectin domain family 2 member L,39649,0.0110012834860326,0.00526994586328001,0.000672189594003737,0.0213303773780614,0.0368611607353208
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IL18RAP,Interleukin-18 receptor accessory protein,41936,-0.035993435526897,0.0172435235336807,-0.0697907416529112,-0.00219612940088276,0.0368745705081464
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CFHR2,Complement factor H-related protein 2,39904,0.0122352445095385,0.00586152161872827,0.000746662136831083,0.0237238268822459,0.0368758059627429
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MSLNL,Mesothelin-like protein,39649,-0.00814527816113786,0.00390253815449452,-0.0157942529439471,-0.000496303378328595,0.0368952213501362
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NELL2,Protein kinase C-binding protein NELL2,42185,0.00616294872108238,0.0029612998386082,0.000358801037410309,0.0119670964047544,0.0374376396083258
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FGF9,Fibroblast growth factor 9,39539,-0.00882478060532386,0.00424071674878908,-0.0171365854329505,-0.00051297577769726,0.0374603711993907
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CEBPA,CCAAT/enhancer-binding protein alpha,39657,0.00775130040224721,0.00373838115566823,0.00042407333713747,0.0150785274673569,0.0381546643465857
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,KIR2DL3,Killer cell immunoglobulin-like receptor 2DL3,41843,0.0166059212288995,0.00801480080937766,0.000896911642519257,0.0323149308152797,0.0382934337198973
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,KLK7,Kallikrein-7,39475,0.00845591958561199,0.00408293227963401,0.000453372317529321,0.0164584668536947,0.0383785100608636
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IL20,Interleukin-20,41913,-0.00986647503067784,0.00476774270263986,-0.019211250727852,-0.000521699333503713,0.0385256848564967
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TXNDC15,Thioredoxin domain-containing protein 15,42181,-0.00583593858808909,0.00282513974853278,-0.0113732124952133,-0.000298664680964842,0.0388741537046358
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,EPB41L5,Band 4.1-like protein 5,39649,0.0131924783808063,0.00640005514791422,0.00064837029089445,0.0257365864707182,0.0392971045877279
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PRSS53,Serine protease 53,39929,-0.00809577106807121,0.00392820790899524,-0.0157950585697019,-0.000396483566440537,0.0393322590837276
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,RAB2B,Ras-related protein Rab-2B,39919,0.0131839560738689,0.00642462837992416,0.000591684449217512,0.0257762276985202,0.0401832558600657
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GAD1,Glutamate decarboxylase 1,39560,-0.00554624438349001,0.00271092758132692,-0.0108596624428908,-0.000232826324089244,0.0407915642543534
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,BEX3,Protein BEX3,39560,-0.00983159365978614,0.00481496957867679,-0.0192689340339926,-0.00039425328557964,0.0411872518459023
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PADI2,Protein-arginine deiminase type-2,41913,0.0118616618775106,0.00582691358803274,0.000440911244966443,0.0232824125100548,0.0418034581377965
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,UPK3BL1,Uroplakin-3b-like protein 1,39738,-0.0110889464627052,0.00545572490271753,-0.0217821672720316,-0.000395725653378858,0.0421232975560666
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,UBE2Z,Ubiquitin-conjugating enzyme E2 Z,39657,0.0122579227767959,0.00603515022300035,0.000429028339715205,0.0240868172138766,0.0422699152712731
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PDP1,"[Pyruvate dehydrogenase [acetyl-transferring]]-phosphatase 1, mitochondrial",41843,0.0104063256997479,0.00512489065953814,0.0003615400070531,0.0204511113924426,0.042321021292288
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DNAJB8,DnaJ homolog subfamily B member 8,41900,0.011632411350447,0.0057444754616421,0.000373239445628447,0.0228915832552655,0.0428900088278158
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CACNA1H,Voltage-dependent T-type calcium channel subunit alpha-1H,39575,-0.0119458197483121,0.00590084720308611,-0.0235114802663609,-0.000380159230263358,0.0429506620243046
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NPTXR,Neuronal pentraxin receptor,42145,-0.00706220808032388,0.00349567770623993,-0.0139137363845541,-0.000210679776093623,0.0433751730000867
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TNFRSF17,Tumor necrosis factor receptor superfamily member 17,39736,-0.00868554381286822,0.00430724867135284,-0.0171277512087198,-0.000243336417016659,0.0437722388601911
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MNAT1,CDK-activating kinase assembly factor MAT1,39757,0.00936958813471927,0.00465616769141065,0.000243499459554391,0.0184956768098841,0.0442127192393333
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SLIRP,"SRA stem-loop-interacting RNA-binding protein, mitochondrial",39560,0.0117405703078136,0.0058478881802333,0.00027870947455633,0.0232024311410709,0.0447039491224967
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CNDP1,Beta-Ala-His dipeptidase,42217,0.00946585760400587,0.00472254279171262,0.000209673732249147,0.0187220414757626,0.0450471560924572
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PSMC3,26S proteasome regulatory subunit 6A,39560,-0.00628300659635649,0.00313473323992205,-0.0124270837466037,-0.000138929446109264,0.0450604160455691
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MORC3,MORC family CW-type zinc finger protein 3,39929,0.0057853508451609,0.00288710626381828,0.000126622568077077,0.0114440791222447,0.0451090440022505
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MYH4,Myosin-4,39575,-0.00944278709252966,0.00471634967440704,-0.0186868324543675,-0.000198741730691867,0.0452943575495553
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MTIF3,"Translation initiation factor IF-3, mitochondrial",39930,0.0182026845643284,0.00910582481586531,0.000355267925232411,0.0360501012034244,0.0456305253260349
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TGOLN2,Trans-Golgi network integral membrane protein 2,39990,0.00543537248152256,0.00271940416810954,0.000105340312027866,0.0107654046510173,0.0456605900505712
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CCND2,G1/S-specific cyclin-D2,39757,-0.00765563286542321,0.00383097153904677,-0.0151643370819549,-0.000146928648891548,0.0457026452270463
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FOLH1,Glutamate carboxypeptidase 2,39657,0.0215337012106053,0.0107768912770702,0.000410994307547749,0.0426564081136628,0.0457262972248357
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NXPH3,Neurexophilin-3,39657,-0.00616267013234903,0.00309040744443512,-0.0122198687234419,-0.000105471541256197,0.0461625089775579
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,UGDH,UDP-glucose 6-dehydrogenase,39575,0.0204517254555697,0.0102713629088699,0.000319854154184566,0.0405835967569548,0.0464902059410424
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DIPK2B,Divergent protein kinase domain 2B,39736,-0.00609848665175231,0.00308093162110483,-0.0121371126291178,-5.98606743868486e-05,0.047792266730495
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CALY,Neuron-specific vesicular protein calcyon,39575,-0.00790324539522832,0.00400063502613183,-0.0157444900464467,-6.20007440099418e-05,0.0482367049730756
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SLC28A1,Sodium/nucleoside cotransporter 1,39560,0.012053542069916,0.00612492854740111,4.86821170098527e-05,0.0240584020228222,0.049099170256868
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,LRP2BP,LRP2-binding protein,39649,0.015717583893095,0.00799685802267944,4.37421686432515e-05,0.0313914256175467,0.049384882786884
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,RTKN2,Rhotekin-2,39575,-0.0102793744038238,0.00524144974420802,-0.0205526159024715,-6.1329051760442e-06,0.0498844335305005
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CREG1,Protein CREG1,41960,0.00809856268350704,0.00413134588181123,1.1247551570167e-06,0.0161960006118571,0.0499847299198438
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IL6R,Interleukin-6 receptor subunit alpha,42114,0.00684131715174287,0.00349244397806471,-3.87304526396418e-06,0.0136865073487497,0.0501460845014442
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CTAG1A_CTAG1B,Cancer/testis antigen 1,39735,-0.0101633697276907,0.0052028703183928,-0.0203609955517405,3.42560963592364e-05,0.0507953385501225
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,KLHL41,Kelch-like protein 41,39934,0.0105512491813211,0.00540460640450325,-4.17793715052975e-05,0.0211442777341475,0.0509307822444497
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CACNB1,Voltage-dependent L-type calcium channel subunit beta-1,39586,0.011831603176096,0.00606104553529855,-4.80460730891766e-05,0.0237112524252811,0.0509549097640574
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,HS3ST3B1,Heparan sulfate glucosamine 3-O-sulfotransferase 3B1,42070,0.00749800727132299,0.00384911099933429,-4.62502873722149e-05,0.0150422648300182,0.0514376009656374
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MYOM3,Myomesin-3,39736,-0.0193711708447711,0.00998921772425745,-0.0389500375843157,0.000207695894773523,0.0525012432581947
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SOX2,Transcription factor SOX-2,39915,-0.00489525572036214,0.00253019367818732,-0.00985443532960928,6.39238888849973e-05,0.0530476471116202
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PRG2,Bone marrow proteoglycan,39966,-0.0101461661818939,0.00527076619615676,-0.0204768679263612,0.000184535562573342,0.054255679558616
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CPOX,"Oxygen-dependent coproporphyrinogen-III oxidase, mitochondrial",39657,0.00553934861710181,0.00288237665301769,-0.000110109622812865,0.0111888068570165,0.0546567235390845
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ITGB1BP1,Integrin beta-1-binding protein 1,41843,0.00786984774869545,0.0041085513350019,-0.000182912867908265,0.0159226083652992,0.0554528345292232
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CREBZF,CREB/ATF bZIP transcription factor,39560,-0.0051240512207684,0.00268450767936282,-0.0103856862723195,0.000137583830782721,0.0563205777246533
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ADGRB3,Adhesion G protein-coupled receptor B3,41992,0.00655820461308883,0.00344356688600544,-0.000191186483481835,0.0133075957096595,0.0568690910263101
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CD109,CD109 antigen,42137,0.00661058834090792,0.00348698450739243,-0.000223901293581249,0.0134450779753971,0.0580091726366706
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MAPK13,Mitogen-activated protein kinase 13,39560,0.00849713202791336,0.00449153192045487,-0.000306270536178186,0.0173005345920049,0.0585424288145388
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FLT3,Receptor-type tyrosine-protein kinase FLT3,41843,-0.0058466761286864,0.00309365659150499,-0.0119102430480362,0.000216890790663382,0.0587942554856436
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NENF,Neudesin,39919,0.0218697587085403,0.0115788435399589,-0.000824774629779111,0.0445642920468598,0.058948354800821
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ART3,Ecto-ADP-ribosyltransferase 3,42217,-0.00690462896143198,0.0036685672738603,-0.0140950208181982,0.000285762895334216,0.0598430619998228
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ATF2,Cyclic AMP-dependent transcription factor ATF-2,41839,0.0132166692332345,0.00702269579335013,-0.000547814521731719,0.0269811529882008,0.0598587878126723
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GUK1,Guanylate kinase,39575,-0.00775312987910879,0.00414291279208856,-0.0158732389516024,0.000366979193384782,0.0613134700224998
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NTRK2,BDNF/NT-3 growth factors receptor,42145,-0.00482055815068844,0.00258148288925996,-0.00988026461363795,0.00023914831226107,0.0618728997187828
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GP6,Platelet glycoprotein VI,42115,0.016699686286658,0.0090005727741116,-0.000941436350600715,0.0343408089239168,0.0635605110959261
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,KCNH2,Potassium voltage-gated channel subfamily H member 2,39649,0.0146946153149919,0.00793863087218359,-0.000865101194487948,0.0302543318244717,0.0641924243237973
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,LHPP,Phospholysine phosphohistidine inorganic pyrophosphate phosphatase,42129,0.0109432276993454,0.00591398436490729,-0.000648181655872869,0.0225346370545637,0.0642779241374718
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SLC44A4,Choline transporter-like protein 4,39649,-0.0130955487676113,0.00708179545048375,-0.0269758678505594,0.000784770315336835,0.0644578195950727
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CPLX2,Complexin-2,39560,-0.00583307738166843,0.00315571423100233,-0.012018277274433,0.000352122511096127,0.0645688889628336
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,39575,-0.00688409054518218,0.00375111844384356,-0.0142362826951156,0.000468101604751194,0.0665016073371945
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FLT1,Vascular endothelial growth factor receptor 1,42042,-0.00407769578247857,0.00222548656768492,-0.00843964945514102,0.000284257890183878,0.0669330805911705
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DARS1,"Aspartate--tRNA ligase, cytoplasmic",41997,0.0134495623921878,0.00736046881937165,-0.000976956493780646,0.0278760812781562,0.0676814478589474
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TGFB2,Transforming growth factor beta-2 proprotein,39919,0.00977832730069287,0.00535691686667639,-0.000721229757992844,0.0202778843593786,0.0679723408251532
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GM2A,Ganglioside GM2 activator,39733,0.00722493738775819,0.00396158461771204,-0.000539768462957401,0.0149896432384738,0.0682167706935131
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TPM3,Tropomyosin alpha-3 chain,39575,-0.00867842801891295,0.00476537363304504,-0.0180185603396812,0.000661704301855331,0.0686122977831049
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,APPL2,DCC-interacting protein 13-beta,39736,0.0211633656132788,0.0116320863660862,-0.00163552366425023,0.0439622548908078,0.0688779522616243
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CYB5A,Cytochrome b5,39560,0.0132969479144502,0.00732829722036045,-0.0010665146374563,0.0276604104663567,0.0696333030350446
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TYRO3,Tyrosine-protein kinase receptor TYRO3,42145,0.00524310347177776,0.00289989006146886,-0.000440681048701204,0.0109268879922567,0.070623184413037
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IL13RA2,Interleukin-13 receptor subunit alpha-2,39586,-0.00547659210988805,0.00303066224931339,-0.0114166901185423,0.000463505898766186,0.0707800862571935
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CD3D,T-cell surface glycoprotein CD3 delta chain,39586,-0.00642036540241333,0.0035566648435115,-0.0133914284956959,0.000550697690869214,0.0710762987748883
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,BCL7B,B-cell CLL/lymphoma 7 protein family member B,39919,0.00857633440929628,0.00475437210483501,-0.000742234916180329,0.0178949037347729,0.0712761143375079
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IGSF21,Immunoglobulin superfamily member 21,39638,0.00746406734207654,0.00413900491917821,-0.000648382299512747,0.0155765169836658,0.071360795135341
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CXCL14,C-X-C motif chemokine 14,41913,0.0105216015904052,0.00584199230411598,-0.000928703325662149,0.0219719065064725,0.0717208213808886
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,BHMT2,S-methylmethionine--homocysteine S-methyltransferase BHMT2,39575,-0.00486703513428902,0.00270586867879426,-0.0101705377447258,0.000436467476147735,0.0720942493123734
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GIPC3,PDZ domain-containing protein GIPC3,39930,0.0183010047274578,0.01019251227566,-0.0016763193328357,0.0382783287877514,0.0725952609458853
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CHGA,Chromogranin-A,39966,0.015692945836014,0.00874020384796156,-0.00143785370599065,0.0328237453780187,0.0726022687391733
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DTX2,Probable E3 ubiquitin-protein ligase DTX2,39649,-0.0109964280343619,0.00613417350902405,-0.0230194081120491,0.00102655204332523,0.0730562022018233
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,KRT14,"Keratin, type I cytoskeletal 14",41482,-0.00548441612365545,0.00306053107712011,-0.0114830570348109,0.000514224787499963,0.0731593347835768
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ACP6,Lysophosphatidic acid phosphatase type 6,42247,0.0123927893181653,0.0069175716521252,-0.00116565112000007,0.0259512297563307,0.0732361780059411
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DCUN1D2,DCN1-like protein 2,39560,-0.0147162605062218,0.0082156244113536,-0.0308188843524749,0.00138636334003121,0.0732803135938403
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,EVPL,Envoplakin,39757,-0.00614307133962726,0.00344550024154627,-0.0128962518130579,0.000610109133803421,0.0746255595800464
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CGA,Glycoprotein hormones alpha chain,42137,0.0112612862685634,0.00632238311856229,-0.00113058464381866,0.0236531571809455,0.0749058813331556
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,BRDT,Bromodomain testis-specific protein,39575,0.00670603726205494,0.00376575792161024,-0.000674848264301136,0.014086922788411,0.0749738426535448
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PDIA5,Protein disulfide-isomerase A5,39560,0.0112968574945723,0.00634499029335474,-0.00113932348040302,0.0237330384695476,0.0750321130064134
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TFPI2,Tissue factor pathway inhibitor 2,42142,0.00694825330439012,0.00390324876939246,-0.000702114283619102,0.0145986208923993,0.0750786519997369
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,USP47,Ubiquitin carboxyl-terminal hydrolase 47,39575,0.0159913341148867,0.00898566327934621,-0.00162056591263189,0.0336032341424053,0.0751609499555492
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CLNS1A,Methylosome subunit pICln,39649,0.00614816141721319,0.00345703040212341,-0.000627618170948688,0.0129239410053751,0.0753571970033527
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,42185,-0.0079185791116377,0.00446777144825403,-0.0166754111502156,0.000838252926940201,0.0763542648911335
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PPM1A,Protein phosphatase 1A,41843,0.00568236438479031,0.00320827528985826,-0.000605855183331875,0.0119705839529125,0.0765573265654796
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,VCPKMT,Protein-lysine methyltransferase METTL21D,39560,0.0152629736039646,0.00862024256056369,-0.0016327018147402,0.0321586490226694,0.0766555713399629
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PPIF,"Peptidyl-prolyl cis-trans isomerase F, mitochondrial",39966,0.0114665584687474,0.00647763441272819,-0.0012296049801998,0.0241627219176947,0.076724487317706
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IL7,Interleukin-7,42119,0.0116779054295411,0.00660227236768758,-0.00126254841112654,0.0246183592702088,0.0769547055854397
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DEFB118,Beta-defensin 118,39586,0.0103483883805662,0.00587158622283088,-0.00115992061618232,0.0218566973773147,0.0780207769615534
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CNTN4,Contactin-4,42137,-0.00423208810671747,0.00240193457622071,-0.00893987987611007,0.000475703662675129,0.0781003497162301
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NLGN1,Neuroligin-1,39649,-0.0121665532496378,0.00691355529097513,-0.0257171216199491,0.0013840151206734,0.0784674625469114
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CDC26,Anaphase-promoting complex subunit CDC26,39911,0.0127242094457799,0.00723217648670983,-0.00145085646817137,0.0268992753597312,0.0785385450788865
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,RAD23B,UV excision repair protein RAD23 homolog B,41843,0.00831607148112619,0.00473228469510758,-0.000959206521284669,0.0175913494835371,0.0788887987905536
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MAP1LC3B2,Microtubule-associated proteins 1A/1B light chain 3 beta 2,39575,-0.0119105292780149,0.0067906274323663,-0.0252201590454528,0.00139910048942304,0.0794642511462548
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,OSMR,Oncostatin-M-specific receptor subunit beta,42230,-0.00344889659436,0.00196706638769795,-0.00730434671424799,0.000406553525527993,0.0795695929050954
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CEACAM1,Carcinoembryonic antigen-related cell adhesion molecule 1,42159,0.00409521829146973,0.00233789513861241,-0.0004870561802106,0.00867749276315006,0.0798533581095915
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CLASP1,CLIP-associating protein 1,39560,0.0135347698579757,0.00773526042492416,-0.00162634057487569,0.028695880290827,0.0801894928734781
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PAPPA,Pappalysin-1,41913,-0.00847379009436908,0.00484786505396963,-0.0179756056001496,0.00102802541141141,0.0804970102072064
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PPM1F,Protein phosphatase 1F,39958,0.00958714634433661,0.00548893156554165,-0.00117115952412502,0.0203454522127982,0.0807281339952483
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CBLN1,Cerebellin-1,39586,-0.0166356509773172,0.00954630405727406,-0.0353464069295744,0.0020751049749399,0.0814267019250143
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ENO2,Gamma-enolase,42249,0.0115507398399415,0.00665232524266723,-0.00148781763568623,0.0245892973155693,0.0825251978548375
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ROBO4,Roundabout homolog 4,39638,0.00325249671985623,0.00187735899275835,-0.000427126905950137,0.0069321203456626,0.0832151380044695
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CASP4,Caspase-4,39757,-0.0296544452539465,0.0171258109081743,-0.0632210346339681,0.00391214412607509,0.0833787835498633
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PDRG1,p53 and DNA damage-regulated protein 1,39649,0.00900000077014788,0.00519796207058601,-0.0011880048882007,0.0191880064284965,0.0833998140706285
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SPRED2,"Sprouty-related, EVH1 domain-containing protein 2",39657,0.00797011151175964,0.00460337181587229,-0.00105249724735005,0.0169927202708693,0.0834147852260808
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SLK,STE20-like serine/threonine-protein kinase,39757,-0.0139988258126878,0.00815029018100936,-0.0299733945674662,0.00197574294209054,0.0858998714034057
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DDI2,Protein DDI1 homolog 2,39736,0.0132256500494386,0.00771438973415062,-0.00189455382949667,0.0283458539283738,0.08648072748262
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ARNTL,Aryl hydrocarbon receptor nuclear translocator-like protein 1,39575,-0.00892059661784082,0.00522723521299058,-0.0191659776353023,0.00132478439962071,0.0879319379296191
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,BRD1,Bromodomain-containing protein 1,39757,0.00535316604673242,0.00313947633190237,-0.000800207563796233,0.0115065396572611,0.0882009435863798
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,LAMA4,Laminin subunit alpha-4,42185,0.00595036892573677,0.00349788922770433,-0.000905493960563712,0.0128062318120372,0.0889412151942641
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NLGN2,Neuroligin-2,39586,-0.00818963473046817,0.00481692681687013,-0.0176308112915336,0.00125154183059728,0.0891256866488991
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MECR,"Enoyl-[acyl-carrier-protein] reductase, mitochondrial",39638,0.016076819511517,0.00947516671679863,-0.00249450725340834,0.0346481462764423,0.0897755156838774
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CYP24A1,"1,25-dihydroxyvitamin D(3) 24-hydroxylase, mitochondrial",39575,-0.0146079066382871,0.00862407294036372,-0.0315110896014,0.00229527632482579,0.0903217093436043
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MAP1LC3A,Microtubule-associated proteins 1A/1B light chain 3A,39586,-0.0056480286504715,0.00334071636104021,-0.0121958327181103,0.000899775417167317,0.09092937425871
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DCLRE1C,Protein artemis,39560,-0.00529574341644654,0.00313400790559045,-0.0114383989114038,0.000846912078510747,0.0911009624737569
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ACADM,"Medium-chain specific acyl-CoA dehydrogenase, mitochondrial",39757,0.0120609090263005,0.00713907159526445,-0.00193167130041782,0.0260534893530188,0.0911664095615539
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CLEC4C,C-type lectin domain family 4 member C,42119,-0.00836391589695687,0.00495754589882308,-0.0180807058586501,0.00135287406473637,0.0916056358364265
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,AHCY,Adenosylhomocysteinase,42145,0.0116047967280815,0.00688597709356621,-0.00189171837530831,0.0251013118314712,0.0919576744432163
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FES,Tyrosine-protein kinase Fes/Fps,41843,0.00817498159450833,0.00485390445605548,-0.00133867113936041,0.0176886343283771,0.0921651675812245
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,RAB39B,Ras-related protein Rab-39B,39575,0.0160012195287848,0.00950381384045829,-0.00262625559851341,0.0346286946560831,0.0922752584857067
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TPMT,Thiopurine S-methyltransferase,41843,0.0123161579524734,0.0073190741589307,-0.00202922739903079,0.0266615433039776,0.0924474436619852
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,STX1B,Syntaxin-1B,39649,0.00693787638214596,0.00413268188028705,-0.00116218010321666,0.0150379328675086,0.093222605833418
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CLEC4G,C-type lectin domain family 4 member G,42119,0.00571771936360213,0.00341966636293872,-0.000984826707757749,0.012420265434962,0.0945453183560911
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SSBP1,"Single-stranded DNA-binding protein, mitochondrial",39657,-0.0058991830120593,0.00353712644494451,-0.0128319508441505,0.00103358482003194,0.0953858005958537
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SPRR1B,Cornifin-B,39757,0.0148447803549011,0.00891525783634729,-0.00262912500433955,0.0323186857141418,0.0959212299759856
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,RGS8,Regulator of G-protein signaling 8,41913,-0.0108579389368357,0.00653039299972011,-0.0236575092162871,0.00194163134261576,0.0964005049709144
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NPHS2,Podocin,39657,-0.0174476430039563,0.0104942201799254,-0.0380163145566101,0.00312102854869751,0.0964217809524138
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DHODH,Dihydroorotate dehydrogenase,39575,0.00795045075414957,0.00478210568839442,-0.0014224763951035,0.0173233779034026,0.0964327388272369
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GKN1,Gastrokine-1,41538,0.00481770374368656,0.00290155750562445,-0.000869348967337358,0.0105047564547105,0.0968611761572254
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SPRING1,SREBP regulating gene protein,39560,0.010584801451698,0.00639048488284696,-0.00194054891868203,0.0231101518220781,0.0976820621558339
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ROBO2,Roundabout homolog 2,42249,0.00382517213047709,0.0023128313507546,-0.000707977317001925,0.0083583215779561,0.098172553757243
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CXCL3,C-X-C motif chemokine 3,42129,0.0161024382991692,0.0097511258666242,-0.00300976839941424,0.0352146449977526,0.0986920824938107
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MYL3,Myosin light chain 3,39638,0.0132939169735548,0.00808664943092542,-0.00255591591105907,0.0291437498581686,0.100218339867546
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,COPB2,Coatomer subunit beta',39575,0.0072677552754683,0.00442945476132393,-0.00141397605672659,0.0159494866076632,0.100872005026794
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CORO6,Coronin-6,39586,0.00658811743430569,0.00402296590176843,-0.00129689573316044,0.0144731306017718,0.10152817418294
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PALLD,Palladin,39657,-0.00642148777277183,0.00392692135495571,-0.014118253628485,0.00127527808294136,0.102025668637777
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,APOH,Beta-2-glycoprotein 1,42137,-0.00611062447856465,0.00373994746422394,-0.0134409215084436,0.00121967255131428,0.102307353810668
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,EDNRB,Endothelin receptor type B,39657,0.00735193319418507,0.0045134525832011,-0.00149443386888909,0.0161983002572592,0.103364072126856
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,KLK6,Kallikrein-6,42158,0.00512791853827609,0.00315927978683683,-0.0010642698439241,0.0113201069204763,0.104585087158057
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FADD,FAS-associated death domain protein,42145,0.012668735489235,0.00781179723345365,-0.0026423870883342,0.0279798580668041,0.104881442724228
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,VASP,Vasodilator-stimulated phosphoprotein,39990,0.0122309681778972,0.00755252647218431,-0.00257198370758406,0.0270339200633784,0.10537733066643
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FCER1A,High affinity immunoglobulin epsilon receptor subunit alpha,39934,0.00402398219562181,0.0024888127803156,-0.000854090853796771,0.00890205524504039,0.105943242807324
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NPTX2,Neuronal pentraxin-2,39966,-0.00568581605890513,0.00351868247252698,-0.012582433705058,0.00121080158724776,0.106145099960494
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ENO1,Alpha-enolase,42119,-0.012951371676465,0.00803680555166556,-0.0287035105577295,0.00280076720479946,0.10709251817261
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TJP3,Tight junction protein ZO-3,39586,-0.00690108418794916,0.00428573359589265,-0.0153011220358987,0.00149895366000043,0.10737295327511
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,B4GAT1,"Beta-1,4-glucuronyltransferase 1",42137,-0.00395972515334563,0.00246116365823985,-0.00878360592349572,0.000864155616804473,0.107665176511942
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PSMG4,Proteasome assembly chaperone 4,39657,0.00924483618209155,0.00576241637611836,-0.00204949991510045,0.0205391722792835,0.108669176287136
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TEX101,Testis-expressed protein 101,39649,0.0101669576197604,0.00633935633026063,-0.00225818078755044,0.0225920960270712,0.108790276740912
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,KIRREL1,Kin of IRRE-like protein 1,39586,-0.00916703363224882,0.00575102804728473,-0.0204390486049269,0.00210498134042926,0.110968894157891
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FGF5,Fibroblast growth factor 5,41913,0.00553808438480576,0.00348416953493623,-0.00129088790366924,0.0123670566732808,0.111971499638434
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ATP6V1D,V-type proton ATPase subunit D,42070,-0.00421903731740572,0.00265656373988413,-0.00942590224757862,0.000987827612767171,0.112274566062812
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,OTOA,Otoancorin,39586,-0.00858265498104494,0.00541404970606162,-0.0191941924049257,0.00202888244283583,0.112936955058825
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IL25,Interleukin-25,39510,-0.0055737247383051,0.00353661732643777,-0.0125054946981231,0.00135804522151293,0.115053765714116
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SIRT1,NAD-dependent protein deacetylase sirtuin-1,39657,0.0140245522328197,0.00889972711286436,-0.00341891290839447,0.0314680173740338,0.115091128153182
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,STX5,Syntaxin-5,39657,0.00642283716957902,0.00409674207291995,-0.00160677729334409,0.0144524516325021,0.116958428079547
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TEX33,Testis-expressed protein 33,39757,-0.00623819882739649,0.00397969225464758,-0.0140383956465057,0.00156199799171277,0.117024393528061
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CENPJ,Centromere protein J,39757,0.0113349845387174,0.00725059820365802,-0.00287618794045231,0.0255461570178871,0.118006377492116
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,KRT6C,"Keratin, type II cytoskeletal 6C",39575,0.00614332432822785,0.00393352348763785,-0.00156638170754234,0.013853030363998,0.118367098979464
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PPT1,Palmitoyl-protein thioesterase 1,39649,0.0123861071513314,0.00796985823186612,-0.00323481498312618,0.028007029285789,0.120184703495384
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PNPT1,"Polyribonucleotide nucleotidyltransferase 1, mitochondrial",41913,0.0183915117585657,0.011836398929894,-0.00480783014402655,0.041590853661158,0.120253580732284
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FCGR2A,Low affinity immunoglobulin gamma Fc region receptor II-a,42122,0.00936333331840569,0.0060272192523873,-0.00245001641627342,0.0211766830530848,0.120325222895846
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SERPINB5,Serpin B5,41900,0.00772371394360867,0.00497440325886659,-0.00202611644376984,0.0174735443309872,0.120520633894258
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SEZ6L,Seizure 6-like protein,42181,-0.00434497239014944,0.00281465880169553,-0.00986170364147268,0.0011717588611738,0.122685738103881
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NRXN3,Neurexin-3,39649,0.00570897807038933,0.00370138374414578,-0.0015457340681364,0.0129636902089151,0.123007435811408
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CST6,Cystatin-M,41864,0.00783191306275788,0.00508418076440145,-0.00213308123546897,0.0177969073609847,0.123475188593762
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ITPRIP,"Inositol 1,4,5-trisphosphate receptor-interacting protein",39586,0.00717752245534599,0.00466876427952253,-0.00197325553251816,0.0163283004432101,0.124236543393968
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ZNF830,Zinc finger protein 830,39919,0.0122482517658589,0.00799591458130629,-0.00342374081350144,0.0279202443452192,0.125596352791272
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,KHDC3L,KH domain-containing protein 3,39560,-0.0105623541701186,0.00690815241963225,-0.0241023329125978,0.00297762457236059,0.126300870530265
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CADPS,Calcium-dependent secretion activator 1,39649,-0.00640719888979087,0.00419870988489515,-0.0146366702641854,0.00182227248460362,0.127040408636301
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,RILPL2,RILP-like protein 2,39958,0.015478427874168,0.0101690643347017,-0.00445293822184727,0.0354097939701832,0.128009522982716
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GABARAP,Gamma-aminobutyric acid receptor-associated protein,39919,0.00756242181628448,0.00498003538985888,-0.00219844754783892,0.0173232911804079,0.128904286438716
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,STEAP4,Metalloreductase STEAP4,39586,0.0113663539054991,0.00750129817202268,-0.00333619051166535,0.0260688983226635,0.129737475056139
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TPT1,Translationally-controlled tumor protein,41913,-0.00992081579904922,0.00654760797106978,-0.022754127422346,0.00291249582424755,0.129750136233361
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,EDDM3B,Epididymal secretory protein E3-beta,39919,-0.0095607476571461,0.00632922083162323,-0.0219660204871276,0.00284452517283543,0.130925290189884
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,S100A16,Protein S100-A16,41814,0.00939168854404151,0.00622724536562574,-0.00281371237258493,0.021597089460668,0.131537235425294
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MDM1,Nuclear protein MDM1,39649,0.0048802313781818,0.00323792321616768,-0.00146609812550685,0.0112265608818704,0.131785337986532
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GSTT2B,Glutathione S-transferase theta-2B,39929,0.0373906195448906,0.0248165319162959,-0.0112497830110493,0.0860310221008306,0.131920093943282
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CCL24,C-C motif chemokine 24,42166,0.0126840551513147,0.00842177520435392,-0.00382262424921896,0.0291907345518484,0.132064192872771
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CCDC50,Coiled-coil domain-containing protein 50,39934,-0.0115167370545738,0.00766387598418833,-0.0265379339835829,0.00350445987443531,0.13293652016559
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SCN2A,Sodium channel protein type 2 subunit alpha,39586,0.00749676715348888,0.00499753953220299,-0.00229841032962898,0.0172919446366068,0.133619408580332
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,BRME1,Break repair meiotic recombinase recruitment factor 1,39586,-0.00638812695672443,0.00426098011880174,-0.0147396479895758,0.00196339407612697,0.133846498544127
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,COL28A1,Collagen alpha-1(XXVIII) chain,39649,0.0126667929629157,0.00845222695908177,-0.00389957187688459,0.029233157802716,0.133997229078321
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,C1S,Complement C1s subcomponent,39979,-0.0032275686538902,0.00216899179255822,-0.0074787925673043,0.0010236552595239,0.136765367822967
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CNTF,Ciliary neurotrophic factor,39586,-0.00529514959383354,0.00356031997581299,-0.012273376746427,0.00168307755875992,0.136972769702037
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FCGR3B,Low affinity immunoglobulin gamma Fc region receptor III-B,42179,-0.00740872419073206,0.00498368627053077,-0.0171767492809724,0.00235930089950824,0.137144968138136
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IGFBP3,Insulin-like growth factor-binding protein 3,42217,0.00489204682086221,0.00329462934382997,-0.00156542669304452,0.0113495203347689,0.137605389277635
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PSMD1,26S proteasome non-ATPase regulatory subunit 1,39934,0.00748327345166222,0.00507730979507217,-0.00246825374667923,0.0174348006500037,0.140545489970676
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,WASF3,Wiskott-Aldrich syndrome protein family member 3,41839,-0.0127926346725747,0.00869821092756542,-0.0298411280906029,0.00425585874545357,0.141390562147196
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SMPDL3B,Acid sphingomyelinase-like phosphodiesterase 3b,39919,-0.011444039521171,0.00778809223591717,-0.0267087003035687,0.00382062126122662,0.141744574058551
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GC,Vitamin D-binding protein,39979,0.00389175479602876,0.00265475049486272,-0.00131155617390218,0.00909506576595969,0.14268714872394
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PNMA2,Paraneoplastic antigen Ma2,39586,0.00666552351248308,0.00458437782423926,-0.00231985702302587,0.015650904047992,0.145984660462926
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TOP1,DNA topoisomerase 1,39930,0.0180399541204931,0.0124263438947576,-0.00631567991323179,0.042395588154218,0.146598609941677
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TP73,Tumor protein p73,39649,-0.00511930107777876,0.003527149511757,-0.0120325141208225,0.00179391196526496,0.146697194589504
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DLGAP5,Disks large-associated protein 5,39934,-0.00736728680417389,0.00509211869395778,-0.0173478394443311,0.00261326583598336,0.147980080110478
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PDGFRB,Platelet-derived growth factor receptor beta,42310,-0.00513020817120086,0.00355113001100861,-0.0120904229927777,0.00183000665037601,0.148573676961595
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CNTNAP4,Contactin-associated protein-like 4,39649,0.0156400637568643,0.0108627850159627,-0.00565099487442265,0.0369311223881512,0.149956858318503
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CD3E,T-cell surface glycoprotein CD3 epsilon chain,39757,-0.00515639981891654,0.00358812641535581,-0.0121891275930139,0.00187632795518085,0.15072527629867
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MRPL24,"39S ribosomal protein L24, mitochondrial",39575,0.00573297055450671,0.00399068949210351,-0.00208878085001617,0.0135547219590296,0.150864032991078
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CD99,CD99 antigen,42137,-0.00292435184076926,0.00203696569585414,-0.00691680460464337,0.00106810092310486,0.151127575169935
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PRAME,Melanoma antigen preferentially expressed in tumors,39560,-0.00374945651626212,0.00261596401032336,-0.0088767459764959,0.00137783294397166,0.15180115981147
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IL36A,Interleukin-36 alpha,39657,-0.00847095396708708,0.00591654388071344,-0.0200673799732854,0.00312547203911126,0.15224644039875
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TNFRSF10C,Tumor necrosis factor receptor superfamily member 10C,42178,0.00713581892659256,0.00498725352740424,-0.00263919798711975,0.0169108358403049,0.152507303865379
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,AMY1A_AMY1B_AMY1C,Alpha-amylase 1A_Alpha-amylase 1B_Alpha-amylase 1C,39336,0.00758985482152744,0.00533845991536079,-0.0028735266125797,0.0180532362556346,0.155133358070726
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GJA8,Gap junction alpha-8 protein,39560,0.00911768776768304,0.00642441136985842,-0.00347415851723946,0.0217095340526055,0.155861752771132
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,KIF20B,Kinesin-like protein KIF20B,39586,-0.0109308500589158,0.00770281718015947,-0.0260283717320283,0.00416667161419679,0.15590647659238
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,KLRC1,NKG2-A/NKG2-B type II integral membrane protein,39586,-0.00899489130994031,0.0063398798230245,-0.0214210557630683,0.00343127314318772,0.155991689251325
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,EFNB2,Ephrin-B2,39649,0.00843867083812759,0.00595430839606991,-0.00323177361816943,0.0201091152944246,0.156441614782457
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PDGFRA,Platelet-derived growth factor receptor alpha,42145,0.00412886227385656,0.00291813311190315,-0.00159067862547362,0.00984840317318674,0.157121234921855
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PTPN9,Tyrosine-protein phosphatase non-receptor type 9,39635,-0.00569194003980658,0.00402387666972812,-0.0135787383124737,0.00219485823286052,0.157231222445363
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,LILRB5,Leukocyte immunoglobulin-like receptor subfamily B member 5,42310,0.0100774757953825,0.00716209594516819,-0.00396023225714716,0.0241151838479122,0.15943321558438
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SPINK8,Serine protease inhibitor Kazal-type 8,39575,-0.00517422010392517,0.00368093715789103,-0.0123888569333916,0.00204041672554125,0.159847447275876
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PLA2G1B,Phospholipase A2,42299,-0.00639573970885623,0.00455200979019933,-0.0153176788976469,0.00252619947993445,0.160033112919061
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TRIM26,Tripartite motif-containing protein 26,39560,0.00828517919767959,0.00591107673179904,-0.00330053119664653,0.0198708895920057,0.16105222528094
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PECR,Peroxisomal trans-2-enoyl-CoA reductase,39638,0.0039819983528738,0.0028502083906977,-0.00160441009289369,0.00956840679864129,0.162414517444398
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ITGB7,Integrin beta-7,42262,0.00659280438842445,0.00471969430473466,-0.00265779644885548,0.0158434052257044,0.162475037355578
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,JUN,Transcription factor AP-1,41913,0.00685755416026352,0.00493411434146776,-0.00281330994901328,0.0165284182695403,0.164605343947302
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TPRKB,EKC/KEOPS complex subunit TPRKB,39560,-0.00974530118153078,0.0070260642352331,-0.0235163870825877,0.00402578471952609,0.16546345514299
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TPPP3,Tubulin polymerization-promoting protein family member 3,41839,-0.00550760697880581,0.00397109263228796,-0.0132909485380902,0.00227573458047859,0.165488035132338
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,AMBN,Ameloblastin,41913,-0.00385757832117332,0.00279589042688792,-0.00933752355787364,0.001622366915527,0.167692477106288
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,LILRA3,Leukocyte immunoglobulin-like receptor subfamily A member 3,39966,0.0196462065961264,0.0142500601777948,-0.00828391135235153,0.0475763245446043,0.168022007930447
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,RANGAP1,Ran GTPase-activating protein 1,41843,-0.00678769217310719,0.00492771973055732,-0.0164460228449995,0.00287063849878517,0.168396151584521
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CD33,Myeloid cell surface antigen CD33,42181,0.0111911212710256,0.00812574702932776,-0.00473534290645677,0.0271175854485081,0.168460093485877
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IL2RG,Cytokine receptor common subunit gamma,39919,0.00504631984851903,0.00366515012727762,-0.00213737440094511,0.0122300140979832,0.168589411362405
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,EXTL1,Exostosin-like 1,39575,0.00668691462501979,0.00489947117035932,-0.00291604886888448,0.0162898781189241,0.17233643083722
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GPR101,Probable G-protein coupled receptor 101,39586,-0.00816413825565265,0.00598731773620479,-0.019899281018614,0.00357100450730874,0.172730279118299
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,LRFN2,Leucine-rich repeat and fibronectin type-III domain-containing protein 2,39649,0.00637470762460366,0.00467604471473105,-0.0027903400162692,0.0155397552654765,0.172825470646457
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GP2,Pancreatic secretory granule membrane major glycoprotein GP2,41701,0.0117626575408395,0.00863725020823361,-0.00516635286729832,0.0286916679489774,0.173267974254283
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,EPN1,Epsin-1,39757,0.0060793025399606,0.00446396071943027,-0.00267006047012273,0.0148286655500439,0.173268649375422
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PAIP2B,Polyadenylate-binding protein-interacting protein 2B,39539,-0.00753530040684277,0.00553473357846305,-0.0183833782206304,0.00331277740694482,0.173397432128211
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MYL1,"Myosin light chain 1/3, skeletal muscle isoform",39575,0.00566545068533262,0.00417277324124708,-0.00251318486751167,0.0138440862381769,0.174580994704217
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,RELB,Transcription factor RelB,39657,0.00655477419586029,0.00483127461184024,-0.00291452404334659,0.0160240724350672,0.174892149251537
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,VTCN1,V-set domain-containing T-cell activation inhibitor 1,41843,-0.00441158454905251,0.00325426381684464,-0.010789941630068,0.00196677253196299,0.175239365035881
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GBP2,Guanylate-binding protein 2,41913,0.0083843606422246,0.00619821339990314,-0.00376413762158556,0.0205328589060348,0.176172536256819
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PFDN4,Prefoldin subunit 4,39560,-0.00729569611383275,0.0054335424353101,-0.0179454392870405,0.00335404705937504,0.179392250878566
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,LELP1,Late cornified envelope-like proline-rich protein 1,39586,-0.00978462743928241,0.00728920771175554,-0.0240714745543233,0.00450221967575845,0.1795120783519
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,THSD1,Thrombospondin type-1 domain-containing protein 1,39585,-0.00476941173607766,0.00355477702837634,-0.0117367747116953,0.00219795123953997,0.17972399568915
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GGA1,ADP-ribosylation factor-binding protein GGA1,41839,0.00913452984260066,0.00683884958047139,-0.00426961533512326,0.0225386750203246,0.181676121978579
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SRPX,Sushi repeat-containing protein SRPX,39958,0.00529288498591234,0.00396512528208459,-0.00247876056697346,0.0130645305387981,0.181949104444666
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CD99L2,CD99 antigen-like protein 2,42137,-0.00333254064914854,0.00251318166229402,-0.00825837670724482,0.00159329540894775,0.184853930264784
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FDX2,"Ferredoxin-2, mitochondrial",39575,0.00751637492745076,0.00568280955558664,-0.00362193180149906,0.0186546816564006,0.185978955678313
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FOLR3,Folate receptor gamma,42132,0.0259156403742299,0.0196338218430783,-0.0125666504382037,0.0643979311866634,0.186874427349094
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,RANBP2,E3 SUMO-protein ligase RanBP2,39586,-0.00450574154165033,0.00342627205522021,-0.0112212347698819,0.00220975168658128,0.188518342430532
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ID4,DNA-binding protein inhibitor ID-4,39757,-0.00567439070720021,0.00433162778820177,-0.0141643811720757,0.00281559975767526,0.190226062602254
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MEP1B,Meprin A subunit beta,42145,-0.0152398121965014,0.0117373787183313,-0.0382450744844307,0.00776545009142789,0.194172034607039
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CA11,Carbonic anhydrase-related protein 11,41843,0.00405229460885184,0.00312309847787666,-0.00206897840778641,0.0101735676254901,0.194473622288436
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CEACAM5,Carcinoembryonic antigen-related cell adhesion molecule 5,41662,0.00825700534931925,0.00638979316129417,-0.00426698924681732,0.0207809999454558,0.196304541266881
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IL31,Interleukin-31,39657,-0.00737430498950591,0.00572620093117598,-0.0185976588146108,0.00384904883559901,0.197836254832247
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CTSH,Pro-cathepsin H,41865,0.00980584661676312,0.00762648340135449,-0.00514206084989167,0.0247537540834179,0.198548394179217
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,INPP1,Inositol polyphosphate 1-phosphatase,42070,0.00698885600125421,0.00544399593814215,-0.00368137603750441,0.0176590880400128,0.199243411322892
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FGF7,Fibroblast growth factor 7,39560,-0.0102286230531009,0.00800134012940664,-0.0259112497067379,0.00545400360053611,0.201148275382949
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MUCL3,Mucin-like protein 3,39560,-0.00560769016954799,0.00438704916829628,-0.0142063065394087,0.00299092620031272,0.201192814126493
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,WFIKKN1,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 1",41976,-0.00528964847631796,0.00417023838150751,-0.0134633157040727,0.00288401875143676,0.204667107430023
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MYBPC2,"Myosin-binding protein C, fast-type",39638,0.0114365392332038,0.00905511755550092,-0.00631149117557802,0.0291845696419856,0.206618804550061
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MRPL28,"39S ribosomal protein L28, mitochondrial",39934,-0.00470041146807175,0.00373379149003187,-0.0120186427885342,0.00261781985239072,0.208098054923334
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SNAP25,Synaptosomal-associated protein 25,39586,0.00623220333600384,0.00496096720687379,-0.0034912923894688,0.0159556990614765,0.209052912829123
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TNFSF11,Tumor necrosis factor ligand superfamily member 11,42119,-0.00786708428419313,0.00626944056939628,-0.0201551878002098,0.00442101923182358,0.209562045716202
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SIGLEC15,Sialic acid-binding Ig-like lectin 15,41839,0.00969742010050308,0.00774052925251361,-0.00547401723442359,0.0248688574354297,0.210296629518893
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SCN3B,Sodium channel subunit beta-3,39586,-0.00599773330709575,0.00480033829206948,-0.0154063963595519,0.00341092974536043,0.211530908607731
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,LAG3,Lymphocyte activation gene 3 protein,42070,-0.00519579045102009,0.00415998199314752,-0.0133493551575892,0.00295777425554905,0.211689157657793
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MMP13,Collagenase 3,41839,-0.00412027311711384,0.00330122469102182,-0.0105906735115166,0.00235012727728892,0.212014894184158
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MYOC,Myocilin,42137,-0.00570195718574128,0.00457090139017767,-0.0146609239104895,0.00325700953900696,0.212255225169564
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DCC,Netrin receptor DCC,39649,0.00285883449131742,0.00230103820678956,-0.00165120039399012,0.00736886937662495,0.214111437176099
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,HRAS,GTPase Hras,39750,0.0127037365211562,0.0102264760886043,-0.00734015661250829,0.0327476296548206,0.214174192831943
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,LYPD3,Ly6/PLAUR domain-containing protein 3,42082,0.00427157955011135,0.00345701047135495,-0.00250416097374436,0.0110473200739671,0.216618335266679
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GUCY2C,Heat-stable enterotoxin receptor,39757,-0.0104197994061368,0.00844929716754271,-0.0269804218545205,0.00614082304224688,0.217521568280994
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,RALB,Ras-related protein Ral-B,39657,0.00376472160141038,0.00305434028490621,-0.00222178535700578,0.00975122855982655,0.217758360852401
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,BRD2,Bromodomain-containing protein 2,39586,0.00443562871979394,0.00360967272189148,-0.00263932981511336,0.0115105872547012,0.21916658963213
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NPR1,Atrial natriuretic peptide receptor 1,39575,-0.00537843004529077,0.00439420700412367,-0.0139910757733732,0.00323421568279163,0.220985312647291
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SEPTIN9,Septin-9,42070,0.0036027164300373,0.00294356789047216,-0.00216667663528814,0.00937210949536273,0.221000634696341
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ACP1,Low molecular weight phosphotyrosine protein phosphatase,39657,0.00556836001260526,0.00456464277494715,-0.00337833982629115,0.0145150598515017,0.222532766978355
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TP53BP1,TP53-binding protein 1,39657,0.0107232719429436,0.00885691961605665,-0.00663629050452741,0.0280828343904147,0.226027650988328
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TMEM25,Transmembrane protein 25,39934,0.0058463371091209,0.0048294483256477,-0.00361938160914859,0.0153120558273904,0.226089314426297
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GSTM4,Glutathione S-transferase Mu 4,39575,-0.00930077459024942,0.00769215150813584,-0.0243773915461957,0.00577584236569683,0.226640778013847
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ATP1B3,Sodium/potassium-transporting ATPase subunit beta-3,39575,-0.00491296174851695,0.00406503975789837,-0.0128804396739978,0.00305451617696385,0.226846878552464
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IL20RB,Interleukin-20 receptor subunit beta,39657,-0.00520659178807623,0.00431778034544171,-0.013669441265142,0.00325625768898952,0.227901460421018
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,C1QBP,"Complement component 1 Q subcomponent-binding protein, mitochondrial",39934,0.00836977852489507,0.00694401285996802,-0.00524048668064225,0.0219800437304324,0.228103791736152
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,C1QL2,Complement C1q-like protein 2,39657,-0.00534304136596687,0.00443544425222665,-0.0140365121003311,0.00335042936839737,0.228374377999487
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CACNA1C,Voltage-dependent L-type calcium channel subunit alpha-1C,39586,-0.00390263261564759,0.00324845483579643,-0.0102696040938086,0.00246433886251342,0.229629258470641
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,KCNIP4,Kv channel-interacting protein 4,41839,-0.00625204274561242,0.00521040996918207,-0.0164644462852093,0.00396036079398443,0.230194297794909
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,AOC1,Amiloride-sensitive amine oxidase [copper-containing],41913,-0.00660076814912828,0.00550411396968272,-0.0173888315297064,0.00418729523144985,0.230454956716846
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MSLN,Mesothelin,42048,0.0071162324766608,0.00595274507485889,-0.00455114787006262,0.0187836128233842,0.231930806673895
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GLP1R,Glucagon-like peptide 1 receptor,39586,-0.00460841069139619,0.0038589517353209,-0.0121719560926251,0.00295513470983277,0.232420406058759
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ENG,Endoglin,42310,0.00210575636051686,0.0017659589821771,-0.00135552324455026,0.00556703596558397,0.233119114604507
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ITM2A,Integral membrane protein 2A,42119,0.00753650826603658,0.00634574377653114,-0.00490114953596446,0.0199741660680376,0.234993086101686
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GBP6,Guanylate-binding protein 6,39575,-0.00540984490598428,0.00460286576302977,-0.0144314618015226,0.00361177198955407,0.239891802963045
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PCARE,Photoreceptor cilium actin regulator,39586,-0.0100778655971149,0.00857760636129816,-0.0268899740652593,0.00673424287102946,0.240058516101424
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CA7,Carbonic anhydrase 7,39757,-0.00406326926134,0.00346264426446997,-0.0108500520197011,0.00272351349702115,0.240637049255173
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,HADH,"Hydroxyacyl-coenzyme A dehydrogenase, mitochondrial",39575,0.00806551788807634,0.00690852928529472,-0.00547519951110132,0.021606235287254,0.243044974780802
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MYLPF,"Myosin regulatory light chain 2, skeletal muscle isoform",39649,0.0067340209860874,0.00578236877221205,-0.00459942180744822,0.018067463779623,0.244214890224227
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FGF3,Fibroblast growth factor 3,39657,-0.00354231347035397,0.00305085791437435,-0.0095219949825277,0.00243736804181976,0.245631318903245
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PRR4,Proline-rich protein 4,39652,0.00849406105532455,0.00731724553944244,-0.00584774020198262,0.0228358623126317,0.245737062314614
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ARTN,Artemin,41913,0.00534635609112618,0.00461990767065342,-0.00370866294335452,0.0144013751256069,0.247193832206915
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,C5,Complement C5,39979,0.00178539684478854,0.00154465426885356,-0.00124212552216445,0.00481291921174152,0.247764611293334
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,BMP4,Bone morphogenetic protein 4,41992,-0.00557306860031262,0.0048322898600372,-0.0150443567259855,0.0038982195253603,0.248808812504351
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FH,"Fumarate hydratase, mitochondrial",39586,0.00975862822620856,0.00847921556661172,-0.00686063428435041,0.0263778907367675,0.249803325670714
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FGF16,Fibroblast growth factor 16,39657,0.00548866292928463,0.00478980485339523,-0.00389935458337002,0.0148766804419393,0.251859123353672
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TG,Thyroglobulin,39919,-0.0123643353837326,0.0107921998671221,-0.0335170471232919,0.00878837635582684,0.251954571023693
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,WAS,Wiskott-Aldrich syndrome protein,41913,0.00767143512864714,0.0067063624736231,-0.00547303531965413,0.0208159055769484,0.252684002623807
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MYOM1,Myomesin-1,39586,0.00576963831223199,0.00504596977045962,-0.00412046243786887,0.0156597390623328,0.252891177651044
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SLC13A1,Solute carrier family 13 member 1,39919,0.00704218601950671,0.00618712240155571,-0.00508457388754248,0.0191689459265559,0.25506084626969
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DEFB104A_DEFB104B,Beta-defensin 104,39586,-0.00652822861640386,0.00575649799523468,-0.0178109646870638,0.00475450745425612,0.256793069398568
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ANPEP,Aminopeptidase N,42187,0.0031598791394574,0.00279095327374504,-0.00231038927708287,0.00863014755599768,0.257576087053241
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IDI2,Isopentenyl-diphosphate delta-isomerase 2,41839,0.00567125150879856,0.00501710816607626,-0.00416228049671092,0.015504783514308,0.258335542937889
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,BTC,Probetacellulin,41843,0.00848246801400907,0.00750609894067513,-0.00622948590971419,0.0231944219377323,0.258464346160127
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,RAD51,DNA repair protein RAD51 homolog 1,39757,0.00608327739270968,0.00541867444706814,-0.00453732452354388,0.0167038793089632,0.261610131151445
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CRYGD,Gamma-crystallin D,39929,0.0113012124417585,0.0100846968328392,-0.00846479335060629,0.0310672182341232,0.262469202099801
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,BABAM1,BRISC and BRCA1-A complex member 1,39657,0.00339787838392406,0.00304338966616692,-0.0025671653617631,0.00936292212961121,0.264241734318124
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NECTIN1,Nectin-1,39657,0.00379153615288682,0.00339923365968994,-0.00287096182010547,0.0104540341258791,0.26469939349109
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ESPL1,Separin,39560,-0.00611198011087539,0.00549458155187509,-0.0168813599525506,0.00465739973079979,0.266005652349867
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SLITRK6,SLIT and NTRK-like protein 6,41900,0.00392980095213007,0.00353407242255025,-0.00299698099606842,0.0108565829003286,0.266168905121297
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SFRP1,Secreted frizzled-related protein 1,41968,0.00486376672309235,0.00439073502202956,-0.00374207392008558,0.0134696073662703,0.267996616635669
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,OSTN,Osteocrin,39649,0.00461209143232046,0.00416462926828586,-0.00355058193351983,0.0127747647981608,0.268126354177982
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,41843,-0.00397401423293488,0.00361343835045523,-0.0110563533998271,0.00310832493395737,0.271444723178516
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CD82,CD82 antigen,39757,-0.00469701560897313,0.0042760914036502,-0.0130781547601275,0.00368412354218127,0.272037560073906
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DIPK1C,Divergent protein kinase domain 1C,39649,-0.00474126742112289,0.00432471705300159,-0.013217712845006,0.00373517800276022,0.272963299294847
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,LTB,Lymphotoxin-beta,39919,0.00387843828722926,0.00354481355609692,-0.00306939628272069,0.0108262728571792,0.273927257464594
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PDE4D,"cAMP-specific 3',5'-cyclic phosphodiesterase 4D",39575,-0.00689055322201456,0.00633573075142365,-0.0193085854948049,0.00552747905077579,0.2768086876316
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,VTA1,Vacuolar protein sorting-associated protein VTA1 homolog,42249,-0.00778905613148359,0.00716984132593287,-0.021841945130312,0.00626383286734484,0.277337251901155
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IFNAR1,Interferon alpha/beta receptor 1,39930,0.00274810172753468,0.00253454976849174,-0.00221961581870913,0.0077158192737785,0.278274216347495
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,AMY2A,Pancreatic alpha-amylase,41665,0.00542033316855735,0.00500203412948077,-0.00438365372522496,0.0152243200623397,0.278550749684258
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GHRHR,Growth hormone-releasing hormone receptor,41839,-0.00599424773207102,0.00553233662566207,-0.0168376275183687,0.00484913205422664,0.278609410360349
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,HIF1A,Hypoxia-inducible factor 1-alpha,39657,0.00696750888348068,0.00644874397996849,-0.00567202931725755,0.0196070470842189,0.279967928893476
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NMRK2,Nicotinamide riboside kinase 2,39560,-0.00433978677585464,0.00402111164443556,-0.0122211655989483,0.00354159204723905,0.280499820457417
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ARG2,"Arginase-2, mitochondrial",39919,-0.00468047157828442,0.00434478241851386,-0.0131962451185716,0.00383530196200275,0.281385926643465
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DCN,Decorin,41900,0.0025301654133928,0.00235026657111188,-0.00207635706598649,0.00713668789277209,0.281703553393285
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ENOPH1,Enolase-phosphatase E1,39919,-0.00589134675607726,0.00549263653076887,-0.0166569143563842,0.00487422084422971,0.283478001687418
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,RAP1A,Ras-related protein Rap-1A,39657,-0.00762739151085265,0.00712317139364691,-0.0215888074424006,0.00633402442069529,0.284289079540782
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SHD,SH2 domain-containing adapter protein D,39554,0.00906564089806408,0.00848747858809723,-0.0075698171346065,0.0257010989307347,0.28549017474059
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,KLK4,Kallikrein-4,42262,0.00680280688268116,0.00640434688748086,-0.00574971301678133,0.0193553267821437,0.288155906910242
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SMPD3,Sphingomyelin phosphodiesterase 3,39657,0.00623699047234483,0.00588123737665436,-0.00529023478589772,0.0177642157305874,0.288945129215077
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ERC2,ERC protein 2,39649,0.00804056856918467,0.00758878293187967,-0.00683344597729949,0.0229145831156688,0.289380112373374
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SMC3,Structural maintenance of chromosomes protein 3,39560,0.00564625060653143,0.0053658846352188,-0.00487088327849741,0.0161633844915603,0.292708191695899
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DOC2B,Double C2-like domain-containing protein beta,39649,0.00396928542734663,0.00377763084503112,-0.00343487102891435,0.0113734418836076,0.293403724545632
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IL36G,Interleukin-36 gamma,39624,0.00725062217294558,0.00691807447703477,-0.00630880380204256,0.0208100481479337,0.294629609984791
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SYT1,Synaptotagmin-1,39929,-0.0043160443515533,0.00412027940264043,-0.0123917919807285,0.00375970327762195,0.294885597820952
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,KIR3DL1,Killer cell immunoglobulin-like receptor 3DL1,41843,0.0135330247581124,0.0129228238357162,-0.0117957099598914,0.0388617594761162,0.29501776418635
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CPB2,Carboxypeptidase B2,39959,-0.00240911941546436,0.00231078535924862,-0.00693825871959166,0.00212001988866294,0.297176911381512
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FGFR4,Fibroblast growth factor receptor 4,39736,0.00562563220219144,0.00540166709375332,-0.00496163530156507,0.0162128997059479,0.297683687999513
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,C1R,Complement C1r subcomponent,39979,-0.00200796364050514,0.00193300869803717,-0.005796660688658,0.00178073340764773,0.298930853901142
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PDCL2,Phosducin-like protein 2,39560,0.00557890714781478,0.00537596967731018,-0.00495799341971317,0.0161158077153427,0.299409820722292
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ADAMTS16,A disintegrin and metalloproteinase with thrombospondin motifs 16,41900,0.00333698776848839,0.00321735056350413,-0.00296901933597971,0.00964299487295648,0.299668500069319
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SAP18,Histone deacetylase complex subunit SAP18,39757,-0.00768861176639892,0.00745942023995302,-0.0223090754367068,0.006931851903909,0.302692087883717
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CCNE1,G1/S-specific cyclin-E1,39657,0.00971262826794748,0.00943535842648842,-0.00878067424796983,0.0282059307838648,0.303320722493904
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,HTR1B,5-hydroxytryptamine receptor 1B,39586,0.00460866315610488,0.00450279560874901,-0.00421681623704317,0.0134341425492529,0.306088594612352
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CFD,Complement factor D,39979,0.00212137276036574,0.00208118419524655,-0.0019577482623175,0.00620049378304897,0.30807728389987
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SULT1A1,Sulfotransferase 1A1,42249,-0.0132975984781551,0.0131348442390809,-0.0390418931867536,0.0124466962304434,0.311369071919426
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MFAP3,Microfibril-associated glycoprotein 3,41900,0.0049441477964802,0.00488602601602214,-0.00463246319492319,0.0145207587878836,0.311606423489346
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FGF12,Fibroblast growth factor 12,39657,0.00471145940324308,0.00466957906774091,-0.0044409155695291,0.0138638343760153,0.313011695352359
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,BLMH,Bleomycin hydrolase,42310,0.0031777872977665,0.00315814373403323,-0.00301217442093863,0.00936774901647163,0.314327525522033
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,AIF1L,Allograft inflammatory factor 1-like,39638,-0.00584778313888734,0.00583959064942563,-0.0172933808117616,0.0055978145339869,0.316654003906527
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,LEG1,Protein LEG1 homolog,39398,0.00725763913225868,0.0072581121379683,-0.00696826065815919,0.0214835389226765,0.317364453858176
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ENSA,Alpha-endosulfine,39919,0.00545276568892657,0.00546155036205249,-0.0052518730206963,0.0161574043985495,0.318110875769751
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,JCHAIN,Immunoglobulin J chain,41913,0.00624289861190518,0.00626390641101015,-0.00603435795367471,0.0185201551774851,0.318954379500787
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SPINK5,Serine protease inhibitor Kazal-type 5,42137,-0.00360861410788005,0.00362578912970249,-0.0107151608020969,0.00349793258633683,0.319626111910296
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FZD10,Frizzled-10,39649,0.00610322499991466,0.00613981656946422,-0.00593081547623522,0.0181372654760645,0.32022502468477
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CNTN2,Contactin-2,42262,0.00447285351689872,0.00450309894594284,-0.00435322041714925,0.0132989274509467,0.320589447188715
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GABARAPL1,Gamma-aminobutyric acid receptor-associated protein-like 1,39757,0.00672004195868987,0.00678043134790836,-0.00656960348321051,0.0200096874005903,0.321661382306591
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,EPGN,Epigen,39919,-0.0047137856544567,0.00477116217799229,-0.0140652635233216,0.00463769221440818,0.323186348968745
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CRYBB2,Beta-crystallin B2,39929,0.00710597265763628,0.00719348995354852,-0.00699326765131882,0.0212052129665914,0.323255138092295
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,HMOX1,Heme oxygenase 1,42007,-0.00494780119252725,0.00504493929245284,-0.0148358822057348,0.00494027982068031,0.32673598805517
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CFP,Properdin,39979,0.00238707332588396,0.00243424496371894,-0.00238404680300517,0.00715819345477309,0.326800199500425
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,KIR2DS4,Killer cell immunoglobulin-like receptor 2DS4,39930,0.0173817691761198,0.0177302229396229,-0.0173694677855411,0.0521330061377807,0.326935841528483
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,RBM25,RNA-binding protein 25,39560,-0.00471906360951827,0.00482049129403808,-0.0141672265458329,0.00472909932679637,0.327621818012895
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,KRT17,"Keratin, type I cytoskeletal 17",39575,-0.0040686537389813,0.00415623362860709,-0.0122148716510512,0.00407756417308859,0.327637102225532
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,RBM19,Probable RNA-binding protein 19,39575,-0.00483581551254096,0.00495036752923482,-0.0145385358698412,0.00486690484475929,0.32866004920585
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ATP1B1,Sodium/potassium-transporting ATPase subunit beta-1,39575,0.00485577070395546,0.0049795063783982,-0.00490406179770501,0.0146156032056159,0.329506848423731
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,VIPR1,Vasoactive intestinal polypeptide receptor 1,39638,-0.00236916525418127,0.00243010095026265,-0.00713216311669606,0.00239383260833352,0.329619015645159
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MAEA,E3 ubiquitin-protein transferase MAEA,41843,0.00389036961335249,0.00399639162699706,-0.00394255797556175,0.0117232972022667,0.330337263180844
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MEGF11,Multiple epidermal growth factor-like domains protein 11,39575,0.00328524693632699,0.00337657655207982,-0.00333284310574945,0.00990333697840343,0.330598597785898
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ACTN2,Alpha-actinin-2,39575,-0.00643158068860775,0.00665054051489615,-0.0194666400978042,0.00660347872058871,0.333527158757631
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,KIAA1549L,UPF0606 protein KIAA1549L,39757,-0.00272329413670383,0.002822150072935,-0.00825470827965643,0.00280812000624878,0.334580046603272
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SEPTIN7,Septin-7,39757,-0.0052971852166916,0.00549069846320692,-0.0160589542045772,0.00546458377119397,0.334687864317338
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,LYPLA2,Acyl-protein thioesterase 2,39586,0.0107903296835129,0.0111956564707058,-0.0111531569990706,0.0327338163660964,0.33516939223597
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PSTPIP2,Proline-serine-threonine phosphatase-interacting protein 2,39424,0.0107345933912716,0.0111711496448982,-0.0111608599127289,0.0326300466952722,0.336613306065212
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MAPT,Microtubule-associated protein tau,41839,-0.00517963228485468,0.00540566965219197,-0.0157747448031509,0.00541548023344157,0.337986910980148
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CYTH3,Cytohesin-3,39560,0.00720035465910001,0.00752548086092029,-0.00754958782830376,0.0219502971465038,0.338691022016455
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SSH3,Protein phosphatase Slingshot homolog 3,39560,0.00291642980510332,0.00304906642773765,-0.00305974039326247,0.00889260000346911,0.338841151289711
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CDSN,Corneodesmosin,42246,0.00427705639045427,0.00447798658719881,-0.00449979732045539,0.0130539101013639,0.339529210608715
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IL21R,Interleukin-21 receptor,39657,0.00532093507232937,0.00557660847782186,-0.00560921754420149,0.0162510876888602,0.340027299302756
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,COPE,Coatomer subunit epsilon,41839,-0.00450773533230381,0.0047462661083168,-0.0138104169046047,0.00479494623999713,0.342259943232483
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PM20D1,N-fatty-acyl-amino acid synthase/hydrolase PM20D1,42085,0.018601495466704,0.0196618467416382,-0.0199357241469069,0.0571387150803148,0.344129521123479
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FXN,"Frataxin, mitochondrial",42262,0.00702568881522645,0.00743563387552606,-0.00754815358080463,0.0215995312112575,0.344743233488487
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PRRT3,Proline-rich transmembrane protein 3,39638,0.00376406242426648,0.00398398776484492,-0.00404455359482956,0.0115726784433625,0.344782853199051
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TBR1,T-box brain protein 1,39649,-0.00465365320534908,0.00493801392111229,-0.0143321604907292,0.00502485408003101,0.346001352507239
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CHRM1,Muscarinic acetylcholine receptor M1,39649,-0.0035110492636432,0.00372608421797012,-0.0108141743308646,0.00379207580357824,0.34606515020786
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GP1BA,Platelet glycoprotein Ib alpha chain,42117,0.00320840736521246,0.00341106363830892,-0.00347727736587302,0.00989409209629794,0.346932565588065
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,RAC3,Ras-related C3 botulinum toxin substrate 3,39649,0.006686745324812,0.00711435148178911,-0.00725738357949466,0.0206308742291187,0.347291829195025
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,RUVBL1,RuvB-like 1,41843,0.00949706928603353,0.010128137596604,-0.0103540804033102,0.0293482189753773,0.348420035490684
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IL12RB2,Interleukin-12 receptor subunit beta-2,39657,-0.00399155757393035,0.00426083462508686,-0.0123427934391006,0.0043596782912399,0.348880976386258
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GADD45B,Growth arrest and DNA damage-inducible protein GADD45 beta,39757,0.00462269437950777,0.00495178440517543,-0.00508280305463607,0.0143281918136516,0.350560850161283
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MPRIP,Myosin phosphatase Rho-interacting protein,39892,0.00435765393501237,0.00467940394143041,-0.00481397779019123,0.013529285660216,0.351748697699355
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FRMD7,FERM domain-containing protein 7,39649,-0.00324142336882368,0.00349840149920955,-0.0100982903072744,0.00361544356962703,0.354183512543881
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,BCL7A,B-cell CLL/lymphoma 7 protein family member A,39560,0.00611752902300081,0.00660920404581822,-0.0068365109068029,0.0190715689528045,0.354670359208857
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DSG3,Desmoglein-3,42196,0.00332168941376774,0.00359176163504112,-0.00371816339091286,0.0103615422184483,0.355082271589484
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CA13,Carbonic anhydrase 13,41967,0.00998803980891068,0.0108071690203861,-0.011194011471046,0.0311700910888674,0.355396268009984
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SMPD1,Sphingomyelin phosphodiesterase,42176,-0.00481726756237341,0.00523050057581034,-0.0150690486909617,0.00543451356621486,0.357069134804664
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ZP4,Zona pellucida sperm-binding protein 4,39560,0.00295718002457819,0.00321209565603056,-0.00333852746124171,0.00925288751039808,0.357259279070822
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MTPN,Myotrophin,41900,-0.00305420879613614,0.00331978839799737,-0.00956099405621099,0.00345257646393871,0.357588898600894
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,HAGH,"Hydroxyacylglutathione hydrolase, mitochondrial",42224,0.00644457047362414,0.00700906299871372,-0.00729319300385475,0.020182333951103,0.357869998515171
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IL20RA,Interleukin-20 receptor subunit alpha,41913,0.00416353279546357,0.00453165982344342,-0.00471852045848552,0.0130455860494127,0.358234876129795
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CD5L,CD5 antigen-like,39925,0.00452741646116812,0.00493423433673771,-0.00514368283883778,0.014198515761174,0.358873009857036
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ARHGAP1,Rho GTPase-activating protein 1,41843,0.00436948780192387,0.00476583421964541,-0.00497154726858113,0.0137105228724289,0.359245344454961
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IL5,Interleukin-5,41913,0.0129237507942025,0.0141188302732942,-0.0147491565414542,0.0405966581298592,0.360021542024933
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ZNF75D,Zinc finger protein 75D,39757,-0.00577732118467343,0.0063119553170949,-0.0181487536061794,0.00659411123683259,0.360054898187199
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,THRAP3,Thyroid hormone receptor-associated protein 3,39575,-0.00997288438122672,0.0109069684338985,-0.0313505425116677,0.0114047737492143,0.360548343119745
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CCL28,C-C motif chemokine 28,42075,0.00549992381826951,0.00602620922849196,-0.00631144626957474,0.0173112939061138,0.361433900154289
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PSMA1,Proteasome subunit alpha type-1,41843,0.00429588501595054,0.00473792319479448,-0.00499044444584664,0.0135822144777477,0.364580837885311
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IFIT1,Interferon-induced protein with tetratricopeptide repeats 1,39757,0.00481658230086122,0.00532045396849997,-0.00561150747739871,0.0152446720791212,0.365328481481058
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SERPINF2,Alpha-2-antiplasmin,39786,-0.00124236054009527,0.00137639432824392,-0.00394009342345334,0.00145537234326281,0.366747239813678
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MANEAL,"Glycoprotein endo-alpha-1,2-mannosidase-like protein",39560,0.00481895464202203,0.00534248255342063,-0.0056523111626824,0.0152902204467265,0.367073171667094
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TUBB3,Tubulin beta-3 chain,39586,-0.00264878355084222,0.00294946859034367,-0.00842974198791581,0.00313217488623137,0.369176173561334
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,OSBPL2,Oxysterol-binding protein-related protein 2,39929,0.0035450228258443,0.00395094827054823,-0.00419883578443023,0.0112888814361188,0.369599939736817
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,LCP1,Plastin-2,39966,-0.00441404516868555,0.00492404323028279,-0.0140651699000398,0.00523707956266871,0.370043752033381
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NPHS1,Nephrin,39657,-0.00307178935300983,0.00343017206935362,-0.00979492660894292,0.00365134790292326,0.370528415035191
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SAT1,Diamine acetyltransferase 1,39575,-0.00444985449457698,0.0049794203438747,-0.0142095183685714,0.00530980937941743,0.371529263917248
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CLINT1,Clathrin interactor 1,39560,-0.0045842449248943,0.00514509252078646,-0.0146686262656358,0.00550013641584715,0.372952118836977
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ARL2BP,ADP-ribosylation factor-like protein 2-binding protein,39575,0.00367736744681933,0.00413635784877287,-0.00442989393677549,0.0117846288304141,0.374003683985392
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TSLP,Thymic stromal lymphopoietin,41900,0.00546363605691507,0.00615296198098313,-0.00659616942581188,0.017523441539642,0.374573785356199
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NEB,Nebulin,39575,0.00363190336669723,0.00409742158056197,-0.00439904293120423,0.0116628496645987,0.375428161762696
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SOWAHA,Ankyrin repeat domain-containing protein SOWAHA,39649,0.00433334494733683,0.00488993653567042,-0.00525093066257719,0.0139176205572509,0.3755419204287
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PDIA2,Protein disulfide-isomerase A2,39560,-0.00361956008959319,0.00411464987422511,-0.0116842738430744,0.00444515366388803,0.379053963864986
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MUC16,Mucin-16,42070,0.0171865704402303,0.0195420727745105,-0.0211158921978103,0.0554890330782709,0.379164852010912
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CDAN1,Codanin-1,39929,-0.00197575751451462,0.00224855464796014,-0.00638292462451648,0.00243140959548725,0.379594040127727
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,KLB,Beta-klotho,41839,-0.00669827752489648,0.00764293370835132,-0.0216784275932651,0.00828187254347212,0.380827778653797
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TMEM132A,Transmembrane protein 132A,39638,0.00562952684702365,0.006459107380428,-0.00703032361861522,0.0182893773126625,0.383465116563336
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CAPS,Calcyphosin,39929,-0.00851255365386177,0.00977079326798115,-0.0276633084591048,0.0106382011513813,0.383650092492523
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,HK2,Hexokinase-2,41900,-0.00242791939394717,0.00278888778496804,-0.00789413945248452,0.00303830066459019,0.384005213226952
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NOTCH1,Neurogenic locus notch homolog protein 1,42310,0.00143388444130544,0.00164894488034908,-0.00179804752417877,0.00466581640678964,0.384546868316027
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,COL9A2,Collagen alpha-2(IX) chain,39757,0.00399965109416147,0.00460367742492826,-0.00502355665869791,0.0130228588470209,0.384978055700937
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SIRT5,"NAD-dependent protein deacylase sirtuin-5, mitochondrial",41839,0.00465729045288761,0.00536804822952508,-0.00586408407698153,0.0151786649827568,0.385631947600219
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ECM1,Extracellular matrix protein 1,39720,-0.00324485696737929,0.00374749013348829,-0.0105899376290163,0.00410022369425776,0.386577548761298
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CORO1A,Coronin-1A,41883,0.00777761286681072,0.00906854834540332,-0.00999674189017979,0.0255519676238012,0.391102913254972
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,VSTM2B,V-set and transmembrane domain-containing protein 2B,39757,0.00362531855220538,0.00423770623002044,-0.00468058565863468,0.0119312227630454,0.392297884718709
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SCN2B,Sodium channel subunit beta-2,39649,-0.00247612831138477,0.0029035876962132,-0.00816716019596264,0.00321490357319311,0.393798503854886
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GPC1,Glypican-1,42262,0.0025610163526458,0.00302359877537498,-0.00336523724708916,0.00848726995238075,0.397004761507269
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CSF3,Granulocyte colony-stimulating factor,41913,0.00415072047698641,0.00490553787526863,-0.00546413375854009,0.0137655747125129,0.397495694455218
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CHIT1,Chitotriosidase-1,42207,0.0134740622451429,0.0159956792672966,-0.0178774691187585,0.0448255936090443,0.399603314792896
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SOX9,Transcription factor SOX-9,39649,0.00239270860299317,0.00284449290928637,-0.00318249749920811,0.00796791470519446,0.400269627869881
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,BCAM,Basal cell adhesion molecule,42137,0.00210431816393771,0.0025090295651192,-0.00281337978369592,0.00702201611157133,0.401653590981991
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,AMY2B,Alpha-amylase 2B,41300,0.00426785352808097,0.00511897569101879,-0.00576533882631586,0.0143010458824778,0.404447736180802
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PGD,"6-phosphogluconate dehydrogenase, decarboxylating",39958,0.00448989081429875,0.00540488457458704,-0.00610368295189185,0.0150834645804894,0.40615502605242
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ROR1,Inactive tyrosine-protein kinase transmembrane receptor ROR1,42145,-0.00273324673427467,0.00330081904642639,-0.0092028520652704,0.00373635859672105,0.407656168952502
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,COL15A1,Collagen alpha-1(XV) chain,39966,0.00228749729586346,0.0027768042820973,-0.00315503909704724,0.00773003368877417,0.410077465780981
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,LTO1,Protein LTO1 homolog,41913,-0.00346694884787151,0.00422149052425093,-0.0117410702754033,0.00480717257966032,0.411511875614233
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MLLT1,Protein ENL,39560,-0.005598930144721,0.00683091339920695,-0.0189875204071666,0.00778966011772462,0.41243582407471
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IKZF2,Zinc finger protein Helios,41843,-0.00745018488081734,0.0090968616128553,-0.0252800336420137,0.010379663880379,0.412810231434149
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SERPINA7,Thyroxine-binding globulin,39979,0.0015436467285549,0.00188708252675815,-0.00215503502389108,0.00524232848100088,0.413370314926028
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CDKL5,Cyclin-dependent kinase-like 5,39586,0.00440377023130786,0.00538408704475493,-0.0061490403764118,0.0149565808390275,0.413418725169198
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TFAP2A,Transcription factor AP-2-alpha,39586,0.00500853359227606,0.00613210578726879,-0.00701039375077076,0.0170274609353229,0.41407632733818
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ABHD14B,Protein ABHD14B,41976,0.00465288936683585,0.00570537214306302,-0.00652964003356766,0.0158354187672394,0.41478480202518
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TLR4,Toll-like receptor 4,39657,0.00238417998026857,0.00292400517442096,-0.0033468701615965,0.00811523012213365,0.414871483629206
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SEMA6C,Semaphorin-6C,39657,0.0021536395574834,0.00265811978547696,-0.00305627522205144,0.00736355433701823,0.417835992557098
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CRIM1,Cysteine-rich motor neuron 1 protein,42185,0.00168797849980588,0.00208400479388634,-0.00239667089621134,0.0057726278958231,0.417972394877016
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IL3,Interleukin-3,39560,-0.00507375742465994,0.0063052184045722,-0.0174319854976215,0.00728447064830158,0.421015018685058
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,VWA5A,von Willebrand factor A domain-containing protein 5A,39560,0.0063709944516363,0.00794386642013771,-0.0091989837318336,0.0219409726351062,0.422569357522963
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SSB,Lupus La protein,41839,0.00482585908965318,0.0060234297888059,-0.00698006329640638,0.0166317814757127,0.4230410947348
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TMOD4,Tropomodulin-4,39560,0.00329685002669187,0.00412279700970616,-0.00478383211233221,0.011377532165716,0.423923152903606
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MSMB,Beta-microseminoprotein,42103,0.00570063260709104,0.00713631046534868,-0.00828653590499237,0.0196878011191745,0.424408428802632
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,RTN4IP1,"Reticulon-4-interacting protein 1, mitochondrial",39934,0.00760809073036365,0.00954873557740084,-0.011107431001342,0.0263236124620693,0.425604675674102
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GTF2IRD1,General transcription factor II-I repeat domain-containing protein 1,39757,0.00567005041369327,0.00711664456970982,-0.00827857294293797,0.0196186737703245,0.425624305227193
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PRC1,Protein regulator of cytokinesis 1,39919,0.00360459157013085,0.00454398836269903,-0.00530162562075925,0.012510808761021,0.427639476717704
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PYDC1,Pyrin domain-containing protein 1,39638,0.00336619438261777,0.00424497913369995,-0.00495396471943414,0.0116863534846697,0.427805033006657
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SF3B4,Splicing factor 3B subunit 4,42070,0.00584914963588889,0.00741268226742963,-0.00867970760827319,0.020378006880051,0.430083056026329
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,LMNB1,Lamin-B1,39908,0.0049548723932563,0.00629283535156446,-0.00737908489581005,0.0172888296823226,0.431074122164563
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,BRD3,Bromodomain-containing protein 3,39575,0.00384932111079178,0.00488940513946098,-0.00573391296255176,0.0134325551841353,0.431136144791155
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,RNF4,E3 ubiquitin-protein ligase RNF4,39757,0.00527942104425133,0.00674046484788001,-0.00793189005759349,0.0184907321460962,0.433501128900259
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CEP350,Centrosome-associated protein 350,39560,-0.00294711808960517,0.00376349265751886,-0.0103235636983421,0.00442932751913179,0.433596702539208
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TARM1,"T-cell-interacting, activating receptor on myeloid cells protein 1",39649,-0.00621696083102732,0.00794673404602067,-0.0217925595612278,0.00935863789917319,0.434037988793826
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,STAM,Signal transducing adapter molecule 1,39919,-0.00290665971267871,0.00372669714486342,-0.010210986116611,0.00439766669125359,0.435433096418729
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,F2,Prothrombin,39979,-0.00119081151133236,0.00152872318405927,-0.00418710895208853,0.00180548592942382,0.436020516977203
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,KIR2DL2,Killer cell immunoglobulin-like receptor 2DL2,39919,0.00715002707291896,0.0091887339297768,-0.0108598914294436,0.0251599455752815,0.436508800861595
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FAM171B,Protein FAM171B,39919,0.00212212462162301,0.00273566570889889,-0.00323978016781881,0.00748402941106484,0.437927509004436
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CEND1,Cell cycle exit and neuronal differentiation protein 1,39586,-0.00483956135863306,0.00624274456800886,-0.0170753407119304,0.00739621799466431,0.438220593063492
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DYNC1H1,Cytoplasmic dynein 1 heavy chain 1,39919,0.0037629103118099,0.00485606956856362,-0.0057549860425748,0.0132808066661946,0.438421996716412
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SLC1A4,Neutral amino acid transporter A,39649,0.00401788495971766,0.00522947319340939,-0.00623188249936476,0.0142676524188001,0.442316228681901
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,EP300,Histone acetyltransferase p300,39657,0.00242076451086923,0.00317146173998051,-0.00379530049949257,0.00863682952123103,0.445303087453272
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,RICTOR,Rapamycin-insensitive companion of mTOR,39657,-0.00360161757057308,0.00472509220269204,-0.0128627982878495,0.00565956314670331,0.445937671667416
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IGDCC3,Immunoglobulin superfamily DCC subclass member 3,39586,-0.00383076586683265,0.0050341479051429,-0.0136976957609127,0.00603616402724743,0.446699584307387
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,LILRA4,Leukocyte immunoglobulin-like receptor subfamily A member 4,39575,-0.00384880616439188,0.00509443958279097,-0.0138339077466622,0.00613629541787842,0.449970301055449
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,S100A3,Protein S100-A3,39919,0.00331636563047442,0.00439816516300022,-0.005304038089006,0.0119367693499548,0.450844551636914
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IL33,Interleukin-33,41913,0.003025787350126,0.00403159810016567,-0.00487614492619871,0.0109277196264507,0.452955990365709
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,EIF5A,Eukaryotic translation initiation factor 5A-1,41913,-0.00235162670596869,0.00315885545894758,-0.00854298340550596,0.00383972999356857,0.456614211021284
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SEZ6,Seizure protein 6 homolog,39649,-0.0023960150852231,0.00322317355365021,-0.0087134352503775,0.00392140507993131,0.457272651497346
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CLSTN2,Calsyntenin-2,42296,-0.00302005161949636,0.00409516613464542,-0.0110465772434014,0.00500647400440866,0.460850780274643
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SYNGAP1,Ras/Rap GTPase-activating protein SynGAP,39586,-0.00433385672290286,0.0058885332800916,-0.0158753819518824,0.00720766850607669,0.461757135856391
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,HMMR,Hyaluronan mediated motility receptor,39541,0.00366130692098542,0.00497822872676653,-0.00609602138347698,0.0134186352254478,0.462072855496532
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CCS,Copper chaperone for superoxide dismutase,42016,0.0034661238416265,0.00473000058616757,-0.00580467730726193,0.0127369249905149,0.463695879052391
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MORF4L1,Mortality factor 4-like protein 1,39757,0.00296028876992471,0.00406649226362067,-0.0050100360667718,0.0109306136066212,0.466646566034607
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,HTR1A,5-hydroxytryptamine receptor 1A,39586,-0.00541389952767831,0.0074563322021836,-0.0200283106439582,0.00920051158860154,0.467804716640354
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,UXS1,UDP-glucuronic acid decarboxylase 1,41843,-0.00377456084136058,0.00524998468194105,-0.014064530817965,0.00651540913524387,0.472174512857704
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,C1GALT1C1,C1GALT1-specific chaperone 1,39575,0.00240450626128851,0.00335985503343211,-0.00418080960423843,0.00898982212681546,0.474217935994666
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SERPINA11,Serpin A11,42310,0.00305501759164675,0.00426895317580494,-0.00531213063293092,0.0114221658162244,0.474228178793505
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CDC25A,M-phase inducer phosphatase 1,39560,-0.00292275351100521,0.00412398729940973,-0.0110057686178483,0.00516026159583786,0.478513139315406
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,LYPD1,Ly6/PLAUR domain-containing protein 1,41839,-0.00437501581927373,0.00617779685652539,-0.0164834976580635,0.00773346601951604,0.478843576219807
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,HSD17B3,Testosterone 17-beta-dehydrogenase 3,39575,0.00349062567324583,0.00492990837759158,-0.00617199474683367,0.0131532460933253,0.478928734794753
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SUSD4,Sushi domain-containing protein 4,39919,-0.00280392791864451,0.00397006138826172,-0.0105852482396375,0.00497739240234846,0.480035931996415
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ERCC1,DNA excision repair protein ERCC-1,39560,-0.00243006985397989,0.00344125916404185,-0.00917493781550192,0.00431479810754215,0.480105408338512
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NT5C3A,Cytosolic 5'-nucleotidase 3A,42087,-0.00623418386546375,0.00883309974997393,-0.0235470593754127,0.0110786916444852,0.480340058005355
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,RGMA,Repulsive guidance molecule A,42249,0.00231967669975551,0.00328707127021004,-0.00412298298985617,0.00876233638936719,0.480388561664813
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PLXDC1,Plexin domain-containing protein 1,41843,0.00230031371246514,0.00329633366774229,-0.00416050027630974,0.00876112770124002,0.48528946972644
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,C1RL,Complement C1r subcomponent-like protein,39958,-0.00140533122022128,0.00202689593481315,-0.00537804725245505,0.00256738481201249,0.488109395565913
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TCN1,Transcobalamin-1,39806,0.00253797523346553,0.00367085969904711,-0.00465690977666681,0.00973286024359788,0.489338309878951
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TPBGL,Trophoblast glycoprotein-like,39649,-0.00287882597670165,0.00418349713611231,-0.0110784803634818,0.00532082841007846,0.491379934061454
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TXK,Tyrosine-protein kinase TXK,39757,0.00516946000611943,0.00755660572913935,-0.00964148722299369,0.0199804072352326,0.493927397816125
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MN1,Transcriptional activator MN1,39649,-0.00413393366155937,0.00606288901865369,-0.0160171961381206,0.00774932881500187,0.495353021085365
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SPINT3,Kunitz-type protease inhibitor 3,39930,-0.0116447007866472,0.0171084437703487,-0.0451772505765306,0.0218878490032362,0.496112863078115
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,EIF2AK3,Eukaryotic translation initiation factor 2-alpha kinase 3,39575,0.00455176431820619,0.00673516160995646,-0.00864915243730848,0.0177526810737209,0.499168477135882
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,BST1,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 2,42249,0.00321809530805862,0.00477200908941244,-0.00613504250718977,0.012571233123307,0.500088126191752
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PRR5,Proline-rich protein 5,39657,-0.00327687723248037,0.00486014521120805,-0.0128027618464482,0.00624900738148741,0.500176379308425
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,RNF168,E3 ubiquitin-protein ligase RNF168,39657,0.00283087844958946,0.00420145366235496,-0.00540397072862626,0.0110657276278052,0.500461795221639
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TAGLN3,Transgelin-3,39560,-0.00415974594714004,0.00617879151012225,-0.0162701773069796,0.00795068541269957,0.500815365083086
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CASP8,Caspase-8,42224,0.00420647506296165,0.00625278940478043,-0.008048992170408,0.0164619422963313,0.501126819738047
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,KIR3DL2,Killer cell immunoglobulin-like receptor 3DL2,39560,-0.00564194887993106,0.00840190119871452,-0.0221096752294115,0.0108257774695494,0.501910737868927
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TMED4,Transmembrane emp24 domain-containing protein 4,39575,-0.00382572835062391,0.00570313792489401,-0.0150038786834162,0.00735242198216835,0.502354977525281
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ITIH1,Inter-alpha-trypsin inhibitor heavy chain H1,39979,0.00126506753836896,0.00188655593431376,-0.00243258209288602,0.00496271716962393,0.502508201306893
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TPPP2,Tubulin polymerization-promoting protein family member 2,39757,-0.00523887373942626,0.00786969039474519,-0.0206634669131268,0.0101857194342743,0.505614942501007
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PODXL2,Podocalyxin-like protein 2,42181,-0.00193332074299932,0.00292191915941509,-0.00766028229545289,0.00379364080945425,0.508199556584878
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TSC1,Hamartin,39657,-0.00500152581674466,0.00762196869258413,-0.0199405844542095,0.00993753282072023,0.511709951062721
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,BPIFA2,BPI fold-containing family A member 2,39281,-0.0074324361527412,0.0114023931320937,-0.0297811266916448,0.0149162543861624,0.514524065938649
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CAMLG,Guided entry of tail-anchored proteins factor CAMLG,39649,0.0036544128596034,0.00562386243050345,-0.00736835750418337,0.0146771832233902,0.515831820231603
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PRDX5,"Peroxiredoxin-5, mitochondrial",42296,0.00437883138371388,0.00675390153546143,-0.00885881562579052,0.0176164783932183,0.516775280332247
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TNFAIP8L2,Tumor necrosis factor alpha-induced protein 8-like protein 2,39736,0.00423100949855814,0.00658234412124789,-0.00867038497908773,0.017132403976204,0.520379076266525
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NDST1,Bifunctional heparan sulfate N-deacetylase/N-sulfotransferase 1,39919,-0.00391081784781765,0.00610979347704885,-0.0158860130628334,0.00806437736719811,0.522127030796161
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SHH,Sonic hedgehog protein,39657,0.00280636581745969,0.00439414742987203,-0.00580616314508949,0.0114188947800089,0.523057424168581
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,JMJD1C,Probable JmjC domain-containing histone demethylation protein 2C,39560,-0.0038639489408451,0.0060521604281655,-0.0157261833800495,0.00799828549835929,0.523199818444304
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DUSP29,Dual specificity phosphatase 29,39649,-0.00440910146992716,0.00693214645329799,-0.0179961085183912,0.00917790557853689,0.524765495776522
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MEPE,Matrix extracellular phosphoglycoprotein,42123,-0.00152528802592731,0.00240483831250303,-0.00623877111843325,0.00318819506657863,0.52592316644346
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ECE1,Endothelin-converting enzyme 1,41839,0.00229005428679106,0.00361384698076916,-0.00479308579551649,0.00937319436909861,0.526294895612803
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,KCNC4,Potassium voltage-gated channel subfamily C member 4,39586,-0.00358955387980013,0.00567144446829021,-0.0147055850376489,0.00752647727804868,0.526800989195072
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SCN3A,Sodium channel protein type 3 subunit alpha,39649,0.00238665022033069,0.00377845281907817,-0.00501911730506253,0.00979241774572391,0.527630318258729
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PCNA,Proliferating cell nuclear antigen,39560,-0.00418431914694361,0.0066380729609097,-0.0171949421503266,0.0088263038564394,0.528477787324371
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NFKB2,Nuclear factor NF-kappa-B p100 subunit,39757,0.00360414524630552,0.00572129923290454,-0.00760960125018739,0.0148178917427984,0.528738735388544
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ITGA6,Integrin alpha-6,42119,0.00327815194625398,0.00520693669926183,-0.0069274439842992,0.0134837478768072,0.528983980466913
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,H2AP,Huntingtin-interacting protein M,39560,-0.00324903071339778,0.00518683259169002,-0.0134152225931102,0.00691716116631466,0.531065809761664
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,BAG3,BAG family molecular chaperone regulator 3,41992,0.00259104726842747,0.00414206606110428,-0.00552740221133692,0.0107094967481919,0.531624312131166
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CES2,Cocaine esterase,42070,0.00355430957804769,0.00569749676276266,-0.00761278407696712,0.0147214032330625,0.53274516833381
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,HDAC9,Histone deacetylase 9,39586,0.0042852772000466,0.00687504714308482,-0.00918981520039964,0.0177603696004928,0.533094573344516
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SH3BGRL2,SH3 domain-binding glutamic acid-rich-like protein 2,39586,0.00396464824043065,0.00637340030259033,-0.00852721635264639,0.0164565128335077,0.533914205855798
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IL13RA1,Interleukin-13 receptor subunit alpha-1,41936,-0.00152648329461524,0.0024548144794869,-0.00633791967440956,0.00328495308517908,0.534062678332688
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CEP290,Centrosomal protein of 290 kDa,39757,0.00339611760478436,0.00547292090525054,-0.0073308073695067,0.0141230425790754,0.534920863150929
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MAG,Myelin-associated glycoprotein,39649,-0.00310209226632508,0.00500747465522858,-0.0129167425905731,0.00671255805792293,0.535604830434119
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,BNIP2,BCL2/adenovirus E1B 19 kDa protein-interacting protein 2,39958,-0.00218299337883191,0.00352697400246006,-0.00909586242365363,0.00472987566598981,0.535966788338987
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NUDT10,Diphosphoinositol polyphosphate phosphohydrolase 3-alpha,39638,0.00162915038255329,0.00263623505122924,-0.00353787031785602,0.0067961710829626,0.536598810421481
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PPM1B,Protein phosphatase 1B,39657,0.00391664166823509,0.00635406571013882,-0.00853732712363699,0.0163706104601072,0.537643703797521
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MFAP3L,Microfibrillar-associated protein 3-like,39649,0.00406517999620183,0.00663116256706599,-0.00893189863524751,0.0170622586276512,0.539861303419611
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,OFD1,Oral-facial-digital syndrome 1 protein,39757,-0.00418165238564503,0.00682592437319305,-0.0175604641571034,0.00919715938581334,0.540144515732334
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CEACAM18,Carcinoembryonic antigen-related cell adhesion molecule 18,39757,-0.00430720463493518,0.00704300130472026,-0.0181114871921869,0.00949707792231652,0.540842614658803
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GPR158,Probable G-protein coupled receptor 158,39934,-0.00217758603720856,0.00357331301994926,-0.0091812795563091,0.00482610748189199,0.542269868876519
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PTEN,"Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN",41839,0.00187762629094389,0.00308972467117156,-0.00417823406455236,0.00793348664644014,0.543396755979224
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CREB3,Cyclic AMP-responsive element-binding protein 3,39560,0.00349829889244654,0.00578158471434597,-0.00783360714767156,0.0148302049325646,0.545140942407687
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IZUMO1,Izumo sperm-egg fusion protein 1,39560,-0.0030350370903939,0.00503307135651877,-0.0128998569491707,0.0068297827683829,0.54650860192518
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TYRP1,"5,6-dihydroxyindole-2-carboxylic acid oxidase",39657,0.00386066123862734,0.00641674688241681,-0.00871616265090962,0.0164374851281643,0.547416830878073
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,VSIG10L,V-set and immunoglobulin domain-containing protein 10-like,39575,-0.002106217104141,0.00350234436073269,-0.00897081205117707,0.00475837784289507,0.547603662242275
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FAM171A2,Protein FAM171A2,39934,0.00963982952805428,0.0160954357703196,-0.0219072245817721,0.0411868836378806,0.549240228200609
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MANSC1,MANSC domain-containing protein 1,42181,-0.00169854879662988,0.00284217399447291,-0.00726920982579679,0.00387211223253703,0.550101420081078
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,BSND,Barttin,39560,0.00204467809059574,0.00345465376360678,-0.00472644328607355,0.00881579946726503,0.553955247632888
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,LYVE1,Lymphatic vessel endothelial hyaluronic acid receptor 1,39979,-0.00117028414803822,0.00199075806848144,-0.00507216996226184,0.0027316016661854,0.556638907220908
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ITIH5,Inter-alpha-trypsin inhibitor heavy chain H5,39919,-0.00265161239976743,0.00454073129573156,-0.0115514457394013,0.00624822093986642,0.559257830663232
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MRPL58,"Peptidyl-tRNA hydrolase ICT1, mitochondrial",39934,0.00420081092747724,0.00721296335326681,-0.00993659724492571,0.0183382190998802,0.560310633889284
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TRAF3IP2,E3 ubiquitin ligase TRAF3IP2,39575,0.00282418592917464,0.00487734222219077,-0.00673540482631928,0.0123837766846685,0.562572726673866
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,LHB,Lutropin subunit beta,41843,-0.00521001008374493,0.00905465493941294,-0.0229571337649943,0.0125371135975044,0.565033445405479
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SEMA4C,Semaphorin-4C,42070,-0.0016346606576484,0.00285062365870795,-0.00722188302871599,0.00395256171341919,0.566356617727015
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PLCB1,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-1",39657,-0.00251825584403921,0.00439731398135107,-0.0111369912474873,0.00610047955940888,0.566872706752913
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MZT1,Mitotic-spindle organizing protein 1,41843,0.00305897023935386,0.00537699415289783,-0.00747993830032589,0.0135978787790336,0.569433871815845
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TCL1B,T-cell leukemia/lymphoma protein 1B,41900,-0.00440375836264708,0.00776383782160789,-0.0196208804929986,0.0108133637677044,0.570578295580297
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,BTN1A1,Butyrophilin subfamily 1 member A1,39894,-0.00223013000476209,0.00394695658303748,-0.00996616490751555,0.00550590489799137,0.572067834146664
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DDX25,ATP-dependent RNA helicase DDX25,39649,-0.00207686371203446,0.00368927142843635,-0.00930783571176971,0.00515410828770079,0.573482502257637
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CCL26,C-C motif chemokine 26,42119,0.00512374273541448,0.00918127530455204,-0.0128715568615075,0.0231190423323365,0.576809662248262
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,HDAC8,Histone deacetylase 8,39657,0.00344875295602378,0.00620160401206322,-0.00870639090762014,0.0156038968196677,0.578149232620816
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CGB3_CGB5_CGB8,Choriogonadotropin subunit beta 3,39990,-0.00210352967220051,0.00379941419169401,-0.00955038148792078,0.00534332214351976,0.579832149598133
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,KLK1,Kallikrein-1,42016,-0.00721935578669138,0.0130846192727168,-0.0328652095612163,0.0184264979878336,0.58113317911849
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PFDN6,Prefoldin subunit 6,39649,-0.0036820906002419,0.00667515795978192,-0.0167654002014145,0.00940121900093066,0.581226049208383
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SFTPA2,Pulmonary surfactant-associated protein A2,41843,-0.00292483926644789,0.00530615275628561,-0.0133248986687677,0.00747522013587191,0.581494529118528
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TCP11,T-complex protein 11 homolog,39757,-0.00327467540415509,0.00596872670794959,-0.0149733797517363,0.00842402894342611,0.583264291627206
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,AFP,Alpha-fetoprotein,41976,-0.00364771186650741,0.00665584025334388,-0.0166931587630614,0.00939773503004659,0.58366892276115
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MTHFD2,"Bifunctional methylenetetrahydrofolate dehydrogenase/cyclohydrolase, mitochondrial",39929,0.00141141352866052,0.00260812157530294,-0.00370050475893325,0.00652333181625428,0.588407296682999
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NUDT15,Nucleotide triphosphate diphosphatase NUDT15,39575,0.00282424192164458,0.0052330186535689,-0.00743247463935046,0.0130809584826396,0.589417294229859
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MELTF,Melanotransferrin,39958,-0.00166939832809958,0.0030946574088965,-0.00773492684953673,0.00439613019333757,0.589590219973406
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GRIK2,"Glutamate receptor ionotropic, kainate 2",39934,0.00231318076711962,0.00429188739057632,-0.00609891851840995,0.0107252800526492,0.589920999353507
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IMPG1,Interphotoreceptor matrix proteoglycan 1,39586,-0.00167809088247477,0.00312306456319549,-0.00779929742633793,0.00444311566138839,0.591056185758137
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,HBZ,Hemoglobin subunit zeta,39958,-0.00593617337072375,0.01104821611462,-0.0275906769553789,0.0157183302139314,0.591073003144858
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IL5RA,Interleukin-5 receptor subunit alpha,42119,-0.00312520580554967,0.00581935013276501,-0.0145311320657691,0.00828072045466976,0.591250957773321
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ANKRA2,Ankyrin repeat family A protein 2,39560,0.00302005866553558,0.00566656078990134,-0.00808640048267105,0.0141265178137422,0.594071046248243
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IMPA1,Inositol monophosphatase 1,42016,-0.00331894542823838,0.00624167999652739,-0.0155526382214321,0.0089147473649553,0.594915497726904
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ECSCR,Endothelial cell-specific chemotaxis regulator,39586,0.00272794352250436,0.00515928817462403,-0.00738426129975875,0.0128401483447675,0.596993616283324
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CLPS,Colipase,42115,-0.00398241212878674,0.00753690758607462,-0.018754750997493,0.0107899267399195,0.597238685130681
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,KLK12,Kallikrein-12,41843,0.00720932861101845,0.0136526716882315,-0.0195499078979152,0.0339685651199521,0.597471684833212
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PITHD1,PITH domain-containing protein 1,39539,-0.00419464775308799,0.007949477018645,-0.0197756227096322,0.0113863272034562,0.597743710408087
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,EDAR,Tumor necrosis factor receptor superfamily member EDAR,42119,0.00491747766033811,0.00936392315183191,-0.0134358117172524,0.0232707670379287,0.599486536116465
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TET2,Methylcytosine dioxygenase TET2,39750,0.0054306925227322,0.0103675761626618,-0.014889756756085,0.0257511418015494,0.600417589180647
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FHIP2A,FHF complex subunit HOOK interacting protein 2A,39575,-0.00247644027845407,0.00477193953616574,-0.0118294417693389,0.00687656121243079,0.603799897653904
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ISM2,Isthmin-2,39966,-0.00231302646396502,0.00446242161199778,-0.0110593728234807,0.00643331989555063,0.604235091300564
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NRN1,Neuritin,39934,-0.00185561753914597,0.00358385119781295,-0.00887996588685934,0.00516873080856741,0.604627513248933
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DLL4,Delta-like protein 4,39638,0.00468605011527683,0.00907604206366859,-0.0131029923295136,0.0224750925600673,0.605648345300579
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PTPRZ1,Receptor-type tyrosine-protein phosphatase zeta,39958,-0.00163412236426862,0.0031853257031675,-0.00787736074247691,0.00460911601393968,0.607950256840371
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DDA1,DET1- and DDB1-associated protein 1,39575,-0.00206598889862146,0.00403158441219645,-0.0099678943465265,0.00583591654928358,0.608345816080544
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,HSP90B1,Endoplasmin,41774,-0.00332792182812181,0.00649584714863155,-0.0160597822394397,0.00940393858319603,0.6084389531904
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DUSP3,Dual specificity protein phosphatase 3,41839,0.00449893713275419,0.00878658710649713,-0.0127227735959802,0.0217206478614886,0.608643258909505
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,HEPACAM2,HEPACAM family member 2,39929,-0.00228935815062779,0.00449394541112311,-0.0110974911564291,0.00651877485517351,0.610459599263645
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GBA,Lysosomal acid glucosylceramidase,39649,0.00288873217372504,0.00570764347668804,-0.00829824904058352,0.0140757133880336,0.612785010728443
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CDH23,Cadherin-23,39929,0.00138609508679253,0.00275261257442445,-0.0040090255590794,0.00678121573266445,0.61458307948707
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,KLKB1,Plasma kallikrein,39759,0.00126485442621492,0.0025175938744797,-0.00366962956776529,0.00619933842019512,0.61539182898242
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PGR,Progesterone receptor,39657,0.00517983620362935,0.0103226722380862,-0.0150526013830196,0.0254122737902783,0.615823705821138
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IL13,Interleukin-13,41913,-0.00248634277392198,0.00496692084757868,-0.0122215076351762,0.00724882208733222,0.61667479828499
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CA4,Carbonic anhydrase 4,42310,-0.00123842209616359,0.00247939831904555,-0.00609804280149286,0.00362119860916568,0.617445815855906
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TMED10,Transmembrane emp24 domain-containing protein 10,39575,0.00239281579953648,0.00479896758398732,-0.00701316066507866,0.0117987922641516,0.61806377369978
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IL4,Interleukin-4,41913,-0.00477810832674102,0.0096467106781178,-0.0236856612558519,0.0141294446023699,0.620389776353898
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FBLN2,Fibulin-2,39966,-0.0016335726228464,0.00330317450482049,-0.00810779465229457,0.00484064940660176,0.620929997432603
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,BTNL10,Butyrophilin-like protein 10,39560,-0.00202780607757767,0.00410600103778608,-0.0100755681116384,0.00601995595648304,0.621412130515168
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CSRP3,Cysteine and glycine-rich protein 3,39575,0.0051304211219565,0.0104181392824373,-0.0152891318716205,0.0255499741155335,0.622410538924349
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CCDC28A,Coiled-coil domain-containing protein 28A,39649,0.00151066533635598,0.00310080446590991,-0.00456691141682745,0.0075882420895394,0.626136919155655
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PSMD5,26S proteasome non-ATPase regulatory subunit 5,39649,-0.00270439902485108,0.0055682416022537,-0.0136181525652683,0.00820935451556618,0.627201729968216
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,EXOSC10,Exosome component 10,39575,-0.00285922268584671,0.00600110673417846,-0.0146213918848365,0.00890294651314308,0.633763853689231
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,LMOD2,Leiomodin-2,39586,0.00301779506179549,0.00633632713265253,-0.00940140611820347,0.0154369962417944,0.633892345550743
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,LYSMD3,LysM and putative peptidoglycan-binding domain-containing protein 3,39649,0.0050821803032608,0.01067759046909,-0.0158458970161557,0.0260102576226772,0.63410732541086
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CASQ2,Calsequestrin-2,39575,-0.00232359488840621,0.00489859157429209,-0.0119248343740187,0.00727764459720628,0.635267351102434
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ATP2B4,Plasma membrane calcium-transporting ATPase 4,39575,0.00306447509093503,0.00647100226701788,-0.00961868935242002,0.0157476395342901,0.635815711580638
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,RLN1,Prorelaxin H1,39934,0.00215585117826245,0.00456710312926279,-0.00679567095509261,0.0111073733116175,0.636907979009434
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,HNF1A,Hepatocyte nuclear factor 1-alpha,39649,0.00335605619361602,0.00719175222000717,-0.010739778157598,0.0174518905448301,0.64075701921228
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PHLDB2,Pleckstrin homology-like domain family B member 2,39560,0.00437126110389154,0.00942345853192807,-0.0140987176186875,0.0228412398264706,0.64274999402359
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PTPRR,Receptor-type tyrosine-protein phosphatase R,39929,-0.0017935708192102,0.00388986695975263,-0.00941771006032536,0.00583056842190497,0.644744351367343
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,YY1,Transcriptional repressor protein YY1,39657,-0.00131128155103968,0.00287314496001812,-0.0069426456726752,0.00432008257059584,0.648116787416246
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ARHGEF5,Rho guanine nucleotide exchange factor 5,39586,0.00354604699631735,0.00780383046442667,-0.0117494607139589,0.0188415547065936,0.649551180886998
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MYO6,Unconventional myosin-VI,39934,0.0017461716360854,0.00385641189669778,-0.00581239568144225,0.00930473895361306,0.650703610039315
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PGLYRP4,Peptidoglycan recognition protein 4,39575,-0.00269780832289943,0.00605756855072343,-0.0145706426823174,0.00917502603651849,0.656067253860305
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CLSTN1,Calsyntenin-1,41839,-0.00230863469713684,0.00518493727250754,-0.0124711117512516,0.00785384235697794,0.656140610535747
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MB,Myoglobin,42310,0.00252604267883623,0.00573326980432473,-0.00871116613764024,0.0137632514953127,0.659514095651737
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PAEP,Glycodelin,42016,-0.00466404674723794,0.0106927797294341,-0.0256218950169288,0.016293801522453,0.662708401048266
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,OGT,UDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunit,39757,0.00283889512248279,0.00653480917700878,-0.00996933086445441,0.01564712110942,0.663987065197229
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,LAMA1,Laminin subunit alpha-1,39575,-0.00229542420337269,0.00532083621615325,-0.0127242631870331,0.00813341478028768,0.666183911178202
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,KLK15,Kallikrein-15,39900,0.00231662549392057,0.00541734758629199,-0.00830137577521174,0.0129346267630529,0.668927977938788
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PRKAG3,5'-AMP-activated protein kinase subunit gamma-3,39649,0.00137593211170241,0.00322963389275032,-0.00495415031808822,0.00770601454149303,0.670091761381485
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IL2RB,Interleukin-2 receptor subunit beta,41913,-0.00156648714865696,0.00371932457339346,-0.00885636331250814,0.00572338901519423,0.673633975652163
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,RASA1,Ras GTPase-activating protein 1,41839,-0.00139653087972666,0.00333507855083489,-0.00793328483936304,0.00514022307990971,0.675412932722927
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MANSC4,MANSC domain-containing protein 4,39575,-0.00292644083577424,0.00699659840011969,-0.0166397737000088,0.0107868920284603,0.675760660968246
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,RASGRF1,Ras-specific guanine nucleotide-releasing factor 1,39560,-0.00189247363876829,0.00452970777123258,-0.0107707008703841,0.00698575359284756,0.676107712741842
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DDX39A,ATP-dependent RNA helicase DDX39A,39657,0.00104621296347583,0.00252918383486665,-0.00391098735286281,0.00600341327981446,0.679133818476065
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,OMP,Olfactory marker protein,39586,-0.00201666897267317,0.00494095639108956,-0.0117009434992087,0.00766760555386238,0.68316888983679
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,UHRF2,E3 ubiquitin-protein ligase UHRF2,39575,-0.00143869224026707,0.00354066019693801,-0.00837838622626556,0.00550100174573142,0.684504793210339
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GATA3,Trans-acting T-cell-specific transcription factor GATA-3,39560,0.00111327977308784,0.00274585799377365,-0.00426860189470852,0.00649516144088419,0.685162266214055
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,METAP1,Methionine aminopeptidase 1,41839,0.00119650245166907,0.00297072973325456,-0.00462612782550986,0.007019132728848,0.687128483690787
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,BHLHE40,Class E basic helix-loop-helix protein 40,39586,0.00293682926617368,0.00730614034417455,-0.0113832058084084,0.0172568643407558,0.687715935963652
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TGFBR3,Transforming growth factor beta receptor type 3,42310,0.00122782503357284,0.00306901660414275,-0.00478744751054695,0.00724309757769263,0.689110338175356
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MORN4,MORN repeat-containing protein 4,39560,0.00321399204904453,0.00805820075983605,-0.0125800814402341,0.0190080655383232,0.690013453067793
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SCG3,Secretogranin-3,42144,-0.00134801940094388,0.00340391211415344,-0.00801968714468461,0.00532364834279686,0.692096051585579
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GSAP,Gamma-secretase-activating protein,41843,0.00341331833280513,0.00862164981511414,-0.0134851153048186,0.0203117519704288,0.692184565311056
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,RRP15,RRP15-like protein,39586,-0.00369667586487481,0.00939723169589367,-0.0221152499888264,0.0147218982590768,0.694047033824122
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MAGEA3,Melanoma-associated antigen 3,39757,0.00345873203015545,0.00889239858715119,-0.0139703692006609,0.0208878332609718,0.697317761378538
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CSH1,Chorionic somatomammotropin hormone 1,39990,0.00113691416643174,0.0029377754704817,-0.00462112575571239,0.00689495408857586,0.698764683162533
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TAP1,Antigen peptide transporter 1,39757,0.00230825363898775,0.0060207209101504,-0.00949235934490704,0.0141088666228825,0.701441683299025
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NINJ1,Ninjurin-1,41843,-0.00209213398514253,0.00555985252348551,-0.0129894449311741,0.00880517696088907,0.706705057430963
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MCTS1,Malignant T-cell-amplified sequence 1,39930,0.00100878224412623,0.00269547834791613,-0.00427435531778937,0.00629191980604184,0.708225476887958
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DUOX2,Dual oxidase 2,41900,-0.00264186368777225,0.00718113508830054,-0.0167168884608413,0.0114331610852968,0.712961537064457
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ITGB6,Integrin beta-6,41913,-0.0011463950289657,0.00314019977668617,-0.00730118659127059,0.00500839653333918,0.715064407581411
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GZMB,Granzyme B,42119,0.00251749674697052,0.00693621433999924,-0.011077483359428,0.016112476853369,0.716648151625183
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CINP,Cyclin-dependent kinase 2-interacting protein,39757,0.0015671310027345,0.0043528886984079,-0.00696453084614499,0.010098792851614,0.718838302270966
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ANXA4,Annexin A4,42088,0.00265260076797044,0.00741669605212474,-0.0118841234941941,0.0171893250301349,0.72060889126852
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IL1B,Interleukin-1 beta,41825,0.00206137420698124,0.00576489259028058,-0.0092378152699687,0.0133605636839312,0.720668038800784
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,C1QTNF5,Complement C1q tumor necrosis factor-related protein 5,39736,0.00135219146778168,0.00378724474212825,-0.00607080822678968,0.00877519116235305,0.721069890277973
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CTLA4,Cytotoxic T-lymphocyte protein 4,39966,0.00110254319134513,0.00311075970112438,-0.00499454582285866,0.00719963220554892,0.723024041981368
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,RGS10,Regulator of G-protein signaling 10,39934,0.0021694844548888,0.00613634547434262,-0.00985775267482273,0.0141967215846003,0.723685229521906
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,RAB6B,Ras-related protein Rab-6B,41839,0.00170248757445872,0.00484572974839445,-0.00779514273239441,0.0112001178813118,0.725340601290357
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ITGA2,Integrin alpha-2,39736,0.00125168303754079,0.00356554862779866,-0.00573679227294458,0.00824015834802616,0.725558069564743
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,KIAA2013,Uncharacterized protein KIAA2013,39919,0.0019339922400815,0.00553440058068358,-0.00891343289805832,0.0127814173782213,0.726758550933431
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PPIE,Peptidyl-prolyl cis-trans isomerase E,39757,0.0022138367091379,0.00633560777427968,-0.0102039545284503,0.0146316279467261,0.726774852561885
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ITGB5,Integrin beta-5,42181,-0.00135339397143095,0.00392992990832383,-0.00905605659174565,0.00634926864888375,0.730564958789289
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CA8,Carbonic anhydrase-related protein,39657,0.000938851121734266,0.00274402057531257,-0.00443942920587837,0.0063171314493469,0.73224876958212
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ITGB2,Integrin beta-2,42079,-0.000999682884384767,0.00293451162340068,-0.0067513256662501,0.00475195989748057,0.733361745331756
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ATP1B4,Protein ATP1B4,39560,-0.00146584579290799,0.0043119405689042,-0.00991724930796022,0.00698555772214424,0.733900417616316
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DCDC2C,Doublecortin domain-containing protein 2C,39560,0.00221490073631866,0.00653782448433311,-0.0105992352529742,0.0150290367256116,0.734780051009934
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,EPHA10,Ephrin type-A receptor 10,41839,-0.0022746299211245,0.00672730977022529,-0.0154601570707661,0.0109108972285171,0.735279023429857
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GABRA4,Gamma-aminobutyric acid receptor subunit alpha-4,39586,-0.00222527723425643,0.00669811077246901,-0.0153535743482957,0.0109030198797828,0.739726000813743
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NXPE4,NXPE family member 4,39575,-0.00109201458923686,0.00329378780920378,-0.00754783869527627,0.00536380951680254,0.740244755683031
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,KDM3A,Lysine-specific demethylase 3A,39657,0.00300896106565642,0.00913278132250417,-0.0148912903264517,0.0209092124577646,0.741808063378049
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IVD,"Isovaleryl-CoA dehydrogenase, mitochondrial",41839,0.0017067033695554,0.00521052951914163,-0.00850593448796219,0.011919341227073,0.743257920331979
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,VWF,von Willebrand factor,42310,-0.00246663348861353,0.00756769582036099,-0.0172993172965211,0.012366050319294,0.744472854886747
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PTPN6,Tyrosine-protein phosphatase non-receptor type 6,42166,-0.00297710530152681,0.00918964822024644,-0.0209888158132098,0.0150346052101562,0.745971098900827
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NOS2,"Nitric oxide synthase, inducible",39575,-0.00134260949781021,0.0041500780155354,-0.00947676240825959,0.00679154341263918,0.746311959278268
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SKIV2L,Helicase SKI2W,39575,0.00130968176204112,0.00407403587802471,-0.00667542855888731,0.00929479208296955,0.747860095722413
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ASGR2,Asialoglycoprotein receptor 2,39990,0.000873587750050837,0.00272375668445624,-0.0044649753514834,0.00621215085158507,0.74842165469813
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ENDOU,Poly(U)-specific endoribonuclease,39090,0.00186579336834327,0.00582342662770501,-0.00954812282195855,0.0132797095586451,0.748675740326025
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,LMOD1,Leiomodin-1,39934,-0.00114096420709296,0.0035753744868474,-0.00814869820131386,0.00586676978712794,0.74964337124212
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GAMT,Guanidinoacetate N-methyltransferase,39575,-0.00116015235661852,0.00364207364255004,-0.00829861669601661,0.00597831198277956,0.750080124381219
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NME1,Nucleoside diphosphate kinase A,39657,-0.000714902557847633,0.00225989295017532,-0.00514429274019127,0.003714487624496,0.751747730704322
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NPTN,Neuroplastin,41843,0.0025009928738093,0.00801422872369639,-0.0132068954246356,0.0182088811722542,0.75499294807269
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SCIN,Adseverin,39586,0.00237021291899995,0.0076037055441028,-0.0125330499474415,0.0172734757854414,0.755260658918243
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TERF1,Telomeric repeat-binding factor 1,39657,-0.000932529223324068,0.00299510186765553,-0.0068029288839289,0.00493787043728076,0.755539349715248
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CALCB,Calcitonin gene-related peptide 2,39929,0.00130074499603528,0.00417845072844777,-0.00688901843172234,0.0094905084237929,0.755579516802018
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FAP,Prolyl endopeptidase FAP,42310,-0.000858531997720755,0.00281251003301361,-0.00637105166242743,0.00465398766698592,0.760176783822416
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TNFAIP8,Tumor necrosis factor alpha-induced protein 8,41913,-0.00112374404007594,0.00376765382704198,-0.00850834554107821,0.00626085746092634,0.765508654543621
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TOP1MT,"DNA topoisomerase I, mitochondrial",39560,-0.00148017629676464,0.00496332372565487,-0.0112082907990482,0.0082479382055189,0.765538774722485
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MYOM2,Myomesin-2,39575,0.00167907170926178,0.0057378921091673,-0.00956719682470612,0.0129253402432297,0.769811532617524
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,HMGCS1,"Hydroxymethylglutaryl-CoA synthase, cytoplasmic",39575,-0.00128305222282864,0.00438659816498688,-0.00988078462620293,0.00731468018054565,0.769914723506856
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CD164L2,CD164 sialomucin-like 2 protein,39649,-0.00109779263753248,0.00376371139877549,-0.00847466697913245,0.00627908170406749,0.770538139885408
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ITGAX,Integrin alpha-X,39757,0.00154351969143452,0.00532959663977723,-0.00890248972252884,0.0119895291053979,0.772117814091751
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IL9,Interleukin-9,39757,-0.00166951782946863,0.00579471971560806,-0.0130271684720604,0.00968813281312317,0.773267740294986
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ADRA2A,Alpha-2A adrenergic receptor,39575,-0.00204503243943509,0.00715351980049195,-0.0160659312483993,0.0119758663695291,0.774977119668201
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FOS,Proto-oncogene c-Fos,39539,-0.00105154736327037,0.00371606339734954,-0.00833503162207547,0.00623193689553474,0.777202526566658
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,AMIGO1,Amphoterin-induced protein 1,39649,0.00147087303789233,0.00522141571812668,-0.00876310176963595,0.0117048478454206,0.778178796288839
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ZP3,Zona pellucida sperm-binding protein 3,39638,-0.00769177752494018,0.0274359583997487,-0.0614662559884477,0.0460827009385673,0.779211267270092
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ARID3A,AT-rich interactive domain-containing protein 3A,39586,-0.00114662029648892,0.0041508676179373,-0.00928232082764604,0.00698908023466819,0.782371777241616
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DDX53,Probable ATP-dependent RNA helicase DDX53,39649,-0.00102329496893212,0.00372788095137694,-0.00832994163363092,0.00628335169576669,0.783707257062371
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,BLOC1S2,Biogenesis of lysosome-related organelles complex 1 subunit 2,39586,0.00211197188793617,0.00770055251034479,-0.0129811110323396,0.017205054808212,0.783888146540087
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IL11,Interleukin-11,41913,-0.00170580682195863,0.00622659698449201,-0.013909936911563,0.0104983232676457,0.784123522570056
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PSCA,Prostate stem cell antigen,39930,0.00726648315466283,0.0267682125144843,-0.0451992133737265,0.0597321796830521,0.786042660417564
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GID8,Glucose-induced degradation protein 8 homolog,39934,-0.000947732226844223,0.00350138055706803,-0.00781043811869756,0.00591497366500911,0.786646804039
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GLT8D2,Glycosyltransferase 8 domain-containing protein 2,41839,0.00124195826836714,0.00459096850668566,-0.00775634000473674,0.010240256541471,0.786762863200133
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,BRK1,Protein BRICK1,41839,0.0012415760289481,0.00464711815623736,-0.00786677555727714,0.0103499276151733,0.789341528473324
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MMP15,Matrix metalloproteinase-15,39958,0.00132295746194773,0.00500427361651081,-0.00848541882641346,0.0111313337503089,0.791503064360206
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MRPS16,"28S ribosomal protein S16, mitochondrial",39657,0.000798960685117995,0.00303193335306271,-0.00514362868688491,0.0067415500571209,0.792158379009356
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PPP1R14D,Protein phosphatase 1 regulatory subunit 14D,39934,-0.00101971142223177,0.00391592105642401,-0.00869491669282283,0.00665549384835929,0.794558874545732
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PTTG1,Securin,39757,0.00111780966328069,0.00429471836497313,-0.00729983833206664,0.00953545765862801,0.794656127775384
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,COL24A1,Collagen alpha-1(XXIV) chain,39930,0.00151166209008482,0.0058082925376887,-0.00987259128378503,0.0128959154639547,0.794668502312574
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,WASL,Neural Wiskott-Aldrich syndrome protein,39657,0.001531910277982,0.00605995020453319,-0.0103455921229031,0.0134094126788671,0.800433222602691
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PZP,Pregnancy zone protein,39979,0.000851348386271185,0.00341176199163005,-0.00583570511732371,0.00753840188986608,0.80295275409329
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GIPR,Gastric inhibitory polypeptide receptor,39657,0.00115655381229186,0.00465193775626611,-0.00796124418998971,0.0102743518145734,0.803661175175917
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SHC1,SHC-transforming protein 1,39560,-0.00299130510206927,0.0120450431423589,-0.0265995896610927,0.0206169794569542,0.803873494780387
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CRHR1,Corticotropin-releasing factor receptor 1,41900,-0.00147839142332718,0.00595953672148257,-0.013159083397433,0.0102023005507786,0.80408288878992
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NEDD9,Enhancer of filamentation 1,39657,0.000864080088224687,0.00348767793745125,-0.00597176866917977,0.00769992884562914,0.804330695515678
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MED21,Mediator of RNA polymerase II transcription subunit 21,39575,0.00122622071248091,0.00502756101369875,-0.00862779887436864,0.0110802402993305,0.807313046639525
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GLI2,Zinc finger protein GLI2,39657,0.000833352839975557,0.00341884463102179,-0.00586758263682716,0.00753428831677827,0.807426825431056
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SUMF1,Formylglycine-generating enzyme,39657,0.00165157272680052,0.00680550467689508,-0.0116872164399138,0.0149903618935149,0.808256340326762
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GAGE2A,G antigen 2A,39560,-0.00161314506101317,0.0067289633899543,-0.0148019133053236,0.0115756231832972,0.810542830386424
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FASLG,Tumor necrosis factor ligand superfamily member 6,42296,0.000877067948294004,0.00376579810215841,-0.00650389633193647,0.00825803222852448,0.81583974047695
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,AMDHD2,N-acetylglucosamine-6-phosphate deacetylase,39966,-0.000617107156561815,0.00267717165874194,-0.00586436360769601,0.00463014929457238,0.817701871985215
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SFTPA1,Pulmonary surfactant-associated protein A1,41843,-0.00130679575837518,0.00582208358989021,-0.01271807959456,0.0101044880778096,0.822406743023176
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TNFRSF21,Tumor necrosis factor receptor superfamily member 21,42249,0.000638498027934269,0.00285611755469408,-0.00495949237926614,0.00623648843513467,0.823107290826625
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CSF2RB,Cytokine receptor common subunit beta,39657,0.00095443572666625,0.00438139707330973,-0.00763310253702082,0.00954197399035332,0.827559186398157
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ESR1,Estrogen receptor,39657,0.00125590330046091,0.00588714828232378,-0.0102829073328937,0.0127947139338155,0.831073779166714
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CEP112,Centrosomal protein of 112 kDa,39575,-0.000970484463912692,0.00457077397351517,-0.00992920145200242,0.00798823252417704,0.831858309732324
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,HGFAC,Hepatocyte growth factor activator,39897,-0.000585708910622156,0.0027889803340562,-0.00605211036537231,0.004880692544128,0.833665012438763
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IL2,Interleukin-2,41913,0.00068558564694612,0.00326857598256148,-0.00572082327887439,0.00709199457276663,0.833865570576371
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GFOD2,Glucose-fructose oxidoreductase domain-containing protein 2,41843,0.00264410283405841,0.0126668187366258,-0.0221828618897282,0.027471067557845,0.834652506620709
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FSHB,Follitropin subunit beta,39638,-0.000868854121149545,0.00422206301842187,-0.00914409763725641,0.00740638939495732,0.836959530126996
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PXDNL,Peroxidasin-like protein,39919,-0.00120531649161335,0.00589541293301774,-0.0127603258403281,0.0103496928571014,0.838005627235263
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FABP6,Gastrotropin,41881,0.00118194455659093,0.00580605590875648,-0.0101979250245718,0.0125618141377536,0.838691882921522
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,AFAP1,Actin filament-associated protein 1,39736,0.00175204108673611,0.00861070096411734,-0.0151249328029339,0.0186290149764061,0.838769434339059
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ATF4,Cyclic AMP-dependent transcription factor ATF-4,39560,0.000689921535125121,0.00345443262609985,-0.00608076641203059,0.00746060948228083,0.841702766700823
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ZPR1,Zinc finger protein ZPR1,39586,-0.00198291231139301,0.00993019440200829,-0.0214460933393293,0.0174802687165432,0.841730527937412
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IL24,Interleukin-24,41913,0.000970382069415783,0.00492856177573302,-0.00868959901102093,0.0106303631498525,0.843917015274499
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PVALB,Parvalbumin alpha,42208,0.00223313697543805,0.0114351376254686,-0.0201797327704804,0.0246460067213565,0.845170966492858
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,RAB3GAP1,Rab3 GTPase-activating protein catalytic subunit,39586,0.00117880673971376,0.00605394791143105,-0.0106869311666911,0.0130445446461186,0.845618081870055
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IFNL2,Interferon lambda-2,39586,-0.00117299230097573,0.00603187648242126,-0.0129954702065214,0.0106494856045699,0.845814947631074
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IGFL4,Insulin growth factor-like family member 4,39657,-0.001409416246643,0.00736288324576213,-0.0158406674083368,0.0130218349150508,0.848198669221967
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MMUT,"Methylmalonyl-CoA mutase, mitochondrial",39575,-0.000988921889395303,0.00520054411434463,-0.0111819883535108,0.00920414457472017,0.849189317477646
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CPA4,Carboxypeptidase A4,39518,0.000837683304238306,0.0045351679933593,-0.00805124596274593,0.00972661257122254,0.85346124324549
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MTR,Methionine synthase,39575,0.00122438273743087,0.00672526343402175,-0.0119571335932518,0.0144058990681135,0.855541186601774
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CLSPN,Claspin,41820,-0.000649508840909298,0.00363450839476613,-0.00777314529465092,0.00647412761283233,0.858171213238595
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,UNG,Uracil-DNA glycosylase,39919,0.000645609464550728,0.00362896192896901,-0.00646715591622854,0.00775837484533,0.858800985646643
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DNM1,Dynamin-1,39930,0.00211635085525552,0.011922317140974,-0.0212513907410536,0.0254840924515646,0.859109644425874
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CEP152,Centrosomal protein of 152 kDa,39560,-0.000742520962054827,0.00432945494563527,-0.00922825265549995,0.0077432107313903,0.863830266541245
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FRZB,Secreted frizzled-related protein 3,41973,-0.000426941661621439,0.00252048541121348,-0.00536709306759987,0.00451320974435699,0.865493499908569
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PDE1C,"Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1C",39560,-0.000910427100816321,0.00555184866153551,-0.0117920504774259,0.00997119627579328,0.869744955397455
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ATP5PO,"ATP synthase subunit O, mitochondrial",41839,-0.000695232402610915,0.00426463309558462,-0.00905391326995677,0.00766344846473494,0.87050297595702
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TSPAN7,Tetraspanin-7,39586,0.00163261730906542,0.0100531360541357,-0.0180715293570406,0.0213367639751714,0.870994796411488
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TMED1,Transmembrane emp24 domain-containing protein 1,39757,0.000896047686799459,0.00554946281232998,-0.00998089942536729,0.0117729947989662,0.871729577846093
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,LRP2,Low-density lipoprotein receptor-related protein 2,39649,-0.000608434334492775,0.00377651004755999,-0.00801039402771036,0.00679352535872481,0.872009542840607
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IL1A,Interleukin-1 alpha,41913,-0.000950045203500844,0.00591458607469912,-0.0125426339099111,0.0106425435029094,0.87238922757523
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,APCS,Serum amyloid P-component,39870,-0.000536087732982008,0.00334891429588148,-0.00709995975290972,0.0060277842869457,0.872822445805581
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CEP164,Centrosomal protein of 164 kDa,41913,0.00101403275098617,0.00636131209876269,-0.0114541389625887,0.013482204464561,0.87335125253676
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ADGRV1,Adhesion G-protein coupled receptor V1,39586,-0.00113847342090761,0.00714277251470687,-0.0151383075497331,0.0128613607079179,0.87336599084384
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GART,Trifunctional purine biosynthetic protein adenosine-3,39934,-0.00043975394915728,0.00279611112059968,-0.00592013174553266,0.0050406238472181,0.875032171468605
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ACTN4,Alpha-actinin-4,41913,0.000504344114200523,0.00322428650474751,-0.00581525743510459,0.00682394566350563,0.875704047273426
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CSPG5,Chondroitin sulfate proteoglycan 5,39586,-0.000799539054502548,0.00515089255617995,-0.0108952884646152,0.00929621035561015,0.876648053180429
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FGF20,Fibroblast growth factor 20,39657,-0.000688251502336854,0.0044455530199895,-0.00940153542151628,0.00802503241684257,0.876967648344154
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GDF2,Growth/differentiation factor 2,42145,0.000557435234686624,0.00361845748957835,-0.00653474144488693,0.00764961191426018,0.877570022892342
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TNPO1,Transportin-1,39757,0.00056175102008008,0.00366156551026172,-0.00661491738003289,0.00773841942019305,0.878071218243563
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FUT1,"Galactoside alpha-(1,2)-fucosyltransferase 1",39730,-0.000942021903233048,0.0063965293232344,-0.0134792193767725,0.0115951755703064,0.882920957663343
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CDC123,Cell division cycle protein 123 homolog,39560,0.000948782837800283,0.00646280681056502,-0.0117183185109072,0.0136158841865077,0.88328735772924
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CNPY2,Protein canopy homolog 2,41900,-0.000912628889488974,0.00622160961964779,-0.0131069837439986,0.0112817259650207,0.883381349126726
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NTF4,Neurotrophin-4,41843,0.000565210793725122,0.00387531629856038,-0.00703040915145323,0.00816083073890347,0.884042856263913
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CEACAM6,Carcinoembryonic antigen-related cell adhesion molecule 6,39966,0.000609890568916584,0.00419833501870754,-0.00761884606775019,0.00883862720558336,0.884500569092784
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PRKCQ,Protein kinase C theta type,41913,-0.000634559285205772,0.0043714352942908,-0.00920257246201574,0.00793345389160419,0.884586430359083
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TSPAN15,Tetraspanin-15,39575,-0.000735128152774434,0.00517723057752131,-0.0108825000847162,0.00941224377916733,0.887088499495089
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MDGA1,MAM domain-containing glycosylphosphatidylinositol anchor protein 1,42016,-0.000988902192089068,0.00711045888692132,-0.0149254016104549,0.0129475972262767,0.889391290244965
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MAMDC2,MAM domain-containing protein 2,39958,-0.00050894715067756,0.0036598657743689,-0.0076822840684406,0.00666438976708548,0.88940385976846
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CDH4,Cadherin-4,39586,-0.000662014939234135,0.00479381372376812,-0.0100578898378196,0.00873385995935137,0.890165686686561
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DDX4,Probable ATP-dependent RNA helicase DDX4,39657,0.000768450195437107,0.00558047037105149,-0.0101692717318238,0.011706172122698,0.890477275608498
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SAG,S-arrestin,39586,-0.000739549358476023,0.00538796552133446,-0.0112999617802916,0.00982086306333953,0.890828210951577
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TEF,Thyrotroph embryonic factor,39575,-0.000604860530424646,0.0044089870676295,-0.00924647518297847,0.00803675412212918,0.890884638379372
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,HLA_DRA,,42060,-0.000498062022159911,0.00372186908733688,-0.0077929254333402,0.00679680138902038,0.893546593499207
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DOCK9,Dedicator of cytokinesis protein 9,39586,0.00160150734716077,0.0121089498001819,-0.0221320342611957,0.0253350489555173,0.894782526928465
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TPSG1,Tryptase gamma,39657,0.000351654822234932,0.00269885803056029,-0.00493810691766323,0.0056414165621331,0.896333320322628
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CRTAM,Cytotoxic and regulatory T-cell molecule,42016,-0.000670958929587933,0.00523701586845907,-0.0109355100317677,0.00959359217259184,0.89805706897395
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GAS6,Growth arrest-specific protein 6,42236,-0.00032689046349895,0.00257738402381792,-0.00537856315018207,0.00472478222318417,0.899076560599016
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SCGB3A1,Secretoglobin family 3A member 1,39736,0.000340557429100697,0.00270141099229575,-0.00495420811579897,0.00563532297400037,0.899681560763522
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PMCH,Pro-MCH,39575,-0.00103522407213993,0.00849528313710814,-0.0176859790208719,0.015615530876592,0.903013163560434
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CDH22,Cadherin-22,39757,-0.000339477355164439,0.00284473286226537,-0.00591515376520457,0.00523619905487569,0.9050117813925
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ZNF174,Zinc finger protein 174,39657,-0.000447869108203119,0.00378786919343453,-0.00787209272733479,0.00697635451092855,0.905881432038073
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CD177,CD177 antigen,42123,0.00155118647061849,0.0131587577012145,-0.024239978623762,0.0273423515649989,0.906162557514183
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ALMS1,Alstrom syndrome protein 1,39757,0.000538767676479099,0.00458255811072181,-0.00844304622053564,0.00952058157349384,0.906411129327535
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IL17F,Interleukin-17F,41913,-0.000868081296982607,0.00750098478571045,-0.0155700114769751,0.0138338488830099,0.907869085560552
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ICAM3,Intercellular adhesion molecule 3,42310,0.000318887347401468,0.00276736137200192,-0.00510514094172229,0.00574291563652523,0.908263277462804
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,BCAT2,"Branched-chain-amino-acid aminotransferase, mitochondrial",39586,-0.000622455766942152,0.00552855909992301,-0.0114584316027913,0.010213520068907,0.910358344879014
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,APOB,Apolipoprotein B-100,39990,-0.000259475104151425,0.00234977238602344,-0.00486502898075736,0.00434607877245451,0.912073770425077
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,LSM8,U6 snRNA-associated Sm-like protein LSm8,39757,-0.000854801891249172,0.00826249023243616,-0.017049282746824,0.0153396789643257,0.917603149148724
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GNPDA2,Glucosamine-6-phosphate isomerase 2,39736,0.000385627273014466,0.00384492993426126,-0.00715043539813761,0.00792168994416654,0.920111927145088
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,LRTM1,Leucine-rich repeat and transmembrane domain-containing protein 1,39649,0.000423185977653577,0.00430204799744386,-0.00800882809733638,0.00885520005264354,0.921641476769041
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IGLON5,IgLON family member 5,39560,-0.000935373333931827,0.00953929156584641,-0.0196323848029908,0.0177616381351271,0.921890571350214
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,RIPK4,Receptor-interacting serine/threonine-protein kinase 4,39575,-0.000686498553685099,0.00702434621553501,-0.0144542171361337,0.0130812200287635,0.922147437884164
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PALM,Paralemmin-1,39859,-0.000300031650779926,0.00315336026870629,-0.00648061777744426,0.00588055447588441,0.924200041799744
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CTNNA1,Catenin alpha-1,39586,0.000327149169433206,0.00348485966953562,-0.00650317578285661,0.00715747412172302,0.92520834888646
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PFDN2,Prefoldin subunit 2,41839,-0.000519716835390807,0.00564551186712404,-0.0115849200949539,0.0105454864241723,0.926653026468973
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ATP5F1D,"ATP synthase subunit delta, mitochondrial",39575,-0.000466282561673427,0.00511461141158718,-0.0104909209283843,0.00955835580503744,0.927361748744657
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,KIAA1549,UPF0606 protein KIAA1549,39757,0.000625348716747442,0.00706243900179099,-0.0132170317267629,0.0144677291602578,0.92944454026509
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,BTLA,B- and T-lymphocyte attenuator,39560,-0.000778146819110029,0.00882200787172146,-0.0180692822476841,0.016512988609464,0.929715209422987
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MEGF10,Multiple epidermal growth factor-like domains protein 10,42123,0.000350332923468513,0.00406778934911966,-0.00762253420080601,0.00832320004774304,0.931369387334672
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GP5,Platelet glycoprotein V,39736,-0.000315278220511735,0.00376851981075622,-0.00770157704959392,0.00707102060857045,0.93332745179134
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DENND2B,DENN domain-containing protein 2B,39575,0.000384770455715798,0.00504423091524616,-0.00950192213816668,0.0102714630495983,0.939198276168456
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MYH7B,Myosin-7B,39560,0.000329467570961711,0.00441585294790206,-0.00832560420692633,0.00898453934884975,0.940526238103214
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CAPN3,Calpain-3,39919,-0.000298564913849575,0.00401958162375675,-0.00817694489641281,0.00757981506871366,0.940790805460441
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MOG,Myelin-oligodendrocyte glycoprotein,42262,-0.000251159618885255,0.00340149740702414,-0.00691809453665256,0.00641577529888205,0.941140405200803
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,OXCT1,"Succinyl-CoA:3-ketoacid coenzyme A transferase 1, mitochondrial",39638,-0.000538011715441011,0.00734677126729587,-0.0149376833993409,0.0138616599684589,0.941623591630963
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,RPGR,X-linked retinitis pigmentosa GTPase regulator,39649,0.000293320034845344,0.00416423652437476,-0.00786858355292919,0.00845522362261988,0.943846408918636
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CR1,Complement receptor type 1,39970,-0.000249351844289021,0.00365550877389832,-0.00741414904112973,0.00691544535255169,0.945617577607555
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GPC5,Glypican-5,42016,-0.000373766272046781,0.0057509660516807,-0.011645659733341,0.0108981271892474,0.948181409303287
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TRPV3,Transient receptor potential cation channel subfamily V member 3,39575,0.000331835703839803,0.00512476339987274,-0.00971270055991077,0.0103763719675904,0.948373101294726
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NCLN,Nicalin,41913,-0.000333808637665809,0.00523409469853075,-0.0105926342467861,0.00992501697145446,0.949149696038689
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,INHBB,Inhibin beta B chain,39736,0.000337292340930817,0.00537942853051571,-0.01020638757888,0.0108809722607416,0.950006201159397
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FABP9,Fatty acid-binding protein 9,42119,-0.000345818113934715,0.00576378876652336,-0.0116428440963205,0.0109512078684511,0.952157794478482
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ENPEP,Glutamyl aminopeptidase,39575,0.000255478316907088,0.00436864571010808,-0.00830706727490475,0.00881802390871893,0.953367372947208
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PGM2,Phosphoglucomutase-2,39649,0.000354905372562276,0.00624796303364551,-0.0118911021733829,0.0126009129185075,0.95470285441282
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DBH,Dopamine beta-hydroxylase,39978,-0.000638471470943177,0.0117476595323846,-0.0236638841544171,0.0223869412125307,0.956658205915285
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SCARB1,Scavenger receptor class B member 1,41839,0.000295505518319488,0.00568426468890589,-0.0108456532719361,0.011436664308575,0.958540165657799
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,RPA2,Replication protein A 32 kDa subunit,39657,-0.000160777863924086,0.00318925357635059,-0.00641171487357124,0.00609015914572306,0.959794681534295
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SEPTIN3,Neuronal-specific septin-3,39934,0.000364664459757335,0.00807094073063258,-0.0154543793722825,0.0161837082917972,0.963962719926205
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ICOSLG,ICOS ligand,42070,8.77424208062912e-05,0.00195738836764101,-0.0037487387797701,0.00392422362138268,0.964246449627512
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SERPINC1,Antithrombin-III,39959,6.49107211661418e-05,0.00148741646155997,-0.00285042554349141,0.00298024698582369,0.965192205121696
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CHEK2,Serine/threonine-protein kinase Chk2,41900,-0.000141022671021968,0.00338190773989886,-0.00676956184122374,0.0064875164991798,0.966739159185014
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TMPRSS11B,Transmembrane protease serine 11B,39586,-0.000304767327530816,0.00782231922645621,-0.015636513011385,0.0150269783563234,0.968921991859999
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CRX,Cone-rod homeobox protein,41900,-0.000398607359775563,0.010987316001005,-0.0219337467217454,0.0211365320021943,0.971060546162498
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GATD3,"Glutamine amidotransferase-like class 1 domain-containing protein 3B, mitochondrial",39638,-0.000271836286168952,0.00787931600272899,-0.0157152956515178,0.0151716230791799,0.972479077905168
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CHP1,Calcineurin B homologous protein 1,39586,0.00022365830770859,0.00760562013774203,-0.0146833571622658,0.015130673777683,0.976540541354474
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FGF6,Fibroblast growth factor 6,39657,0.000114056739317851,0.00402465653535275,-0.00777427006997354,0.00800238354860924,0.977391891134291
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CNGB3,Cyclic nucleotide-gated cation channel beta-3,39586,0.000152280433212469,0.00554686418951306,-0.0107195733782331,0.0110241342446581,0.978098584048335
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DEFB116,Beta-defensin 116,39586,-0.000207897249241261,0.00773685666531989,-0.0153721363132683,0.0149563418147857,0.978563093957318
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PDXDC1,Pyridoxal-dependent decarboxylase domain-containing protein 1,39560,0.00010660486431093,0.00557743056819033,-0.0108251590493421,0.011038368777964,0.984750817605926
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FGFBP2,Fibroblast growth factor-binding protein 2,39966,-9.27883762197643e-05,0.00528667898958258,-0.0104546791958016,0.0102691024433621,0.985997072372394
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TLR2,Toll-like receptor 2,39757,3.59253987553387e-05,0.00238864194727813,-0.00464581281790979,0.00471766361542047,0.988000462752107
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TIE1,Tyrosine-protein kinase receptor Tie-1,42310,-5.88913293739853e-05,0.00416696798282571,-0.00822614857571238,0.00810836591696441,0.98872416069195
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TPK1,Thiamin pyrophosphokinase 1,39958,4.01236473150147e-05,0.00287883276411657,-0.00560238857035347,0.0056826358649835,0.988880112122196
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,LRRC25,Leucine-rich repeat-containing protein 25,42070,4.84421472864997e-05,0.00402725757533356,-0.00784498270036727,0.00794186699494027,0.990402999745069
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,AGBL2,Cytosolic carboxypeptidase 2,39586,7.30392883518441e-05,0.00947232906482109,-0.0184927256786975,0.0186388042554012,0.993847868202617
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NFU1,"NFU1 iron-sulfur cluster scaffold homolog, mitochondrial",39930,-3.87417367314359e-05,0.010716441034088,-0.0210429661635438,0.020965482690081,0.99711558304678
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GH2,Growth hormone variant,41843,-3.94126854496773e-05,0.0165891134449752,-0.032554075037601,0.0324752496667016,0.998104410455942
